S	202
T	33
We	0	2	PRP	we	O	_	_
reported	3	11	VBD	report	O	_	_
recently	12	20	RB	recently	O	_	_
that	21	25	IN	that	O	_	_
apoptosis	26	35	NN	apoptosis	B-GENE	_	_
stimulating	36	47	NN	stimulating	I-GENE	_	_
protein	48	55	NN	protein	I-GENE	_	_
of	56	58	IN	of	O	_	_
p53	59	62	NN	p53	B-GENE	_	_
(	63	64	CD	(	I-GENE	_	_
ASPP	64	68	NN	aspp	I-GENE	_	_
)	68	69	NN	)	I-GENE	_	_
2	70	71	CD	2	I-GENE	_	_
,	71	72	,	,	O	_	_
an	73	75	DT	a	O	_	_
activator	76	85	NN	activator	O	_	_
of	86	88	IN	of	O	_	_
p53	89	92	NN	p53	B-GENE	_	_
,	92	93	,	,	O	_	_
co-operates	94	105	VBZ	co-operate	O	_	_
with	106	110	IN	with	O	_	_
oncogenic	111	120	JJ	oncogenic	B-GENE	_	_
RAS	121	124	NN	ra	I-GENE	_	_
to	125	127	TO	to	O	_	_
enhance	128	135	VB	enhance	O	_	_
the	136	139	DT	the	O	_	_
transcription	140	153	NN	transcription	O	_	_
and	154	157	CC	and	O	_	_
apoptotic	158	167	JJ	apoptotic	O	_	_
function	168	176	NN	function	O	_	_
of	177	179	IN	of	O	_	_
p53	180	183	NN	p53	B-GENE	_	_
.	183	184	.	.	O	_	_
D	1

1	0	nsubj
1	2	advmod
1	19	ccomp
6	4	nn
6	5	nn
6	7	prep
6	15	appos
11	8	nn
11	10	nn
11	12	dep
15	14	det
15	17	prep_of
19	3	mark
19	6	nsubj
19	22	prep_with
19	24	xcomp
22	21	amod
24	23	aux
24	29	dobj
26	28	conj_and
29	25	det
29	26	nn
29	28	nn
29	31	prep_of
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	32	3	VBD	0	1	2	1	reported	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	SBAR	1	3	32	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	32	2	NP	0	4	19	4	NP	0	4	13	2	NP	2	4	7	3	NN	0	4	5	1	apoptosis	4	4	5	0	NN	0	5	6	1	stimulating	5	5	6	0	NN	0	6	7	1	protein	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	13	2	NP	3	8	12	4	NN	0	8	9	1	p53	8	8	9	0	CD	0	9	10	1	-LRB-	9	9	10	0	NN	0	10	11	1	ASPP	10	10	11	0	NN	0	11	12	1	-RRB-	11	11	12	0	NP	0	12	13	1	CD	0	12	13	1	2	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	18	2	NP	1	14	16	2	DT	0	14	15	1	an	14	14	15	0	NN	0	15	16	1	activator	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	p53	17	17	18	0	,	0	18	19	1	,	18	18	19	0	VP	0	19	32	3	VBZ	0	19	20	1	co-operates	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	with	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	oncogenic	21	21	22	0	NN	0	22	23	1	RAS	22	22	23	0	S	0	23	32	1	VP	1	23	32	2	TO	0	23	24	1	to	23	23	24	0	VP	0	24	32	2	VB	0	24	25	1	enhance	24	24	25	0	NP	0	25	32	2	NP	2	25	30	3	DT	0	25	26	1	the	25	25	26	0	NP	0	26	29	3	NN	0	26	27	1	transcription	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	JJ	0	28	29	1	apoptotic	28	28	29	0	NN	0	29	30	1	function	29	29	30	0	PP	0	30	32	2	IN	0	30	31	1	of	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	p53	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	8
However	185	192	RB	however	O	_	_
,	192	193	,	,	O	_	_
the	194	197	DT	the	O	_	_
detailed	198	206	JJ	detailed	O	_	_
mechanism	207	216	NN	mechanism	O	_	_
remains	217	224	VBZ	remain	O	_	_
unknown	225	232	JJ	unknown	O	_	_
.	232	233	.	.	O	_	_
D	1
6
4	2	det
4	3	amod
6	0	advmod
6	4	nsubj
6	5	cop
EOX
Y	1
ROOT	0	0	8	1	S	3	0	8	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	detailed	3	3	4	0	NN	0	4	5	1	mechanism	4	4	5	0	VP	1	5	7	2	VBZ	0	5	6	1	remains	5	5	6	0	ADJP	0	6	7	1	JJ	0	6	7	1	unknown	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	18
Here	234	238	RB	here	O	_	_
we	239	241	PRP	we	O	_	_
show	242	246	VBP	show	O	_	_
that	247	251	IN	that	O	_	_
ASPP2	252	257	NN	aspp2	B-GENE	_	_
is	258	260	VBZ	be	O	_	_
a	261	262	DT	a	O	_	_
novel	263	268	JJ	novel	O	_	_
substrate	269	278	NN	substrate	O	_	_
of	279	281	IN	of	O	_	_
mitogen	282	289	NN	mitogen	B-GENE	_	_
activated	290	299	VBN	activate	I-GENE	_	_
protein	300	307	NN	protein	I-GENE	_	_
kinase	308	314	NN	kinase	I-GENE	_	_
(	315	316	CD	(	B-GENE	_	_
MAPK	316	320	NN	mapk	I-GENE	_	_
)	320	321	NN	)	O	_	_
.	321	322	.	.	O	_	_
D	1

2	0	advmod
2	1	nsubj
2	8	ccomp
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	12	prep_of
12	10	nn
12	11	amod
16	13	nn
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	2	0	18	4	ADVP	0	0	1	1	RB	0	0	1	1	Here	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	17	2	VBP	0	2	3	1	show	2	2	3	0	SBAR	1	3	17	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	17	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	17	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	17	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	17	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	NN	0	10	11	1	mitogen	10	10	11	0	VBN	0	11	12	1	activated	11	11	12	0	NN	0	12	13	1	protein	12	12	13	0	NP	3	13	17	4	NN	0	13	14	1	kinase	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NN	0	15	16	1	MAPK	15	15	16	0	NN	0	16	17	1	-RRB-	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	21
Phosphorylation	323	338	NN	phosphorylation	O	_	_
of	339	341	IN	of	O	_	_
ASPP2	342	347	NN	aspp2	B-GENE	_	_
by	348	350	IN	by	O	_	_
MAPK	351	355	NN	mapk	B-GENE	_	_
is	356	358	VBZ	be	O	_	_
required	359	367	VBN	require	O	_	_
for	368	371	IN	for	O	_	_
RAS	372	375	NN	ra	O	_	_
induced	376	383	VBD	induce	O	_	_
increased	384	393	VBN	increase	O	_	_
binding	394	401	VBG	bind	O	_	_
to	402	404	TO	to	O	_	_
p53	405	408	NN	p53	B-GENE	_	_
and	409	412	CC	and	O	_	_
increased	413	422	VBD	increase	O	_	_
transactivation	423	438	NN	transactivation	O	_	_
of	439	441	IN	of	O	_	_
pro-apoptotic	442	455	JJ	pro-apoptotic	O	_	_
genes	456	461	NNS	gene	O	_	_
.	461	462	.	.	O	_	_
D	1
6
0	2	prep_of
2	4	prep_by
6	0	nsubjpass
6	5	auxpass
6	9	advcl
6	15	advcl
9	7	mark
9	8	nsubj
9	10	dobj
9	15	conj_and
10	11	amod
10	13	prep_to
15	8	nsubj
15	16	dobj
16	19	prep_of
19	18	amod
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	2	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	1	5	20	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	20	2	VBN	0	6	7	1	required	6	6	7	0	SBAR	1	7	20	2	IN	0	7	8	1	for	7	7	8	0	S	1	8	20	2	NP	0	8	9	1	NN	0	8	9	1	RAS	8	8	9	0	VP	0	9	20	3	VP	0	9	14	2	VBD	0	9	10	1	induced	9	9	10	0	NP	0	10	14	2	NP	0	10	12	2	VBN	0	10	11	1	increased	10	10	11	0	VBG	0	11	12	1	binding	11	11	12	0	PP	0	12	14	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	p53	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	VP	0	15	20	2	VBD	0	15	16	1	increased	15	15	16	0	NP	0	16	20	2	NP	0	16	17	1	NN	0	16	17	1	transactivation	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	of	17	17	18	0	NP	1	18	20	2	JJ	0	18	19	1	pro-apoptotic	18	18	19	0	NNS	0	19	20	1	genes	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	19
In	463	465	IN	in	O	_	_
contrast	466	474	NN	contrast	O	_	_
,	474	475	,	,	O	_	_
an	476	478	DT	a	O	_	_
ASPP2	479	484	NN	aspp2	B-GENE	_	_
phosphorylation	485	500	NN	phosphorylation	O	_	_
mutant	501	507	NN	mutant	O	_	_
exhibits	508	516	VBZ	exhibit	O	_	_
reduced	517	524	VBN	reduce	O	_	_
p53	525	528	NN	p53	B-GENE	_	_
binding	529	536	NN	binding	O	_	_
and	537	540	CC	and	O	_	_
fails	541	546	VBZ	fail	O	_	_
to	547	549	TO	to	O	_	_
enhance	550	557	VB	enhance	O	_	_
transactivation	558	573	NN	transactivation	O	_	_
and	574	577	CC	and	O	_	_
apoptosis	578	587	NN	apoptosis	O	_	_
.	587	588	.	.	O	_	_
D	1
7
6	3	det
6	4	nn
6	5	nn
7	1	prep_in
7	6	nsubj
7	8	dep
7	12	conj_and
8	10	dobj
10	9	nn
12	6	nsubj
12	14	xcomp
14	13	aux
14	15	dobj
14	17	dobj
15	17	conj_and
EOX
Y	1
ROOT	0	0	19	1	S	3	0	19	5	PP	0	0	2	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	contrast	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	3	3	7	4	DT	0	3	4	1	an	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	NN	0	6	7	1	mutant	6	6	7	0	VP	0	7	18	3	VP	0	7	11	2	VBZ	0	7	8	1	exhibits	7	7	8	0	VP	0	8	11	2	VBN	0	8	9	1	reduced	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	p53	9	9	10	0	NN	0	10	11	1	binding	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VP	0	12	18	2	VBZ	0	12	13	1	fails	12	12	13	0	S	0	13	18	1	VP	1	13	18	2	TO	0	13	14	1	to	13	13	14	0	VP	0	14	18	2	VB	0	14	15	1	enhance	14	14	15	0	NP	0	15	18	3	NN	0	15	16	1	transactivation	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	NN	0	17	18	1	apoptosis	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	32
Thus	589	593	RB	thus	O	_	_
phosphorylation	594	609	NN	phosphorylation	O	_	_
of	610	612	IN	of	O	_	_
ASPP2	613	618	NN	aspp2	B-GENE	_	_
by	619	621	IN	by	O	_	_
RAS	622	625	NN	ra	B-GENE	_	_
/	625	626	:	/	B-GENE	_	_
MAPK	626	630	NN	mapk	I-GENE	_	_
pathway	631	638	NN	pathway	O	_	_
provides	639	647	VBZ	provide	O	_	_
a	648	649	DT	a	O	_	_
novel	650	655	JJ	novel	O	_	_
link	656	660	NN	link	O	_	_
between	661	668	IN	between	O	_	_
RAS	669	672	NN	ra	B-GENE	_	_
and	673	676	CC	and	O	_	_
p53	677	680	NN	p53	B-GENE	_	_
in	681	683	IN	in	O	_	_
regulating	684	694	VBG	regulate	B-GENE	_	_
apoptosis.p53	695	708	NN	apoptosis.p53	I-GENE	_	_
is	709	711	VBZ	be	O	_	_
the	712	715	DT	the	O	_	_
most	716	720	RBS	most	O	_	_
commonly	721	729	RB	commonly	O	_	_
mutated	730	737	VBN	mutate	O	_	_
tumour	738	744	NN	tumour	O	_	_
suppressor	745	755	NN	suppressor	O	_	_
protein	756	763	NN	protein	O	_	_
thus	764	768	RB	thus	O	_	_
far	769	772	RB	far	O	_	_
identified	773	783	VBN	identify	O	_	_
.	783	784	.	.	O	_	_
D	1
27
1	3	prep_of
1	9	dep
3	5	prep_by
8	7	nn
9	6	punct
9	8	nsubj
9	12	dobj
9	18	prepc_in
12	10	det
12	11	amod
12	14	prep_between
12	16	prep_between
14	16	conj_and
18	19	dobj
24	22	advmod
24	23	advmod
27	0	advmod
27	1	nsubj
27	20	cop
27	21	det
27	24	amod
27	25	nn
27	26	nn
27	30	vmod
29	28	advmod
30	29	advmod
EOX
Y	1
ROOT	0	0	32	1	S	2	0	32	4	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	20	2	NP	0	1	6	2	NP	0	1	2	1	NN	0	1	2	1	phosphorylation	1	1	2	0	PP	0	2	6	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	6	2	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	PRN	1	6	20	2	:	0	6	7	1	/	6	6	7	0	S	1	7	20	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	20	3	VBZ	0	9	10	1	provides	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	JJ	0	11	12	1	novel	11	11	12	0	NN	0	12	13	1	link	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	between	13	13	14	0	NP	0	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	S	0	18	20	1	VP	0	18	20	2	VBG	0	18	19	1	regulating	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	apoptosis.p53	19	19	20	0	VP	1	20	31	2	VBZ	0	20	21	1	is	20	20	21	0	NP	0	21	31	2	NP	4	21	28	5	DT	0	21	22	1	the	21	21	22	0	ADJP	2	22	25	3	RBS	0	22	23	1	most	22	22	23	0	RB	0	23	24	1	commonly	23	23	24	0	VBN	0	24	25	1	mutated	24	24	25	0	NN	0	25	26	1	tumour	25	25	26	0	NN	0	26	27	1	suppressor	26	26	27	0	NN	0	27	28	1	protein	27	27	28	0	VP	1	28	31	2	ADVP	1	28	30	2	RB	0	28	29	1	thus	28	28	29	0	RB	0	29	30	1	far	29	29	30	0	VBN	0	30	31	1	identified	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	35
Although	785	793	IN	although	O	_	_
p53	794	797	NN	p53	B-GENE	_	_
is	798	800	VBZ	be	O	_	_
mutated	801	808	VBN	mutate	O	_	_
in	809	811	IN	in	O	_	_
more	812	816	JJR	more	O	_	_
than	817	821	IN	than	O	_	_
50	822	824	CD	50	O	_	_
%	824	825	NN	%	O	_	_
of	826	828	IN	of	O	_	_
tumours	829	836	NNS	tumour	O	_	_
,	836	837	,	,	O	_	_
its	838	841	PRP$	its	O	_	_
mutation	842	850	NN	mutation	O	_	_
rate	851	855	NN	rate	O	_	_
varies	856	862	VBZ	vary	O	_	_
significantly	863	876	RB	significantly	O	_	_
between	877	884	IN	between	O	_	_
different	885	894	JJ	different	O	_	_
types	895	900	NNS	type	O	_	_
of	901	903	IN	of	O	_	_
human	904	909	JJ	human	O	_	_
cancer	910	916	NN	cancer	O	_	_
,	916	917	,	,	O	_	_
with	918	922	IN	with	O	_	_
a	923	924	DT	a	O	_	_
particularly	925	937	RB	particularly	O	_	_
high	938	942	JJ	high	O	_	_
incidence	943	952	NN	incidence	O	_	_
in	953	955	IN	in	O	_	_
colorectal	956	966	JJ	colorectal	O	_	_
and	967	970	CC	and	O	_	_
pancreatic	971	981	JJ	pancreatic	O	_	_
tumours	982	989	NNS	tumour	O	_	_
.	989	990	.	.	O	_	_
D	1
15
3	0	mark
3	1	nsubjpass
3	2	auxpass
3	8	prep_in
6	5	mwe
7	6	quantmod
8	7	num
8	10	prep_of
14	12	poss
14	13	nn
15	3	advcl
15	14	nsubj
15	16	advmod
15	19	prep_between
15	28	prep_with
19	18	amod
19	22	prep_of
22	21	amod
27	26	advmod
28	25	det
28	27	amod
28	33	prep_in
30	32	conj_and
33	30	amod
33	32	amod
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	SBAR	1	0	11	2	IN	0	0	1	1	Although	0	0	1	0	S	1	1	11	2	NP	0	1	2	1	NN	0	1	2	1	p53	1	1	2	0	VP	1	2	11	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	11	2	VBN	0	3	4	1	mutated	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	11	2	NP	1	5	9	2	QP	1	5	8	2	XS	1	5	7	2	JJR	0	5	6	1	more	5	5	6	0	IN	0	6	7	1	than	6	6	7	0	CD	0	7	8	1	50	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NNS	0	10	11	1	tumours	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	2	12	15	3	PRP$	0	12	13	1	its	12	12	13	0	NN	0	13	14	1	mutation	13	13	14	0	NN	0	14	15	1	rate	14	14	15	0	VP	0	15	34	5	VBZ	0	15	16	1	varies	15	15	16	0	ADVP	0	16	17	1	RB	0	16	17	1	significantly	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	between	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	JJ	0	18	19	1	different	18	18	19	0	NNS	0	19	20	1	types	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	of	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	human	21	21	22	0	NN	0	22	23	1	cancer	22	22	23	0	,	0	23	24	1	,	23	23	24	0	PP	0	24	34	2	IN	0	24	25	1	with	24	24	25	0	NP	0	25	34	2	NP	2	25	29	3	DT	0	25	26	1	a	25	25	26	0	ADJP	1	26	28	2	RB	0	26	27	1	particularly	26	26	27	0	JJ	0	27	28	1	high	27	27	28	0	NN	0	28	29	1	incidence	28	28	29	0	PP	0	29	34	2	IN	0	29	30	1	in	29	29	30	0	NP	1	30	34	2	ADJP	0	30	33	3	JJ	0	30	31	1	colorectal	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	JJ	0	32	33	1	pancreatic	32	32	33	0	NNS	0	33	34	1	tumours	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	18
Interestingly	991	1004	RB	interestingly	O	_	_
,	1004	1005	,	,	O	_	_
the	1006	1009	DT	the	O	_	_
mediator	1010	1018	NN	mediator	O	_	_
of	1019	1021	IN	of	O	_	_
signal	1022	1028	NN	signal	B-GENE	_	_
transduction	1029	1041	NN	transduction	I-GENE	_	_
RAS	1042	1045	NN	ra	I-GENE	_	_
is	1046	1048	VBZ	be	O	_	_
also	1049	1053	RB	also	O	_	_
commonly	1054	1062	RB	commonly	O	_	_
mutated	1063	1070	VBN	mutate	O	_	_
in	1071	1073	IN	in	O	_	_
these	1074	1079	DT	these	O	_	_
particular	1080	1090	JJ	particular	O	_	_
tumour	1091	1097	NN	tumour	O	_	_
types	1098	1103	NNS	type	O	_	_
.	1103	1104	.	.	O	_	_
D	1
11
3	2	det
3	7	prep_of
7	5	nn
7	6	nn
11	0	advmod
11	3	nsubjpass
11	8	auxpass
11	9	advmod
11	10	advmod
11	16	prep_in
16	13	det
16	14	amod
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	8	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	mediator	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	of	4	4	5	0	NP	2	5	8	3	NN	0	5	6	1	signal	5	5	6	0	NN	0	6	7	1	transduction	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	VP	2	8	17	3	VBZ	0	8	9	1	is	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	also	9	9	10	0	VP	1	10	17	3	ADVP	0	10	11	1	RB	0	10	11	1	commonly	10	10	11	0	VBN	0	11	12	1	mutated	11	11	12	0	PP	0	12	17	2	IN	0	12	13	1	in	12	12	13	0	NP	3	13	17	4	DT	0	13	14	1	these	13	13	14	0	JJ	0	14	15	1	particular	14	14	15	0	NN	0	15	16	1	tumour	15	15	16	0	NNS	0	16	17	1	types	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	21
It	1105	1107	PRP	it	O	_	_
remains	1108	1115	VBZ	remain	O	_	_
unclear	1116	1123	JJ	unclear	O	_	_
why	1124	1127	WRB	why	O	_	_
there	1128	1133	EX	there	O	_	_
exists	1134	1140	VBZ	exist	O	_	_
such	1141	1145	PDT	such	O	_	_
a	1146	1147	DT	a	O	_	_
tight	1148	1153	JJ	tight	O	_	_
association	1154	1165	NN	association	O	_	_
between	1166	1173	IN	between	O	_	_
the	1174	1177	DT	the	O	_	_
p53	1178	1181	NN	p53	B-GENE	_	_
and	1182	1185	CC	and	I-GENE	_	_
RAS	1186	1189	NN	ra	I-GENE	_	_
mutation	1190	1198	NN	mutation	I-GENE	_	_
status	1199	1205	NN	status	O	_	_
[	1206	1207	CD	[	O	_	_
1	1207	1208	CD	1	O	_	_
]	1208	1209	NN	]	O	_	_
.	1209	1210	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	5	advcl
5	3	advmod
5	4	expl
5	9	dobj
5	16	dobj
9	6	dep
9	7	det
9	8	amod
9	12	prep_between
9	16	conj_and
12	11	det
16	14	nn
16	15	nn
16	19	dep
18	17	number
19	18	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	20	3	VBZ	0	1	2	1	remains	1	1	2	0	ADJP	0	2	3	1	JJ	0	2	3	1	unclear	2	2	3	0	SBAR	1	3	20	2	WHADVP	0	3	4	1	WRB	0	3	4	1	why	3	3	4	0	S	1	4	20	2	NP	0	4	5	1	EX	0	4	5	1	there	4	4	5	0	VP	0	5	20	2	VBZ	0	5	6	1	exists	5	5	6	0	NP	1	6	20	4	PDT	0	6	7	1	such	6	6	7	0	NP	0	7	13	2	NP	2	7	10	3	DT	0	7	8	1	a	7	7	8	0	JJ	0	8	9	1	tight	8	8	9	0	NN	0	9	10	1	association	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	between	10	10	11	0	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	p53	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	NN	0	15	16	1	mutation	15	15	16	0	NN	0	16	17	1	status	16	16	17	0	NP	1	17	20	2	QP	1	17	19	2	CD	0	17	18	1	[	17	17	18	0	CD	0	18	19	1	1	18	18	19	0	NN	0	19	20	1	]	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	33
We	1211	1213	PRP	we	O	_	_
reported	1214	1222	VBD	report	O	_	_
recently	1223	1231	RB	recently	O	_	_
that	1232	1236	IN	that	O	_	_
apoptosis	1237	1246	NN	apoptosis	B-GENE	_	_
stimulating	1247	1258	NN	stimulating	I-GENE	_	_
protein	1259	1266	NN	protein	I-GENE	_	_
of	1267	1269	IN	of	O	_	_
p53	1270	1273	NN	p53	B-GENE	_	_
(	1274	1275	CD	(	I-GENE	_	_
ASPP	1275	1279	NN	aspp	I-GENE	_	_
)	1279	1280	NN	)	I-GENE	_	_
2	1281	1282	CD	2	I-GENE	_	_
co-operates	1283	1294	NNS	co-operate	O	_	_
with	1295	1299	IN	with	O	_	_
oncogenic	1300	1309	JJ	oncogenic	B-GENE	_	_
RAS	1310	1313	NN	ra	I-GENE	_	_
to	1314	1316	TO	to	O	_	_
enhance	1317	1324	VB	enhance	O	_	_
the	1325	1328	DT	the	O	_	_
transcription	1329	1342	NN	transcription	O	_	_
and	1343	1346	CC	and	O	_	_
apoptotic	1347	1356	JJ	apoptotic	O	_	_
function	1357	1365	NN	function	O	_	_
of	1366	1368	IN	of	O	_	_
p53	1369	1372	NN	p53	B-GENE	_	_
in	1373	1375	IN	in	O	_	_
cancer	1376	1382	NN	cancer	O	_	_
cells	1383	1388	NNS	cell	O	_	_
[	1389	1390	VBP	[	O	_	_
2	1390	1391	CD	2	O	_	_
]	1391	1392	CD	]	O	_	_
.	1392	1393	.	.	O	_	_
D	1

1	0	nsubj
1	2	advmod
1	29	conj_and
6	4	nn
6	5	nn
6	10	prep_of
10	8	nn
11	3	mark
11	6	nsubj
11	13	dobj
11	18	xcomp
13	12	num
13	16	prep_with
16	15	amod
18	17	aux
18	20	dobj
20	19	det
23	22	amod
23	25	prep_of
25	28	prep_in
28	27	nn
29	23	nsubj
29	31	dobj
31	30	number
EOX
Y	1
ROOT	0	0	33	1	S	0	0	33	4	S	1	0	21	2	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	21	3	VBD	0	1	2	1	reported	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	SBAR	1	3	21	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	21	2	NP	0	4	11	2	NP	2	4	7	3	NN	0	4	5	1	apoptosis	4	4	5	0	NN	0	5	6	1	stimulating	5	5	6	0	NN	0	6	7	1	protein	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	p53	8	8	9	0	CD	0	9	10	1	-LRB-	9	9	10	0	NN	0	10	11	1	ASPP	10	10	11	0	VP	0	11	21	3	NN	0	11	12	1	-RRB-	11	11	12	0	NP	0	12	17	2	NP	1	12	14	2	CD	0	12	13	1	2	12	12	13	0	NNS	0	13	14	1	co-operates	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	with	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	oncogenic	15	15	16	0	NN	0	16	17	1	RAS	16	16	17	0	S	0	17	21	1	VP	1	17	21	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	21	2	VB	0	18	19	1	enhance	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	transcription	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	S	1	22	32	2	NP	0	22	29	2	NP	1	22	24	2	JJ	0	22	23	1	apoptotic	22	22	23	0	NN	0	23	24	1	function	23	23	24	0	PP	0	24	29	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	29	2	NP	0	25	26	1	NN	0	25	26	1	p53	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	in	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	cancer	27	27	28	0	NNS	0	28	29	1	cells	28	28	29	0	VP	0	29	32	2	VBP	0	29	30	1	[	29	29	30	0	NP	0	30	32	1	QP	1	30	32	2	CD	0	30	31	1	2	30	30	31	0	CD	0	31	32	1	]	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	28
This	1394	1398	DT	this	O	_	_
may	1399	1402	MD	may	O	_	_
be	1403	1405	VB	be	O	_	_
achieved	1406	1414	VBN	achieve	O	_	_
via	1415	1418	IN	via	O	_	_
the	1419	1422	DT	the	O	_	_
ability	1423	1430	NN	ability	O	_	_
of	1431	1433	IN	of	O	_	_
active	1434	1440	JJ	active	O	_	_
RAS	1441	1444	NN	ra	O	_	_
to	1445	1447	TO	to	O	_	_
induce	1448	1454	VB	induce	O	_	_
ASPP2	1455	1460	NN	aspp2	O	_	_
,	1460	1461	,	,	O	_	_
thereby	1462	1469	RB	thereby	O	_	_
promoting	1470	1479	VBG	promote	O	_	_
ASPP2	1480	1485	NN	aspp2	O	_	_
's	1485	1487	POS	's	O	_	_
interaction	1488	1499	NN	interaction	O	_	_
with	1500	1504	IN	with	O	_	_
p53	1505	1508	NN	p53	B-GENE	_	_
and	1509	1512	CC	and	O	_	_
enhancing	1513	1522	VBG	enhance	O	_	_
the	1523	1526	DT	the	O	_	_
activity	1527	1535	NN	activity	O	_	_
of	1536	1538	IN	of	O	_	_
p53	1539	1542	NN	p53	B-GENE	_	_
.	1542	1543	.	.	O	_	_
D	1
3
3	0	nsubjpass
3	1	aux
3	2	auxpass
3	6	prep_via
3	11	xcomp
3	15	ccomp
3	22	ccomp
6	5	det
6	9	prep_of
9	8	amod
11	10	aux
11	12	dobj
15	14	advmod
15	18	dobj
15	22	conj_and
18	16	poss
18	20	prep_with
22	24	dobj
24	23	det
24	26	prep_of
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	1	1	27	2	MD	0	1	2	1	may	1	1	2	0	VP	1	2	27	2	VB	0	2	3	1	be	2	2	3	0	VP	0	3	27	5	VBN	0	3	4	1	achieved	3	3	4	0	PP	0	4	10	2	IN	0	4	5	1	via	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	ability	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	JJ	0	8	9	1	active	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	S	0	10	13	1	VP	1	10	13	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	13	2	VB	0	11	12	1	induce	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	ASPP2	12	12	13	0	,	0	13	14	1	,	13	13	14	0	S	1	14	27	2	ADVP	0	14	15	1	RB	0	14	15	1	thereby	14	14	15	0	VP	0	15	27	3	VP	0	15	21	2	VBG	0	15	16	1	promoting	15	15	16	0	NP	0	16	21	2	NP	1	16	19	2	NP	0	16	18	2	NN	0	16	17	1	ASPP2	16	16	17	0	POS	0	17	18	1	's	17	17	18	0	NN	0	18	19	1	interaction	18	18	19	0	PP	0	19	21	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	p53	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	VP	0	22	27	2	VBG	0	22	23	1	enhancing	22	22	23	0	NP	0	23	27	2	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	activity	24	24	25	0	PP	0	25	27	2	IN	0	25	26	1	of	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	p53	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	13
However	1544	1551	RB	however	O	_	_
,	1551	1552	,	,	O	_	_
the	1553	1556	DT	the	O	_	_
detailed	1557	1565	JJ	detailed	O	_	_
mechanism	1566	1575	NN	mechanism	O	_	_
underlying	1576	1586	VBG	underlie	O	_	_
this	1587	1591	DT	this	O	_	_
observation	1592	1603	NN	observation	O	_	_
remains	1604	1611	VBZ	remain	O	_	_
to	1612	1614	TO	to	O	_	_
be	1615	1617	VB	be	O	_	_
elucidated	1618	1628	VBN	elucidate	O	_	_
.	1628	1629	.	.	O	_	_
D	1
8
4	2	det
4	3	amod
4	5	vmod
5	7	dobj
7	6	det
8	0	advmod
8	4	nsubj
8	11	xcomp
11	9	aux
11	10	auxpass
EOX
Y	1
ROOT	0	0	13	1	S	3	0	13	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	8	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	detailed	3	3	4	0	NN	0	4	5	1	mechanism	4	4	5	0	VP	0	5	8	2	VBG	0	5	6	1	underlying	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	this	6	6	7	0	NN	0	7	8	1	observation	7	7	8	0	VP	0	8	12	2	VBZ	0	8	9	1	remains	8	8	9	0	S	0	9	12	1	VP	1	9	12	2	TO	0	9	10	1	to	9	9	10	0	VP	1	10	12	2	VB	0	10	11	1	be	10	10	11	0	VP	0	11	12	1	VBN	0	11	12	1	elucidated	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	22
Activated	1630	1639	VBN	activate	O	_	_
RAS	1640	1643	NN	ra	B-GENE	_	_
promotes	1644	1652	VBZ	promote	O	_	_
the	1653	1656	DT	the	O	_	_
protein	1657	1664	NN	protein	B-GENE	_	_
kinase	1665	1671	NN	kinase	I-GENE	_	_
activity	1672	1680	NN	activity	O	_	_
of	1681	1683	IN	of	O	_	_
RAF	1684	1687	NN	raf	B-GENE	_	_
,	1687	1688	,	,	O	_	_
which	1689	1694	WDT	which	O	_	_
phosphorylates	1695	1709	VBZ	phosphorylate	O	_	_
and	1710	1713	CC	and	O	_	_
activates	1714	1723	VBZ	activate	O	_	_
MEK	1724	1727	NN	mek	B-GENE	_	_
(	1728	1729	NN	(	O	_	_
also	1729	1733	RB	also	O	_	_
known	1734	1739	VBN	know	O	_	_
as	1740	1742	IN	as	O	_	_
MAPKK	1743	1748	NNP	MAPKK	B-GENE	_	_
)	1748	1749	CD	)	O	_	_
.	1749	1750	.	.	O	_	_
D	1

0	1	dobj
0	2	dep
0	6	nsubj
6	3	det
6	4	nn
6	5	nn
6	8	prep_of
6	11	rcmod
6	13	rcmod
11	10	nsubj
11	13	conj_and
13	10	nsubj
15	14	nn
15	17	vmod
17	16	advmod
17	19	prep_as
EOX
Y	1
ROOT	0	0	22	1	SINV	0	0	22	4	VP	0	0	2	2	VBN	0	0	1	1	Activated	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	0	2	3	1	VBZ	0	2	3	1	promotes	2	2	3	0	NP	0	3	21	4	NP	3	3	7	4	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	protein	4	4	5	0	NN	0	5	6	1	kinase	5	5	6	0	NN	0	6	7	1	activity	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	RAF	8	8	9	0	,	0	9	10	1	,	9	9	10	0	SBAR	1	10	21	2	WHNP	0	10	11	1	WDT	0	10	11	1	which	10	10	11	0	S	0	11	21	1	VP	0	11	21	4	VBZ	0	11	12	1	phosphorylates	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	VBZ	0	13	14	1	activates	13	13	14	0	NP	0	14	21	2	NP	1	14	16	2	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	-LRB-	15	15	16	0	VP	1	16	21	3	ADVP	0	16	17	1	RB	0	16	17	1	also	16	16	17	0	VBN	0	17	18	1	known	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	as	18	18	19	0	NP	0	19	21	2	NNP	0	19	20	1	MAPKK	19	19	20	0	CD	0	20	21	1	-RRB-	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	22
MEK	1751	1754	NN	mek	B-GENE	_	_
phosphorylates	1755	1769	VBZ	phosphorylate	O	_	_
and	1770	1773	CC	and	O	_	_
activates	1774	1783	VBZ	activate	O	_	_
a	1784	1785	DT	a	O	_	_
mitogen	1786	1793	NN	mitogen	B-GENE	_	_
activated	1794	1803	VBN	activate	I-GENE	_	_
protein	1804	1811	NN	protein	I-GENE	_	_
kinase	1812	1818	NN	kinase	I-GENE	_	_
(	1819	1820	CD	(	B-GENE	_	_
MAPK	1820	1824	NN	mapk	I-GENE	_	_
/	1824	1825	:	/	B-GENE	_	_
ERK	1825	1828	NN	erk	I-GENE	_	_
)	1828	1829	NN	)	O	_	_
,	1829	1830	,	,	O	_	_
a	1831	1832	DT	a	O	_	_
serine	1833	1839	NN	serine	O	_	_
/	1839	1840	:	/	O	_	_
threonine-selective	1840	1859	JJ	threonine-selective	O	_	_
protein	1860	1867	NN	protein	O	_	_
kinase	1868	1874	NN	kinase	O	_	_
.	1874	1875	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	conj_and
1	5	dobj
3	0	nsubj
5	4	det
5	6	vmod
6	8	dobj
8	7	nn
8	10	dep
10	20	dep
13	11	punct
13	12	nn
13	16	appos
13	17	punct
16	15	det
20	18	amod
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	NN	0	0	1	1	MEK	0	0	1	0	VP	0	1	21	4	VBZ	0	1	2	1	phosphorylates	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	VBZ	0	3	4	1	activates	3	3	4	0	NP	0	4	21	2	NP	1	4	6	2	DT	0	4	5	1	a	4	4	5	0	NN	0	5	6	1	mitogen	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	activated	6	6	7	0	NP	0	7	21	2	NP	1	7	9	2	NN	0	7	8	1	protein	7	7	8	0	NN	0	8	9	1	kinase	8	8	9	0	NP	0	9	21	2	NP	1	9	18	3	CD	0	9	10	1	-LRB-	9	9	10	0	NN	0	10	11	1	MAPK	10	10	11	0	PRN	1	11	18	3	:	0	11	12	1	/	11	11	12	0	NP	0	12	17	3	NP	1	12	14	2	NN	0	12	13	1	ERK	12	12	13	0	NN	0	13	14	1	-RRB-	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	DT	0	15	16	1	a	15	15	16	0	NN	0	16	17	1	serine	16	16	17	0	:	0	17	18	1	/	17	17	18	0	NP	2	18	21	3	JJ	0	18	19	1	threonine-selective	18	18	19	0	NN	0	19	20	1	protein	19	19	20	0	NN	0	20	21	1	kinase	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	26
The	1876	1879	DT	the	O	_	_
MAPK	1880	1884	NN	mapk	O	_	_
enzymes	1885	1892	NNS	enzyme	O	_	_
require	1893	1900	VBP	require	O	_	_
a	1901	1902	DT	a	O	_	_
specific	1903	1911	JJ	specific	O	_	_
phosphorylation	1912	1927	NN	phosphorylation	O	_	_
sequence	1928	1936	NN	sequence	O	_	_
where	1937	1942	WRB	where	O	_	_
a	1943	1944	DT	a	O	_	_
serine	1945	1951	NN	serine	O	_	_
or	1952	1954	CC	or	O	_	_
threonine	1955	1964	NN	threonine	O	_	_
is	1965	1967	VBZ	be	O	_	_
followed	1968	1976	VBN	follow	O	_	_
by	1977	1979	IN	by	O	_	_
proline	1980	1987	NN	proline	O	_	_
(	1988	1989	CD	(	O	_	_
S	1989	1990	NN	s	O	_	_
/	1990	1991	:	/	O	_	_
TP	1991	1993	NN	tp	O	_	_
)	1993	1994	CD	)	O	_	_
[	1995	1996	CD	[	O	_	_
3	1996	1997	CD	3	O	_	_
]	1997	1998	NN	]	O	_	_
.	1998	1999	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	7	dobj
3	14	advcl
7	4	det
7	5	amod
7	6	nn
10	9	det
10	12	conj_or
14	8	advmod
14	10	nsubjpass
14	12	nsubjpass
14	13	auxpass
14	15	prep
15	16	dep
16	18	dep
16	19	punct
16	20	dep
20	24	dep
23	22	number
24	23	num
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	MAPK	1	1	2	0	NNS	0	2	3	1	enzymes	2	2	3	0	VP	0	3	25	3	VBP	0	3	4	1	require	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	a	4	4	5	0	JJ	0	5	6	1	specific	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	NN	0	7	8	1	sequence	7	7	8	0	SBAR	1	8	25	2	WHADVP	0	8	9	1	WRB	0	8	9	1	where	8	8	9	0	S	1	9	25	2	NP	1	9	13	4	DT	0	9	10	1	a	9	9	10	0	NN	0	10	11	1	serine	10	10	11	0	CC	0	11	12	1	or	11	11	12	0	NN	0	12	13	1	threonine	12	12	13	0	VP	1	13	25	2	VBZ	0	13	14	1	is	13	13	14	0	VP	0	14	25	2	VBN	0	14	15	1	followed	14	14	15	0	PP	0	15	25	2	IN	0	15	16	1	by	15	15	16	0	FRAG	0	16	25	3	NP	0	16	19	2	NP	0	16	17	1	NN	0	16	17	1	proline	16	16	17	0	NP	1	17	19	2	CD	0	17	18	1	-LRB-	17	17	18	0	NN	0	18	19	1	S	18	18	19	0	:	0	19	20	1	/	19	19	20	0	NP	0	20	25	2	NP	0	20	22	2	NN	0	20	21	1	TP	20	20	21	0	CD	0	21	22	1	-RRB-	21	21	22	0	NP	1	22	25	2	QP	1	22	24	2	CD	0	22	23	1	[	22	22	23	0	CD	0	23	24	1	3	23	23	24	0	NN	0	24	25	1	]	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	31
It	2000	2002	PRP	it	O	_	_
was	2003	2006	VBD	be	O	_	_
shown	2007	2012	VBN	show	O	_	_
that	2013	2017	IN	that	O	_	_
endogenous	2018	2028	JJ	endogenous	O	_	_
RAS	2029	2032	NN	ra	O	_	_
is	2033	2035	VBZ	be	O	_	_
necessary	2036	2045	JJ	necessary	O	_	_
for	2046	2049	IN	for	O	_	_
the	2050	2053	DT	the	O	_	_
full	2054	2058	JJ	full	O	_	_
apoptotic	2059	2068	JJ	apoptotic	O	_	_
activity	2069	2077	NN	activity	O	_	_
of	2078	2080	IN	of	O	_	_
ASPP2	2081	2086	NN	aspp2	B-GENE	_	_
,	2086	2087	,	,	O	_	_
which	2088	2093	WDT	which	O	_	_
suggests	2094	2102	VBZ	suggest	O	_	_
that	2103	2107	IN	that	O	_	_
RAS	2108	2111	NN	ra	B-GENE	_	_
signalling	2112	2122	NN	signalling	O	_	_
may	2123	2126	MD	may	O	_	_
modify	2127	2133	VB	modify	O	_	_
ASPP2	2134	2139	NN	aspp2	B-GENE	_	_
,	2139	2140	,	,	O	_	_
potentially	2141	2152	RB	potentially	O	_	_
via	2153	2156	IN	via	O	_	_
a	2157	2158	DT	a	O	_	_
phosphorylation	2159	2174	NN	phosphorylation	O	_	_
event	2175	2180	NN	event	O	_	_
.	2180	2181	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	7	ccomp
5	4	amod
7	3	mark
7	5	nsubj
7	6	cop
7	12	prep_for
12	9	det
12	10	amod
12	11	amod
12	14	prep_of
12	29	prep_via
14	17	rcmod
17	16	nsubj
17	22	ccomp
20	19	nn
22	18	mark
22	20	nsubj
22	21	aux
22	23	dobj
22	25	advmod
29	27	det
29	28	nn
EOX
Y	1
ROOT	0	0	31	1	S	1	0	31	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	30	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	30	2	VBN	0	2	3	1	shown	2	2	3	0	SBAR	1	3	30	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	30	2	NP	1	4	6	2	JJ	0	4	5	1	endogenous	4	4	5	0	NN	0	5	6	1	RAS	5	5	6	0	VP	1	6	30	2	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	30	2	JJ	0	7	8	1	necessary	7	7	8	0	PP	0	8	30	2	IN	0	8	9	1	for	8	8	9	0	NP	0	9	30	3	NP	3	9	13	4	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	full	10	10	11	0	JJ	0	11	12	1	apoptotic	11	11	12	0	NN	0	12	13	1	activity	12	12	13	0	PP	0	13	26	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	26	3	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	,	0	15	16	1	,	15	15	16	0	SBAR	1	16	26	2	WHNP	0	16	17	1	WDT	0	16	17	1	which	16	16	17	0	S	0	17	26	1	VP	0	17	26	2	VBZ	0	17	18	1	suggests	17	17	18	0	SBAR	1	18	26	2	IN	0	18	19	1	that	18	18	19	0	S	1	19	26	2	NP	1	19	21	2	NN	0	19	20	1	RAS	19	19	20	0	NN	0	20	21	1	signalling	20	20	21	0	VP	1	21	26	2	MD	0	21	22	1	may	21	21	22	0	VP	0	22	26	4	VB	0	22	23	1	modify	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	,	0	24	25	1	,	24	24	25	0	ADVP	0	25	26	1	RB	0	25	26	1	potentially	25	25	26	0	PP	0	26	30	2	IN	0	26	27	1	via	26	26	27	0	NP	2	27	30	3	DT	0	27	28	1	a	27	27	28	0	NN	0	28	29	1	phosphorylation	28	28	29	0	NN	0	29	30	1	event	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	28
Phosphorylation	2182	2197	NN	phosphorylation	O	_	_
by	2198	2200	IN	by	O	_	_
RAS	2201	2204	NN	ra	B-GENE	_	_
/	2204	2205	:	/	B-GENE	_	_
MAPK	2205	2209	NN	mapk	I-GENE	_	_
modulates	2210	2219	VBZ	modulate	O	_	_
the	2220	2223	DT	the	O	_	_
activation	2224	2234	NN	activation	O	_	_
of	2235	2237	IN	of	O	_	_
most	2238	2242	JJS	most	O	_	_
of	2243	2245	IN	of	O	_	_
their	2246	2251	PRP$	they	O	_	_
substrates	2252	2262	NNS	substrate	O	_	_
and	2263	2266	CC	and	O	_	_
in	2267	2269	IN	in	O	_	_
some	2270	2274	DT	some	O	_	_
cases	2275	2280	NNS	case	O	_	_
the	2281	2284	DT	the	O	_	_
phosphorylation	2285	2300	NN	phosphorylation	O	_	_
mediates	2301	2309	VBZ	mediate	O	_	_
changes	2310	2317	NNS	change	O	_	_
in	2318	2320	IN	in	O	_	_
subcellular	2321	2332	JJ	subcellular	O	_	_
localisation	2333	2345	NN	localisation	O	_	_
[	2346	2347	NN	[	O	_	_
4	2347	2348	CD	4	O	_	_
]	2348	2349	NN	]	O	_	_
.	2349	2350	.	.	O	_	_
D	1
0
0	2	prep_by
0	3	punct
0	19	dep
5	4	nsubj
5	5	conj_and
5	7	dobj
5	9	prep_of
5	16	prep_in
5	18	pobj
7	6	det
9	12	prep_of
12	11	poss
16	15	det
18	17	det
19	5	dep
19	20	dobj
19	24	prep_in
19	26	nsubj
24	22	amod
24	23	nn
26	25	num
EOX
Y	1
ROOT	0	0	28	1	FRAG	0	0	28	4	NP	0	0	3	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	by	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	:	0	3	4	1	/	3	3	4	0	SINV	1	4	27	3	S	1	4	19	2	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	0	5	19	3	VBZ	0	5	6	1	modulates	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	activation	7	7	8	0	PP	0	8	19	4	PP	0	8	13	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	13	2	NP	0	9	10	1	JJS	0	9	10	1	most	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	of	10	10	11	0	NP	1	11	13	2	PRP$	0	11	12	1	their	11	11	12	0	NNS	0	12	13	1	substrates	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	in	14	14	15	0	NP	1	15	17	2	DT	0	15	16	1	some	15	15	16	0	NNS	0	16	17	1	cases	16	16	17	0	NP	1	17	19	2	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	VP	0	19	25	3	VBZ	0	19	20	1	mediates	19	19	20	0	NP	0	20	21	1	NNS	0	20	21	1	changes	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	in	21	21	22	0	NP	2	22	25	3	JJ	0	22	23	1	subcellular	22	22	23	0	NN	0	23	24	1	localisation	23	23	24	0	NN	0	24	25	1	[	24	24	25	0	NP	1	25	27	2	CD	0	25	26	1	4	25	25	26	0	NN	0	26	27	1	]	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	16
ASPP2	2351	2356	NN	aspp2	B-GENE	_	_
belongs	2357	2364	VBZ	belong	O	_	_
to	2365	2367	TO	to	O	_	_
an	2368	2370	DT	a	O	_	_
evolutionarily	2371	2385	RB	evolutionarily	O	_	_
conserved	2386	2395	VBN	conserve	O	_	_
ASPP	2396	2400	NN	aspp	B-GENE	_	_
family	2401	2407	NN	family	I-GENE	_	_
of	2408	2410	IN	of	O	_	_
proteins	2411	2419	NNS	protein	O	_	_
,	2419	2420	,	,	O	_	_
alongside	2421	2430	IN	alongside	O	_	_
ASPP1	2431	2436	NN	aspp1	O	_	_
and	2437	2440	CC	and	O	_	_
iASPP	2441	2446	NN	iaspp	O	_	_
.	2446	2447	.	.	O	_	_
D	1
1
1	0	nsubj
1	7	prep_to
4	5	dep
7	3	det
7	4	amod
7	6	nn
7	9	prep_of
7	12	prep_alongside
7	14	prep_alongside
12	14	conj_and
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	15	2	VBZ	0	1	2	1	belongs	1	1	2	0	PP	0	2	15	2	TO	0	2	3	1	to	2	2	3	0	NP	0	3	15	4	NP	3	3	8	4	DT	0	3	4	1	an	3	3	4	0	ADJP	0	4	6	2	RB	0	4	5	1	evolutionarily	4	4	5	0	S	0	5	6	1	VP	0	5	6	1	VBN	0	5	6	1	conserved	5	5	6	0	NN	0	6	7	1	ASPP	6	6	7	0	NN	0	7	8	1	family	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	proteins	9	9	10	0	,	0	10	11	1	,	10	10	11	0	PP	0	11	15	2	IN	0	11	12	1	alongside	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	ASPP1	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	iASPP	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	22
All	2448	2451	DT	all	O	_	_
three	2452	2457	CD	three	O	_	_
contain	2458	2465	VBP	contain	O	_	_
signature	2466	2475	NN	signature	O	_	_
sequences	2476	2485	NNS	sequence	O	_	_
in	2486	2488	IN	in	O	_	_
their	2489	2494	PRP$	they	O	_	_
C-termini	2495	2504	NNS	c-terminus	O	_	_
;	2504	2505	:	;	O	_	_
ankyrin	2506	2513	NN	ankyrin	B-GENE	_	_
repeats	2514	2521	NNS	repeat	O	_	_
,	2521	2522	,	,	O	_	_
SH3	2523	2526	NN	sh3	B-GENE	_	_
domain	2527	2533	NN	domain	I-GENE	_	_
and	2534	2537	CC	and	O	_	_
proline	2538	2545	NN	proline	O	_	_
rich	2546	2550	JJ	rich	O	_	_
sequences	2551	2560	NNS	sequence	O	_	_
[	2561	2562	VBP	[	O	_	_
5	2562	2563	CD	5	O	_	_
]	2563	2564	CD	]	O	_	_
.	2564	2565	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	4	dobj
2	18	parataxis
4	3	nn
4	7	prep_in
7	6	poss
10	9	nn
10	13	conj_and
10	17	conj_and
13	12	nn
17	15	nn
17	16	amod
18	10	nsubj
18	13	nsubj
18	17	nsubj
18	20	dobj
20	19	number
EOX
Y	1
ROOT	0	0	22	1	S	0	0	22	4	S	1	0	8	2	NP	1	0	2	2	DT	0	0	1	1	All	0	0	1	0	CD	0	1	2	1	three	1	1	2	0	VP	0	2	8	2	VBP	0	2	3	1	contain	2	2	3	0	NP	0	3	8	2	NP	1	3	5	2	NN	0	3	4	1	signature	3	3	4	0	NNS	0	4	5	1	sequences	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	in	5	5	6	0	NP	1	6	8	2	PRP$	0	6	7	1	their	6	6	7	0	NNS	0	7	8	1	C-termini	7	7	8	0	:	0	8	9	1	;	8	8	9	0	S	1	9	21	2	NP	0	9	18	5	NP	1	9	11	2	NN	0	9	10	1	ankyrin	9	9	10	0	NNS	0	10	11	1	repeats	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	SH3	12	12	13	0	NN	0	13	14	1	domain	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	2	15	18	3	NN	0	15	16	1	proline	15	15	16	0	JJ	0	16	17	1	rich	16	16	17	0	NNS	0	17	18	1	sequences	17	17	18	0	VP	0	18	21	2	VBP	0	18	19	1	[	18	18	19	0	NP	0	19	21	1	QP	1	19	21	2	CD	0	19	20	1	5	19	19	20	0	CD	0	20	21	1	]	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	11
ASPP2	2566	2571	NN	aspp2	B-GENE	_	_
binds	2572	2577	VBZ	bind	O	_	_
to	2578	2580	TO	to	O	_	_
RAS	2581	2584	NN	ra	O	_	_
through	2585	2592	IN	through	O	_	_
its	2593	2596	PRP$	its	O	_	_
N-terminus	2597	2607	NN	n-terminus	O	_	_
[	2608	2609	CD	[	O	_	_
2,6	2609	2612	CD	2,6	O	_	_
]	2612	2613	NN	]	O	_	_
.	2613	2614	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	prep_to
1	6	prep_through
1	9	dep
6	5	poss
8	7	number
9	8	num
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	10	3	VBZ	0	1	2	1	binds	1	1	2	0	PP	0	2	4	2	TO	0	2	3	1	to	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	RAS	3	3	4	0	PP	0	4	10	3	IN	0	4	5	1	through	4	4	5	0	NP	1	5	7	2	PRP$	0	5	6	1	its	5	5	6	0	NN	0	6	7	1	N-terminus	6	6	7	0	NP	1	7	10	2	QP	1	7	9	2	CD	0	7	8	1	[	7	7	8	0	CD	0	8	9	1	2,6	8	8	9	0	NN	0	9	10	1	]	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	14
The	2615	2618	DT	the	O	_	_
functions	2619	2628	NNS	function	O	_	_
of	2629	2631	IN	of	O	_	_
ASPP2	2632	2637	NN	aspp2	B-GENE	_	_
are	2638	2641	VBP	be	O	_	_
potentially	2642	2653	RB	potentially	O	_	_
controlled	2654	2664	VBN	control	O	_	_
by	2665	2667	IN	by	O	_	_
its	2668	2671	PRP$	its	O	_	_
binding	2672	2679	VBG	bind	O	_	_
partners	2680	2688	NNS	partner	O	_	_
and	2689	2692	CC	and	O	_	_
localisation	2693	2705	NN	localisation	O	_	_
.	2705	2706	.	.	O	_	_
D	1
6
1	0	det
1	3	prep_of
6	1	nsubjpass
6	4	auxpass
6	5	advmod
6	10	agent
6	12	agent
10	8	poss
10	9	amod
10	12	conj_and
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	0	0	4	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	functions	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	VP	1	4	13	2	VBP	0	4	5	1	are	4	4	5	0	ADJP	1	5	13	3	RB	0	5	6	1	potentially	5	5	6	0	VBN	0	6	7	1	controlled	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	13	3	NP	2	8	11	3	PRP$	0	8	9	1	its	8	8	9	0	VBG	0	9	10	1	binding	9	9	10	0	NNS	0	10	11	1	partners	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	localisation	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	50
When	2707	2711	WRB	when	O	_	_
ASPP2	2712	2717	NN	aspp2	O	_	_
locates	2718	2725	VBZ	locate	O	_	_
at	2726	2728	IN	at	O	_	_
the	2729	2732	DT	the	O	_	_
cell-cell	2733	2742	JJ	cell-cell	O	_	_
junctions	2743	2752	NNS	junction	O	_	_
,	2752	2753	,	,	O	_	_
it	2754	2756	PRP	it	O	_	_
binds	2757	2762	VBZ	bind	O	_	_
and	2763	2766	CC	and	O	_	_
co-localises	2767	2779	VBZ	co-localise	O	_	_
with	2780	2784	IN	with	O	_	_
PAR3	2785	2789	NN	par3	B-GENE	_	_
via	2790	2793	IN	via	O	_	_
its	2794	2797	PRP$	its	O	_	_
N-terminus	2798	2808	NN	n-terminus	O	_	_
to	2809	2811	TO	to	O	_	_
maintain	2812	2820	VB	maintain	O	_	_
the	2821	2824	DT	the	O	_	_
integrity	2825	2834	NN	integrity	O	_	_
of	2835	2837	IN	of	O	_	_
cell	2838	2842	NN	cell	O	_	_
polarity	2843	2851	NN	polarity	O	_	_
and	2852	2855	CC	and	O	_	_
adherence	2856	2865	NN	adherence	O	_	_
junction	2866	2874	NN	junction	O	_	_
[	2875	2876	CD	[	O	_	_
7,8	2876	2879	CD	7,8	O	_	_
]	2879	2880	NN	]	O	_	_
,	2880	2881	,	,	O	_	_
whereas	2882	2889	IN	whereas	O	_	_
in	2890	2892	IN	in	O	_	_
the	2893	2896	DT	the	O	_	_
cytosol	2897	2904	NN	cytosol	O	_	_
/	2904	2905	:	/	O	_	_
nucleus	2905	2912	NN	nucleus	O	_	_
,	2912	2913	,	,	O	_	_
ASPP2	2914	2919	NN	aspp2	B-GENE	_	_
enhances	2920	2928	VBZ	enhance	O	_	_
p53	2929	2932	NN	p53	B-GENE	_	_
induced	2933	2940	JJ	induced	O	_	_
apoptosis	2941	2950	NN	apoptosis	O	_	_
in	2951	2953	IN	in	O	_	_
cancer	2954	2960	NN	cancer	O	_	_
cells	2961	2966	NNS	cell	O	_	_
[	2967	2968	VBP	[	O	_	_
9	2968	2969	CD	9	O	_	_
]	2969	2970	NN	]	O	_	_
.	2970	2971	.	.	O	_	_
D	1
39
2	0	advmod
2	1	nsubj
2	6	prep_at
6	4	det
6	5	amod
9	2	advcl
9	8	nsubj
9	11	conj_and
9	13	prep_with
11	8	nsubj
13	16	prep_via
16	15	poss
16	18	vmod
18	17	aux
18	20	dobj
20	19	det
20	23	prep_of
20	26	prep_of
23	22	nn
23	26	conj_and
23	29	dep
23	36	dep
26	25	nn
28	27	number
29	28	num
34	32	dep
34	33	det
36	31	mark
36	34	dep
36	35	punct
39	9	ccomp
39	11	ccomp
39	38	nsubj
39	46	ccomp
42	40	nn
42	41	amod
42	45	prep_in
45	44	nn
46	42	nsubj
46	48	dobj
48	47	num
EOX
Y	1
ROOT	0	0	50	1	S	3	0	50	5	S	3	0	37	4	SBAR	1	0	7	2	WHADVP	0	0	1	1	WRB	0	0	1	1	When	0	0	1	0	S	1	1	7	2	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	0	2	7	2	VBZ	0	2	3	1	locates	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	at	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	the	4	4	5	0	JJ	0	5	6	1	cell-cell	5	5	6	0	NNS	0	6	7	1	junctions	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	PRP	0	8	9	1	it	8	8	9	0	VP	0	9	37	4	VBZ	0	9	10	1	binds	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	VBZ	0	11	12	1	co-localises	11	11	12	0	PP	0	12	37	2	IN	0	12	13	1	with	12	12	13	0	NP	0	13	37	2	NP	0	13	14	1	NN	0	13	14	1	PAR3	13	13	14	0	PP	0	14	37	2	IN	0	14	15	1	via	14	14	15	0	NP	1	15	37	3	PRP$	0	15	16	1	its	15	15	16	0	NN	0	16	17	1	N-terminus	16	16	17	0	S	0	17	37	1	VP	1	17	37	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	37	2	VB	0	18	19	1	maintain	18	18	19	0	NP	0	19	37	2	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	integrity	20	20	21	0	PP	0	21	37	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	37	3	NP	0	22	30	2	NP	0	22	27	3	NP	1	22	24	2	NN	0	22	23	1	cell	22	22	23	0	NN	0	23	24	1	polarity	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	NP	1	25	27	2	NN	0	25	26	1	adherence	25	25	26	0	NN	0	26	27	1	junction	26	26	27	0	NP	1	27	30	2	QP	1	27	29	2	CD	0	27	28	1	[	27	27	28	0	CD	0	28	29	1	7,8	28	28	29	0	NN	0	29	30	1	]	29	29	30	0	,	0	30	31	1	,	30	30	31	0	SBAR	1	31	37	2	IN	0	31	32	1	whereas	31	31	32	0	FRAG	2	32	37	3	X	1	32	35	2	IN	0	32	33	1	in	32	32	33	0	NP	1	33	35	2	DT	0	33	34	1	the	33	33	34	0	NN	0	34	35	1	cytosol	34	34	35	0	:	0	35	36	1	/	35	35	36	0	NP	0	36	37	1	NN	0	36	37	1	nucleus	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	39	1	NN	0	38	39	1	ASPP2	38	38	39	0	VP	0	39	49	2	VBZ	0	39	40	1	enhances	39	39	40	0	SBAR	0	40	49	1	S	1	40	49	2	NP	0	40	46	2	NP	2	40	43	3	NN	0	40	41	1	p53	40	40	41	0	JJ	0	41	42	1	induced	41	41	42	0	NN	0	42	43	1	apoptosis	42	42	43	0	PP	0	43	46	2	IN	0	43	44	1	in	43	43	44	0	NP	1	44	46	2	NN	0	44	45	1	cancer	44	44	45	0	NNS	0	45	46	1	cells	45	45	46	0	VP	0	46	49	2	VBP	0	46	47	1	[	46	46	47	0	NP	1	47	49	2	CD	0	47	48	1	9	47	47	48	0	NN	0	48	49	1	]	48	48	49	0	.	0	49	50	1	.	49	49	50	0
EOS
T	17
It	2972	2974	PRP	it	O	_	_
also	2975	2979	RB	also	O	_	_
binds	2980	2985	VBZ	bind	O	_	_
ATG5	2986	2990	NN	atg5	B-GENE	_	_
and	2991	2994	CC	and	O	_	_
inhibits	2995	3003	VBZ	inhibit	O	_	_
RAS	3004	3007	NN	ra	O	_	_
induced	3008	3015	VBD	induce	O	_	_
autophagy	3016	3025	NN	autophagy	O	_	_
,	3025	3026	,	,	O	_	_
independently	3027	3040	RB	independently	O	_	_
of	3041	3043	IN	of	O	_	_
p53	3044	3047	NN	p53	B-GENE	_	_
[	3048	3049	CD	[	I-GENE	_	_
10	3049	3051	CD	10	I-GENE	_	_
]	3051	3052	NN	]	I-GENE	_	_
.	3052	3053	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	3	dobj
2	5	conj_and
5	0	nsubj
5	7	ccomp
7	6	nsubj
7	8	dobj
8	15	rcmod
10	12	prep_of
14	13	number
15	10	advmod
15	14	num
EOX
Y	1
ROOT	0	0	17	1	S	2	0	17	4	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	also	1	1	2	0	VP	0	2	16	3	VP	0	2	4	2	VBZ	0	2	3	1	binds	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ATG5	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	VP	0	5	16	2	VBZ	0	5	6	1	inhibits	5	5	6	0	SBAR	0	6	16	1	S	1	6	16	2	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	VP	0	7	16	2	VBD	0	7	8	1	induced	7	7	8	0	NP	0	8	16	3	NP	0	8	9	1	NN	0	8	9	1	autophagy	8	8	9	0	,	0	9	10	1	,	9	9	10	0	RRC	1	10	16	2	ADVP	0	10	13	2	RB	0	10	11	1	independently	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	p53	12	12	13	0	NP	1	13	16	2	QP	1	13	15	2	CD	0	13	14	1	[	13	13	14	0	CD	0	14	15	1	10	14	14	15	0	NN	0	15	16	1	]	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	16
Thus	3054	3058	RB	thus	O	_	_
it	3059	3061	PRP	it	O	_	_
is	3062	3064	VBZ	be	O	_	_
important	3065	3074	JJ	important	O	_	_
to	3075	3077	TO	to	O	_	_
find	3078	3082	VB	find	O	_	_
the	3083	3086	DT	the	O	_	_
molecular	3087	3096	JJ	molecular	O	_	_
event	3097	3102	NN	event	O	_	_
that	3103	3107	WDT	that	O	_	_
controls	3108	3116	VBZ	control	O	_	_
the	3117	3120	DT	the	O	_	_
localisation	3121	3133	NN	localisation	O	_	_
of	3134	3136	IN	of	O	_	_
ASPP2	3137	3142	NN	aspp2	B-GENE	_	_
.	3142	3143	.	.	O	_	_
D	1
3
3	0	advmod
3	1	nsubj
3	2	cop
3	5	xcomp
5	4	aux
5	8	dobj
8	6	det
8	7	amod
8	10	rcmod
10	9	nsubj
10	12	dobj
12	11	det
12	14	prep_of
EOX
Y	1
ROOT	0	0	16	1	S	2	0	16	4	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	it	1	1	2	0	VP	1	2	15	2	VBZ	0	2	3	1	is	2	2	3	0	ADJP	0	3	15	2	JJ	0	3	4	1	important	3	3	4	0	S	0	4	15	1	VP	1	4	15	2	TO	0	4	5	1	to	4	4	5	0	VP	0	5	15	2	VB	0	5	6	1	find	5	5	6	0	NP	0	6	15	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	JJ	0	7	8	1	molecular	7	7	8	0	NN	0	8	9	1	event	8	8	9	0	SBAR	1	9	15	2	WHNP	0	9	10	1	WDT	0	9	10	1	that	9	9	10	0	S	0	10	15	1	VP	0	10	15	2	VBZ	0	10	11	1	controls	10	10	11	0	NP	0	11	15	2	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	localisation	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	14
Here	3144	3148	RB	here	O	_	_
we	3149	3151	PRP	we	O	_	_
show	3152	3156	VBP	show	O	_	_
that	3157	3161	IN	that	O	_	_
ASPP2	3162	3167	NN	aspp2	B-GENE	_	_
is	3168	3170	VBZ	be	O	_	_
a	3171	3172	DT	a	O	_	_
novel	3173	3178	JJ	novel	O	_	_
substrate	3179	3188	NN	substrate	O	_	_
of	3189	3191	IN	of	O	_	_
RAS	3192	3195	NN	ra	B-GENE	_	_
/	3195	3196	:	/	B-GENE	_	_
MAPK	3196	3200	NN	mapk	I-GENE	_	_
.	3200	3201	.	.	O	_	_
D	1
2
2	0	advmod
2	1	nsubj
2	8	ccomp
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	10	prep_of
10	12	dep
12	11	punct
EOX
Y	1
ROOT	0	0	14	1	S	2	0	14	4	ADVP	0	0	1	1	RB	0	0	1	1	Here	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	13	2	VBP	0	2	3	1	show	2	2	3	0	SBAR	1	3	13	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	13	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	13	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	13	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	13	2	NP	0	10	11	1	NN	0	10	11	1	RAS	10	10	11	0	PRN	1	11	13	2	:	0	11	12	1	/	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	MAPK	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	24
Phosphorylation	3202	3217	NN	phosphorylation	O	_	_
of	3218	3220	IN	of	O	_	_
ASPP2	3221	3226	NN	aspp2	B-GENE	_	_
by	3227	3229	IN	by	O	_	_
MAPK	3230	3234	NN	mapk	B-GENE	_	_
is	3235	3237	VBZ	be	O	_	_
required	3238	3246	VBN	require	O	_	_
for	3247	3250	IN	for	O	_	_
the	3251	3254	DT	the	O	_	_
RAS	3255	3258	NN	ra	O	_	_
induced	3259	3266	VBD	induce	O	_	_
translocation	3267	3280	NN	translocation	O	_	_
of	3281	3283	IN	of	O	_	_
ASPP2	3284	3289	NN	aspp2	B-GENE	_	_
,	3289	3290	,	,	O	_	_
which	3291	3296	WDT	which	O	_	_
results	3297	3304	VBZ	result	O	_	_
in	3305	3307	IN	in	O	_	_
the	3308	3311	DT	the	O	_	_
increased	3312	3321	VBN	increase	O	_	_
binding	3322	3329	NN	binding	O	_	_
to	3330	3332	TO	to	O	_	_
p53	3333	3336	NN	p53	B-GENE	_	_
.	3336	3337	.	.	O	_	_
D	1
6
0	2	prep_of
2	4	prep_by
6	0	nsubjpass
6	5	auxpass
6	10	advcl
9	8	det
10	7	mark
10	9	nsubj
10	11	dobj
11	13	prep_of
13	16	rcmod
16	15	nsubj
16	20	prep_in
20	18	det
20	19	amod
20	22	prep_to
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	2	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	1	5	23	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	23	2	VBN	0	6	7	1	required	6	6	7	0	SBAR	1	7	23	2	IN	0	7	8	1	for	7	7	8	0	S	1	8	23	2	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	VP	0	10	23	2	VBD	0	10	11	1	induced	10	10	11	0	NP	0	11	23	2	NP	0	11	12	1	NN	0	11	12	1	translocation	11	11	12	0	PP	0	12	23	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	23	3	NP	0	13	14	1	NN	0	13	14	1	ASPP2	13	13	14	0	,	0	14	15	1	,	14	14	15	0	SBAR	1	15	23	2	WHNP	0	15	16	1	WDT	0	15	16	1	which	15	15	16	0	S	0	16	23	1	VP	0	16	23	2	VBZ	0	16	17	1	results	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	23	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	VBN	0	19	20	1	increased	19	19	20	0	NN	0	20	21	1	binding	20	20	21	0	PP	0	21	23	2	TO	0	21	22	1	to	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	p53	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	25
Consequently	3338	3350	RB	consequently	O	_	_
,	3350	3351	,	,	O	_	_
the	3352	3355	DT	the	O	_	_
pro-apoptotic	3356	3369	JJ	pro-apoptotic	O	_	_
activity	3370	3378	NN	activity	O	_	_
of	3379	3381	IN	of	O	_	_
ASPP2	3382	3387	NN	aspp2	B-GENE	_	_
is	3388	3390	VBZ	be	O	_	_
increased	3391	3400	VBN	increase	O	_	_
by	3401	3403	IN	by	O	_	_
the	3404	3407	DT	the	O	_	_
RAS	3408	3411	NN	ra	B-GENE	_	_
/	3411	3412	:	/	I-GENE	_	_
Raf/MAPK	3412	3420	NN	raf/mapk	B-GENE	_	_
signalling	3421	3431	NN	signalling	O	_	_
cascade	3432	3439	NN	cascade	O	_	_
as	3440	3442	IN	as	O	_	_
ASPP2	3443	3448	NN	aspp2	B-GENE	_	_
phosphorylation	3449	3464	NN	phosphorylation	O	_	_
mutant	3465	3471	JJ	mutant	O	_	_
fails	3472	3477	VBZ	fail	O	_	_
to	3478	3480	TO	to	O	_	_
do	3481	3483	VB	do	O	_	_
so	3484	3486	RB	so	O	_	_
.	3486	3487	.	.	O	_	_
D	1
8
4	2	det
4	3	amod
4	6	prep_of
8	0	advmod
8	4	nsubjpass
8	7	auxpass
8	11	agent
11	10	det
11	19	dep
11	20	rcmod
15	13	nn
15	14	nn
15	18	prep_as
18	17	nn
19	12	punct
19	15	dep
20	22	xcomp
22	21	aux
22	23	advmod
EOX
Y	1
ROOT	0	0	25	1	S	3	0	25	5	ADVP	0	0	1	1	RB	0	0	1	1	Consequently	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	pro-apoptotic	3	3	4	0	NN	0	4	5	1	activity	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	ASPP2	6	6	7	0	VP	1	7	24	2	VBZ	0	7	8	1	is	7	7	8	0	VP	0	8	24	2	VBN	0	8	9	1	increased	8	8	9	0	PP	0	9	24	2	IN	0	9	10	1	by	9	9	10	0	NP	0	10	24	2	NP	0	10	20	2	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	PRN	1	12	20	2	:	0	12	13	1	/	12	12	13	0	S	1	13	20	2	NP	0	13	19	2	NP	2	13	16	3	NN	0	13	14	1	Raf/MAPK	13	13	14	0	NN	0	14	15	1	signalling	14	14	15	0	NN	0	15	16	1	cascade	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	as	16	16	17	0	NP	1	17	19	2	NN	0	17	18	1	ASPP2	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	ADJP	0	19	20	1	JJ	0	19	20	1	mutant	19	19	20	0	SBAR	0	20	24	1	S	0	20	24	1	VP	0	20	24	2	VBZ	0	20	21	1	fails	20	20	21	0	S	0	21	24	1	VP	1	21	24	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	24	2	VB	0	22	23	1	do	22	22	23	0	ADVP	0	23	24	1	RB	0	23	24	1	so	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	21
Thus	3488	3492	RB	thus	O	_	_
phosphorylation	3493	3508	NN	phosphorylation	O	_	_
of	3509	3511	IN	of	O	_	_
ASPP2	3512	3517	NN	aspp2	B-GENE	_	_
by	3518	3520	IN	by	O	_	_
RAS	3521	3524	NN	ra	B-GENE	_	_
/	3524	3525	:	/	B-GENE	_	_
MAPK	3525	3529	NN	mapk	I-GENE	_	_
pathway	3530	3537	NN	pathway	O	_	_
provides	3538	3546	VBZ	provide	O	_	_
a	3547	3548	DT	a	O	_	_
novel	3549	3554	JJ	novel	O	_	_
link	3555	3559	NN	link	O	_	_
between	3560	3567	IN	between	O	_	_
RAS	3568	3571	NN	ra	B-GENE	_	_
and	3572	3575	CC	and	O	_	_
p53	3576	3579	NN	p53	B-GENE	_	_
in	3580	3582	IN	in	O	_	_
regulating	3583	3593	VBG	regulate	O	_	_
apoptosis	3594	3603	NN	apoptosis	O	_	_
.	3603	3604	.	.	O	_	_
D	1
1
1	0	advmod
1	3	prep_of
1	5	prep_by
1	6	punct
1	9	dep
8	7	nn
9	8	nsubj
9	12	dobj
9	18	prepc_in
12	10	det
12	11	amod
12	14	prep_between
12	16	prep_between
14	16	conj_and
18	19	dobj
EOX
Y	1
ROOT	0	0	21	1	FRAG	0	0	21	4	NP	0	0	6	2	NP	1	0	4	3	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	phosphorylation	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	20	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	20	3	VBZ	0	9	10	1	provides	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	JJ	0	11	12	1	novel	11	11	12	0	NN	0	12	13	1	link	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	between	13	13	14	0	NP	0	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	S	0	18	20	1	VP	0	18	20	2	VBG	0	18	19	1	regulating	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	apoptosis	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	20
It	3607	3609	PRP	it	O	_	_
has	3610	3613	VBZ	have	O	_	_
recently	3614	3622	RB	recently	O	_	_
been	3623	3627	VBN	be	O	_	_
shown	3628	3633	VBN	show	O	_	_
that	3634	3638	IN	that	O	_	_
oncogenic	3639	3648	JJ	oncogenic	O	_	_
RAS	3649	3652	NN	ra	O	_	_
can	3653	3656	MD	can	O	_	_
enhance	3657	3664	VB	enhance	O	_	_
the	3665	3668	DT	the	O	_	_
apoptotic	3669	3678	JJ	apoptotic	O	_	_
function	3679	3687	NN	function	O	_	_
of	3688	3690	IN	of	O	_	_
p53	3691	3694	NN	p53	B-GENE	_	_
via	3695	3698	IN	via	I-GENE	_	_
ASPP1	3699	3704	NN	aspp1	I-GENE	_	_
and	3705	3708	CC	and	O	_	_
ASPP2	3709	3714	NN	aspp2	B-GENE	_	_
.	3714	3715	.	.	O	_	_
D	1
4
4	0	nsubjpass
4	1	aux
4	2	advmod
4	3	auxpass
4	9	ccomp
7	6	amod
9	5	mark
9	7	nsubj
9	8	aux
9	12	dobj
12	10	det
12	11	amod
12	14	prep_of
14	16	prep_via
14	18	prep_via
16	18	conj_and
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	2	1	19	3	VBZ	0	1	2	1	has	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	VP	1	3	19	2	VBN	0	3	4	1	been	3	3	4	0	VP	0	4	19	2	VBN	0	4	5	1	shown	4	4	5	0	SBAR	1	5	19	2	IN	0	5	6	1	that	5	5	6	0	S	1	6	19	2	NP	1	6	8	2	JJ	0	6	7	1	oncogenic	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	VP	1	8	19	2	MD	0	8	9	1	can	8	8	9	0	VP	0	9	19	2	VB	0	9	10	1	enhance	9	9	10	0	NP	0	10	19	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	apoptotic	11	11	12	0	NN	0	12	13	1	function	12	12	13	0	PP	0	13	19	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	19	2	NP	0	14	15	1	NN	0	14	15	1	p53	14	14	15	0	PP	0	15	19	2	IN	0	15	16	1	via	15	15	16	0	NP	0	16	19	3	NN	0	16	17	1	ASPP1	16	16	17	0	CC	0	17	18	1	and	17	17	18	0	NN	0	18	19	1	ASPP2	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	19
Mechanistically	3716	3731	RB	mechanistically	O	_	_
ASPP1	3732	3737	NN	aspp1	B-GENE	_	_
and	3738	3741	CC	and	O	_	_
ASPP2	3742	3747	NN	aspp2	B-GENE	_	_
bind	3748	3752	VBP	bind	O	_	_
RAS-GTP	3753	3760	NN	ras-gtp	O	_	_
and	3761	3764	CC	and	O	_	_
potentiates	3765	3776	VBZ	potentiate	O	_	_
RAS	3777	3780	NN	ra	B-GENE	_	_
signalling	3781	3791	NN	signalling	O	_	_
to	3792	3794	TO	to	O	_	_
enhance	3795	3802	VB	enhance	O	_	_
p53	3803	3806	NN	p53	B-GENE	_	_
mediated	3807	3815	JJ	mediated	O	_	_
apoptosis	3816	3825	NN	apoptosis	O	_	_
[	3826	3827	NN	[	O	_	_
2	3827	3828	CD	2	O	_	_
]	3828	3829	NN	]	O	_	_
.	3829	3830	.	.	O	_	_
D	1
4
1	3	conj_and
4	0	advmod
4	1	nsubj
4	3	nsubj
4	5	dobj
4	7	conj_and
4	17	dobj
7	1	nsubj
7	9	dobj
7	11	xcomp
9	8	nn
11	10	aux
11	12	dobj
17	13	amod
17	14	nn
17	15	nn
17	16	num
EOX
Y	1
ROOT	0	0	19	1	S	2	0	19	4	ADVP	0	0	1	1	RB	0	0	1	1	Mechanistically	0	0	1	0	NP	0	1	4	3	NN	0	1	2	1	ASPP1	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	ASPP2	3	3	4	0	VP	0	4	18	4	VP	0	4	6	2	VBP	0	4	5	1	bind	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS-GTP	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	VP	0	7	13	3	VBZ	0	7	8	1	potentiates	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	RAS	8	8	9	0	NN	0	9	10	1	signalling	9	9	10	0	S	0	10	13	1	VP	1	10	13	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	13	2	VB	0	11	12	1	enhance	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	p53	12	12	13	0	NP	4	13	18	5	JJ	0	13	14	1	mediated	13	13	14	0	NN	0	14	15	1	apoptosis	14	14	15	0	NN	0	15	16	1	[	15	15	16	0	CD	0	16	17	1	2	16	16	17	0	NN	0	17	18	1	]	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	31
As	3831	3833	IN	as	O	_	_
RAS	3834	3837	NN	ra	O	_	_
is	3838	3840	VBZ	be	O	_	_
upstream	3841	3849	JJ	upstream	O	_	_
of	3850	3852	IN	of	O	_	_
several	3853	3860	JJ	several	O	_	_
signalling	3861	3871	NN	signalling	O	_	_
cascades	3872	3880	NNS	cascade	O	_	_
[	3881	3882	VBP	[	O	_	_
13	3882	3884	CD	13	O	_	_
]	3884	3885	CD	]	O	_	_
,	3885	3886	,	,	O	_	_
we	3887	3889	PRP	we	O	_	_
queried	3890	3897	VBD	query	O	_	_
whether	3898	3905	IN	whether	O	_	_
the	3906	3909	DT	the	O	_	_
activity	3910	3918	NN	activity	O	_	_
of	3919	3921	IN	of	O	_	_
ASPP2	3922	3927	NN	aspp2	B-GENE	_	_
is	3928	3930	VBZ	be	O	_	_
regulated	3931	3940	VBN	regulate	O	_	_
by	3941	3943	IN	by	O	_	_
the	3944	3947	DT	the	O	_	_
activation	3948	3958	NN	activation	O	_	_
of	3959	3961	IN	of	O	_	_
a	3962	3963	DT	a	O	_	_
RAS	3964	3967	NN	ra	B-GENE	_	_
mediated	3968	3976	VBD	mediate	O	_	_
signalling	3977	3987	NN	signalling	O	_	_
pathway	3988	3995	NN	pathway	O	_	_
.	3995	3996	.	.	O	_	_
D	1
13
3	0	mark
3	1	nsubj
3	2	cop
3	7	prep_of
3	8	rcmod
7	5	amod
7	6	nn
8	10	dobj
10	9	num
13	3	advcl
13	12	nsubj
13	20	ccomp
16	15	det
16	18	prep_of
20	14	mark
20	16	nsubjpass
20	19	auxpass
20	23	agent
23	22	det
23	26	prep_of
26	25	det
26	27	vmod
27	29	dobj
29	28	nn
EOX
Y	1
ROOT	0	0	31	1	S	3	0	31	5	SBAR	1	0	11	2	IN	0	0	1	1	As	0	0	1	0	S	1	1	11	2	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	1	2	11	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	11	3	NP	0	3	4	1	JJ	0	3	4	1	upstream	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	of	4	4	5	0	NP	2	5	8	3	JJ	0	5	6	1	several	5	5	6	0	NN	0	6	7	1	signalling	6	6	7	0	NNS	0	7	8	1	cascades	7	7	8	0	SBAR	0	8	11	1	S	0	8	11	1	VP	0	8	11	2	VBP	0	8	9	1	[	8	8	9	0	NP	1	9	11	2	CD	0	9	10	1	13	9	9	10	0	CD	0	10	11	1	]	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	PRP	0	12	13	1	we	12	12	13	0	VP	0	13	30	2	VBD	0	13	14	1	queried	13	13	14	0	SBAR	1	14	30	2	IN	0	14	15	1	whether	14	14	15	0	S	1	15	30	2	NP	0	15	19	2	NP	1	15	17	2	DT	0	15	16	1	the	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	ASPP2	18	18	19	0	VP	1	19	30	2	VBZ	0	19	20	1	is	19	19	20	0	VP	0	20	30	2	VBN	0	20	21	1	regulated	20	20	21	0	PP	0	21	30	2	IN	0	21	22	1	by	21	21	22	0	NP	0	22	30	2	NP	1	22	24	2	DT	0	22	23	1	the	22	22	23	0	NN	0	23	24	1	activation	23	23	24	0	PP	0	24	30	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	30	2	NP	1	25	27	2	DT	0	25	26	1	a	25	25	26	0	NN	0	26	27	1	RAS	26	26	27	0	VP	0	27	30	2	VBD	0	27	28	1	mediated	27	27	28	0	NP	1	28	30	2	NN	0	28	29	1	signalling	28	28	29	0	NN	0	29	30	1	pathway	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	15
One	3997	4000	CD	one	O	_	_
of	4001	4003	IN	of	O	_	_
the	4004	4007	DT	the	O	_	_
most	4008	4012	RBS	most	O	_	_
studied	4013	4020	VBN	study	O	_	_
downstream	4021	4031	JJ	downstream	O	_	_
pathways	4032	4040	NNS	pathway	O	_	_
of	4041	4043	IN	of	O	_	_
RAS	4044	4047	NN	ra	O	_	_
signalling	4048	4058	NN	signalling	O	_	_
is	4059	4061	VBZ	be	O	_	_
the	4062	4065	DT	the	O	_	_
Raf-MAPK	4066	4074	NN	raf-mapk	B-GENE	_	_
pathway	4075	4082	NN	pathway	O	_	_
.	4082	4083	.	.	O	_	_
D	1
13
0	2	prep_of
2	3	advmod
2	4	vmod
4	6	dobj
6	5	amod
6	9	prep_of
9	8	nn
13	0	nsubj
13	10	cop
13	11	det
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	10	2	NP	0	0	1	1	CD	0	0	1	1	One	0	0	1	0	PP	0	1	10	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	10	2	NP	0	2	4	2	DT	0	2	3	1	the	2	2	3	0	RBS	0	3	4	1	most	3	3	4	0	VP	0	4	10	2	VBN	0	4	5	1	studied	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	JJ	0	5	6	1	downstream	5	5	6	0	NNS	0	6	7	1	pathways	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	RAS	8	8	9	0	NN	0	9	10	1	signalling	9	9	10	0	VP	1	10	14	2	VBZ	0	10	11	1	is	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	Raf-MAPK	12	12	13	0	NN	0	13	14	1	pathway	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	15
Interestingly	4084	4097	RB	interestingly	O	_	_
,	4097	4098	,	,	O	_	_
we	4099	4101	PRP	we	O	_	_
observed	4102	4110	VBD	observe	O	_	_
two	4111	4114	CD	two	O	_	_
conserved	4115	4124	VBN	conserve	O	_	_
putative	4125	4133	JJ	putative	O	_	_
MAPK	4134	4138	NN	mapk	B-GENE	_	_
phosphorylation	4139	4154	NN	phosphorylation	O	_	_
sites	4155	4160	NNS	site	O	_	_
in	4161	4163	IN	in	O	_	_
ASPP1	4164	4169	NN	aspp1	B-GENE	_	_
and	4170	4173	CC	and	O	_	_
ASPP2	4174	4179	NN	aspp2	B-GENE	_	_
.	4179	4180	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	4	dobj
4	5	vmod
5	9	dobj
9	6	amod
9	7	nn
9	8	nn
9	11	prep_in
9	13	prep_in
11	13	conj_and
EOX
Y	1
ROOT	0	0	15	1	S	3	0	15	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	VP	0	3	14	2	VBD	0	3	4	1	observed	3	3	4	0	NP	0	4	14	2	NP	0	4	5	1	CD	0	4	5	1	two	4	4	5	0	VP	0	5	14	2	VBN	0	5	6	1	conserved	5	5	6	0	NP	0	6	14	2	NP	3	6	10	4	JJ	0	6	7	1	putative	6	6	7	0	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	phosphorylation	8	8	9	0	NNS	0	9	10	1	sites	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	14	3	NN	0	11	12	1	ASPP1	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	21
The	4181	4184	DT	the	O	_	_
ASPP1	4185	4190	NN	aspp1	B-GENE	_	_
sites	4191	4196	NNS	site	I-GENE	_	_
are	4197	4200	VBP	be	O	_	_
at	4201	4203	IN	at	O	_	_
residues	4204	4212	NNS	residue	O	_	_
671	4213	4216	CD	671	O	_	_
and	4217	4220	CC	and	O	_	_
746	4221	4224	CD	746	O	_	_
,	4224	4225	,	,	O	_	_
and	4226	4229	CC	and	O	_	_
the	4230	4233	DT	the	O	_	_
ASPP2	4234	4239	NN	aspp2	B-GENE	_	_
sites	4240	4245	NNS	site	I-GENE	_	_
are	4246	4249	VBP	be	O	_	_
at	4250	4252	IN	at	O	_	_
residues	4253	4261	NNS	residue	O	_	_
698	4262	4265	CD	698	O	_	_
and	4266	4269	CC	and	O	_	_
827	4270	4273	CD	827	O	_	_
.	4285	4286	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	5	prep_at
3	8	prep_at
3	14	conj_and
5	6	num
5	8	conj_and
13	11	det
13	12	nn
14	13	nsubj
14	16	prep_at
14	19	prep_at
16	17	num
16	19	conj_and
EOX
Y	1
ROOT	0	0	21	1	S	0	0	21	5	S	1	0	9	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP1	1	1	2	0	NNS	0	2	3	1	sites	2	2	3	0	VP	0	3	9	2	VBP	0	3	4	1	are	3	3	4	0	PP	0	4	9	2	IN	0	4	5	1	at	4	4	5	0	NP	0	5	9	4	NNS	0	5	6	1	residues	5	5	6	0	CD	0	6	7	1	671	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	CD	0	8	9	1	746	8	8	9	0	,	0	9	10	1	,	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	S	1	11	20	2	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	NNS	0	13	14	1	sites	13	13	14	0	VP	0	14	20	2	VBP	0	14	15	1	are	14	14	15	0	PP	0	15	20	2	IN	0	15	16	1	at	15	15	16	0	NP	0	16	20	4	NNS	0	16	17	1	residues	16	16	17	0	CD	0	17	18	1	698	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	CD	0	19	20	1	827	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	11
We	4287	4289	PRP	we	O	_	_
thus	4290	4294	RB	thus	O	_	_
tested	4295	4301	VBD	test	O	_	_
whether	4302	4309	IN	whether	O	_	_
RAS	4310	4313	NN	ra	B-GENE	_	_
activation	4314	4324	NN	activation	O	_	_
may	4325	4328	MD	may	O	_	_
regulate	4329	4337	VB	regulate	O	_	_
ASPP2	4338	4343	NN	aspp2	B-GENE	_	_
phosphorylation	4344	4359	NN	phosphorylation	O	_	_
.	4359	4360	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	7	ccomp
5	4	nn
7	3	mark
7	5	nsubj
7	6	aux
7	9	dobj
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	2	0	11	4	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	thus	1	1	2	0	VP	0	2	10	2	VBD	0	2	3	1	tested	2	2	3	0	SBAR	1	3	10	2	IN	0	3	4	1	whether	3	3	4	0	S	1	4	10	2	NP	1	4	6	2	NN	0	4	5	1	RAS	4	4	5	0	NN	0	5	6	1	activation	5	5	6	0	VP	1	6	10	2	MD	0	6	7	1	may	6	6	7	0	VP	0	7	10	2	VB	0	7	8	1	regulate	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	phosphorylation	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	24
An	4361	4363	DT	a	O	_	_
in	4364	4366	FW	in	O	_	_
vitro	4367	4372	FW	vitro	O	_	_
phophorylation	4373	4387	NN	phophorylation	O	_	_
assay	4388	4393	NN	assay	O	_	_
was	4394	4397	VBD	be	O	_	_
performed	4398	4407	VBN	perform	O	_	_
with	4408	4412	IN	with	O	_	_
a	4413	4414	DT	a	O	_	_
purified	4415	4423	VBN	purify	O	_	_
C-terminus	4424	4434	NN	c-terminus	O	_	_
fragment	4435	4443	NN	fragment	O	_	_
of	4444	4446	IN	of	O	_	_
ASPP2	4447	4452	NN	aspp2	O	_	_
(	4453	4454	CD	(	O	_	_
693-1128	4454	4462	CD	693-1128	O	_	_
)	4462	4463	NN	)	O	_	_
containing	4464	4474	VBG	contain	O	_	_
both	4475	4479	CC	both	O	_	_
MAPK	4480	4484	NN	mapk	O	_	_
putative	4485	4493	JJ	putative	O	_	_
phosphorylation	4494	4509	NN	phosphorylation	O	_	_
sites	4510	4515	NNS	site	O	_	_
.	4515	4516	.	.	O	_	_
D	1

0	3	rcmod
0	4	dep
2	1	nn
3	2	advmod
6	0	nsubjpass
6	5	auxpass
6	11	prep_with
11	8	det
11	9	amod
11	10	nn
11	13	prep_of
16	15	num
16	17	vmod
17	18	prep
18	22	pobj
22	19	nn
22	20	amod
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	4	NP	0	0	5	2	NP	0	0	4	2	DT	0	0	1	1	An	0	0	1	0	RRC	1	1	4	2	ADVP	1	1	3	2	FW	0	1	2	1	in	1	1	2	0	FW	0	2	3	1	vitro	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	phophorylation	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	assay	4	4	5	0	VP	1	5	15	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	15	2	VBN	0	6	7	1	performed	6	6	7	0	PP	0	7	15	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	15	2	NP	3	8	12	4	DT	0	8	9	1	a	8	8	9	0	VBN	0	9	10	1	purified	9	9	10	0	NN	0	10	11	1	C-terminus	10	10	11	0	NN	0	11	12	1	fragment	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	15	2	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NP	0	15	23	2	NP	1	15	17	2	CD	0	15	16	1	693-1128	15	15	16	0	NN	0	16	17	1	-RRB-	16	16	17	0	VP	0	17	23	2	VBG	0	17	18	1	containing	17	17	18	0	PP	0	18	23	2	CC	0	18	19	1	both	18	18	19	0	NP	3	19	23	4	NN	0	19	20	1	MAPK	19	19	20	0	JJ	0	20	21	1	putative	20	20	21	0	NN	0	21	22	1	phosphorylation	21	21	22	0	NNS	0	22	23	1	sites	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	18
When	4517	4521	WRB	when	O	_	_
compared	4522	4530	VBN	compare	O	_	_
to	4531	4533	TO	to	O	_	_
p38	4534	4537	NN	p38	B-GENE	_	_
SAPK	4538	4542	NN	sapk	I-GENE	_	_
,	4542	4543	,	,	O	_	_
MAPK1	4544	4549	NN	mapk1	B-GENE	_	_
was	4550	4553	VBD	be	O	_	_
clearly	4554	4561	RB	clearly	O	_	_
able	4562	4566	JJ	able	O	_	_
to	4567	4569	TO	to	O	_	_
phosphorylate	4570	4583	VB	phosphorylate	O	_	_
the	4584	4587	DT	the	O	_	_
ASPP2	4588	4593	NN	aspp2	O	_	_
fragment	4594	4602	NN	fragment	O	_	_
in	4603	4605	FW	in	O	_	_
vitro	4606	4611	FW	vitro	O	_	_
.	4647	4648	.	.	O	_	_
D	1
9
1	0	advmod
1	4	prep_to
4	3	nn
9	1	advcl
9	6	nsubj
9	7	cop
9	8	advmod
9	11	xcomp
11	10	aux
11	14	dobj
11	16	advmod
14	12	det
14	13	nn
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	SBAR	1	0	5	2	WHADVP	0	0	1	1	WRB	0	0	1	1	When	0	0	1	0	S	0	1	5	1	VP	0	1	5	2	VBN	0	1	2	1	compared	1	1	2	0	PP	0	2	5	2	TO	0	2	3	1	to	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	p38	3	3	4	0	NN	0	4	5	1	SAPK	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	MAPK1	6	6	7	0	VP	2	7	17	3	VBD	0	7	8	1	was	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	clearly	8	8	9	0	ADJP	0	9	17	2	JJ	0	9	10	1	able	9	9	10	0	S	0	10	17	1	VP	1	10	17	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	17	3	VB	0	11	12	1	phosphorylate	11	11	12	0	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	NN	0	14	15	1	fragment	14	14	15	0	ADVP	1	15	17	2	FW	0	15	16	1	in	15	15	16	0	FW	0	16	17	1	vitro	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	60
As	4649	4651	IN	as	O	_	_
shown	4652	4657	VBN	show	O	_	_
in	4658	4660	IN	in	O	_	_
,	4670	4671	,	,	O	_	_
histone	4672	4679	NN	histone	B-GENE	_	_
2B	4680	4682	NN	2b	I-GENE	_	_
phosphorylated	4683	4697	VBN	phosphorylate	O	_	_
by	4698	4700	IN	by	O	_	_
p38	4701	4704	NN	p38	B-GENE	_	_
SAPK	4705	4709	NN	sapk	I-GENE	_	_
had	4710	4713	VBD	have	O	_	_
high	4714	4718	JJ	high	O	_	_
levels	4719	4725	NNS	level	O	_	_
of	4726	4728	IN	of	O	_	_
incorporated	4729	4741	JJ	incorporated	O	_	_
32P	4742	4745	NN	32p	O	_	_
,	4745	4746	,	,	O	_	_
suggesting	4747	4757	VBG	suggest	O	_	_
that	4758	4762	IN	that	O	_	_
p38	4763	4766	NN	p38	B-GENE	_	_
SAPK	4767	4771	NN	sapk	O	_	_
was	4772	4775	VBD	be	O	_	_
active	4776	4782	JJ	active	O	_	_
;	4782	4783	:	;	O	_	_
while	4784	4789	IN	while	O	_	_
under	4790	4795	IN	under	O	_	_
the	4796	4799	DT	the	O	_	_
same	4800	4804	JJ	same	O	_	_
conditions	4805	4815	NNS	condition	O	_	_
,	4815	4816	,	,	O	_	_
ASPP2	4817	4822	NN	aspp2	O	_	_
(	4823	4824	CD	(	O	_	_
693-1128	4824	4832	CD	693-1128	O	_	_
)	4832	4833	NN	)	O	_	_
fragment	4834	4842	NN	fragment	O	_	_
phosphorylated	4843	4857	VBN	phosphorylate	O	_	_
by	4858	4860	IN	by	O	_	_
p38	4861	4864	NN	p38	B-GENE	_	_
SAPK	4865	4869	NN	sapk	O	_	_
had	4870	4873	VBD	have	O	_	_
very	4874	4878	RB	very	O	_	_
low	4879	4882	JJ	low	O	_	_
levels	4883	4889	NNS	level	O	_	_
of	4890	4892	IN	of	O	_	_
incorporated	4893	4905	JJ	incorporated	O	_	_
32P	4906	4909	NN	32p	O	_	_
,	4909	4910	,	,	O	_	_
indicating	4911	4921	VBG	indicate	O	_	_
that	4922	4926	IN	that	O	_	_
p38	4927	4930	NN	p38	B-GENE	_	_
SAPK	4931	4935	NN	sapk	I-GENE	_	_
is	4936	4938	VBZ	be	O	_	_
not	4939	4942	RB	not	O	_	_
an	4943	4945	DT	a	O	_	_
efficient	4946	4955	JJ	efficient	O	_	_
kinase	4956	4962	NN	kinase	O	_	_
for	4963	4966	IN	for	O	_	_
ASPP2	4967	4972	NN	aspp2	B-GENE	_	_
phosphorylation	4973	4988	NN	phosphorylation	O	_	_
.	4988	4989	.	.	O	_	_
D	1
10
1	0	mark
1	2	prep
5	4	nn
5	6	vmod
6	9	agent
9	8	nn
10	1	advcl
10	5	nsubj
10	12	dobj
10	17	vmod
12	11	amod
12	15	prep_of
15	14	amod
17	22	ccomp
20	19	nn
22	18	mark
22	20	nsubj
22	21	cop
22	39	parataxis
28	26	det
28	27	amod
28	30	appos
34	32	num
34	35	vmod
35	38	agent
38	37	nn
39	24	mark
39	28	prep_under
39	34	nsubj
39	42	dobj
39	47	vmod
41	40	advmod
42	41	amod
42	45	prep_of
45	44	amod
47	55	ccomp
50	49	nn
55	48	mark
55	50	nsubj
55	51	cop
55	52	neg
55	53	det
55	54	amod
55	58	prep_for
58	57	nn
EOX
Y	1
ROOT	0	0	60	1	S	3	0	60	5	SBAR	1	0	3	2	IN	0	0	1	1	As	0	0	1	0	S	0	1	3	1	VP	0	1	3	2	VBN	0	1	2	1	shown	1	1	2	0	PP	0	2	3	1	IN	0	2	3	1	in	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	10	2	NP	1	4	6	2	NN	0	4	5	1	histone	4	4	5	0	NN	0	5	6	1	2B	5	5	6	0	VP	0	6	10	2	VBN	0	6	7	1	phosphorylated	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	by	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	p38	8	8	9	0	NN	0	9	10	1	SAPK	9	9	10	0	VP	0	10	59	4	VBD	0	10	11	1	had	10	10	11	0	NP	0	11	16	2	NP	1	11	13	2	JJ	0	11	12	1	high	11	11	12	0	NNS	0	12	13	1	levels	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	of	13	13	14	0	NP	1	14	16	2	JJ	0	14	15	1	incorporated	14	14	15	0	NN	0	15	16	1	32P	15	15	16	0	,	0	16	17	1	,	16	16	17	0	S	0	17	59	1	VP	0	17	59	2	VBG	0	17	18	1	suggesting	17	17	18	0	SBAR	1	18	59	2	IN	0	18	19	1	that	18	18	19	0	S	1	19	59	4	NP	1	19	21	2	NN	0	19	20	1	p38	19	19	20	0	NN	0	20	21	1	SAPK	20	20	21	0	VP	1	21	23	2	VBD	0	21	22	1	was	21	21	22	0	ADJP	0	22	23	1	JJ	0	22	23	1	active	22	22	23	0	:	0	23	24	1	;	23	23	24	0	SBAR	1	24	59	2	IN	0	24	25	1	while	24	24	25	0	S	2	25	59	3	PP	0	25	32	2	IN	0	25	26	1	under	25	25	26	0	NP	0	26	32	3	NP	2	26	29	3	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	same	27	27	28	0	NNS	0	28	29	1	conditions	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	0	30	32	2	NN	0	30	31	1	ASPP2	30	30	31	0	CD	0	31	32	1	-LRB-	31	31	32	0	NP	0	32	39	2	NP	2	32	35	3	CD	0	32	33	1	693-1128	32	32	33	0	NN	0	33	34	1	-RRB-	33	33	34	0	NN	0	34	35	1	fragment	34	34	35	0	VP	0	35	39	2	VBN	0	35	36	1	phosphorylated	35	35	36	0	PP	0	36	39	2	IN	0	36	37	1	by	36	36	37	0	NP	1	37	39	2	NN	0	37	38	1	p38	37	37	38	0	NN	0	38	39	1	SAPK	38	38	39	0	VP	0	39	59	4	VBD	0	39	40	1	had	39	39	40	0	NP	0	40	46	2	NP	1	40	43	2	ADJP	1	40	42	2	RB	0	40	41	1	very	40	40	41	0	JJ	0	41	42	1	low	41	41	42	0	NNS	0	42	43	1	levels	42	42	43	0	PP	0	43	46	2	IN	0	43	44	1	of	43	43	44	0	NP	1	44	46	2	JJ	0	44	45	1	incorporated	44	44	45	0	NN	0	45	46	1	32P	45	45	46	0	,	0	46	47	1	,	46	46	47	0	S	0	47	59	1	VP	0	47	59	2	VBG	0	47	48	1	indicating	47	47	48	0	SBAR	1	48	59	2	IN	0	48	49	1	that	48	48	49	0	S	1	49	59	2	NP	1	49	51	2	NN	0	49	50	1	p38	49	49	50	0	NN	0	50	51	1	SAPK	50	50	51	0	VP	2	51	59	3	VBZ	0	51	52	1	is	51	51	52	0	RB	0	52	53	1	not	52	52	53	0	NP	0	53	59	2	NP	2	53	56	3	DT	0	53	54	1	an	53	53	54	0	JJ	0	54	55	1	efficient	54	54	55	0	NN	0	55	56	1	kinase	55	55	56	0	PP	0	56	59	2	IN	0	56	57	1	for	56	56	57	0	NP	1	57	59	2	NN	0	57	58	1	ASPP2	57	57	58	0	NN	0	58	59	1	phosphorylation	58	58	59	0	.	0	59	60	1	.	59	59	60	0
EOS
T	22
The	4990	4993	DT	the	O	_	_
phosphorylated	4994	5008	VBN	phosphorylate	B-GENE	_	_
ASPP2	5009	5014	NN	aspp2	I-GENE	_	_
fragment	5015	5023	NN	fragment	I-GENE	_	_
by	5024	5026	IN	by	O	_	_
MAPK1	5027	5032	NN	mapk1	B-GENE	_	_
was	5033	5036	VBD	be	O	_	_
digested	5037	5045	VBN	digest	O	_	_
by	5046	5048	IN	by	O	_	_
trypsin	5049	5056	NN	trypsin	B-GENE	_	_
and	5057	5060	CC	and	O	_	_
fractioned	5061	5071	VBN	fraction	O	_	_
on	5072	5074	IN	on	O	_	_
a	5075	5076	DT	a	O	_	_
high	5077	5081	JJ	high	O	_	_
performance	5082	5093	NN	performance	O	_	_
liquid	5094	5100	JJ	liquid	O	_	_
chromatography	5101	5115	NN	chromatography	O	_	_
(	5116	5117	CD	(	O	_	_
HPLC	5117	5121	NN	hplc	O	_	_
)	5121	5122	NN	)	O	_	_
.	5122	5123	.	.	O	_	_
D	1
7
0	1	vmod
1	3	dobj
1	5	agent
3	2	nn
7	0	nsubjpass
7	6	auxpass
7	9	agent
7	11	conj_and
11	0	nsubjpass
11	17	prep_on
17	13	det
17	14	amod
17	15	nn
17	16	amod
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	6	2	NP	0	0	1	1	DT	0	0	1	1	The	0	0	1	0	VP	0	1	6	3	VBN	0	1	2	1	phosphorylated	1	1	2	0	NP	1	2	4	2	NN	0	2	3	1	ASPP2	2	2	3	0	NN	0	3	4	1	fragment	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	MAPK1	5	5	6	0	VP	1	6	21	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	21	4	VP	0	7	10	2	VBN	0	7	8	1	digested	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	by	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	trypsin	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	VP	0	11	18	2	VBN	0	11	12	1	fractioned	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	on	12	12	13	0	NP	4	13	18	5	DT	0	13	14	1	a	13	13	14	0	JJ	0	14	15	1	high	14	14	15	0	NN	0	15	16	1	performance	15	15	16	0	JJ	0	16	17	1	liquid	16	16	17	0	NN	0	17	18	1	chromatography	17	17	18	0	NP	2	18	21	3	CD	0	18	19	1	-LRB-	18	18	19	0	NN	0	19	20	1	HPLC	19	19	20	0	NN	0	20	21	1	-RRB-	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	10
Each	5124	5128	DT	each	O	_	_
eluted	5129	5135	VBN	elute	O	_	_
fraction	5136	5144	NN	fraction	O	_	_
was	5145	5148	VBD	be	O	_	_
measured	5149	5157	VBN	measure	O	_	_
for	5158	5161	IN	for	O	_	_
its	5162	5165	PRP$	its	O	_	_
radioactivity	5166	5179	NN	radioactivity	O	_	_
content	5180	5187	NN	content	O	_	_
.	5212	5213	.	.	O	_	_
D	1
4
0	1	vmod
1	2	dobj
4	0	nsubjpass
4	3	auxpass
4	8	prep_for
8	6	poss
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	3	2	NP	0	0	1	1	DT	0	0	1	1	Each	0	0	1	0	VP	0	1	3	2	VBN	0	1	2	1	eluted	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	fraction	2	2	3	0	VP	1	3	9	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	measured	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	for	5	5	6	0	NP	2	6	9	3	PRP$	0	6	7	1	its	6	6	7	0	NN	0	7	8	1	radioactivity	7	7	8	0	NN	0	8	9	1	content	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	12
The	5214	5217	DT	the	O	_	_
fractions	5218	5227	NNS	fraction	O	_	_
representing	5228	5240	VBG	represent	O	_	_
these	5241	5246	DT	these	O	_	_
radioactive	5247	5258	JJ	radioactive	O	_	_
peaks	5259	5264	NNS	peak	O	_	_
were	5265	5269	VBD	be	O	_	_
analysed	5270	5278	VBN	analyse	O	_	_
by	5279	5281	IN	by	O	_	_
mass	5282	5286	NN	mass	O	_	_
spectrometry	5287	5299	NN	spectrometry	O	_	_
.	5299	5300	.	.	O	_	_
D	1
7
1	0	det
1	2	vmod
2	5	dobj
5	3	det
5	4	amod
7	1	nsubjpass
7	6	auxpass
7	10	agent
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	6	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	fractions	1	1	2	0	VP	0	2	6	2	VBG	0	2	3	1	representing	2	2	3	0	NP	2	3	6	3	DT	0	3	4	1	these	3	3	4	0	JJ	0	4	5	1	radioactive	4	4	5	0	NNS	0	5	6	1	peaks	5	5	6	0	VP	1	6	11	2	VBD	0	6	7	1	were	6	6	7	0	VP	0	7	11	2	VBN	0	7	8	1	analysed	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	by	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	mass	9	9	10	0	NN	0	10	11	1	spectrometry	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	41
Of	5301	5303	IN	of	O	_	_
the	5304	5307	DT	the	O	_	_
two	5308	5311	CD	two	O	_	_
radioactive	5312	5323	JJ	radioactive	O	_	_
peaks	5324	5329	NNS	peak	O	_	_
,	5329	5330	,	,	O	_	_
one	5331	5334	CD	one	O	_	_
represented	5335	5346	VBD	represent	O	_	_
the	5347	5350	DT	the	O	_	_
linker	5351	5357	NN	linker	O	_	_
region	5358	5364	NN	region	O	_	_
between	5365	5372	IN	between	O	_	_
the	5373	5376	DT	the	O	_	_
GST	5377	5380	NN	gst	O	_	_
and	5381	5384	CC	and	O	_	_
our	5385	5388	PRP$	we	O	_	_
ASPP2	5389	5394	NN	aspp2	O	_	_
fragment	5395	5403	NN	fragment	O	_	_
and	5404	5407	CC	and	O	_	_
the	5408	5411	DT	the	O	_	_
other	5412	5417	JJ	other	O	_	_
corresponded	5418	5430	VBD	correspond	O	_	_
to	5431	5433	TO	to	O	_	_
a	5434	5435	DT	a	O	_	_
fragment	5436	5444	NN	fragment	O	_	_
of	5445	5447	IN	of	O	_	_
the	5448	5451	DT	the	O	_	_
same	5452	5456	JJ	same	O	_	_
mass	5457	5461	NN	mass	O	_	_
as	5462	5464	IN	as	O	_	_
that	5465	5469	DT	that	O	_	_
containing	5470	5480	VBG	contain	O	_	_
the	5481	5484	DT	the	O	_	_
second	5485	5491	JJ	second	O	_	_
putative	5492	5500	JJ	putative	O	_	_
phosphorylation	5501	5516	NN	phosphorylation	O	_	_
site	5517	5521	NN	site	O	_	_
,	5521	5522	,	,	O	_	_
serine	5523	5529	NN	serine	O	_	_
827	5530	5533	CD	827	O	_	_
.	5533	5534	.	.	O	_	_
D	1
7
4	1	det
4	2	num
4	3	amod
7	4	prep_of
7	6	nsubj
7	21	ccomp
10	8	det
10	9	nn
10	13	prep_between
10	17	prep_between
13	12	det
13	17	conj_and
13	20	conj_and
17	15	poss
17	16	nn
17	20	conj_and
20	19	det
21	10	nsubj
21	24	prep_to
21	31	prepc_as
24	23	det
24	28	prep_of
28	26	det
28	27	amod
31	30	nsubj
31	36	dobj
36	32	det
36	33	amod
36	34	amod
36	35	nn
36	38	appos
38	39	num
EOX
Y	1
ROOT	0	0	41	1	S	3	0	41	5	PP	0	0	5	2	IN	0	0	1	1	Of	0	0	1	0	NP	3	1	5	4	DT	0	1	2	1	the	1	1	2	0	CD	0	2	3	1	two	2	2	3	0	JJ	0	3	4	1	radioactive	3	3	4	0	NNS	0	4	5	1	peaks	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	7	1	CD	0	6	7	1	one	6	6	7	0	VP	0	7	40	2	VBD	0	7	8	1	represented	7	7	8	0	SBAR	0	8	40	1	S	1	8	40	2	NP	0	8	21	2	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	linker	9	9	10	0	NN	0	10	11	1	region	10	10	11	0	PP	0	11	21	2	IN	0	11	12	1	between	11	11	12	0	NP	0	12	21	3	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	GST	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	0	15	21	3	NP	2	15	18	3	PRP$	0	15	16	1	our	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	NN	0	17	18	1	fragment	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	JJ	0	20	21	1	other	20	20	21	0	VP	0	21	40	3	VBD	0	21	22	1	corresponded	21	21	22	0	PP	0	22	29	2	TO	0	22	23	1	to	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	DT	0	23	24	1	a	23	23	24	0	NN	0	24	25	1	fragment	24	24	25	0	PP	0	25	29	2	IN	0	25	26	1	of	25	25	26	0	NP	2	26	29	3	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	same	27	27	28	0	NN	0	28	29	1	mass	28	28	29	0	PP	0	29	40	2	IN	0	29	30	1	as	29	29	30	0	S	1	30	40	2	NP	0	30	31	1	DT	0	30	31	1	that	30	30	31	0	VP	0	31	40	2	VBG	0	31	32	1	containing	31	31	32	0	NP	0	32	40	3	NP	4	32	37	5	DT	0	32	33	1	the	32	32	33	0	JJ	0	33	34	1	second	33	33	34	0	JJ	0	34	35	1	putative	34	34	35	0	NN	0	35	36	1	phosphorylation	35	35	36	0	NN	0	36	37	1	site	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	40	2	NN	0	38	39	1	serine	38	38	39	0	CD	0	39	40	1	827	39	39	40	0	.	0	40	41	1	.	40	40	41	0
EOS
T	13
Hence	5535	5540	RB	hence	O	_	_
ASPP2	5541	5546	NN	aspp2	O	_	_
can	5547	5550	MD	can	O	_	_
be	5551	5553	VB	be	O	_	_
phosphorylated	5554	5568	VBN	phosphorylate	O	_	_
at	5569	5571	IN	at	O	_	_
serine	5572	5578	NN	serine	O	_	_
827	5579	5582	CD	827	O	_	_
by	5583	5585	IN	by	O	_	_
MAPK1	5586	5591	NN	mapk1	B-GENE	_	_
in	5592	5594	FW	in	O	_	_
vitro	5595	5600	FW	vitro	O	_	_
.	5600	5601	.	.	O	_	_
D	1
4
4	0	advmod
4	1	nsubjpass
4	2	aux
4	3	auxpass
4	6	prep_at
4	11	advmod
6	7	num
6	9	prep_by
11	10	nn
EOX
Y	1
ROOT	0	0	13	1	S	2	0	13	4	ADVP	0	0	1	1	RB	0	0	1	1	Hence	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	12	2	MD	0	2	3	1	can	2	2	3	0	VP	1	3	12	2	VB	0	3	4	1	be	3	3	4	0	VP	0	4	12	3	VBN	0	4	5	1	phosphorylated	4	4	5	0	PP	0	5	10	2	IN	0	5	6	1	at	5	5	6	0	NP	0	6	10	2	NP	0	6	8	2	NN	0	6	7	1	serine	6	6	7	0	CD	0	7	8	1	827	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	by	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	MAPK1	9	9	10	0	ADVP	1	10	12	2	FW	0	10	11	1	in	10	10	11	0	FW	0	11	12	1	vitro	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	17
(	5603	5604	NN	(	O	_	_
A	5604	5605	NN	a	O	_	_
)	5605	5606	CD	)	O	_	_
ASPP1	5607	5612	NN	aspp1	B-GENE	_	_
and	5613	5616	CC	and	O	_	_
ASPP2	5617	5622	NN	aspp2	B-GENE	_	_
have	5623	5627	VBP	have	O	_	_
two	5628	5631	CD	two	O	_	_
conserved	5632	5641	VBN	conserve	O	_	_
putative	5642	5650	JJ	putative	O	_	_
MAPK2	5651	5656	NN	mapk2	B-GENE	_	_
phosphorylation	5657	5672	NN	phosphorylation	O	_	_
sites	5673	5678	NNS	site	O	_	_
in	5679	5681	IN	in	O	_	_
their	5682	5687	PRP$	they	O	_	_
C-terminus	5688	5698	NN	c-terminus	O	_	_
.	5698	5699	.	.	O	_	_
D	1
6
1	3	dep
1	5	conj_and
6	1	nsubj
6	5	nsubj
6	7	dobj
7	8	vmod
8	12	dobj
12	9	amod
12	10	nn
12	11	nn
12	15	prep_in
15	14	poss
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	0	0	6	3	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	1	2	4	2	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	ASPP1	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	ASPP2	5	5	6	0	VP	0	6	16	2	VBP	0	6	7	1	have	6	6	7	0	NP	0	7	16	2	NP	0	7	8	1	CD	0	7	8	1	two	7	7	8	0	VP	0	8	16	2	VBN	0	8	9	1	conserved	8	8	9	0	NP	0	9	16	2	NP	3	9	13	4	JJ	0	9	10	1	putative	9	9	10	0	NN	0	10	11	1	MAPK2	10	10	11	0	NN	0	11	12	1	phosphorylation	11	11	12	0	NNS	0	12	13	1	sites	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	in	13	13	14	0	NP	1	14	16	2	PRP$	0	14	15	1	their	14	14	15	0	NN	0	15	16	1	C-terminus	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	19
(	5700	5701	NN	(	O	_	_
B	5701	5702	NN	b	O	_	_
)	5702	5703	CD	)	O	_	_
The	5704	5707	DT	the	O	_	_
C-terminus	5708	5718	NN	c-terminus	O	_	_
fragment	5719	5727	NN	fragment	O	_	_
of	5728	5730	IN	of	O	_	_
ASPP2	5731	5736	NN	aspp2	B-GENE	_	_
is	5737	5739	VBZ	be	O	_	_
phosphorylated	5740	5754	VBN	phosphorylate	O	_	_
in	5755	5757	FW	in	O	_	_
vitro	5758	5763	FW	vitro	O	_	_
by	5764	5766	IN	by	O	_	_
MAPK1	5767	5772	NN	mapk1	B-GENE	_	_
(	5773	5774	CD	(	O	_	_
left	5774	5778	VBD	leave	O	_	_
panel	5779	5784	NN	panel	O	_	_
)	5784	5785	NN	)	O	_	_
.	5785	5786	.	.	O	_	_
D	1
9
1	5	dep
5	3	det
5	4	nn
5	7	prep_of
9	1	nsubjpass
9	8	auxpass
9	11	advmod
9	13	agent
11	10	nn
13	15	vmod
17	16	nn
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	8	3	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	NP	0	3	8	2	NP	2	3	6	3	DT	0	3	4	1	The	3	3	4	0	NN	0	4	5	1	C-terminus	4	4	5	0	NN	0	5	6	1	fragment	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	VP	1	8	18	2	VBZ	0	8	9	1	is	8	8	9	0	VP	0	9	18	3	VBN	0	9	10	1	phosphorylated	9	9	10	0	ADVP	1	10	12	2	FW	0	10	11	1	in	10	10	11	0	FW	0	11	12	1	vitro	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	by	12	12	13	0	NP	0	13	18	2	NP	0	13	15	2	NN	0	13	14	1	MAPK1	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	VP	0	15	18	2	VBD	0	15	16	1	left	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	panel	16	16	17	0	NN	0	17	18	1	-RRB-	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	11
The	5787	5790	DT	the	O	_	_
intensity	5791	5800	NN	intensity	O	_	_
of	5801	5803	IN	of	O	_	_
phosphorylation	5804	5819	NN	phosphorylation	O	_	_
is	5820	5822	VBZ	be	O	_	_
quantified	5823	5833	VBN	quantify	O	_	_
(	5834	5835	RB	(	O	_	_
middle	5835	5841	JJ	middle	O	_	_
panel	5842	5847	NN	panel	O	_	_
)	5847	5848	NN	)	O	_	_
.	5848	5849	.	.	O	_	_
D	1

1	0	det
1	3	prep_of
5	1	nsubjpass
5	4	auxpass
9	7	amod
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	4	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	intensity	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	phosphorylation	3	3	4	0	VP	1	4	10	2	VBZ	0	4	5	1	is	4	4	5	0	VP	0	5	10	2	VBN	0	5	6	1	quantified	5	5	6	0	NP	2	6	10	3	ADJP	1	6	8	2	RB	0	6	7	1	-LRB-	6	6	7	0	JJ	0	7	8	1	middle	7	7	8	0	NN	0	8	9	1	panel	8	8	9	0	NN	0	9	10	1	-RRB-	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	25
The	5850	5853	DT	the	O	_	_
MAPK1	5854	5859	NN	mapk1	O	_	_
phosphorylated	5860	5874	VBN	phosphorylate	B-GENE	_	_
ASPP2	5875	5880	NN	aspp2	I-GENE	_	_
fragment	5881	5889	NN	fragment	I-GENE	_	_
was	5890	5893	VBD	be	O	_	_
digested	5894	5902	VBN	digest	O	_	_
with	5903	5907	IN	with	O	_	_
trypsin	5908	5915	NN	trypsin	O	_	_
and	5916	5919	CC	and	O	_	_
chromatographed	5920	5935	NN	chromatographed	O	_	_
and	5936	5939	CC	and	O	_	_
the	5940	5943	DT	the	O	_	_
radioactive	5944	5955	JJ	radioactive	O	_	_
peptides	5956	5964	NNS	peptide	O	_	_
were	5965	5969	VBD	be	O	_	_
measured	5970	5978	VBN	measure	O	_	_
by	5979	5981	IN	by	O	_	_
mass	5982	5986	NN	mass	O	_	_
spectrometry	5987	5999	NN	spectrometry	O	_	_
(	6000	6001	RB	(	O	_	_
right	6001	6006	JJ	right	O	_	_
panel	6007	6012	NN	panel	O	_	_
)	6012	6013	NN	)	O	_	_
.	6013	6014	.	.	O	_	_
D	1

1	0	det
1	2	vmod
2	4	dobj
4	3	nn
6	1	nsubjpass
6	5	auxpass
6	8	prep_with
6	10	prep_with
6	16	conj_and
8	10	conj_and
14	12	det
14	13	amod
16	14	nsubjpass
16	15	auxpass
16	17	prep
19	18	nn
23	19	nn
23	21	amod
23	22	nn
EOX
Y	1
ROOT	0	0	25	1	S	0	0	25	4	S	1	0	11	2	NP	0	0	5	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	MAPK1	1	1	2	0	VP	0	2	5	2	VBN	0	2	3	1	phosphorylated	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	ASPP2	3	3	4	0	NN	0	4	5	1	fragment	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	digested	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	trypsin	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	chromatographed	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	S	1	12	24	2	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	radioactive	13	13	14	0	NNS	0	14	15	1	peptides	14	14	15	0	VP	1	15	24	2	VBD	0	15	16	1	were	15	15	16	0	VP	0	16	24	2	VBN	0	16	17	1	measured	16	16	17	0	PP	0	17	24	2	IN	0	17	18	1	by	17	17	18	0	NP	3	18	24	4	NP	1	18	20	2	NN	0	18	19	1	mass	18	18	19	0	NN	0	19	20	1	spectrometry	19	19	20	0	ADJP	1	20	22	2	RB	0	20	21	1	-LRB-	20	20	21	0	JJ	0	21	22	1	right	21	21	22	0	NN	0	22	23	1	panel	22	22	23	0	NN	0	23	24	1	-RRB-	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	24
The	6015	6018	DT	the	O	_	_
first	6019	6024	JJ	first	O	_	_
peak	6025	6029	NN	peak	O	_	_
represents	6030	6040	VBZ	represent	O	_	_
the	6041	6044	DT	the	O	_	_
GST	6045	6048	NN	gst	O	_	_
linker	6049	6055	NN	linker	O	_	_
region	6056	6062	NN	region	O	_	_
whereas	6063	6070	IN	whereas	O	_	_
the	6071	6074	DT	the	O	_	_
second	6075	6081	JJ	second	O	_	_
presented	6082	6091	VBN	present	O	_	_
a	6092	6093	DT	a	O	_	_
region	6094	6100	NN	region	O	_	_
of	6101	6103	IN	of	O	_	_
equal	6104	6109	JJ	equal	O	_	_
mass	6110	6114	NN	mass	O	_	_
to	6115	6117	TO	to	O	_	_
the	6118	6121	DT	the	O	_	_
fragment	6122	6130	NN	fragment	O	_	_
containing	6131	6141	VBG	contain	O	_	_
serine	6142	6148	NN	serine	O	_	_
827	6149	6152	CD	827	O	_	_
.	6152	6153	.	.	O	_	_
D	1
3
2	0	det
2	1	amod
3	2	nsubj
3	7	dobj
3	11	advcl
7	4	det
7	5	nn
7	6	nn
10	9	det
11	8	mark
11	10	nsubj
11	13	dobj
11	19	prep_to
13	12	det
13	16	prep_of
16	15	amod
19	18	det
19	20	vmod
20	21	dobj
21	22	num
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	first	1	1	2	0	NN	0	2	3	1	peak	2	2	3	0	VP	0	3	23	3	VBZ	0	3	4	1	represents	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	GST	5	5	6	0	NN	0	6	7	1	linker	6	6	7	0	NN	0	7	8	1	region	7	7	8	0	SBAR	1	8	23	2	IN	0	8	9	1	whereas	8	8	9	0	S	1	9	23	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	second	10	10	11	0	VP	0	11	23	3	VBN	0	11	12	1	presented	11	11	12	0	NP	0	12	17	2	NP	1	12	14	2	DT	0	12	13	1	a	12	12	13	0	NN	0	13	14	1	region	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	of	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	equal	15	15	16	0	NN	0	16	17	1	mass	16	16	17	0	PP	0	17	23	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	DT	0	18	19	1	the	18	18	19	0	NN	0	19	20	1	fragment	19	19	20	0	VP	0	20	23	2	VBG	0	20	21	1	containing	20	20	21	0	NP	0	21	23	2	NN	0	21	22	1	serine	21	21	22	0	CD	0	22	23	1	827	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	23
(	6154	6155	NN	(	O	_	_
C	6155	6156	NN	c	O	_	_
)	6156	6157	CD	)	O	_	_
An	6158	6160	DT	a	O	_	_
in	6161	6163	FW	in	O	_	_
vitro	6164	6169	FW	vitro	O	_	_
phosphorylation	6170	6185	NN	phosphorylation	O	_	_
assay	6186	6191	NN	assay	O	_	_
was	6192	6195	VBD	be	O	_	_
performed	6196	6205	VBN	perform	O	_	_
on	6206	6208	IN	on	O	_	_
the	6209	6212	DT	the	O	_	_
ASPP2	6213	6218	NN	aspp2	B-GENE	_	_
C-terminus	6219	6229	NN	c-terminus	I-GENE	_	_
fragment	6230	6238	NN	fragment	I-GENE	_	_
with	6239	6243	IN	with	O	_	_
recombinant	6244	6255	JJ	recombinant	B-GENE	_	_
MAPK1	6256	6261	NN	mapk1	I-GENE	_	_
and	6262	6265	CC	and	O	_	_
non	6266	6269	JJ	non	O	_	_
radioactive	6270	6281	JJ	radioactive	O	_	_
ATP	6282	6285	NN	atp	O	_	_
.	6285	6286	.	.	O	_	_
D	1
9
1	3	dep
3	7	rcmod
5	4	nn
7	5	advmod
7	6	nn
9	1	nsubjpass
9	8	auxpass
9	14	prep_on
9	17	prep_with
9	21	prep_with
14	11	det
14	12	nn
14	13	nn
17	16	amod
17	21	conj_and
21	19	amod
21	20	amod
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	0	0	8	3	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	C	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	NP	0	3	8	2	DT	0	3	4	1	An	3	3	4	0	RRC	1	4	8	2	ADVP	1	4	6	2	FW	0	4	5	1	in	4	4	5	0	FW	0	5	6	1	vitro	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	phosphorylation	6	6	7	0	NN	0	7	8	1	assay	7	7	8	0	VP	1	8	22	2	VBD	0	8	9	1	was	8	8	9	0	VP	0	9	22	3	VBN	0	9	10	1	performed	9	9	10	0	PP	0	10	15	2	IN	0	10	11	1	on	10	10	11	0	NP	3	11	15	4	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	NN	0	13	14	1	C-terminus	13	13	14	0	NN	0	14	15	1	fragment	14	14	15	0	PP	0	15	22	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	22	3	NP	1	16	18	2	JJ	0	16	17	1	recombinant	16	16	17	0	NN	0	17	18	1	MAPK1	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NP	2	19	22	3	JJ	0	19	20	1	non	19	19	20	0	JJ	0	20	21	1	radioactive	20	20	21	0	NN	0	21	22	1	ATP	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	20
The	6287	6290	DT	the	O	_	_
phosphorylation	6291	6306	NN	phosphorylation	O	_	_
status	6307	6313	NN	status	O	_	_
of	6314	6316	IN	of	O	_	_
ASPP2	6317	6322	NN	aspp2	O	_	_
was	6323	6326	VBD	be	O	_	_
assessed	6327	6335	VBN	assess	O	_	_
using	6336	6341	VBG	use	O	_	_
the	6342	6345	DT	the	O	_	_
purified	6346	6354	VBN	purify	O	_	_
NGH.S4	6355	6361	NN	ngh.s4	B-GENE	_	_
phospho	6362	6369	NN	phospho	I-GENE	_	_
specific	6370	6378	JJ	specific	I-GENE	_	_
ASPP2	6379	6384	NN	aspp2	I-GENE	_	_
antibody	6385	6393	NN	antibody	I-GENE	_	_
(	6394	6395	CD	(	O	_	_
upper	6395	6400	JJ	upper	O	_	_
panel	6401	6406	NN	panel	O	_	_
)	6406	6407	NN	)	O	_	_
.	6407	6408	.	.	O	_	_
D	1
6
2	0	det
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	7	ccomp
7	11	dobj
7	14	dep
11	8	det
11	9	amod
11	10	nn
14	12	amod
14	13	nn
18	16	amod
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	NN	0	2	3	1	status	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	19	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	19	2	VBN	0	6	7	1	assessed	6	6	7	0	SBAR	0	7	19	1	S	0	7	19	2	VP	0	7	12	2	VBG	0	7	8	1	using	7	7	8	0	NP	3	8	12	4	DT	0	8	9	1	the	8	8	9	0	VBN	0	9	10	1	purified	9	9	10	0	NN	0	10	11	1	NGH.S4	10	10	11	0	NN	0	11	12	1	phospho	11	11	12	0	NP	0	12	19	2	NP	2	12	15	3	JJ	0	12	13	1	specific	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	NN	0	14	15	1	antibody	14	14	15	0	NP	3	15	19	4	CD	0	15	16	1	-LRB-	15	15	16	0	JJ	0	16	17	1	upper	16	16	17	0	NN	0	17	18	1	panel	17	17	18	0	NN	0	18	19	1	-RRB-	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	9
Total	6409	6414	JJ	total	O	_	_
ASPP2	6415	6420	NN	aspp2	O	_	_
is	6421	6423	VBZ	be	O	_	_
shown	6424	6429	VBN	show	O	_	_
in	6430	6432	IN	in	O	_	_
the	6433	6436	DT	the	O	_	_
lower	6437	6442	JJR	lower	O	_	_
panel	6443	6448	NN	panel	O	_	_
.	6448	6449	.	.	O	_	_
D	1
3
1	0	amod
3	1	nsubjpass
3	2	auxpass
3	7	prep_in
7	5	det
7	6	amod
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	JJ	0	0	1	1	Total	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	in	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	JJR	0	6	7	1	lower	6	6	7	0	NN	0	7	8	1	panel	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	14
(	6450	6451	NN	(	O	_	_
D	6451	6452	NN	d	O	_	_
)	6452	6453	CD	)	O	_	_
Saos2	6454	6459	NN	saos2	O	_	_
cells	6460	6465	NNS	cell	O	_	_
were	6466	6470	VBD	be	O	_	_
starved	6471	6478	VBN	starve	O	_	_
then	6479	6483	RB	then	O	_	_
stimulated	6484	6494	VBN	stimulate	O	_	_
with	6495	6499	IN	with	O	_	_
serum	6500	6505	NN	serum	O	_	_
and	6506	6509	CC	and	O	_	_
EGF	6510	6513	NN	egf	B-GENE	_	_
.	6513	6514	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	7	advmod
6	8	dep
8	10	prep_with
8	12	prep_with
10	12	conj_and
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	D	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	13	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	13	3	VBN	0	6	7	1	starved	6	6	7	0	ADVP	0	7	8	1	RB	0	7	8	1	then	7	7	8	0	S	0	8	13	1	VP	0	8	13	2	VBN	0	8	9	1	stimulated	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	13	3	NN	0	10	11	1	serum	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NN	0	12	13	1	EGF	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	32
At	6515	6517	IN	at	O	_	_
the	6518	6521	DT	the	O	_	_
indicated	6522	6531	JJ	indicated	O	_	_
times	6532	6537	NNS	time	O	_	_
the	6538	6541	DT	the	O	_	_
cells	6542	6547	NNS	cell	O	_	_
were	6548	6552	VBD	be	O	_	_
harvested	6553	6562	VBN	harvest	O	_	_
and	6563	6566	CC	and	O	_	_
either	6567	6573	CC	either	O	_	_
blotted	6574	6581	VBN	blot	O	_	_
for	6582	6585	IN	for	O	_	_
phospho	6586	6593	NN	phospho	O	_	_
/	6593	6594	:	/	O	_	_
total	6594	6599	JJ	total	O	_	_
MAPK	6600	6604	NN	mapk	O	_	_
(	6605	6606	NN	(	O	_	_
upper	6606	6611	JJ	upper	O	_	_
panel	6612	6617	NN	panel	O	_	_
)	6617	6618	NN	)	O	_	_
or	6619	6621	CC	or	O	_	_
immunoprecipitated	6622	6640	VBN	immunoprecipitate	O	_	_
for	6641	6644	IN	for	O	_	_
total	6645	6650	JJ	total	O	_	_
ASPP2	6651	6656	NN	aspp2	B-GENE	_	_
and	6657	6660	CC	and	O	_	_
blotted	6661	6668	VBN	blot	O	_	_
with	6669	6673	IN	with	O	_	_
NGH.S4	6674	6680	NN	ngh.s4	B-GENE	_	_
phospho-ASPP2	6681	6694	NN	phospho-aspp2	I-GENE	_	_
antibody	6695	6703	NN	antibody	I-GENE	_	_
.	6703	6704	.	.	O	_	_
D	1
7
3	1	det
3	2	amod
5	4	det
7	3	prep_at
7	5	nsubjpass
7	6	auxpass
7	9	advmod
7	10	conj_and
7	21	conj_and
10	5	nsubjpass
10	12	prep_for
10	21	conj_or
10	26	conj_or
16	13	punct
16	14	amod
16	15	nn
19	17	amod
19	18	nn
21	24	prep_for
21	26	conj_and
24	23	amod
26	30	prep_with
30	28	nn
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	S	2	0	32	4	PP	0	0	4	2	IN	0	0	1	1	At	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	the	1	1	2	0	JJ	0	2	3	1	indicated	2	2	3	0	NNS	0	3	4	1	times	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NNS	0	5	6	1	cells	5	5	6	0	VP	1	6	31	2	VBD	0	6	7	1	were	6	6	7	0	VP	0	7	31	4	VP	0	7	8	1	VBN	0	7	8	1	harvested	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	ADVP	0	9	10	1	CC	0	9	10	1	either	9	9	10	0	VP	0	10	31	3	VP	0	10	20	3	VBN	0	10	11	1	blotted	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	for	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	phospho	12	12	13	0	PRN	1	13	20	2	:	0	13	14	1	/	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	JJ	0	14	15	1	total	14	14	15	0	NN	0	15	16	1	MAPK	15	15	16	0	NN	0	16	17	1	-LRB-	16	16	17	0	NP	2	17	20	3	JJ	0	17	18	1	upper	17	17	18	0	NN	0	18	19	1	panel	18	18	19	0	NN	0	19	20	1	-RRB-	19	19	20	0	CC	0	20	21	1	or	20	20	21	0	VP	0	21	31	3	VP	0	21	25	2	VBN	0	21	22	1	immunoprecipitated	21	21	22	0	PP	0	22	25	2	IN	0	22	23	1	for	22	22	23	0	NP	1	23	25	2	JJ	0	23	24	1	total	23	23	24	0	NN	0	24	25	1	ASPP2	24	24	25	0	CC	0	25	26	1	and	25	25	26	0	VP	0	26	31	2	VBN	0	26	27	1	blotted	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	with	27	27	28	0	NP	2	28	31	3	NN	0	28	29	1	NGH.S4	28	28	29	0	NN	0	29	30	1	phospho-ASPP2	29	29	30	0	NN	0	30	31	1	antibody	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	27
(	6705	6706	NN	(	O	_	_
E	6706	6707	NN	e	O	_	_
)	6707	6708	CD	)	O	_	_
Total	6709	6714	JJ	total	O	_	_
cell	6715	6719	NN	cell	O	_	_
lysates	6720	6727	NNS	lysate	O	_	_
from	6728	6732	IN	from	O	_	_
HKe3	6733	6737	NN	hke3	B-GENE	_	_
ER	6738	6740	NN	er	I-GENE	_	_
:	6740	6741	:	:	O	_	_
HRASV12	6741	6748	NN	hrasv12	O	_	_
cells	6749	6754	NNS	cell	O	_	_
treated	6755	6762	VBN	treat	O	_	_
with	6763	6767	IN	with	O	_	_
or	6768	6770	CC	or	O	_	_
without	6771	6778	IN	without	O	_	_
4-OHT	6779	6784	NN	4-oht	O	_	_
were	6785	6789	VBD	be	O	_	_
transfected	6790	6801	VBN	transfect	O	_	_
with	6802	6806	IN	with	O	_	_
control	6807	6814	NN	control	O	_	_
siRNA	6815	6820	NN	sirna	O	_	_
or	6821	6823	CC	or	O	_	_
siRNA	6824	6829	NN	sirna	O	_	_
against	6830	6837	IN	against	O	_	_
ASPP2	6838	6843	NN	aspp2	B-GENE	_	_
.	6843	6844	.	.	O	_	_
D	1
18
1	5	npadvmod
1	8	prep_from
5	3	amod
5	4	nn
8	7	nn
8	11	dep
11	10	nn
11	12	vmod
12	12	conj_or
12	16	prep_without
12	16	prep_with
18	1	nsubjpass
18	17	auxpass
18	21	prep_with
18	23	prep_with
18	25	prep_against
21	20	nn
21	23	conj_or
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	17	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	E	1	1	2	0	PP	1	2	17	3	NP	3	2	6	4	CD	0	2	3	1	-RRB-	2	2	3	0	JJ	0	3	4	1	Total	3	3	4	0	NN	0	4	5	1	cell	4	4	5	0	NNS	0	5	6	1	lysates	5	5	6	0	IN	0	6	7	1	from	6	6	7	0	NP	0	7	17	3	NP	1	7	9	2	NN	0	7	8	1	HKe3	7	7	8	0	NN	0	8	9	1	ER	8	8	9	0	:	0	9	10	1	:	9	9	10	0	NP	0	10	17	2	NP	1	10	12	2	NN	0	10	11	1	HRASV12	10	10	11	0	NNS	0	11	12	1	cells	11	11	12	0	VP	0	12	17	2	VBN	0	12	13	1	treated	12	12	13	0	PP	0	13	17	4	IN	0	13	14	1	with	13	13	14	0	CC	0	14	15	1	or	14	14	15	0	IN	0	15	16	1	without	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	4-OHT	16	16	17	0	VP	1	17	26	2	VBD	0	17	18	1	were	17	17	18	0	VP	0	18	26	3	VBN	0	18	19	1	transfected	18	18	19	0	PP	0	19	24	2	IN	0	19	20	1	with	19	19	20	0	NP	1	20	24	4	NN	0	20	21	1	control	20	20	21	0	NN	0	21	22	1	siRNA	21	21	22	0	CC	0	22	23	1	or	22	22	23	0	NN	0	23	24	1	siRNA	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	against	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	ASPP2	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	12
ASPP2	6845	6850	NN	aspp2	B-GENE	_	_
phosphorylation	6851	6866	NN	phosphorylation	O	_	_
was	6867	6870	VBD	be	O	_	_
detected	6871	6879	VBN	detect	O	_	_
with	6880	6884	IN	with	O	_	_
ES1	6885	6888	NN	es1	B-GENE	_	_
phospho-ASPP2	6889	6902	NN	phospho-aspp2	I-GENE	_	_
antibody	6903	6911	NN	antibody	I-GENE	_	_
and	6912	6915	CC	and	O	_	_
total	6916	6921	JJ	total	O	_	_
ASPP2	6922	6927	NN	aspp2	B-GENE	_	_
.	6927	6928	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_with
3	10	prep_with
7	5	nn
7	6	nn
7	10	conj_and
10	9	amod
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	VP	1	2	11	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	11	2	VBN	0	3	4	1	detected	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	with	4	4	5	0	NP	0	5	11	3	NP	2	5	8	3	NN	0	5	6	1	ES1	5	5	6	0	NN	0	6	7	1	phospho-ASPP2	6	6	7	0	NN	0	7	8	1	antibody	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	NP	1	9	11	2	JJ	0	9	10	1	total	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	21
A	6929	6930	DT	a	O	_	_
synthetic	6931	6940	JJ	synthetic	O	_	_
peptide	6941	6948	NN	peptide	O	_	_
encoding	6949	6957	VBG	encode	O	_	_
amino	6958	6963	NN	amino	O	_	_
acids	6964	6969	NNS	acid	O	_	_
824-832	6970	6977	CD	824-832	O	_	_
,	6977	6978	,	,	O	_	_
with	6979	6983	IN	with	O	_	_
a	6984	6985	DT	a	O	_	_
phosphoserine	6986	6999	NN	phosphoserine	O	_	_
at	7000	7002	IN	at	O	_	_
residue	7003	7010	NN	residue	O	_	_
827	7011	7014	CD	827	O	_	_
,	7014	7015	,	,	O	_	_
was	7016	7019	VBD	be	O	_	_
used	7020	7024	VBN	use	O	_	_
to	7025	7027	TO	to	O	_	_
raise	7028	7033	VB	raise	O	_	_
antibodies	7034	7044	NNS	antibody	O	_	_
.	7044	7045	.	.	O	_	_
D	1
16
2	0	det
2	1	amod
2	3	vmod
3	6	xcomp
5	4	nn
6	5	nsubj
6	10	prep_with
10	9	det
10	12	prep_at
12	13	num
16	2	nsubjpass
16	15	auxpass
16	18	xcomp
18	17	aux
18	19	dobj
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	15	2	NP	2	0	3	3	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	synthetic	1	1	2	0	NN	0	2	3	1	peptide	2	2	3	0	VP	0	3	15	2	VBG	0	3	4	1	encoding	3	3	4	0	S	1	4	15	2	NP	1	4	6	2	NN	0	4	5	1	amino	4	4	5	0	NNS	0	5	6	1	acids	5	5	6	0	NP	0	6	15	4	NP	0	6	7	1	CD	0	6	7	1	824-832	6	6	7	0	,	0	7	8	1	,	7	7	8	0	PP	0	8	14	2	IN	0	8	9	1	with	8	8	9	0	NP	0	9	14	2	NP	1	9	11	2	DT	0	9	10	1	a	9	9	10	0	NN	0	10	11	1	phosphoserine	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	at	11	11	12	0	NP	0	12	14	2	NN	0	12	13	1	residue	12	12	13	0	CD	0	13	14	1	827	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	1	15	20	2	VBD	0	15	16	1	was	15	15	16	0	VP	0	16	20	2	VBN	0	16	17	1	used	16	16	17	0	S	0	17	20	1	VP	1	17	20	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	20	2	VB	0	18	19	1	raise	18	18	19	0	NP	0	19	20	1	NNS	0	19	20	1	antibodies	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	11
A	7046	7047	DT	a	O	_	_
polyclonal	7048	7058	JJ	polyclonal	O	_	_
antibody	7059	7067	NN	antibody	O	_	_
NGH.S4	7068	7074	NN	ngh.s4	O	_	_
was	7075	7078	VBD	be	O	_	_
purified	7079	7087	VBN	purify	O	_	_
by	7088	7090	IN	by	O	_	_
affinity	7091	7099	NN	affinity	O	_	_
column	7100	7106	NN	column	O	_	_
purification	7107	7119	NN	purification	O	_	_
.	7119	7120	.	.	O	_	_
D	1
5
3	0	det
3	1	amod
3	2	nn
5	3	nsubjpass
5	4	auxpass
5	9	agent
9	7	nn
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	3	0	4	4	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	polyclonal	1	1	2	0	NN	0	2	3	1	antibody	2	2	3	0	NN	0	3	4	1	NGH.S4	3	3	4	0	VP	1	4	10	2	VBD	0	4	5	1	was	4	4	5	0	VP	0	5	10	2	VBN	0	5	6	1	purified	5	5	6	0	PP	0	6	10	2	IN	0	6	7	1	by	6	6	7	0	NP	2	7	10	3	NN	0	7	8	1	affinity	7	7	8	0	NN	0	8	9	1	column	8	8	9	0	NN	0	9	10	1	purification	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	32
To	7121	7123	TO	to	O	_	_
test	7124	7128	VB	test	O	_	_
the	7129	7132	DT	the	O	_	_
efficacy	7133	7141	NN	efficacy	O	_	_
of	7142	7144	IN	of	O	_	_
the	7145	7148	DT	the	O	_	_
purified	7149	7157	VBN	purify	O	_	_
phospho	7158	7165	NN	phospho	O	_	_
specific	7166	7174	JJ	specific	O	_	_
antibody	7175	7183	NN	antibody	O	_	_
,	7183	7184	,	,	O	_	_
a	7185	7186	DT	a	O	_	_
non	7187	7190	JJ	non	O	_	_
radioactive	7191	7202	JJ	radioactive	O	_	_
in	7203	7205	FW	in	O	_	_
vitro	7206	7211	FW	vitro	O	_	_
phosphorylation	7212	7227	NN	phosphorylation	O	_	_
assay	7228	7233	NN	assay	O	_	_
was	7234	7237	VBD	be	O	_	_
performed	7238	7247	VBN	perform	O	_	_
on	7248	7250	IN	on	O	_	_
the	7251	7254	DT	the	O	_	_
purified	7255	7263	VBN	purify	O	_	_
GST-ASPP2	7264	7273	NN	gst-aspp2	B-GENE	_	_
fragment	7274	7282	NN	fragment	O	_	_
(	7283	7284	CD	(	O	_	_
693-1128	7284	7292	CD	693-1128	O	_	_
)	7292	7293	NN	)	O	_	_
with	7294	7298	IN	with	O	_	_
recombinant	7299	7310	JJ	recombinant	B-GENE	_	_
MAPK1	7311	7316	NN	mapk1	I-GENE	_	_
.	7316	7317	.	.	O	_	_
D	1
19
1	0	aux
1	3	dobj
3	2	det
3	9	prep_of
9	5	det
9	6	amod
9	7	nn
9	8	amod
9	17	appos
13	15	dep
15	14	nn
17	11	det
17	12	amod
17	13	dep
17	16	nn
19	1	csubjpass
19	18	auxpass
19	24	prep_on
24	21	det
24	22	amod
24	23	nn
24	30	prep_with
27	26	dep
30	29	amod
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	S	0	0	18	1	VP	1	0	18	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	18	2	VB	0	1	2	1	test	1	1	2	0	NP	0	2	18	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	efficacy	3	3	4	0	PP	0	4	18	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	18	3	NP	4	5	10	5	DT	0	5	6	1	the	5	5	6	0	VBN	0	6	7	1	purified	6	6	7	0	NN	0	7	8	1	phospho	7	7	8	0	JJ	0	8	9	1	specific	8	8	9	0	NN	0	9	10	1	antibody	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	4	11	18	5	DT	0	11	12	1	a	11	11	12	0	JJ	0	12	13	1	non	12	12	13	0	NAC	0	13	16	2	NP	0	13	14	1	JJ	0	13	14	1	radioactive	13	13	14	0	ADVP	1	14	16	2	FW	0	14	15	1	in	14	14	15	0	FW	0	15	16	1	vitro	15	15	16	0	NN	0	16	17	1	phosphorylation	16	16	17	0	NN	0	17	18	1	assay	17	17	18	0	VP	1	18	31	2	VBD	0	18	19	1	was	18	18	19	0	VP	0	19	31	2	VBN	0	19	20	1	performed	19	19	20	0	PP	0	20	31	2	IN	0	20	21	1	on	20	20	21	0	NP	0	21	31	2	NP	0	21	28	2	NP	3	21	25	4	DT	0	21	22	1	the	21	21	22	0	VBN	0	22	23	1	purified	22	22	23	0	NN	0	23	24	1	GST-ASPP2	23	23	24	0	NN	0	24	25	1	fragment	24	24	25	0	ADJP	1	25	28	2	QP	1	25	27	2	CD	0	25	26	1	-LRB-	25	25	26	0	CD	0	26	27	1	693-1128	26	26	27	0	NN	0	27	28	1	-RRB-	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	with	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	recombinant	29	29	30	0	NN	0	30	31	1	MAPK1	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	18
shows	7328	7333	NNS	show	O	_	_
that	7334	7338	IN	that	O	_	_
the	7339	7342	DT	the	O	_	_
phospho	7343	7350	NN	phospho	O	_	_
specific	7351	7359	JJ	specific	O	_	_
antibody	7360	7368	NN	antibody	O	_	_
is	7369	7371	VBZ	be	O	_	_
specific	7372	7380	JJ	specific	O	_	_
for	7381	7384	IN	for	O	_	_
the	7385	7388	DT	the	O	_	_
ASPP2	7389	7394	NN	aspp2	B-GENE	_	_
fragment	7395	7403	NN	fragment	I-GENE	_	_
phosphorylated	7404	7418	VBN	phosphorylate	O	_	_
in	7419	7421	FW	in	O	_	_
vitro	7422	7427	FW	vitro	O	_	_
by	7428	7430	IN	by	O	_	_
MAPK	7431	7435	NN	mapk	O	_	_
.	7435	7436	.	.	O	_	_
D	1
12
0	7	dep
5	2	det
5	3	nn
5	4	amod
7	1	mark
7	5	nsubj
7	6	cop
7	11	prep_for
11	9	det
11	10	nn
12	0	nsubj
12	14	advmod
12	16	prep_by
14	13	nn
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	0	0	12	2	NP	0	0	1	1	NNS	0	0	1	1	shows	0	0	1	0	SBAR	1	1	12	2	IN	0	1	2	1	that	1	1	2	0	S	1	2	12	2	NP	3	2	6	4	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	phospho	3	3	4	0	JJ	0	4	5	1	specific	4	4	5	0	NN	0	5	6	1	antibody	5	5	6	0	VP	1	6	12	2	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	12	2	JJ	0	7	8	1	specific	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	for	8	8	9	0	NP	2	9	12	3	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	fragment	11	11	12	0	VP	0	12	17	3	VBN	0	12	13	1	phosphorylated	12	12	13	0	ADVP	1	13	15	2	FW	0	13	14	1	in	13	13	14	0	FW	0	14	15	1	vitro	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	by	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	MAPK	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	47
To	7437	7439	TO	to	O	_	_
test	7440	7444	VB	test	O	_	_
whether	7445	7452	IN	whether	O	_	_
endogenous	7453	7463	JJ	endogenous	O	_	_
ASPP2	7464	7469	NN	aspp2	O	_	_
could	7470	7475	MD	could	O	_	_
be	7476	7478	VB	be	O	_	_
phosphorylated	7479	7493	VBN	phosphorylate	O	_	_
in	7494	7496	IN	in	O	_	_
cells	7497	7502	NNS	cell	O	_	_
,	7502	7503	,	,	O	_	_
Saos2	7504	7509	NN	saos2	O	_	_
cells	7510	7515	NNS	cell	O	_	_
were	7516	7520	VBD	be	O	_	_
grown	7521	7526	VBN	grow	O	_	_
in	7527	7529	IN	in	O	_	_
low	7530	7533	JJ	low	O	_	_
serum	7534	7539	NN	serum	O	_	_
for	7540	7543	IN	for	O	_	_
50	7544	7546	CD	50	O	_	_
hours	7547	7552	NNS	hour	O	_	_
to	7553	7555	TO	to	O	_	_
remove	7556	7562	VB	remove	O	_	_
all	7563	7566	DT	all	O	_	_
background	7567	7577	NN	background	O	_	_
stimulation	7578	7589	NN	stimulation	O	_	_
of	7590	7592	IN	of	O	_	_
RAS	7593	7596	NN	ra	O	_	_
,	7596	7597	,	,	O	_	_
after	7598	7603	IN	after	O	_	_
which	7604	7609	WDT	which	O	_	_
the	7610	7613	DT	the	O	_	_
cells	7614	7619	NNS	cell	O	_	_
were	7620	7624	VBD	be	O	_	_
stimulated	7625	7635	VBN	stimulate	O	_	_
with	7636	7640	IN	with	O	_	_
EGF	7641	7644	NN	egf	O	_	_
and	7645	7648	CC	and	O	_	_
20	7649	7651	CD	20	O	_	_
%	7651	7652	NN	%	O	_	_
fetal	7653	7658	JJ	fetal	O	_	_
calf	7659	7663	NN	calf	O	_	_
serum	7664	7669	NN	serum	O	_	_
(	7670	7671	CD	(	O	_	_
FCS	7671	7674	NN	fc	O	_	_
)	7674	7675	NN	)	O	_	_
.	7675	7676	.	.	O	_	_
D	1

1	0	aux
1	7	ccomp
4	3	amod
7	2	mark
7	4	nsubjpass
7	5	aux
7	6	auxpass
7	9	prep_in
12	11	nn
14	1	advcl
14	12	nsubjpass
14	13	auxpass
14	17	prep_in
14	22	xcomp
17	16	amod
17	20	prep_for
20	19	num
22	21	aux
22	25	dobj
25	23	det
25	24	nn
25	27	prep_of
27	34	rcmod
32	31	det
34	30	prep_after
34	32	nsubjpass
34	33	auxpass
34	36	prep_with
34	39	prep_with
36	39	conj_and
39	38	num
45	40	amod
45	41	nn
45	42	nn
45	44	nn
EOX
Y	1
ROOT	0	0	47	1	S	3	0	47	5	S	0	0	10	1	VP	1	0	10	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	10	2	VB	0	1	2	1	test	1	1	2	0	SBAR	1	2	10	2	IN	0	2	3	1	whether	2	2	3	0	S	1	3	10	2	NP	1	3	5	2	JJ	0	3	4	1	endogenous	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	10	2	MD	0	5	6	1	could	5	5	6	0	VP	1	6	10	2	VB	0	6	7	1	be	6	6	7	0	VP	0	7	10	2	VBN	0	7	8	1	phosphorylated	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	in	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	cells	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	Saos2	11	11	12	0	NNS	0	12	13	1	cells	12	12	13	0	VP	1	13	46	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	46	3	VBN	0	14	15	1	grown	14	14	15	0	PP	0	15	21	2	IN	0	15	16	1	in	15	15	16	0	NP	0	16	21	2	NP	1	16	18	2	JJ	0	16	17	1	low	16	16	17	0	NN	0	17	18	1	serum	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	for	18	18	19	0	NP	1	19	21	2	CD	0	19	20	1	50	19	19	20	0	NNS	0	20	21	1	hours	20	20	21	0	S	0	21	46	1	VP	1	21	46	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	46	2	VB	0	22	23	1	remove	22	22	23	0	NP	0	23	46	2	NP	2	23	26	3	DT	0	23	24	1	all	23	23	24	0	NN	0	24	25	1	background	24	24	25	0	NN	0	25	26	1	stimulation	25	25	26	0	PP	0	26	46	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	46	3	NP	0	27	28	1	NN	0	27	28	1	RAS	27	27	28	0	,	0	28	29	1	,	28	28	29	0	SBAR	1	29	46	2	WHPP	0	29	31	2	IN	0	29	30	1	after	29	29	30	0	WHNP	0	30	31	1	WDT	0	30	31	1	which	30	30	31	0	S	1	31	46	2	NP	1	31	33	2	DT	0	31	32	1	the	31	31	32	0	NNS	0	32	33	1	cells	32	32	33	0	VP	1	33	46	2	VBD	0	33	34	1	were	33	33	34	0	VP	0	34	46	2	VBN	0	34	35	1	stimulated	34	34	35	0	PP	0	35	46	2	IN	0	35	36	1	with	35	35	36	0	NP	0	36	46	3	NP	0	36	37	1	NN	0	36	37	1	EGF	36	36	37	0	CC	0	37	38	1	and	37	37	38	0	NP	0	38	46	2	NP	1	38	40	2	CD	0	38	39	1	20	38	38	39	0	NN	0	39	40	1	%	39	39	40	0	NP	5	40	46	6	JJ	0	40	41	1	fetal	40	40	41	0	NN	0	41	42	1	calf	41	41	42	0	NN	0	42	43	1	serum	42	42	43	0	CD	0	43	44	1	-LRB-	43	43	44	0	NN	0	44	45	1	FCS	44	44	45	0	NN	0	45	46	1	-RRB-	45	45	46	0	.	0	46	47	1	.	46	46	47	0
EOS
T	16
Phosphorylated	7677	7691	VBN	phosphorylate	O	_	_
endogenous	7692	7702	JJ	endogenous	O	_	_
ASPP2	7703	7708	NN	aspp2	O	_	_
was	7709	7712	VBD	be	O	_	_
detected	7713	7721	VBN	detect	O	_	_
by	7722	7724	IN	by	O	_	_
the	7725	7728	DT	the	O	_	_
phospho	7729	7736	NN	phospho	O	_	_
specific	7737	7745	JJ	specific	O	_	_
antibody	7746	7754	NN	antibody	O	_	_
30	7755	7757	CD	30	O	_	_
minutes	7758	7765	NNS	minute	O	_	_
after	7766	7771	IN	after	O	_	_
RAS	7772	7775	NN	ra	B-GENE	_	_
stimulation	7776	7787	NN	stimulation	O	_	_
.	7799	7800	.	.	O	_	_
D	1
0
0	2	dobj
0	4	auxpass
0	9	nsubjpass
2	1	amod
4	3	auxpass
4	7	agent
7	6	det
9	8	amod
9	11	dep
9	14	prep_after
11	10	num
14	13	nn
EOX
Y	1
ROOT	0	0	16	1	SINV	0	0	16	4	VP	0	0	3	2	VBN	0	0	1	1	Phosphorylated	0	0	1	0	NP	1	1	3	2	JJ	0	1	2	1	endogenous	1	1	2	0	NN	0	2	3	1	ASPP2	2	2	3	0	VP	1	3	8	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	8	2	VBN	0	4	5	1	detected	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	by	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	phospho	7	7	8	0	NP	0	8	15	3	NP	1	8	10	2	JJ	0	8	9	1	specific	8	8	9	0	NN	0	9	10	1	antibody	9	9	10	0	NP	1	10	12	2	CD	0	10	11	1	30	10	10	11	0	NNS	0	11	12	1	minutes	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	after	12	12	13	0	NP	1	13	15	2	NN	0	13	14	1	RAS	13	13	14	0	NN	0	14	15	1	stimulation	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	63
ASPP2	7801	7806	NN	aspp2	B-GENE	_	_
phosphorylation	7807	7822	NN	phosphorylation	O	_	_
was	7823	7826	VBD	be	O	_	_
rapid	7827	7832	JJ	rapid	O	_	_
and	7833	7836	CC	and	O	_	_
transient	7837	7846	JJ	transient	O	_	_
as	7847	7849	IN	as	O	_	_
3	7850	7851	CD	3	O	_	_
hours	7852	7857	NNS	hour	O	_	_
after	7858	7863	IN	after	O	_	_
EGF	7864	7867	NN	egf	B-GENE	_	_
stimulation	7868	7879	NN	stimulation	O	_	_
phosphorylated	7880	7894	VBN	phosphorylate	O	_	_
ASPP2	7895	7900	NN	aspp2	B-GENE	_	_
was	7901	7904	VBD	be	O	_	_
barely	7905	7911	RB	barely	O	_	_
detec	7912	7917	JJ	detec	O	_	_
Moreover	7924	7932	RB	moreover	O	_	_
,	7932	7933	,	,	O	_	_
with	7934	7938	IN	with	O	_	_
another	7939	7946	DT	another	O	_	_
different	7947	7956	JJ	different	O	_	_
phospho-ASPP2	7957	7970	NN	phospho-aspp2	O	_	_
antibody	7971	7979	NN	antibody	O	_	_
,	7979	7980	,	,	O	_	_
ES1	7981	7984	NN	es1	O	_	_
,	7984	7985	,	,	O	_	_
ASPP2	7986	7991	NN	aspp2	B-GENE	_	_
phosphorylation	7992	8007	NN	phosphorylation	O	_	_
was	8008	8011	VBD	be	O	_	_
also	8012	8016	RB	also	O	_	_
observed	8017	8025	VBN	observe	O	_	_
in	8026	8028	IN	in	O	_	_
a	8029	8030	DT	a	O	_	_
human	8031	8036	JJ	human	O	_	_
colon	8037	8042	NN	colon	O	_	_
cancer	8043	8049	NN	cancer	O	_	_
cell	8050	8054	NN	cell	O	_	_
line	8055	8059	NN	line	O	_	_
HKe3	8060	8064	NN	hke3	O	_	_
ER	8065	8067	NN	er	O	_	_
:	8067	8068	:	:	O	_	_
HRASV12	8068	8075	NN	hrasv12	O	_	_
cells	8076	8081	NNS	cell	O	_	_
,	8081	8082	,	,	O	_	_
in	8083	8085	IN	in	O	_	_
which	8086	8091	WDT	which	O	_	_
RAS	8092	8095	NN	ra	B-GENE	_	_
activation	8096	8106	NN	activation	O	_	_
is	8107	8109	VBZ	be	O	_	_
induced	8110	8117	VBN	induce	O	_	_
upon	8118	8122	IN	upon	O	_	_
the	8123	8126	DT	the	O	_	_
addition	8127	8135	NN	addition	O	_	_
of	8136	8138	IN	of	O	_	_
4-hydroxytamoxifen	8139	8157	JJ	4-hydroxytamoxifen	O	_	_
(	8158	8159	NN	(	O	_	_
4-OHT	8159	8164	NN	4-oht	O	_	_
)	8164	8165	CD	)	O	_	_
[	8166	8167	CD	[	O	_	_
2,10,11	8167	8174	CD	2,10,11	O	_	_
]	8174	8175	NN	]	O	_	_
.	8187	8188	.	.	O	_	_
D	1
31
1	0	nn
3	1	nsubj
3	2	cop
3	5	conj_and
3	8	prep_as
3	16	advcl
5	1	nsubj
8	7	num
11	10	nn
11	12	vmod
12	13	dobj
16	9	mark
16	11	nsubj
16	14	cop
16	15	advmod
16	17	advmod
16	23	prep_with
23	20	det
23	21	amod
23	22	nn
23	25	appos
28	27	nn
31	3	ccomp
31	5	ccomp
31	28	nsubjpass
31	29	auxpass
31	30	advmod
31	40	prep_in
40	33	det
40	34	amod
40	35	nn
40	36	nn
40	37	nn
40	38	nn
40	39	nn
40	43	dep
43	42	nn
43	50	rcmod
48	47	nn
50	46	prep_in
50	48	nsubjpass
50	49	auxpass
50	53	prep_upon
53	52	det
53	57	prep_of
57	55	amod
57	59	dep
59	61	dep
61	60	num
EOX
Y	1
ROOT	0	0	63	1	S	3	0	63	5	S	1	0	26	2	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	VP	1	2	26	4	VBD	0	2	3	1	was	2	2	3	0	ADJP	0	3	6	3	JJ	0	3	4	1	rapid	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	JJ	0	5	6	1	transient	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	as	6	6	7	0	NP	1	7	9	2	CD	0	7	8	1	3	7	7	8	0	NNS	0	8	9	1	hours	8	8	9	0	SBAR	1	9	26	2	IN	0	9	10	1	after	9	9	10	0	S	1	10	26	2	NP	0	10	14	2	NP	1	10	12	2	NN	0	10	11	1	EGF	10	10	11	0	NN	0	11	12	1	stimulation	11	11	12	0	VP	0	12	14	2	VBN	0	12	13	1	phosphorylated	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	ASPP2	13	13	14	0	VP	1	14	26	5	VBD	0	14	15	1	was	14	14	15	0	ADJP	1	15	17	2	RB	0	15	16	1	barely	15	15	16	0	JJ	0	16	17	1	detec	16	16	17	0	ADVP	0	17	18	1	RB	0	17	18	1	Moreover	17	17	18	0	,	0	18	19	1	,	18	18	19	0	PP	0	19	26	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	26	3	NP	3	20	24	4	DT	0	20	21	1	another	20	20	21	0	JJ	0	21	22	1	different	21	21	22	0	NN	0	22	23	1	phospho-ASPP2	22	22	23	0	NN	0	23	24	1	antibody	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	ES1	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	ASPP2	27	27	28	0	NN	0	28	29	1	phosphorylation	28	28	29	0	VP	2	29	62	3	VBD	0	29	30	1	was	29	29	30	0	ADVP	0	30	31	1	RB	0	30	31	1	also	30	30	31	0	VP	0	31	62	2	VBN	0	31	32	1	observed	31	31	32	0	PP	0	32	62	2	IN	0	32	33	1	in	32	32	33	0	NP	0	33	62	3	NP	7	33	41	8	DT	0	33	34	1	a	33	33	34	0	JJ	0	34	35	1	human	34	34	35	0	NN	0	35	36	1	colon	35	35	36	0	NN	0	36	37	1	cancer	36	36	37	0	NN	0	37	38	1	cell	37	37	38	0	NN	0	38	39	1	line	38	38	39	0	NN	0	39	40	1	HKe3	39	39	40	0	NN	0	40	41	1	ER	40	40	41	0	:	0	41	42	1	:	41	41	42	0	NP	0	42	62	3	NP	1	42	44	2	NN	0	42	43	1	HRASV12	42	42	43	0	NNS	0	43	44	1	cells	43	43	44	0	,	0	44	45	1	,	44	44	45	0	SBAR	1	45	62	2	WHPP	0	45	47	2	IN	0	45	46	1	in	45	45	46	0	WHNP	0	46	47	1	WDT	0	46	47	1	which	46	46	47	0	S	1	47	62	2	NP	1	47	49	2	NN	0	47	48	1	RAS	47	47	48	0	NN	0	48	49	1	activation	48	48	49	0	VP	1	49	62	2	VBZ	0	49	50	1	is	49	49	50	0	VP	0	50	62	2	VBN	0	50	51	1	induced	50	50	51	0	PP	0	51	62	2	IN	0	51	52	1	upon	51	51	52	0	NP	0	52	62	2	NP	1	52	54	2	DT	0	52	53	1	the	52	52	53	0	NN	0	53	54	1	addition	53	53	54	0	PP	0	54	62	2	IN	0	54	55	1	of	54	54	55	0	NP	0	55	62	2	NP	2	55	58	3	JJ	0	55	56	1	4-hydroxytamoxifen	55	55	56	0	NN	0	56	57	1	-LRB-	56	56	57	0	NN	0	57	58	1	4-OHT	57	57	58	0	NP	0	58	62	2	NP	0	58	60	1	QP	1	58	60	2	CD	0	58	59	1	-RRB-	58	58	59	0	CD	0	59	60	1	[	59	59	60	0	NP	1	60	62	2	CD	0	60	61	1	2,10,11	60	60	61	0	NN	0	61	62	1	]	61	61	62	0	.	0	62	63	1	.	62	62	63	0
EOS
T	21
The	8189	8192	DT	the	O	_	_
phospho	8193	8200	NN	phospho	O	_	_
specific	8201	8209	JJ	specific	O	_	_
antibody	8210	8218	NN	antibody	O	_	_
for	8219	8222	IN	for	O	_	_
ASPP2	8223	8228	NN	aspp2	B-GENE	_	_
is	8229	8231	VBZ	be	O	_	_
specific	8232	8240	JJ	specific	O	_	_
as	8241	8243	IN	as	O	_	_
knockdown	8244	8253	NN	knockdown	O	_	_
of	8254	8256	IN	of	O	_	_
ASPP2	8257	8262	NN	aspp2	B-GENE	_	_
resulted	8263	8271	VBD	result	O	_	_
in	8272	8274	IN	in	O	_	_
a	8275	8276	DT	a	O	_	_
lack	8277	8281	NN	lack	O	_	_
of	8282	8284	IN	of	O	_	_
detection	8285	8294	NN	detection	O	_	_
of	8295	8297	IN	of	O	_	_
phospho-ASPP2	8298	8311	NN	phospho-aspp2	O	_	_
.	8311	8312	.	.	O	_	_
D	1
7
3	0	det
3	1	nn
3	2	amod
3	5	prep_for
7	3	nsubj
7	6	cop
7	12	advcl
9	11	prep_of
12	8	mark
12	9	nsubj
12	15	prep_in
15	14	det
15	17	prep_of
17	19	prep_of
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	6	2	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	phospho	1	1	2	0	JJ	0	2	3	1	specific	2	2	3	0	NN	0	3	4	1	antibody	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	for	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	ASPP2	5	5	6	0	VP	1	6	20	3	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	8	1	JJ	0	7	8	1	specific	7	7	8	0	SBAR	1	8	20	2	IN	0	8	9	1	as	8	8	9	0	S	1	9	20	2	NP	0	9	12	2	NP	0	9	10	1	NN	0	9	10	1	knockdown	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	VP	0	12	20	2	VBD	0	12	13	1	resulted	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	in	13	13	14	0	NP	0	14	20	2	NP	1	14	16	2	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	lack	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	20	2	NP	0	17	18	1	NN	0	17	18	1	detection	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	phospho-ASPP2	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	24
All	8313	8316	PDT	all	O	_	_
these	8317	8322	DT	these	O	_	_
demonstrate	8323	8334	VBP	demonstrate	O	_	_
that	8335	8339	IN	that	O	_	_
ASPP2	8340	8345	NN	aspp2	B-GENE	_	_
is	8346	8348	VBZ	be	O	_	_
a	8349	8350	DT	a	O	_	_
novel	8351	8356	JJ	novel	O	_	_
substrate	8357	8366	NN	substrate	O	_	_
of	8367	8369	IN	of	O	_	_
MAPK	8370	8374	NN	mapk	O	_	_
and	8375	8378	CC	and	O	_	_
Ser827	8379	8385	NN	ser827	O	_	_
of	8386	8388	IN	of	O	_	_
ASPP2	8389	8394	NN	aspp2	B-GENE	_	_
can	8395	8398	MD	can	O	_	_
be	8399	8401	VB	be	O	_	_
phosphorylated	8402	8416	VBN	phosphorylate	O	_	_
by	8417	8419	IN	by	O	_	_
RAS	8420	8423	NN	ra	B-GENE	_	_
/	8423	8424	:	/	B-GENE	_	_
MAPK	8424	8428	NN	mapk	I-GENE	_	_
pathway	8429	8436	NN	pathway	O	_	_
.	8436	8437	.	.	O	_	_
D	1
2
1	0	predet
2	1	nsubj
2	8	ccomp
2	17	conj_and
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	10	prep_of
12	14	prep_of
17	12	nsubjpass
17	15	aux
17	16	auxpass
17	19	agent
19	22	dep
22	20	punct
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	0	0	24	4	S	1	0	11	2	NP	1	0	2	2	PDT	0	0	1	1	All	0	0	1	0	DT	0	1	2	1	these	1	1	2	0	VP	0	2	11	2	VBP	0	2	3	1	demonstrate	2	2	3	0	SBAR	1	3	11	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	11	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	11	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	11	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	MAPK	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	S	1	12	23	2	NP	0	12	15	2	NP	0	12	13	1	NN	0	12	13	1	Ser827	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	VP	1	15	23	2	MD	0	15	16	1	can	15	15	16	0	VP	1	16	23	2	VB	0	16	17	1	be	16	16	17	0	VP	0	17	23	2	VBN	0	17	18	1	phosphorylated	17	17	18	0	PP	0	18	23	2	IN	0	18	19	1	by	18	18	19	0	NP	0	19	23	2	NP	0	19	20	1	NN	0	19	20	1	RAS	19	19	20	0	PRN	1	20	23	2	:	0	20	21	1	/	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	MAPK	21	21	22	0	NN	0	22	23	1	pathway	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	20
One	8439	8442	CD	one	O	_	_
of	8443	8445	IN	of	O	_	_
the	8446	8449	DT	the	O	_	_
most	8450	8454	RBS	most	O	_	_
studied	8455	8462	VBN	study	O	_	_
downstream	8463	8473	JJ	downstream	O	_	_
pathways	8474	8482	NNS	pathway	O	_	_
of	8483	8485	IN	of	O	_	_
RAS	8486	8489	NN	ra	O	_	_
signalling	8490	8500	NN	signalling	O	_	_
is	8501	8503	VBZ	be	O	_	_
the	8504	8507	DT	the	O	_	_
Raf	8508	8511	NN	raf	B-GENE	_	_
/	8511	8512	:	/	B-GENE	_	_
MAPK	8512	8516	NN	mapk	I-GENE	_	_
pathway	8517	8524	NN	pathway	O	_	_
[	8525	8526	CD	[	O	_	_
13	8526	8528	CD	13	O	_	_
]	8528	8529	NN	]	O	_	_
.	8529	8530	.	.	O	_	_
D	1
18
0	2	prep_of
2	3	advmod
2	4	vmod
4	6	dobj
6	5	amod
6	9	prep_of
9	8	nn
15	13	punct
15	14	nn
15	17	dep
17	16	num
18	0	nsubj
18	10	cop
18	11	det
18	12	nn
18	15	dep
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	10	2	NP	0	0	1	1	CD	0	0	1	1	One	0	0	1	0	PP	0	1	10	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	10	2	NP	0	2	4	2	DT	0	2	3	1	the	2	2	3	0	RBS	0	3	4	1	most	3	3	4	0	VP	0	4	10	2	VBN	0	4	5	1	studied	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	JJ	0	5	6	1	downstream	5	5	6	0	NNS	0	6	7	1	pathways	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	RAS	8	8	9	0	NN	0	9	10	1	signalling	9	9	10	0	VP	1	10	19	2	VBZ	0	10	11	1	is	10	10	11	0	NP	3	11	19	4	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	Raf	12	12	13	0	PRN	1	13	18	2	:	0	13	14	1	/	13	13	14	0	FRAG	0	14	18	2	NP	1	14	16	2	NN	0	14	15	1	MAPK	14	14	15	0	NN	0	15	16	1	pathway	15	15	16	0	NP	1	16	18	2	CD	0	16	17	1	[	16	16	17	0	CD	0	17	18	1	13	17	17	18	0	NN	0	18	19	1	]	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	55
Knowing	8531	8538	VBG	know	O	_	_
ASPP2	8539	8544	NN	aspp2	B-GENE	_	_
is	8545	8547	VBZ	be	O	_	_
a	8548	8549	DT	a	O	_	_
substrate	8550	8559	NN	substrate	O	_	_
of	8560	8562	IN	of	O	_	_
MAPK	8563	8567	NN	mapk	B-GENE	_	_
,	8567	8568	,	,	O	_	_
we	8569	8571	PRP	we	O	_	_
thus	8572	8576	RB	thus	O	_	_
tested	8577	8583	VBD	test	O	_	_
whether	8584	8591	IN	whether	O	_	_
activation	8592	8602	NN	activation	O	_	_
of	8603	8605	IN	of	O	_	_
Raf	8606	8609	NN	raf	B-GENE	_	_
/	8609	8610	:	/	B-GENE	_	_
MAPK	8610	8614	NN	mapk	I-GENE	_	_
pathway	8615	8622	NN	pathway	O	_	_
is	8623	8625	VBZ	be	O	_	_
sufficient	8626	8636	JJ	sufficient	O	_	_
to	8637	8639	TO	to	O	_	_
regulate	8640	8648	VB	regulate	O	_	_
ASPP2	8649	8654	NN	aspp2	B-GENE	_	_
activity	8655	8663	NN	activity	O	_	_
using	8664	8669	VBG	use	O	_	_
a	8670	8671	DT	a	O	_	_
mutant	8672	8678	JJ	mutant	B-GENE	_	_
form	8679	8683	NN	form	I-GENE	_	_
of	8684	8686	IN	of	I-GENE	_	_
Raf	8687	8690	NN	raf	I-GENE	_	_
(	8691	8692	CD	(	B-GENE	_	_
Raf	8692	8695	NN	raf	I-GENE	_	_
CAAX	8696	8700	NN	caax	I-GENE	_	_
)	8700	8701	NN	)	O	_	_
,	8701	8702	,	,	O	_	_
which	8703	8708	WDT	which	O	_	_
is	8709	8711	VBZ	be	O	_	_
constitutively	8712	8726	RB	constitutively	O	_	_
present	8727	8734	JJ	present	O	_	_
at	8735	8737	IN	at	O	_	_
the	8738	8741	DT	the	O	_	_
plasma	8742	8748	NN	plasma	O	_	_
membrane	8749	8757	NN	membrane	O	_	_
,	8757	8758	,	,	O	_	_
so	8759	8761	IN	so	O	_	_
the	8762	8765	DT	the	O	_	_
Raf	8766	8769	NN	raf	B-GENE	_	_
pathway	8770	8777	NN	pathway	O	_	_
is	8778	8780	VBZ	be	O	_	_
constitutively	8781	8795	RB	constitutively	O	_	_
active	8796	8802	JJ	active	O	_	_
[	8803	8804	NN	[	O	_	_
14	8804	8806	CD	14	O	_	_
]	8806	8807	NN	]	O	_	_
.	8807	8808	.	.	O	_	_
D	1
4
1	0	amod
4	1	nsubj
4	2	cop
4	3	det
4	6	prep_of
4	10	ccomp
4	44	dep
4	50	ccomp
10	8	nsubj
10	9	advmod
10	19	ccomp
12	14	prep_of
14	17	dep
17	15	punct
17	16	nn
19	11	mark
19	12	nsubj
19	18	cop
19	21	xcomp
21	20	aux
21	23	dobj
23	22	nn
23	24	vmod
24	27	dobj
27	25	det
27	26	amod
27	28	prep
27	38	rcmod
33	29	nn
33	31	nn
33	32	nn
38	35	nsubj
38	36	cop
38	37	advmod
38	42	prep_at
42	40	det
42	41	nn
47	45	det
47	46	nn
50	47	nsubj
50	48	cop
50	49	advmod
50	51	iobj
51	53	dep
53	52	num
EOX
Y	1
ROOT	0	0	55	1	S	0	0	55	7	S	1	0	7	2	NP	1	0	2	2	VBG	0	0	1	1	Knowing	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	7	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	7	2	NP	1	3	5	2	DT	0	3	4	1	a	3	3	4	0	NN	0	4	5	1	substrate	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	MAPK	6	6	7	0	,	0	7	8	1	,	7	7	8	0	S	2	8	43	3	NP	0	8	9	1	PRP	0	8	9	1	we	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	thus	9	9	10	0	VP	0	10	43	2	VBD	0	10	11	1	tested	10	10	11	0	SBAR	1	11	43	2	IN	0	11	12	1	whether	11	11	12	0	S	1	12	43	2	NP	0	12	18	2	NP	0	12	13	1	NN	0	12	13	1	activation	12	12	13	0	PP	0	13	18	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	18	2	NP	0	14	15	1	NN	0	14	15	1	Raf	14	14	15	0	PRN	1	15	18	2	:	0	15	16	1	/	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	MAPK	16	16	17	0	NN	0	17	18	1	pathway	17	17	18	0	VP	1	18	43	2	VBZ	0	18	19	1	is	18	18	19	0	ADJP	0	19	43	2	JJ	0	19	20	1	sufficient	19	19	20	0	S	0	20	43	1	VP	1	20	43	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	43	2	VB	0	21	22	1	regulate	21	21	22	0	NP	0	22	43	2	NP	1	22	24	2	NN	0	22	23	1	ASPP2	22	22	23	0	NN	0	23	24	1	activity	23	23	24	0	VP	0	24	43	2	VBG	0	24	25	1	using	24	24	25	0	NP	0	25	43	4	NP	2	25	28	3	DT	0	25	26	1	a	25	25	26	0	JJ	0	26	27	1	mutant	26	26	27	0	NN	0	27	28	1	form	27	27	28	0	PP	0	28	34	2	IN	0	28	29	1	of	28	28	29	0	NP	4	29	34	5	NN	0	29	30	1	Raf	29	29	30	0	CD	0	30	31	1	-LRB-	30	30	31	0	NN	0	31	32	1	Raf	31	31	32	0	NN	0	32	33	1	CAAX	32	32	33	0	NN	0	33	34	1	-RRB-	33	33	34	0	,	0	34	35	1	,	34	34	35	0	SBAR	1	35	43	2	WHNP	0	35	36	1	WDT	0	35	36	1	which	35	35	36	0	S	0	36	43	1	VP	1	36	43	2	VBZ	0	36	37	1	is	36	36	37	0	ADJP	1	37	43	3	RB	0	37	38	1	constitutively	37	37	38	0	JJ	0	38	39	1	present	38	38	39	0	PP	0	39	43	2	IN	0	39	40	1	at	39	39	40	0	NP	2	40	43	3	DT	0	40	41	1	the	40	40	41	0	NN	0	41	42	1	plasma	41	41	42	0	NN	0	42	43	1	membrane	42	42	43	0	,	0	43	44	1	,	43	43	44	0	IN	0	44	45	1	so	44	44	45	0	S	1	45	54	2	NP	2	45	48	3	DT	0	45	46	1	the	45	45	46	0	NN	0	46	47	1	Raf	46	46	47	0	NN	0	47	48	1	pathway	47	47	48	0	VP	1	48	54	3	VBZ	0	48	49	1	is	48	48	49	0	ADJP	1	49	51	2	RB	0	49	50	1	constitutively	49	49	50	0	JJ	0	50	51	1	active	50	50	51	0	NP	0	51	54	2	NP	0	51	52	1	NN	0	51	52	1	[	51	51	52	0	NP	1	52	54	2	CD	0	52	53	1	14	52	52	53	0	NN	0	53	54	1	]	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	26
The	8809	8812	DT	the	O	_	_
impact	8813	8819	NN	impact	O	_	_
of	8820	8822	IN	of	O	_	_
co-expression	8823	8836	NN	co-expression	O	_	_
of	8837	8839	IN	of	O	_	_
Raf	8840	8843	NN	raf	B-GENE	_	_
CAAX	8844	8848	NN	caax	I-GENE	_	_
with	8849	8853	IN	with	O	_	_
p53	8854	8857	NN	p53	B-GENE	_	_
and	8858	8861	CC	and	O	_	_
ASPP2	8862	8867	NN	aspp2	B-GENE	_	_
was	8868	8871	VBD	be	O	_	_
tested	8872	8878	VBN	test	O	_	_
by	8879	8881	IN	by	O	_	_
analysing	8882	8891	VBG	analyse	O	_	_
the	8892	8895	DT	the	O	_	_
transcriptional	8896	8911	JJ	transcriptional	O	_	_
activity	8912	8920	NN	activity	O	_	_
of	8921	8923	IN	of	O	_	_
p53	8924	8927	NN	p53	B-GENE	_	_
on	8928	8930	IN	on	O	_	_
the	8931	8934	DT	the	O	_	_
pro-apoptotic	8935	8948	JJ	pro-apoptotic	O	_	_
Bax	8949	8952	NN	bax	O	_	_
reporter	8953	8961	NN	reporter	O	_	_
.	8961	8962	.	.	O	_	_
D	1
12
1	0	det
1	3	prep_of
3	6	prep_of
6	5	nn
6	8	prep_with
6	10	prep_with
8	10	conj_and
12	1	nsubjpass
12	11	auxpass
12	14	agent
14	17	dobj
14	24	prep_on
17	15	det
17	16	amod
17	19	prep_of
24	21	det
24	22	amod
24	23	nn
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	11	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	impact	1	1	2	0	PP	0	2	11	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	11	2	NP	0	3	4	1	NN	0	3	4	1	co-expression	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	11	2	NP	1	5	7	2	NN	0	5	6	1	Raf	5	5	6	0	NN	0	6	7	1	CAAX	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	p53	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	VP	1	11	25	2	VBD	0	11	12	1	was	11	11	12	0	VP	0	12	25	2	VBN	0	12	13	1	tested	12	12	13	0	PP	0	13	25	2	IN	0	13	14	1	by	13	13	14	0	S	0	14	25	1	VP	0	14	25	3	VBG	0	14	15	1	analysing	14	14	15	0	NP	0	15	20	2	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	transcriptional	16	16	17	0	NN	0	17	18	1	activity	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	p53	19	19	20	0	PP	0	20	25	2	IN	0	20	21	1	on	20	20	21	0	NP	3	21	25	4	DT	0	21	22	1	the	21	21	22	0	JJ	0	22	23	1	pro-apoptotic	22	22	23	0	NN	0	23	24	1	Bax	23	23	24	0	NN	0	24	25	1	reporter	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	22
Raf	8963	8966	NN	raf	B-GENE	_	_
CAAX	8967	8971	NN	caax	I-GENE	_	_
increases	8972	8981	VBZ	increase	O	_	_
Bax-luciferase	8982	8996	JJ	bax-luciferase	B-GENE	_	_
levels	8997	9003	NNS	level	O	_	_
by	9004	9006	IN	by	O	_	_
2.5	9007	9010	CD	2.5	O	_	_
fold	9011	9015	NN	fold	O	_	_
over	9016	9020	IN	over	O	_	_
the	9021	9024	DT	the	O	_	_
baseline	9025	9033	NN	baseline	O	_	_
of	9034	9036	IN	of	O	_	_
p53	9037	9040	NN	p53	B-GENE	_	_
and	9041	9044	CC	and	O	_	_
ASPP2	9045	9050	NN	aspp2	B-GENE	_	_
alone	9051	9056	RB	alone	O	_	_
(	9057	9058	RB	(	O	_	_
P	9058	9059	NN	p	O	_	_
=	9059	9060	JJ	=	O	_	_
0.05	9060	9064	CD	0.05	O	_	_
)	9064	9065	NN	)	O	_	_
.	9065	9066	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	4	dobj
2	5	prep
4	3	amod
7	6	number
7	10	prep_over
10	9	det
10	12	prep_of
10	14	prep_of
10	15	advmod
10	17	dep
12	14	conj_and
18	19	dep
20	7	amod
20	18	amod
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	1	0	2	2	NN	0	0	1	1	Raf	0	0	1	0	NN	0	1	2	1	CAAX	1	1	2	0	VP	0	2	21	3	VBZ	0	2	3	1	increases	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	Bax-luciferase	3	3	4	0	NNS	0	4	5	1	levels	4	4	5	0	PP	0	5	21	2	IN	0	5	6	1	by	5	5	6	0	NP	2	6	21	3	ADJP	0	6	18	2	ADJP	1	6	8	2	CD	0	6	7	1	2.5	6	6	7	0	NN	0	7	8	1	fold	7	7	8	0	PP	0	8	18	2	IN	0	8	9	1	over	8	8	9	0	NP	0	9	18	4	NP	0	9	15	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	baseline	10	10	11	0	PP	0	11	15	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	p53	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	ASPP2	14	14	15	0	RB	0	15	16	1	alone	15	15	16	0	RB	0	16	17	1	-LRB-	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	P	17	17	18	0	ADJP	0	18	20	2	JJ	0	18	19	1	=	18	18	19	0	NP	0	19	20	1	CD	0	19	20	1	0.05	19	19	20	0	NN	0	20	21	1	-RRB-	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	21
This	9067	9071	DT	this	O	_	_
effect	9072	9078	NN	effect	O	_	_
is	9079	9081	VBZ	be	O	_	_
likely	9082	9088	JJ	likely	O	_	_
to	9089	9091	TO	to	O	_	_
be	9092	9094	VB	be	O	_	_
mediated	9095	9103	VBN	mediate	O	_	_
by	9104	9106	IN	by	O	_	_
ASPP2	9107	9112	NN	aspp2	B-GENE	_	_
as	9113	9115	IN	as	O	_	_
Raf	9116	9119	NN	raf	B-GENE	_	_
CAAX	9120	9124	NN	caax	I-GENE	_	_
had	9125	9128	VBD	have	O	_	_
little	9129	9135	JJ	little	O	_	_
effect	9136	9142	NN	effect	O	_	_
on	9143	9145	IN	on	O	_	_
p53	9146	9149	NN	p53	B-GENE	_	_
in	9150	9152	IN	in	O	_	_
its	9153	9156	PRP$	its	O	_	_
absence	9157	9164	NN	absence	O	_	_
.	9176	9177	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubj
3	2	cop
3	6	xcomp
6	4	aux
6	5	auxpass
6	8	agent
6	12	advcl
11	10	nn
12	9	mark
12	11	nsubj
12	14	dobj
12	19	prep_in
14	13	amod
14	16	prep_on
19	18	poss
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	1	0	2	2	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	effect	1	1	2	0	VP	1	2	20	2	VBZ	0	2	3	1	is	2	2	3	0	ADJP	0	3	20	2	JJ	0	3	4	1	likely	3	3	4	0	S	0	4	20	1	VP	1	4	20	2	TO	0	4	5	1	to	4	4	5	0	VP	1	5	20	2	VB	0	5	6	1	be	5	5	6	0	VP	0	6	20	3	VBN	0	6	7	1	mediated	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	ASPP2	8	8	9	0	SBAR	1	9	20	2	IN	0	9	10	1	as	9	9	10	0	S	1	10	20	2	NP	1	10	12	2	NN	0	10	11	1	Raf	10	10	11	0	NN	0	11	12	1	CAAX	11	11	12	0	VP	0	12	20	3	VBD	0	12	13	1	had	12	12	13	0	NP	0	13	17	2	NP	1	13	15	2	JJ	0	13	14	1	little	13	13	14	0	NN	0	14	15	1	effect	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	on	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	NP	1	18	20	2	PRP$	0	18	19	1	its	18	18	19	0	NN	0	19	20	1	absence	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	19
(	9179	9180	NN	(	O	_	_
A	9180	9181	NN	a	O	_	_
)	9181	9182	CD	)	O	_	_
Saos2	9183	9188	NN	saos2	O	_	_
cells	9189	9194	NNS	cell	O	_	_
were	9195	9199	VBD	be	O	_	_
transfected	9200	9211	VBN	transfect	O	_	_
as	9212	9214	IN	as	O	_	_
indicated	9215	9224	VBN	indicate	O	_	_
with	9225	9229	IN	with	O	_	_
a	9230	9231	DT	a	O	_	_
Bax-luciferase	9232	9246	NN	bax-luciferase	B-GENE	_	_
reporter	9247	9255	NN	reporter	I-GENE	_	_
and	9256	9259	CC	and	O	_	_
the	9260	9263	DT	the	O	_	_
luciferase	9264	9274	NN	luciferase	B-GENE	_	_
activity	9275	9283	NN	activity	O	_	_
shown	9284	9289	VBN	show	O	_	_
.	9289	9290	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	advcl
8	7	mark
8	12	prep_with
8	16	prep_with
12	10	det
12	11	nn
12	16	conj_and
16	14	det
16	15	nn
16	17	vmod
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	18	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	18	2	VBN	0	6	7	1	transfected	6	6	7	0	SBAR	1	7	18	2	IN	0	7	8	1	as	7	7	8	0	S	0	8	18	1	VP	0	8	18	2	VBN	0	8	9	1	indicated	8	8	9	0	PP	0	9	18	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	18	3	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	NN	0	11	12	1	Bax-luciferase	11	11	12	0	NN	0	12	13	1	reporter	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NP	0	14	18	2	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	luciferase	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	VP	0	17	18	1	VBN	0	17	18	1	shown	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	35
*	9291	9292	SYM	*	O	_	_
P	9293	9294	NN	p	O	_	_
=	9294	9295	JJ	=	O	_	_
0.05	9295	9299	CD	0.05	O	_	_
(	9300	9301	NN	(	O	_	_
B	9301	9302	NN	b	O	_	_
)	9302	9303	CD	)	O	_	_
The	9304	9307	DT	the	O	_	_
value	9308	9313	NN	value	O	_	_
of	9314	9316	IN	of	O	_	_
ASPP2+	9317	9323	JJ	aspp2+	B-GENE	_	_
p53	9323	9326	NN	p53	I-GENE	_	_
was	9327	9330	VBD	be	O	_	_
taken	9331	9336	VBN	take	O	_	_
as	9337	9339	IN	as	O	_	_
1.0	9340	9343	CD	1.0	O	_	_
to	9344	9346	TO	to	O	_	_
reflect	9347	9354	VB	reflect	O	_	_
the	9355	9358	DT	the	O	_	_
fold	9359	9363	JJ	fold	O	_	_
increase	9364	9372	NN	increase	O	_	_
of	9373	9375	IN	of	O	_	_
ASPP2	9376	9381	NN	aspp2	B-GENE	_	_
and	9382	9385	CC	and	O	_	_
p53	9386	9389	NN	p53	B-GENE	_	_
in	9390	9392	IN	in	O	_	_
the	9393	9396	DT	the	O	_	_
presence	9397	9405	NN	presence	O	_	_
of	9406	9408	IN	of	O	_	_
activated	9409	9418	VBN	activate	O	_	_
Raf	9419	9422	NN	raf	B-GENE	_	_
and	9423	9426	CC	and	O	_	_
mutant	9427	9433	JJ	mutant	O	_	_
RAS	9434	9437	NN	ra	O	_	_
.	9437	9438	.	.	O	_	_
D	1
13
1	0	dep
1	2	amod
4	3	num
5	1	dep
8	5	dep
8	7	det
8	11	prep_of
11	10	amod
13	8	dep
13	12	auxpass
13	15	prep_as
13	17	xcomp
17	16	aux
17	20	dobj
17	27	prep_in
20	18	det
20	19	amod
20	22	prep_of
20	24	prep_of
22	24	conj_and
27	26	det
27	30	prep_of
27	33	prep_of
30	29	amod
30	33	conj_and
33	32	amod
EOX
Y	1
ROOT	0	0	35	1	FRAG	1	0	35	3	X	1	0	12	2	X	1	0	7	2	X	1	0	5	2	X	0	0	1	1	SYM	0	0	1	1	*	0	0	1	0	NP	0	1	5	2	NP	0	1	3	2	NN	0	1	2	1	P	1	1	2	0	JJ	0	2	3	1	=	2	2	3	0	NP	1	3	5	2	CD	0	3	4	1	0.05	3	3	4	0	NN	0	4	5	1	-LRB-	4	4	5	0	NP	0	5	7	2	NN	0	5	6	1	B	5	5	6	0	CD	0	6	7	1	-RRB-	6	6	7	0	NP	0	7	12	2	NP	1	7	9	2	DT	0	7	8	1	The	7	7	8	0	NN	0	8	9	1	value	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	of	9	9	10	0	NP	1	10	12	2	JJ	0	10	11	1	ASPP2+	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	VP	1	12	34	2	VBD	0	12	13	1	was	12	12	13	0	VP	0	13	34	3	VBN	0	13	14	1	taken	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	as	14	14	15	0	NP	0	15	16	1	CD	0	15	16	1	1.0	15	15	16	0	S	0	16	34	1	VP	1	16	34	2	TO	0	16	17	1	to	16	16	17	0	VP	0	17	34	3	VB	0	17	18	1	reflect	17	17	18	0	NP	0	18	25	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	JJ	0	19	20	1	fold	19	19	20	0	NN	0	20	21	1	increase	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	25	3	NN	0	22	23	1	ASPP2	22	22	23	0	CC	0	23	24	1	and	23	23	24	0	NN	0	24	25	1	p53	24	24	25	0	PP	0	25	34	2	IN	0	25	26	1	in	25	25	26	0	NP	0	26	34	2	NP	1	26	28	2	DT	0	26	27	1	the	26	26	27	0	NN	0	27	28	1	presence	27	27	28	0	PP	0	28	34	2	IN	0	28	29	1	of	28	28	29	0	NP	0	29	34	3	NP	1	29	31	2	VBN	0	29	30	1	activated	29	29	30	0	NN	0	30	31	1	Raf	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	NP	1	32	34	2	JJ	0	32	33	1	mutant	32	32	33	0	NN	0	33	34	1	RAS	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	10
**	9439	9441	SYM	**	O	_	_
P	9442	9443	NN	p	O	_	_
=	9443	9444	JJ	=	O	_	_
0.0055	9444	9450	CD	0.0055	O	_	_
;	9450	9451	:	;	O	_	_
****	9452	9456	CD	****	O	_	_
P	9457	9458	NN	p	O	_	_
=	9458	9459	JJ	=	O	_	_
0.0001	9459	9465	CD	0.0001	O	_	_
.	9465	9466	.	.	O	_	_
D	1
3
1	0	dep
2	1	dep
3	2	dep
3	6	dep
6	5	num
6	7	amod
7	8	dep
EOX
Y	1
ROOT	0	0	10	1	FRAG	0	0	10	3	FRAG	1	0	4	2	X	1	0	3	2	X	1	0	2	2	X	0	0	1	1	SYM	0	0	1	1	**	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	P	1	1	2	0	NP	0	2	3	1	JJ	0	2	3	1	=	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	0.0055	3	3	4	0	:	0	4	5	1	;	4	4	5	0	FRAG	0	5	10	2	NP	0	5	9	2	NP	1	5	7	2	CD	0	5	6	1	****	5	5	6	0	NN	0	6	7	1	P	6	6	7	0	ADJP	0	7	9	2	JJ	0	7	8	1	=	7	7	8	0	NP	0	8	9	1	CD	0	8	9	1	0.0001	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	20
The	9467	9470	DT	the	O	_	_
effect	9471	9477	NN	effect	O	_	_
of	9478	9480	IN	of	O	_	_
Raf	9481	9484	NN	raf	B-GENE	_	_
CAAX	9485	9489	NN	caax	I-GENE	_	_
on	9490	9492	IN	on	O	_	_
ASPP2	9493	9498	NN	aspp2	B-GENE	_	_
and	9499	9502	CC	and	O	_	_
p53	9503	9506	NN	p53	B-GENE	_	_
was	9507	9510	VBD	be	O	_	_
compared	9511	9519	VBN	compare	O	_	_
to	9520	9522	TO	to	O	_	_
that	9523	9527	DT	that	O	_	_
of	9528	9530	IN	of	O	_	_
HRAS	9531	9535	NNP	HRAS	B-GENE	_	_
V12	9536	9539	NN	v12	I-GENE	_	_
or	9540	9542	CC	or	O	_	_
KRAS	9543	9547	NNP	KRAS	B-GENE	_	_
V12	9548	9551	NN	v12	I-GENE	_	_
.	9551	9552	.	.	O	_	_
D	1
9
1	0	det
1	4	prep_of
4	3	nn
4	6	prep_on
4	8	prep_on
6	8	conj_and
9	1	nsubj
9	11	prepc_compared_to
9	12	pobj
12	15	prep_of
12	18	prep_of
15	14	nn
15	18	conj_or
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	9	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	effect	1	1	2	0	PP	0	2	9	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	9	2	NP	1	3	5	2	NN	0	3	4	1	Raf	3	3	4	0	NN	0	4	5	1	CAAX	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	on	5	5	6	0	NP	0	6	9	3	NN	0	6	7	1	ASPP2	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	NN	0	8	9	1	p53	8	8	9	0	VP	0	9	19	2	VBD	0	9	10	1	was	9	9	10	0	PP	0	10	19	2	VBN	0	10	11	1	compared	10	10	11	0	PP	0	11	19	2	TO	0	11	12	1	to	11	11	12	0	NP	0	12	19	2	NP	0	12	13	1	DT	0	12	13	1	that	12	12	13	0	PP	0	13	19	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	19	3	NP	1	14	16	2	NNP	0	14	15	1	HRAS	14	14	15	0	NN	0	15	16	1	V12	15	15	16	0	CC	0	16	17	1	or	16	16	17	0	NP	1	17	19	2	NNP	0	17	18	1	KRAS	17	17	18	0	NN	0	18	19	1	V12	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	17
All	9553	9556	DT	all	O	_	_
three	9557	9562	CD	three	O	_	_
activate	9563	9571	VBP	activate	O	_	_
ASPP2	9572	9577	NN	aspp2	B-GENE	_	_
and	9578	9581	CC	and	O	_	_
p53	9582	9585	NN	p53	B-GENE	_	_
transactivation	9586	9601	NN	transactivation	O	_	_
activity	9602	9610	NN	activity	O	_	_
to	9611	9613	TO	to	O	_	_
a	9614	9615	DT	a	O	_	_
similar	9616	9623	JJ	similar	O	_	_
extent	9624	9630	NN	extent	O	_	_
,	9630	9631	,	,	O	_	_
namely	9632	9638	RB	namely	O	_	_
2.5	9639	9642	CD	2.5	O	_	_
fold	9643	9647	NN	fold	O	_	_
.	9659	9660	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	7	dobj
2	11	prep_to
3	5	conj_and
7	3	nn
7	5	nn
7	6	nn
11	9	det
11	10	amod
11	15	appos
15	13	advmod
15	14	num
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	1	0	2	2	DT	0	0	1	1	All	0	0	1	0	CD	0	1	2	1	three	1	1	2	0	VP	0	2	16	3	VBP	0	2	3	1	activate	2	2	3	0	NP	2	3	8	3	NP	0	3	6	3	NN	0	3	4	1	ASPP2	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NN	0	5	6	1	p53	5	5	6	0	NN	0	6	7	1	transactivation	6	6	7	0	NN	0	7	8	1	activity	7	7	8	0	PP	0	8	16	2	TO	0	8	9	1	to	8	8	9	0	NP	0	9	16	3	NP	2	9	12	3	DT	0	9	10	1	a	9	9	10	0	JJ	0	10	11	1	similar	10	10	11	0	NN	0	11	12	1	extent	11	11	12	0	,	0	12	13	1	,	12	12	13	0	NP	2	13	16	3	RB	0	13	14	1	namely	13	13	14	0	CD	0	14	15	1	2.5	14	14	15	0	NN	0	15	16	1	fold	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	22
This	9661	9665	DT	this	O	_	_
suggests	9666	9674	VBZ	suggest	O	_	_
that	9675	9679	IN	that	O	_	_
the	9680	9683	DT	the	O	_	_
effect	9684	9690	NN	effect	O	_	_
of	9691	9693	IN	of	O	_	_
activated	9694	9703	VBN	activate	O	_	_
RAS	9704	9707	NN	ra	O	_	_
on	9708	9710	IN	on	O	_	_
ASPP2	9711	9716	NN	aspp2	B-GENE	_	_
and	9717	9720	CC	and	O	_	_
p53	9721	9724	NN	p53	B-GENE	_	_
is	9725	9727	VBZ	be	O	_	_
mediated	9728	9736	VBN	mediate	O	_	_
via	9737	9740	IN	via	O	_	_
the	9741	9744	DT	the	O	_	_
downstream	9745	9755	JJ	downstream	O	_	_
Raf	9756	9759	NN	raf	B-GENE	_	_
/	9760	9761	:	/	B-GENE	_	_
MAPK	9761	9765	NN	mapk	I-GENE	_	_
pathway	9766	9773	NN	pathway	O	_	_
.	9773	9774	.	.	O	_	_
D	1
1
1	0	nsubj
1	13	ccomp
4	3	det
4	7	prep_of
7	6	amod
7	9	prep_on
7	11	prep_on
9	11	conj_and
13	2	mark
13	4	nsubjpass
13	12	auxpass
13	17	prep_via
17	15	det
17	16	amod
17	20	dep
20	18	punct
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	0	1	21	2	VBZ	0	1	2	1	suggests	1	1	2	0	SBAR	1	2	21	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	21	2	NP	0	3	12	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	effect	4	4	5	0	PP	0	5	12	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	12	2	NP	1	6	8	2	VBN	0	6	7	1	activated	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	on	8	8	9	0	NP	0	9	12	3	NN	0	9	10	1	ASPP2	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	VP	1	12	21	2	VBZ	0	12	13	1	is	12	12	13	0	VP	0	13	21	2	VBN	0	13	14	1	mediated	13	13	14	0	PP	0	14	21	2	IN	0	14	15	1	via	14	14	15	0	NP	0	15	21	2	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	downstream	16	16	17	0	NN	0	17	18	1	Raf	17	17	18	0	PRN	1	18	21	2	:	0	18	19	1	/	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	MAPK	19	19	20	0	NN	0	20	21	1	pathway	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	24
To	9776	9778	TO	to	O	_	_
assess	9779	9785	VB	assess	O	_	_
the	9786	9789	DT	the	O	_	_
effect	9790	9796	NN	effect	O	_	_
of	9797	9799	IN	of	O	_	_
MAPK	9800	9804	NN	mapk	B-GENE	_	_
phosphorylation	9805	9820	NN	phosphorylation	O	_	_
on	9821	9823	IN	on	O	_	_
ASPP2	9824	9829	NN	aspp2	B-GENE	_	_
activity	9830	9838	NN	activity	O	_	_
,	9838	9839	,	,	O	_	_
alanine	9840	9847	NN	alanine	O	_	_
substitution	9848	9860	NN	substitution	O	_	_
mutants	9861	9868	NNS	mutant	O	_	_
of	9869	9871	IN	of	O	_	_
the	9872	9875	DT	the	O	_	_
two	9876	9879	CD	two	O	_	_
putative	9880	9888	JJ	putative	O	_	_
MAPK	9889	9893	NN	mapk	B-GENE	_	_
phosphorylation	9894	9909	NN	phosphorylation	O	_	_
sites	9910	9915	NNS	site	O	_	_
were	9916	9920	VBD	be	O	_	_
constructed	9921	9932	VBN	construct	O	_	_
.	9932	9933	.	.	O	_	_
D	1
22
1	0	aux
1	3	dobj
1	9	prep_on
3	2	det
3	6	prep_of
6	5	nn
9	8	nn
13	11	nn
13	12	nn
13	20	prep_of
20	15	det
20	16	num
20	17	amod
20	18	nn
20	19	nn
22	1	advcl
22	13	nsubjpass
22	21	auxpass
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	S	0	0	10	1	VP	1	0	10	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	10	3	VB	0	1	2	1	assess	1	1	2	0	NP	0	2	7	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	effect	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	of	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	MAPK	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	on	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	activity	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	0	11	21	2	NP	2	11	14	3	NN	0	11	12	1	alanine	11	11	12	0	NN	0	12	13	1	substitution	12	12	13	0	NNS	0	13	14	1	mutants	13	13	14	0	PP	0	14	21	2	IN	0	14	15	1	of	14	14	15	0	NP	5	15	21	6	DT	0	15	16	1	the	15	15	16	0	CD	0	16	17	1	two	16	16	17	0	JJ	0	17	18	1	putative	17	17	18	0	NN	0	18	19	1	MAPK	18	18	19	0	NN	0	19	20	1	phosphorylation	19	19	20	0	NNS	0	20	21	1	sites	20	20	21	0	VP	1	21	23	2	VBD	0	21	22	1	were	21	21	22	0	VP	0	22	23	1	VBN	0	22	23	1	constructed	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	29
In	9934	9936	IN	in	O	_	_
conditions	9937	9947	NNS	condition	O	_	_
where	9948	9953	WRB	where	O	_	_
the	9954	9957	DT	the	O	_	_
cells	9958	9963	NNS	cell	O	_	_
were	9964	9968	VBD	be	O	_	_
starved	9969	9976	VBN	starve	O	_	_
of	9977	9979	IN	of	O	_	_
serum	9980	9985	NN	serum	O	_	_
,	9985	9986	,	,	O	_	_
these	9987	9992	DT	these	O	_	_
mutants	9993	10000	NNS	mutant	O	_	_
had	10001	10004	VBD	have	O	_	_
identical	10005	10014	JJ	identical	O	_	_
activity	10015	10023	NN	activity	O	_	_
to	10024	10026	TO	to	O	_	_
wild-type	10027	10036	JJ	wild-type	O	_	_
ASPP2	10037	10042	NN	aspp2	O	_	_
in	10043	10045	IN	in	O	_	_
their	10046	10051	PRP$	they	O	_	_
ability	10052	10059	NN	ability	O	_	_
to	10060	10062	TO	to	O	_	_
enhance	10063	10070	VB	enhance	O	_	_
the	10071	10074	DT	the	O	_	_
transactivation	10075	10090	NN	transactivation	O	_	_
function	10091	10099	NN	function	O	_	_
of	10100	10102	IN	of	O	_	_
p53	10103	10106	NN	p53	B-GENE	_	_
.	10118	10119	.	.	O	_	_
D	1
12
1	6	rcmod
4	3	det
6	2	advmod
6	4	nsubjpass
6	5	auxpass
6	8	prep_of
11	10	det
12	1	prep_in
12	11	nsubj
12	14	dobj
12	20	prep_in
14	13	amod
14	17	prep_to
17	16	amod
20	19	poss
20	22	vmod
22	21	aux
22	25	dobj
25	23	det
25	24	nn
25	27	prep_of
EOX
Y	1
ROOT	0	0	29	1	S	3	0	29	5	PP	0	0	9	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	9	2	NP	0	1	2	1	NNS	0	1	2	1	conditions	1	1	2	0	SBAR	1	2	9	2	WHADVP	0	2	3	1	WRB	0	2	3	1	where	2	2	3	0	S	1	3	9	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	9	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	9	2	VBN	0	6	7	1	starved	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	serum	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	1	10	12	2	DT	0	10	11	1	these	10	10	11	0	NNS	0	11	12	1	mutants	11	11	12	0	VP	0	12	28	3	VBD	0	12	13	1	had	12	12	13	0	NP	0	13	18	2	NP	1	13	15	2	JJ	0	13	14	1	identical	13	13	14	0	NN	0	14	15	1	activity	14	14	15	0	PP	0	15	18	2	TO	0	15	16	1	to	15	15	16	0	NP	1	16	18	2	JJ	0	16	17	1	wild-type	16	16	17	0	NN	0	17	18	1	ASPP2	17	17	18	0	PP	0	18	28	2	IN	0	18	19	1	in	18	18	19	0	NP	1	19	28	3	PRP$	0	19	20	1	their	19	19	20	0	NN	0	20	21	1	ability	20	20	21	0	S	0	21	28	1	VP	1	21	28	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	28	2	VB	0	22	23	1	enhance	22	22	23	0	NP	0	23	28	2	NP	2	23	26	3	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	transactivation	24	24	25	0	NN	0	25	26	1	function	25	25	26	0	PP	0	26	28	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	28	1	NN	0	27	28	1	p53	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	35
However	10120	10127	RB	however	O	_	_
,	10127	10128	,	,	O	_	_
whereas	10129	10136	IN	whereas	O	_	_
activated	10137	10146	VBN	activate	O	_	_
Raf	10147	10150	NN	raf	B-GENE	_	_
CAAX	10151	10155	NN	caax	I-GENE	_	_
was	10156	10159	VBD	be	O	_	_
able	10160	10164	JJ	able	O	_	_
to	10165	10167	TO	to	O	_	_
stimulate	10168	10177	VB	stimulate	O	_	_
wild-type	10178	10187	JJ	wild-type	O	_	_
ASPP2	10188	10193	NN	aspp2	O	_	_
and	10194	10197	CC	and	O	_	_
ASPP2	10198	10203	NN	aspp2	O	_	_
(	10204	10205	CD	(	O	_	_
S698A	10205	10210	NN	s698a	O	_	_
)	10210	10211	CD	)	O	_	_
by	10212	10214	IN	by	O	_	_
2.5	10215	10218	CD	2.5	O	_	_
fold	10219	10223	NN	fold	O	_	_
,	10223	10224	,	,	O	_	_
it	10225	10227	PRP	it	O	_	_
was	10228	10231	VBD	be	O	_	_
unable	10232	10238	JJ	unable	O	_	_
to	10239	10241	TO	to	O	_	_
increase	10242	10250	VB	increase	O	_	_
the	10251	10254	DT	the	O	_	_
activity	10255	10263	NN	activity	O	_	_
of	10264	10266	IN	of	O	_	_
mutant	10267	10273	JJ	mutant	O	_	_
ASPP2	10274	10279	NN	aspp2	O	_	_
(	10280	10281	CD	(	O	_	_
S827A	10281	10286	NN	s827a	O	_	_
)	10286	10287	NN	)	O	_	_
.	10299	10300	.	.	O	_	_
D	1

5	3	amod
5	4	nn
7	2	mark
7	5	nsubj
7	6	cop
7	9	xcomp
9	8	aux
9	11	dobj
9	13	dobj
9	19	prep_by
11	10	amod
11	13	conj_and
13	15	dep
19	18	num
23	0	advmod
23	7	parataxis
23	21	nsubj
23	22	cop
23	25	xcomp
25	24	aux
25	27	iobj
27	26	det
27	30	prep_of
30	29	amod
33	32	nn
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	PRN	1	1	21	3	,	0	1	2	1	,	1	1	2	0	SBAR	1	2	20	2	IN	0	2	3	1	whereas	2	2	3	0	S	1	3	20	2	NP	2	3	6	3	VBN	0	3	4	1	activated	3	3	4	0	NN	0	4	5	1	Raf	4	4	5	0	NN	0	5	6	1	CAAX	5	5	6	0	VP	1	6	20	2	VBD	0	6	7	1	was	6	6	7	0	ADJP	0	7	20	2	JJ	0	7	8	1	able	7	7	8	0	S	0	8	20	1	VP	1	8	20	2	TO	0	8	9	1	to	8	8	9	0	VP	0	9	20	3	VB	0	9	10	1	stimulate	9	9	10	0	NP	0	10	17	3	NP	1	10	12	2	JJ	0	10	11	1	wild-type	10	10	11	0	NN	0	11	12	1	ASPP2	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NP	0	13	17	2	NP	0	13	15	2	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NP	0	15	17	2	NN	0	15	16	1	S698A	15	15	16	0	CD	0	16	17	1	-RRB-	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	by	17	17	18	0	NP	1	18	20	2	CD	0	18	19	1	2.5	18	18	19	0	NN	0	19	20	1	fold	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	0	21	22	1	PRP	0	21	22	1	it	21	21	22	0	VP	1	22	34	2	VBD	0	22	23	1	was	22	22	23	0	ADJP	0	23	34	2	JJ	0	23	24	1	unable	23	23	24	0	S	0	24	34	1	VP	1	24	34	2	TO	0	24	25	1	to	24	24	25	0	VP	0	25	34	3	VB	0	25	26	1	increase	25	25	26	0	NP	0	26	31	2	NP	1	26	28	2	DT	0	26	27	1	the	26	26	27	0	NN	0	27	28	1	activity	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	of	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	mutant	29	29	30	0	NN	0	30	31	1	ASPP2	30	30	31	0	NP	2	31	34	3	CD	0	31	32	1	-LRB-	31	31	32	0	NN	0	32	33	1	S827A	32	32	33	0	NN	0	33	34	1	-RRB-	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	25
These	10301	10306	DT	these	O	_	_
results	10307	10314	NNS	result	O	_	_
suggest	10315	10322	VBP	suggest	O	_	_
that	10323	10327	IN	that	O	_	_
MAPK	10328	10332	NN	mapk	B-GENE	_	_
phosphorylation	10333	10348	NN	phosphorylation	O	_	_
of	10349	10351	IN	of	O	_	_
ASPP2	10352	10357	NN	aspp2	B-GENE	_	_
Ser827	10358	10364	NN	ser827	O	_	_
is	10365	10367	VBZ	be	O	_	_
necessary	10368	10377	JJ	necessary	O	_	_
for	10378	10381	IN	for	O	_	_
Raf	10382	10385	NN	raf	B-GENE	_	_
CAAX	10386	10390	NN	caax	I-GENE	_	_
to	10391	10393	TO	to	O	_	_
stimulate	10394	10403	VB	stimulate	O	_	_
the	10404	10407	DT	the	O	_	_
full	10408	10412	JJ	full	O	_	_
transcriptional	10413	10428	JJ	transcriptional	O	_	_
activity	10429	10437	NN	activity	O	_	_
of	10438	10440	IN	of	O	_	_
p53	10441	10444	NN	p53	B-GENE	_	_
via	10445	10448	IN	via	I-GENE	_	_
ASPP2	10449	10454	NN	aspp2	I-GENE	_	_
.	10454	10455	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	10	ccomp
5	4	nn
5	8	prep_of
8	7	nn
10	3	mark
10	5	nsubj
10	9	cop
10	13	prep_for
10	15	xcomp
13	12	nn
15	14	aux
15	19	dobj
19	16	det
19	17	amod
19	18	amod
19	21	prep_of
21	23	prep_via
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	results	1	1	2	0	VP	0	2	24	2	VBP	0	2	3	1	suggest	2	2	3	0	SBAR	1	3	24	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	24	2	NP	0	4	9	2	NP	1	4	6	2	NN	0	4	5	1	MAPK	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	ASPP2	7	7	8	0	NN	0	8	9	1	Ser827	8	8	9	0	VP	1	9	24	3	VBZ	0	9	10	1	is	9	9	10	0	ADJP	0	10	14	2	JJ	0	10	11	1	necessary	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	for	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	Raf	12	12	13	0	NN	0	13	14	1	CAAX	13	13	14	0	S	0	14	24	1	VP	1	14	24	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	24	2	VB	0	15	16	1	stimulate	15	15	16	0	NP	0	16	24	2	NP	3	16	20	4	DT	0	16	17	1	the	16	16	17	0	JJ	0	17	18	1	full	17	17	18	0	JJ	0	18	19	1	transcriptional	18	18	19	0	NN	0	19	20	1	activity	19	19	20	0	PP	0	20	24	2	IN	0	20	21	1	of	20	20	21	0	NP	0	21	24	2	NP	0	21	22	1	NN	0	21	22	1	p53	21	21	22	0	PP	0	22	24	2	IN	0	22	23	1	via	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	23
(	10457	10458	NN	(	O	_	_
A	10458	10459	NN	a	O	_	_
)	10459	10460	CD	)	O	_	_
Saos2	10461	10466	NN	saos2	O	_	_
cells	10467	10472	NNS	cell	O	_	_
were	10473	10477	VBD	be	O	_	_
transfected	10478	10489	VBN	transfect	O	_	_
with	10490	10494	IN	with	O	_	_
p53	10495	10498	NN	p53	B-GENE	_	_
and	10499	10502	CC	and	O	_	_
either	10503	10509	CC	either	O	_	_
wild-type	10510	10519	JJ	wild-type	O	_	_
or	10520	10522	CC	or	O	_	_
mutant	10523	10529	JJ	mutant	O	_	_
ASPP2	10530	10535	NN	aspp2	O	_	_
as	10536	10538	IN	as	O	_	_
indicated	10539	10548	VBN	indicate	O	_	_
together	10549	10557	RB	together	O	_	_
with	10558	10562	IN	with	O	_	_
a	10563	10564	DT	a	O	_	_
Bax-luciferase	10565	10579	NN	bax-luciferase	B-GENE	_	_
reporter	10580	10588	NN	reporter	I-GENE	_	_
.	10588	10589	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	prep_with
6	16	conj_and
11	10	preconj
11	14	conj_or
14	13	amod
14	15	amod
16	11	nsubj
16	14	nsubj
16	21	prep_together_with
21	19	det
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	S	0	0	23	4	S	1	0	9	2	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	9	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	9	2	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	22	2	NP	1	10	16	4	CC	0	10	11	1	either	10	10	11	0	NP	0	11	12	1	JJ	0	11	12	1	wild-type	11	11	12	0	CC	0	12	13	1	or	12	12	13	0	NP	1	13	16	3	JJ	0	13	14	1	mutant	13	13	14	0	NN	0	14	15	1	ASPP2	14	14	15	0	IN	0	15	16	1	as	15	15	16	0	VP	0	16	22	3	VBN	0	16	17	1	indicated	16	16	17	0	ADVP	0	17	18	1	RB	0	17	18	1	together	17	17	18	0	PP	0	18	22	2	IN	0	18	19	1	with	18	18	19	0	NP	2	19	22	3	DT	0	19	20	1	a	19	19	20	0	NN	0	20	21	1	Bax-luciferase	20	20	21	0	NN	0	21	22	1	reporter	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	9
Luciferase	10590	10600	NN	luciferase	B-GENE	_	_
activity	10601	10609	NN	activity	O	_	_
is	10610	10612	VBZ	be	O	_	_
shown	10613	10618	VBN	show	O	_	_
following	10619	10628	VBG	follow	O	_	_
harvesting	10629	10639	NN	harvesting	O	_	_
of	10640	10642	IN	of	O	_	_
cells	10643	10648	NNS	cell	O	_	_
.	10648	10649	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	5	prep_following
5	7	prep_of
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	NN	0	0	1	1	Luciferase	0	0	1	0	NN	0	1	2	1	activity	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	VBG	0	4	5	1	following	4	4	5	0	NP	0	5	8	2	NP	0	5	6	1	NN	0	5	6	1	harvesting	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NNS	0	7	8	1	cells	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	9
Values	10650	10656	NNS	value	O	_	_
are	10657	10660	VBP	be	O	_	_
Relative	10661	10669	JJ	relative	O	_	_
Light	10670	10675	JJ	light	O	_	_
Units	10676	10681	NNS	unit	O	_	_
(	10682	10683	VBP	(	O	_	_
RLU	10683	10686	NN	rlu	O	_	_
)	10686	10687	NN	)	O	_	_
.	10687	10688	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
4	3	amod
5	4	nsubj
7	6	nn
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Values	0	0	1	0	VP	1	1	8	2	VBP	0	1	2	1	are	1	1	2	0	ADJP	0	2	8	2	JJ	0	2	3	1	Relative	2	2	3	0	SBAR	0	3	8	1	S	1	3	8	2	NP	1	3	5	2	JJ	0	3	4	1	Light	3	3	4	0	NNS	0	4	5	1	Units	4	4	5	0	VP	0	5	8	2	VBP	0	5	6	1	-LRB-	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	RLU	6	6	7	0	NN	0	7	8	1	-RRB-	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	28
(	10689	10690	NN	(	O	_	_
B	10690	10691	NN	b	O	_	_
)	10691	10692	CD	)	O	_	_
Saos2	10693	10698	NN	saos2	O	_	_
cells	10699	10704	NNS	cell	O	_	_
were	10705	10709	VBD	be	O	_	_
transfected	10710	10721	VBN	transfect	O	_	_
with	10722	10726	IN	with	O	_	_
p53	10727	10730	NN	p53	B-GENE	_	_
,	10730	10731	,	,	O	_	_
constitutively	10732	10746	RB	constitutively	O	_	_
active	10747	10753	JJ	active	O	_	_
Raf	10754	10757	NN	raf	B-GENE	_	_
CAAX	10758	10762	NN	caax	I-GENE	_	_
and	10763	10766	CC	and	O	_	_
either	10767	10773	CC	either	O	_	_
wild-type	10774	10783	JJ	wild-type	O	_	_
or	10784	10786	CC	or	O	_	_
mutant	10787	10793	JJ	mutant	O	_	_
ASPP2	10794	10799	NN	aspp2	O	_	_
as	10800	10802	IN	as	O	_	_
indicated	10803	10812	VBN	indicate	O	_	_
together	10813	10821	RB	together	O	_	_
with	10822	10826	IN	with	O	_	_
a	10827	10828	DT	a	O	_	_
Bax-luciferase	10829	10843	NN	bax-luciferase	B-GENE	_	_
reporter	10844	10852	NN	reporter	I-GENE	_	_
.	10852	10853	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	prep_with
6	21	advcl
8	13	appos
8	19	appos
11	10	advmod
13	11	amod
13	12	nn
13	19	conj_and
16	15	preconj
16	18	conj_or
19	16	amod
19	18	amod
21	20	mark
21	26	prep_together_with
26	24	det
26	25	nn
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	27	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	27	3	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	20	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	20	3	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	20	3	NP	2	10	14	3	ADJP	1	10	12	2	RB	0	10	11	1	constitutively	10	10	11	0	JJ	0	11	12	1	active	11	11	12	0	NN	0	12	13	1	Raf	12	12	13	0	NN	0	13	14	1	CAAX	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	1	15	20	2	ADJP	1	15	19	4	CC	0	15	16	1	either	15	15	16	0	JJ	0	16	17	1	wild-type	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	JJ	0	18	19	1	mutant	18	18	19	0	NN	0	19	20	1	ASPP2	19	19	20	0	SBAR	1	20	27	2	IN	0	20	21	1	as	20	20	21	0	S	0	21	27	1	VP	0	21	27	3	VBN	0	21	22	1	indicated	21	21	22	0	ADVP	0	22	23	1	RB	0	22	23	1	together	22	22	23	0	PP	0	23	27	2	IN	0	23	24	1	with	23	23	24	0	NP	2	24	27	3	DT	0	24	25	1	a	24	24	25	0	NN	0	25	26	1	Bax-luciferase	25	25	26	0	NN	0	26	27	1	reporter	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	36
**	10854	10856	SYM	**	O	_	_
P	10857	10858	NN	p	O	_	_
=	10858	10859	JJ	=	O	_	_
0.013	10859	10864	CD	0.013	O	_	_
;	10864	10865	:	;	O	_	_
****	10866	10870	CD	****	O	_	_
P	10871	10872	NN	p	O	_	_
=	10872	10873	JJ	=	O	_	_
0.0001	10873	10879	CD	0.0001	O	_	_
(	10880	10881	NN	(	O	_	_
C	10881	10882	NN	c	O	_	_
)	10882	10883	CD	)	O	_	_
Saos2	10884	10889	NN	saos2	O	_	_
cells	10890	10895	NNS	cell	O	_	_
were	10896	10900	VBD	be	O	_	_
transfected	10901	10912	VBN	transfect	O	_	_
with	10913	10917	IN	with	O	_	_
a	10918	10919	DT	a	O	_	_
Bax-luciferase	10920	10934	NN	bax-luciferase	B-GENE	_	_
reporter	10935	10943	NN	reporter	I-GENE	_	_
,	10943	10944	,	,	O	_	_
ASPP2	10945	10950	NN	aspp2	B-GENE	_	_
and	10951	10954	CC	and	O	_	_
p53	10955	10958	NN	p53	B-GENE	_	_
and	10959	10962	CC	and	O	_	_
treated	10963	10970	VBN	treat	O	_	_
with	10971	10975	IN	with	O	_	_
20	10976	10978	CD	20	O	_	_
microM	10979	10985	NN	microm	O	_	_
UO126	10986	10991	NN	uo126	O	_	_
or	10992	10994	CC	or	O	_	_
DMSO	10995	10999	NN	dmso	O	_	_
for	11000	11003	IN	for	O	_	_
20	11004	11006	CD	20	O	_	_
hours	11007	11012	NNS	hour	O	_	_
.	11012	11013	.	.	O	_	_
D	1
6
1	0	dep
1	3	dep
3	2	amod
6	1	dep
6	5	num
6	10	rcmod
9	7	amod
9	8	num
10	15	ccomp
10	25	ccomp
13	12	nn
15	13	nsubjpass
15	14	auxpass
15	19	prep_with
15	21	prep_with
15	23	prep_with
15	25	conj_and
19	17	det
19	18	nn
19	21	conj_and
19	23	conj_and
25	13	nsubjpass
25	29	prep_with
25	31	prep_with
25	34	prep_for
29	27	num
29	28	nn
29	31	conj_or
34	33	num
EOX
Y	1
ROOT	0	0	36	1	FRAG	2	0	36	4	X	1	0	4	2	X	0	0	1	1	SYM	0	0	1	1	**	0	0	1	0	NP	0	1	4	2	NP	0	1	2	1	NN	0	1	2	1	P	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	=	2	2	3	0	CD	0	3	4	1	0.013	3	3	4	0	:	0	4	5	1	;	4	4	5	0	NP	0	5	35	2	NP	1	5	7	2	CD	0	5	6	1	****	5	5	6	0	NN	0	6	7	1	P	6	6	7	0	SBAR	0	7	35	1	S	1	7	35	2	NP	2	7	10	3	JJ	0	7	8	1	=	7	7	8	0	CD	0	8	9	1	0.0001	8	8	9	0	NN	0	9	10	1	-LRB-	9	9	10	0	VP	0	10	35	2	NN	0	10	11	1	C	10	10	11	0	SBAR	0	11	35	1	S	1	11	35	2	NP	2	11	14	3	CD	0	11	12	1	-RRB-	11	11	12	0	NN	0	12	13	1	Saos2	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	VP	1	14	35	2	VBD	0	14	15	1	were	14	14	15	0	VP	0	15	35	3	VP	0	15	24	2	VBN	0	15	16	1	transfected	15	15	16	0	PP	0	16	24	2	IN	0	16	17	1	with	16	16	17	0	NP	2	17	24	7	DT	0	17	18	1	a	17	17	18	0	NN	0	18	19	1	Bax-luciferase	18	18	19	0	NN	0	19	20	1	reporter	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NN	0	21	22	1	ASPP2	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NN	0	23	24	1	p53	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	VP	0	25	35	3	VBN	0	25	26	1	treated	25	25	26	0	PP	0	26	32	2	IN	0	26	27	1	with	26	26	27	0	NP	0	27	32	3	NP	2	27	30	3	CD	0	27	28	1	20	27	27	28	0	NN	0	28	29	1	microM	28	28	29	0	NN	0	29	30	1	UO126	29	29	30	0	CC	0	30	31	1	or	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	DMSO	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	for	32	32	33	0	NP	1	33	35	2	CD	0	33	34	1	20	33	33	34	0	NNS	0	34	35	1	hours	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	21
Luciferase	11014	11024	NN	luciferase	B-GENE	_	_
activity	11025	11033	NN	activity	O	_	_
is	11034	11036	VBZ	be	O	_	_
shown	11037	11042	VBN	show	O	_	_
in	11043	11045	IN	in	O	_	_
the	11046	11049	DT	the	O	_	_
left	11050	11054	JJ	left	O	_	_
panel	11055	11060	NN	panel	O	_	_
and	11061	11064	CC	and	O	_	_
protein	11065	11072	NN	protein	O	_	_
expression	11073	11083	NN	expression	O	_	_
was	11084	11087	VBD	be	O	_	_
verified	11088	11096	VBN	verify	O	_	_
by	11097	11099	IN	by	O	_	_
Western	11100	11107	JJ	western	O	_	_
Blot	11108	11112	NN	blot	O	_	_
(	11113	11114	RB	(	O	_	_
right	11114	11119	JJ	right	O	_	_
panel	11120	11125	NN	panel	O	_	_
)	11125	11126	NN	)	O	_	_
.	11126	11127	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_in
3	12	conj_and
7	5	det
7	6	amod
10	9	nn
12	10	nsubjpass
12	11	auxpass
12	13	prep
15	14	amod
19	15	nn
19	17	amod
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	0	0	21	4	S	1	0	8	2	NP	1	0	2	2	NN	0	0	1	1	Luciferase	0	0	1	0	NN	0	1	2	1	activity	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	in	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	JJ	0	6	7	1	left	6	6	7	0	NN	0	7	8	1	panel	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	20	2	NP	1	9	11	2	NN	0	9	10	1	protein	9	9	10	0	NN	0	10	11	1	expression	10	10	11	0	VP	1	11	20	2	VBD	0	11	12	1	was	11	11	12	0	VP	0	12	20	2	VBN	0	12	13	1	verified	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	by	13	13	14	0	NP	3	14	20	4	NP	1	14	16	2	JJ	0	14	15	1	Western	14	14	15	0	NN	0	15	16	1	Blot	15	15	16	0	ADJP	1	16	18	2	RB	0	16	17	1	-LRB-	16	16	17	0	JJ	0	17	18	1	right	17	17	18	0	NN	0	18	19	1	panel	18	18	19	0	NN	0	19	20	1	-RRB-	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	5
****	11128	11132	NN	****	O	_	_
P	11133	11134	NN	p	O	_	_
=	11134	11135	JJ	=	O	_	_
0.0001	11135	11141	CD	0.0001	O	_	_
.	11141	11142	.	.	O	_	_
D	1
1
1	0	nn
1	3	num
3	2	quantmod
EOX
Y	1
ROOT	0	0	5	1	NP	0	0	5	3	NP	1	0	2	2	NN	0	0	1	1	****	0	0	1	0	NN	0	1	2	1	P	1	1	2	0	QP	1	2	4	2	JJ	0	2	3	1	=	2	2	3	0	CD	0	3	4	1	0.0001	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	22
To	11143	11145	TO	to	O	_	_
determine	11146	11155	VB	determine	O	_	_
the	11156	11159	DT	the	O	_	_
effect	11160	11166	NN	effect	O	_	_
of	11167	11169	IN	of	O	_	_
MAPK	11170	11174	NN	mapk	B-GENE	_	_
phosphorylation	11175	11190	NN	phosphorylation	O	_	_
on	11191	11193	IN	on	O	_	_
endogenous	11194	11204	JJ	endogenous	O	_	_
ASPP2	11205	11210	NN	aspp2	B-GENE	_	_
activity	11211	11219	NN	activity	O	_	_
,	11219	11220	,	,	O	_	_
cells	11221	11226	NNS	cell	O	_	_
were	11227	11231	VBD	be	O	_	_
treated	11232	11239	VBN	treat	O	_	_
with	11240	11244	IN	with	O	_	_
a	11245	11246	DT	a	O	_	_
MAPK	11247	11251	NN	mapk	B-GENE	_	_
inhibitor	11252	11261	NN	inhibitor	O	_	_
,	11261	11262	,	,	O	_	_
UO126	11263	11268	NN	uo126	O	_	_
.	11268	11269	.	.	O	_	_
D	1
14
1	0	aux
1	3	dobj
1	10	prep_on
3	2	det
3	6	prep_of
6	5	nn
10	8	amod
10	9	nn
14	1	advcl
14	12	nsubjpass
14	13	auxpass
14	18	prep_with
18	16	det
18	17	nn
18	20	appos
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	S	0	0	11	1	VP	1	0	11	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	11	3	VB	0	1	2	1	determine	1	1	2	0	NP	0	2	7	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	effect	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	of	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	MAPK	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	on	7	7	8	0	NP	2	8	11	3	JJ	0	8	9	1	endogenous	8	8	9	0	NN	0	9	10	1	ASPP2	9	9	10	0	NN	0	10	11	1	activity	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	NNS	0	12	13	1	cells	12	12	13	0	VP	1	13	21	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	21	2	VBN	0	14	15	1	treated	14	14	15	0	PP	0	15	21	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	21	3	NP	2	16	19	3	DT	0	16	17	1	a	16	16	17	0	NN	0	17	18	1	MAPK	17	17	18	0	NN	0	18	19	1	inhibitor	18	18	19	0	,	0	19	20	1	,	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	UO126	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	36
Inhibiting	11270	11280	VBG	inhibit	O	_	_
MAPK	11281	11285	NN	mapk	O	_	_
resulted	11286	11294	VBD	result	O	_	_
in	11295	11297	IN	in	O	_	_
a	11298	11299	DT	a	O	_	_
significant	11300	11311	JJ	significant	O	_	_
decrease	11312	11320	NN	decrease	O	_	_
in	11321	11323	IN	in	O	_	_
the	11324	11327	DT	the	O	_	_
ability	11328	11335	NN	ability	O	_	_
of	11336	11338	IN	of	O	_	_
ASPP2	11339	11344	NN	aspp2	B-GENE	_	_
to	11345	11347	TO	to	O	_	_
enhance	11348	11355	VB	enhance	O	_	_
the	11356	11359	DT	the	O	_	_
transcriptional	11360	11375	JJ	transcriptional	O	_	_
activity	11376	11384	NN	activity	O	_	_
of	11385	11387	IN	of	O	_	_
p53	11388	11391	NN	p53	B-GENE	_	_
compared	11392	11400	VBN	compare	O	_	_
to	11401	11403	TO	to	O	_	_
the	11404	11407	DT	the	O	_	_
control	11408	11415	NN	control	O	_	_
cells	11416	11421	NNS	cell	O	_	_
,	11433	11434	,	,	O	_	_
further	11435	11442	RB	further	O	_	_
validating	11443	11453	VBG	validate	O	_	_
the	11454	11457	DT	the	O	_	_
functional	11458	11468	JJ	functional	O	_	_
role	11469	11473	NN	role	O	_	_
of	11474	11476	IN	of	O	_	_
ASPP2	11477	11482	NN	aspp2	B-GENE	_	_
phosphorylation	11483	11498	NN	phosphorylation	O	_	_
by	11499	11501	IN	by	O	_	_
MAPK	11502	11506	NN	mapk	O	_	_
.	11506	11507	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	6	prep_in
2	13	xcomp
2	26	xcomp
6	4	det
6	5	amod
6	9	prep_in
9	8	det
9	11	prep_of
13	12	aux
13	16	dobj
13	20	prepc_compared_to
13	23	pobj
16	14	det
16	15	amod
16	18	prep_of
23	21	det
23	22	nn
26	25	advmod
26	29	dobj
26	34	prep_by
29	27	det
29	28	amod
29	32	prep_of
32	31	nn
EOX
Y	1
ROOT	0	0	36	1	S	1	0	36	3	NP	1	0	2	2	VBG	0	0	1	1	Inhibiting	0	0	1	0	NN	0	1	2	1	MAPK	1	1	2	0	VP	0	2	35	5	VBD	0	2	3	1	resulted	2	2	3	0	PP	0	3	12	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	12	2	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	JJ	0	5	6	1	significant	5	5	6	0	NN	0	6	7	1	decrease	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	in	7	7	8	0	NP	0	8	12	2	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	ability	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	S	0	12	24	1	VP	1	12	24	2	TO	0	12	13	1	to	12	12	13	0	VP	0	13	24	3	VB	0	13	14	1	enhance	13	13	14	0	NP	0	14	19	2	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	JJ	0	15	16	1	transcriptional	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	p53	18	18	19	0	PP	0	19	24	2	VBN	0	19	20	1	compared	19	19	20	0	PP	0	20	24	2	TO	0	20	21	1	to	20	20	21	0	NP	2	21	24	3	DT	0	21	22	1	the	21	21	22	0	NN	0	22	23	1	control	22	22	23	0	NNS	0	23	24	1	cells	23	23	24	0	,	0	24	25	1	,	24	24	25	0	S	1	25	35	2	ADVP	0	25	26	1	RB	0	25	26	1	further	25	25	26	0	VP	0	26	35	3	VBG	0	26	27	1	validating	26	26	27	0	NP	0	27	33	2	NP	2	27	30	3	DT	0	27	28	1	the	27	27	28	0	ADJP	0	28	29	1	JJ	0	28	29	1	functional	28	28	29	0	NN	0	29	30	1	role	29	29	30	0	PP	0	30	33	2	IN	0	30	31	1	of	30	30	31	0	NP	1	31	33	2	NN	0	31	32	1	ASPP2	31	31	32	0	NN	0	32	33	1	phosphorylation	32	32	33	0	PP	0	33	35	2	IN	0	33	34	1	by	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	MAPK	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	18
Moreover	11508	11516	RB	moreover	O	_	_
,	11516	11517	,	,	O	_	_
another	11518	11525	DT	another	O	_	_
MAPK	11526	11530	NN	mapk	B-GENE	_	_
inhibitor	11531	11540	NN	inhibitor	O	_	_
,	11540	11541	,	,	O	_	_
PD	11542	11544	NN	pd	O	_	_
98059	11545	11550	CD	98059	O	_	_
,	11550	11551	,	,	O	_	_
also	11552	11556	RB	also	O	_	_
inhibited	11557	11566	VBD	inhibit	O	_	_
ASPP2	11567	11572	NN	aspp2	B-GENE	_	_
function	11573	11581	NN	function	O	_	_
to	11582	11584	TO	to	O	_	_
a	11585	11586	DT	a	O	_	_
similar	11587	11594	JJ	similar	O	_	_
extent	11595	11601	NN	extent	O	_	_
.	11613	11614	.	.	O	_	_
D	1
10
4	2	det
4	3	nn
4	6	appos
6	7	num
10	0	advmod
10	4	nsubj
10	9	advmod
10	12	dobj
10	16	prep_to
12	11	nn
16	14	det
16	15	amod
EOX
Y	1
ROOT	0	0	18	1	S	4	0	18	6	ADVP	0	0	1	1	RB	0	0	1	1	Moreover	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	9	4	NP	2	2	5	3	DT	0	2	3	1	another	2	2	3	0	NN	0	3	4	1	MAPK	3	3	4	0	NN	0	4	5	1	inhibitor	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	8	2	NN	0	6	7	1	PD	6	6	7	0	CD	0	7	8	1	98059	7	7	8	0	,	0	8	9	1	,	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	also	9	9	10	0	VP	0	10	17	3	VBD	0	10	11	1	inhibited	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	ASPP2	11	11	12	0	NN	0	12	13	1	function	12	12	13	0	PP	0	13	17	2	TO	0	13	14	1	to	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	JJ	0	15	16	1	similar	15	15	16	0	NN	0	16	17	1	extent	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	32
Interestingly	11615	11628	RB	interestingly	O	_	_
,	11628	11629	,	,	O	_	_
the	11630	11633	DT	the	O	_	_
endogenous	11634	11644	JJ	endogenous	B-GENE	_	_
ASPP2	11645	11650	NN	aspp2	I-GENE	_	_
protein	11651	11658	NN	protein	I-GENE	_	_
level	11659	11664	NN	level	O	_	_
was	11665	11668	VBD	be	O	_	_
slightly	11669	11677	RB	slightly	O	_	_
decreased	11678	11687	VBN	decrease	O	_	_
following	11688	11697	VBG	follow	O	_	_
RAS	11698	11701	NN	ra	B-GENE	_	_
/	11701	11702	:	/	B-GENE	_	_
MAPK	11702	11706	NN	mapk	I-GENE	_	_
pathway	11707	11714	NN	pathway	O	_	_
inhibition	11715	11725	NN	inhibition	O	_	_
by	11726	11728	IN	by	O	_	_
UO126	11729	11734	NN	uo126	O	_	_
treatment	11735	11744	NN	treatment	O	_	_
while	11770	11775	IN	while	O	_	_
RAS	11776	11779	NN	ra	B-GENE	_	_
/	11779	11780	:	/	B-GENE	_	_
MAPK	11780	11784	NN	mapk	I-GENE	_	_
pathway	11785	11792	NN	pathway	O	_	_
activation	11793	11803	NN	activation	O	_	_
resulted	11804	11812	VBD	result	O	_	_
in	11813	11815	IN	in	O	_	_
the	11816	11819	DT	the	O	_	_
increased	11820	11829	VBN	increase	O	_	_
ASPP2	11830	11835	NN	aspp2	B-GENE	_	_
expression	11836	11846	NN	expression	O	_	_
.	11870	11871	.	.	O	_	_
D	1
9
6	2	det
6	3	amod
6	4	nn
6	5	nn
9	0	advmod
9	6	nsubjpass
9	7	auxpass
9	8	advmod
9	11	prep_following
11	15	dep
11	25	rcmod
15	12	punct
15	13	nn
15	14	nn
15	18	prep_by
15	21	punct
18	17	nn
18	20	prep_while
24	22	nn
24	23	nn
25	24	nsubj
25	30	prep_in
30	27	det
30	28	amod
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	S	3	0	32	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	4	2	7	5	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	endogenous	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	protein	5	5	6	0	NN	0	6	7	1	level	6	6	7	0	VP	2	7	31	3	VBD	0	7	8	1	was	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	slightly	8	8	9	0	VP	0	9	31	2	VBN	0	9	10	1	decreased	9	9	10	0	PP	0	10	31	2	VBG	0	10	11	1	following	10	10	11	0	NP	0	11	31	2	NP	0	11	22	2	NP	0	11	12	1	NN	0	11	12	1	RAS	11	11	12	0	PRN	1	12	22	3	:	0	12	13	1	/	12	12	13	0	NP	0	13	21	2	NP	2	13	16	3	NN	0	13	14	1	MAPK	13	13	14	0	NN	0	14	15	1	pathway	14	14	15	0	NN	0	15	16	1	inhibition	15	15	16	0	PP	0	16	21	2	IN	0	16	17	1	by	16	16	17	0	NP	0	17	21	2	NP	1	17	19	2	NN	0	17	18	1	UO126	17	17	18	0	NN	0	18	19	1	treatment	18	18	19	0	PP	0	19	21	2	IN	0	19	20	1	while	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	RAS	20	20	21	0	:	0	21	22	1	/	21	21	22	0	SBAR	0	22	31	1	S	1	22	31	2	NP	2	22	25	3	NN	0	22	23	1	MAPK	22	22	23	0	NN	0	23	24	1	pathway	23	23	24	0	NN	0	24	25	1	activation	24	24	25	0	VP	0	25	31	2	VBD	0	25	26	1	resulted	25	25	26	0	PP	0	26	31	2	IN	0	26	27	1	in	26	26	27	0	NP	3	27	31	4	DT	0	27	28	1	the	27	27	28	0	VBN	0	28	29	1	increased	28	28	29	0	NN	0	29	30	1	ASPP2	29	29	30	0	NN	0	30	31	1	expression	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	26
The	11872	11875	DT	the	O	_	_
mRNA	11876	11880	NN	mrna	O	_	_
level	11881	11886	NN	level	O	_	_
of	11887	11889	IN	of	O	_	_
ASPP2	11890	11895	NN	aspp2	B-GENE	_	_
was	11896	11899	VBD	be	O	_	_
not	11900	11903	RB	not	O	_	_
affected	11904	11912	VBN	affect	O	_	_
upon	11913	11917	IN	upon	O	_	_
RAS	11918	11921	NN	ra	B-GENE	_	_
/	11921	11922	:	/	B-GENE	_	_
MAPK	11922	11926	NN	mapk	I-GENE	_	_
pathway	11927	11934	NN	pathway	O	_	_
activation	11935	11945	NN	activation	O	_	_
,	11958	11959	,	,	O	_	_
indicating	11960	11970	VBG	indicate	O	_	_
that	11971	11975	IN	that	O	_	_
the	11976	11979	DT	the	O	_	_
regulation	11980	11990	NN	regulation	O	_	_
is	11991	11993	VBZ	be	O	_	_
not	11994	11997	RB	not	O	_	_
at	11998	12000	IN	at	O	_	_
the	12001	12004	DT	the	O	_	_
transcriptional	12005	12020	JJ	transcriptional	O	_	_
level	12021	12026	NN	level	O	_	_
.	12026	12027	.	.	O	_	_
D	1
7
2	0	det
2	1	nn
2	4	prep_of
7	2	nsubjpass
7	5	auxpass
7	6	neg
7	15	prepc_upon
9	12	dep
9	13	dep
12	10	punct
12	11	nn
15	9	nsubj
15	19	ccomp
18	17	det
19	16	mark
19	18	nsubj
19	20	neg
19	24	prep_at
24	22	det
24	23	amod
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	mRNA	1	1	2	0	NN	0	2	3	1	level	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	2	5	25	3	VBD	0	5	6	1	was	5	5	6	0	RB	0	6	7	1	not	6	6	7	0	VP	0	7	25	2	VBN	0	7	8	1	affected	7	7	8	0	PP	0	8	25	2	IN	0	8	9	1	upon	8	8	9	0	S	1	9	25	2	NP	0	9	15	4	NP	0	9	10	1	NN	0	9	10	1	RAS	9	9	10	0	PRN	1	10	13	2	:	0	10	11	1	/	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	MAPK	11	11	12	0	NN	0	12	13	1	pathway	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	activation	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	0	15	25	2	VBG	0	15	16	1	indicating	15	15	16	0	SBAR	1	16	25	2	IN	0	16	17	1	that	16	16	17	0	S	1	17	25	2	NP	1	17	19	2	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	regulation	18	18	19	0	VP	0	19	25	3	VBZ	0	19	20	1	is	19	19	20	0	RB	0	20	21	1	not	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	at	21	21	22	0	NP	2	22	25	3	DT	0	22	23	1	the	22	22	23	0	JJ	0	23	24	1	transcriptional	23	23	24	0	NN	0	24	25	1	level	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	19
Thus	12028	12032	RB	thus	O	_	_
we	12033	12035	PRP	we	O	_	_
investigated	12036	12048	VBD	investigate	O	_	_
whether	12049	12056	IN	whether	O	_	_
RAS	12057	12060	NNP	RAS	B-GENE	_	_
/	12060	12061	:	/	B-GENE	_	_
MAPK	12061	12065	NN	mapk	I-GENE	_	_
pathway	12066	12073	NN	pathway	O	_	_
activation	12074	12084	NN	activation	O	_	_
could	12085	12090	MD	could	O	_	_
result	12091	12097	VB	result	O	_	_
in	12098	12100	IN	in	O	_	_
the	12101	12104	DT	the	O	_	_
increased	12105	12114	VBN	increase	O	_	_
protein	12115	12122	NN	protein	O	_	_
stability	12123	12132	NN	stability	O	_	_
of	12133	12135	IN	of	O	_	_
ASPP2	12136	12141	NN	aspp2	B-GENE	_	_
.	12141	12142	.	.	O	_	_
D	1
2
2	0	advmod
2	1	nsubj
2	4	dep
4	3	mark
4	5	punct
4	10	dep
8	6	nn
8	7	nn
10	8	nsubj
10	9	aux
10	15	prep_in
15	12	det
15	13	amod
15	14	nn
15	17	prep_of
EOX
Y	1
ROOT	0	0	19	1	S	2	0	19	4	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	18	2	VBD	0	2	3	1	investigated	2	2	3	0	SBAR	1	3	18	2	IN	0	3	4	1	whether	3	3	4	0	FRAG	0	4	18	3	NP	0	4	5	1	NNP	0	4	5	1	RAS	4	4	5	0	:	0	5	6	1	/	5	5	6	0	S	1	6	18	2	NP	2	6	9	3	NN	0	6	7	1	MAPK	6	6	7	0	NN	0	7	8	1	pathway	7	7	8	0	NN	0	8	9	1	activation	8	8	9	0	VP	1	9	18	2	MD	0	9	10	1	could	9	9	10	0	VP	0	10	18	2	VB	0	10	11	1	result	10	10	11	0	PP	0	11	18	2	IN	0	11	12	1	in	11	11	12	0	NP	0	12	18	2	NP	3	12	16	4	DT	0	12	13	1	the	12	12	13	0	VBN	0	13	14	1	increased	13	13	14	0	NN	0	14	15	1	protein	14	14	15	0	NN	0	15	16	1	stability	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	21
The	12143	12146	DT	the	O	_	_
ASPP2	12147	12152	NN	aspp2	B-GENE	_	_
protein	12153	12160	NN	protein	I-GENE	_	_
levels	12161	12167	NNS	level	O	_	_
in	12168	12170	IN	in	O	_	_
the	12171	12174	DT	the	O	_	_
presence	12175	12183	NN	presence	O	_	_
or	12184	12186	CC	or	O	_	_
absence	12187	12194	NN	absence	O	_	_
of	12195	12197	IN	of	O	_	_
oncogenic	12198	12207	JJ	oncogenic	O	_	_
RAS	12208	12211	NN	ra	O	_	_
were	12212	12216	VBD	be	O	_	_
measured	12217	12225	VBN	measure	O	_	_
after	12226	12231	IN	after	O	_	_
cycloheximide	12232	12245	NN	cycloheximide	O	_	_
(	12246	12247	CD	(	O	_	_
CHX	12247	12250	NNP	CHX	O	_	_
)	12250	12251	CD	)	O	_	_
addition	12252	12260	NN	addition	O	_	_
.	12279	12280	.	.	O	_	_
D	1
13
3	0	det
3	1	nn
3	2	nn
3	6	prep_in
3	8	prep_in
6	5	det
6	8	conj_or
6	11	prep_of
11	10	amod
13	3	nsubjpass
13	12	auxpass
13	17	prep_after
17	15	nn
17	19	dep
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	12	2	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	NN	0	2	3	1	protein	2	2	3	0	NNS	0	3	4	1	levels	3	3	4	0	PP	0	4	12	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	12	2	NP	1	5	9	4	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	presence	6	6	7	0	CC	0	7	8	1	or	7	7	8	0	NN	0	8	9	1	absence	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	of	9	9	10	0	NP	1	10	12	2	JJ	0	10	11	1	oncogenic	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	VP	1	12	20	2	VBD	0	12	13	1	were	12	12	13	0	VP	0	13	20	2	VBN	0	13	14	1	measured	13	13	14	0	PP	0	14	20	2	IN	0	14	15	1	after	14	14	15	0	NP	0	15	20	2	NP	2	15	18	3	NN	0	15	16	1	cycloheximide	15	15	16	0	CD	0	16	17	1	-LRB-	16	16	17	0	NNP	0	17	18	1	CHX	17	17	18	0	NP	1	18	20	2	CD	0	18	19	1	-RRB-	18	18	19	0	NN	0	19	20	1	addition	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	49
ASPP2	12281	12286	NN	aspp2	B-GENE	_	_
was	12287	12290	VBD	be	O	_	_
a	12291	12292	DT	a	O	_	_
bit	12293	12296	NN	bit	O	_	_
more	12297	12301	RBR	more	O	_	_
s	12302	12303	NNS	s	O	_	_
oncogenic	12314	12323	JJ	oncogenic	O	_	_
RAS	12324	12327	NN	ra	O	_	_
is	12328	12330	VBZ	be	O	_	_
induced	12331	12338	VBN	induce	O	_	_
in	12339	12341	IN	in	O	_	_
HKe3	12342	12346	NN	hke3	B-GENE	_	_
ER	12347	12349	NN	er	I-GENE	_	_
:	12349	12350	:	:	O	_	_
HRASV12	12350	12357	NN	hrasv12	O	_	_
cells	12358	12363	NNS	cell	O	_	_
or	12377	12379	CC	or	O	_	_
co	12380	12382	NN	co	O	_	_
transfected	12383	12394	VBN	transfect	O	_	_
in	12395	12397	IN	in	O	_	_
Saos2	12398	12403	NN	saos2	O	_	_
cells	12404	12409	NNS	cell	O	_	_
:	12422	12423	:	:	O	_	_
ASPP2	12424	12429	NN	aspp2	B-GENE	_	_
levels	12430	12436	NNS	level	O	_	_
were	12437	12441	VBD	be	O	_	_
considerably	12442	12454	RB	considerably	O	_	_
decreased	12455	12464	VBN	decrease	O	_	_
without	12465	12472	IN	without	O	_	_
oncogenic	12473	12482	JJ	oncogenic	O	_	_
RAS	12483	12486	NN	ra	O	_	_
,	12486	12487	,	,	O	_	_
while	12488	12493	IN	while	O	_	_
in	12494	12496	IN	in	O	_	_
the	12497	12500	DT	the	O	_	_
presence	12501	12509	NN	presence	O	_	_
of	12510	12512	IN	of	O	_	_
HRAS	12513	12517	NNP	HRAS	B-GENE	_	_
V12	12518	12521	NNP	V12	I-GENE	_	_
,	12521	12522	,	,	O	_	_
ASPP2	12523	12528	NN	aspp2	B-GENE	_	_
protein	12529	12536	NN	protein	I-GENE	_	_
levels	12537	12543	NNS	level	O	_	_
remained	12544	12552	VBD	remain	O	_	_
high	12553	12557	JJ	high	O	_	_
after	12558	12563	IN	after	O	_	_
CHX	12564	12567	NN	chx	O	_	_
treatment	12568	12577	NN	treatment	O	_	_
.	12577	12578	.	.	O	_	_
D	1
5
3	2	det
4	3	npadvmod
5	0	nsubj
5	1	cop
5	4	advmod
5	9	rcmod
5	18	parataxis
5	27	parataxis
7	6	amod
9	7	nsubjpass
9	8	auxpass
9	12	prep_in
12	11	nn
15	14	nn
15	17	conj_or
18	15	nsubj
18	17	nsubj
18	21	prep_in
21	20	nn
24	23	nn
27	24	nsubjpass
27	25	auxpass
27	26	advmod
27	30	prep_without
27	44	advcl
30	29	amod
35	34	det
35	38	prep_of
38	37	nn
42	40	nn
42	41	nn
44	32	mark
44	35	prep_in
44	42	nsubj
44	43	cop
44	47	prep_after
47	46	nn
EOX
Y	1
ROOT	0	0	49	1	S	0	0	49	6	S	1	0	13	2	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	2	1	13	3	VBD	0	1	2	1	was	1	1	2	0	ADVP	1	2	5	2	NP	1	2	4	2	DT	0	2	3	1	a	2	2	3	0	NN	0	3	4	1	bit	3	3	4	0	RBR	0	4	5	1	more	4	4	5	0	NP	0	5	13	2	NP	0	5	6	1	NNS	0	5	6	1	s	5	5	6	0	SBAR	0	6	13	1	S	1	6	13	2	NP	1	6	8	2	JJ	0	6	7	1	oncogenic	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	VP	1	8	13	2	VBZ	0	8	9	1	is	8	8	9	0	VP	0	9	13	2	VBN	0	9	10	1	induced	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	HKe3	11	11	12	0	NN	0	12	13	1	ER	12	12	13	0	:	0	13	14	1	:	13	13	14	0	S	1	14	22	2	NP	1	14	18	4	NN	0	14	15	1	HRASV12	14	14	15	0	NNS	0	15	16	1	cells	15	15	16	0	CC	0	16	17	1	or	16	16	17	0	NN	0	17	18	1	co	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	transfected	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	in	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	Saos2	20	20	21	0	NNS	0	21	22	1	cells	21	21	22	0	:	0	22	23	1	:	22	22	23	0	S	1	23	48	2	NP	1	23	25	2	NN	0	23	24	1	ASPP2	23	23	24	0	NNS	0	24	25	1	levels	24	24	25	0	VP	1	25	48	2	VBD	0	25	26	1	were	25	25	26	0	VP	1	26	48	5	ADVP	0	26	27	1	RB	0	26	27	1	considerably	26	26	27	0	VBN	0	27	28	1	decreased	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	without	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	oncogenic	29	29	30	0	NN	0	30	31	1	RAS	30	30	31	0	,	0	31	32	1	,	31	31	32	0	SBAR	1	32	48	2	IN	0	32	33	1	while	32	32	33	0	S	3	33	48	4	PP	0	33	39	2	IN	0	33	34	1	in	33	33	34	0	NP	0	34	39	2	NP	1	34	36	2	DT	0	34	35	1	the	34	34	35	0	NN	0	35	36	1	presence	35	35	36	0	PP	0	36	39	2	IN	0	36	37	1	of	36	36	37	0	NP	1	37	39	2	NNP	0	37	38	1	HRAS	37	37	38	0	NNP	0	38	39	1	V12	38	38	39	0	,	0	39	40	1	,	39	39	40	0	NP	2	40	43	3	NN	0	40	41	1	ASPP2	40	40	41	0	NN	0	41	42	1	protein	41	41	42	0	NNS	0	42	43	1	levels	42	42	43	0	VP	1	43	48	3	VBD	0	43	44	1	remained	43	43	44	0	ADJP	0	44	45	1	JJ	0	44	45	1	high	44	44	45	0	PP	0	45	48	2	IN	0	45	46	1	after	45	45	46	0	NP	1	46	48	2	NN	0	46	47	1	CHX	46	46	47	0	NN	0	47	48	1	treatment	47	47	48	0	.	0	48	49	1	.	48	48	49	0
EOS
T	29
These	12579	12584	DT	these	O	_	_
data	12585	12589	NNS	datum	O	_	_
indicate	12590	12598	VBP	indicate	O	_	_
that	12599	12603	IN	that	O	_	_
ASPP2	12604	12609	NN	aspp2	B-GENE	_	_
phosphorylation	12610	12625	NN	phosphorylation	O	_	_
by	12626	12628	IN	by	O	_	_
RAS	12629	12632	NN	ra	B-GENE	_	_
/	12632	12633	:	/	B-GENE	_	_
MAPK	12633	12637	NN	mapk	I-GENE	_	_
is	12638	12640	VBZ	be	O	_	_
necessary	12641	12650	JJ	necessary	O	_	_
for	12651	12654	IN	for	O	_	_
ASPP2	12655	12660	NN	aspp2	B-GENE	_	_
full	12661	12665	JJ	full	O	_	_
pro-apoptotic	12666	12679	JJ	pro-apoptotic	O	_	_
activity	12680	12688	NN	activity	O	_	_
and	12689	12692	CC	and	O	_	_
this	12693	12697	DT	this	O	_	_
may	12698	12701	MD	may	O	_	_
be	12702	12704	VB	be	O	_	_
mediated	12705	12713	VBN	mediate	O	_	_
by	12714	12716	IN	by	O	_	_
the	12717	12720	DT	the	O	_	_
stabilization	12721	12734	NN	stabilization	O	_	_
of	12735	12737	IN	of	O	_	_
ASPP2	12738	12743	NN	aspp2	B-GENE	_	_
protein	12744	12751	NN	protein	I-GENE	_	_
.	12751	12752	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	21	ccomp
5	4	nn
5	7	prep_by
5	11	dep
11	8	punct
11	9	nsubj
11	10	cop
11	16	prep_for
11	18	prep_for
16	13	nn
16	14	amod
16	15	amod
16	18	conj_and
21	3	mark
21	5	nsubjpass
21	19	aux
21	20	auxpass
21	24	agent
24	23	det
24	27	prep_of
27	26	nn
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	data	1	1	2	0	VP	0	2	28	2	VBP	0	2	3	1	indicate	2	2	3	0	SBAR	1	3	28	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	28	2	NP	0	4	19	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	by	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	RAS	7	7	8	0	PRN	1	8	19	2	:	0	8	9	1	/	8	8	9	0	S	1	9	19	2	NP	0	9	10	1	NN	0	9	10	1	MAPK	9	9	10	0	VP	1	10	19	2	VBZ	0	10	11	1	is	10	10	11	0	ADJP	0	11	19	2	JJ	0	11	12	1	necessary	11	11	12	0	PP	0	12	19	2	IN	0	12	13	1	for	12	12	13	0	NP	0	13	19	3	NP	3	13	17	4	NN	0	13	14	1	ASPP2	13	13	14	0	JJ	0	14	15	1	full	14	14	15	0	JJ	0	15	16	1	pro-apoptotic	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	CC	0	17	18	1	and	17	17	18	0	NP	0	18	19	1	DT	0	18	19	1	this	18	18	19	0	VP	1	19	28	2	MD	0	19	20	1	may	19	19	20	0	VP	1	20	28	2	VB	0	20	21	1	be	20	20	21	0	VP	0	21	28	2	VBN	0	21	22	1	mediated	21	21	22	0	PP	0	22	28	2	IN	0	22	23	1	by	22	22	23	0	NP	0	23	28	2	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	stabilization	24	24	25	0	PP	0	25	28	2	IN	0	25	26	1	of	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	ASPP2	26	26	27	0	NN	0	27	28	1	protein	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	26
It	12754	12756	PRP	it	O	_	_
has	12757	12760	VBZ	have	O	_	_
recently	12761	12769	RB	recently	O	_	_
been	12770	12774	VBN	be	O	_	_
shown	12775	12780	VBN	show	O	_	_
that	12781	12785	IN	that	O	_	_
activation	12786	12796	NN	activation	O	_	_
of	12797	12799	IN	of	O	_	_
RAS	12800	12803	NN	ra	O	_	_
results	12804	12811	VBZ	result	O	_	_
in	12812	12814	IN	in	O	_	_
ASPP2	12815	12820	NN	aspp2	B-GENE	_	_
translocation	12821	12834	NN	translocation	O	_	_
from	12835	12839	IN	from	O	_	_
the	12840	12843	DT	the	O	_	_
plasma	12844	12850	NN	plasma	O	_	_
membrane	12851	12859	NN	membrane	O	_	_
to	12860	12862	TO	to	O	_	_
the	12863	12866	DT	the	O	_	_
cytosol	12867	12874	NN	cytosol	O	_	_
and	12875	12878	CC	and	O	_	_
nucleus	12879	12886	NN	nucleus	O	_	_
[	12887	12888	NN	[	O	_	_
2	12888	12889	CD	2	O	_	_
]	12889	12890	NN	]	O	_	_
.	12890	12891	.	.	O	_	_
D	1
4
4	0	nsubjpass
4	1	aux
4	2	advmod
4	3	auxpass
4	9	ccomp
6	8	prep_of
9	5	mark
9	6	nsubj
9	12	prep_in
9	22	prep_to
12	11	nn
12	16	prep_from
16	14	det
16	15	nn
19	21	conj_and
22	18	det
22	19	nn
22	21	nn
22	24	dep
24	23	num
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	2	1	25	3	VBZ	0	1	2	1	has	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	VP	1	3	25	2	VBN	0	3	4	1	been	3	3	4	0	VP	0	4	25	2	VBN	0	4	5	1	shown	4	4	5	0	SBAR	1	5	25	2	IN	0	5	6	1	that	5	5	6	0	S	1	6	25	2	NP	0	6	9	2	NP	0	6	7	1	NN	0	6	7	1	activation	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	RAS	8	8	9	0	VP	0	9	25	3	VBZ	0	9	10	1	results	9	9	10	0	PP	0	10	17	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	17	2	NP	1	11	13	2	NN	0	11	12	1	ASPP2	11	11	12	0	NN	0	12	13	1	translocation	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	from	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	plasma	15	15	16	0	NN	0	16	17	1	membrane	16	16	17	0	PP	0	17	25	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	25	2	NP	2	18	23	3	DT	0	18	19	1	the	18	18	19	0	NP	0	19	22	3	NN	0	19	20	1	cytosol	19	19	20	0	CC	0	20	21	1	and	20	20	21	0	NN	0	21	22	1	nucleus	21	21	22	0	NN	0	22	23	1	[	22	22	23	0	NP	1	23	25	2	CD	0	23	24	1	2	23	23	24	0	NN	0	24	25	1	]	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	16
We	12892	12894	PRP	we	O	_	_
therefore	12895	12904	RB	therefore	O	_	_
tested	12905	12911	VBD	test	O	_	_
whether	12912	12919	IN	whether	O	_	_
MAPK	12920	12924	NN	mapk	B-GENE	_	_
phosphorylation	12925	12940	NN	phosphorylation	O	_	_
at	12941	12943	IN	at	O	_	_
Ser827	12944	12950	NN	ser827	O	_	_
could	12951	12956	MD	could	O	_	_
affect	12957	12963	VB	affect	O	_	_
the	12964	12967	DT	the	O	_	_
cellular	12968	12976	JJ	cellular	O	_	_
localization	12977	12989	NN	localization	O	_	_
of	12990	12992	IN	of	O	_	_
ASPP2	12993	12998	NN	aspp2	B-GENE	_	_
.	12998	12999	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	9	ccomp
5	4	nn
5	7	prep_at
9	3	mark
9	5	nsubj
9	8	aux
9	12	dobj
12	10	det
12	11	amod
12	14	prep_of
EOX
Y	1
ROOT	0	0	16	1	S	2	0	16	4	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	therefore	1	1	2	0	VP	0	2	15	2	VBD	0	2	3	1	tested	2	2	3	0	SBAR	1	3	15	2	IN	0	3	4	1	whether	3	3	4	0	S	1	4	15	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	MAPK	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	at	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	Ser827	7	7	8	0	VP	1	8	15	2	MD	0	8	9	1	could	8	8	9	0	VP	0	9	15	2	VB	0	9	10	1	affect	9	9	10	0	NP	0	10	15	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	cellular	11	11	12	0	NN	0	12	13	1	localization	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	34
Interestingly	13000	13013	RB	interestingly	O	_	_
,	13013	13014	,	,	O	_	_
we	13015	13017	PRP	we	O	_	_
observed	13018	13026	VBD	observe	O	_	_
that	13027	13031	IN	that	O	_	_
in	13032	13034	IN	in	O	_	_
contrast	13035	13043	NN	contrast	O	_	_
to	13044	13046	TO	to	O	_	_
wild	13047	13051	JJ	wild	B-GENE	_	_
type	13052	13056	NN	type	I-GENE	_	_
ASPP2	13057	13062	NN	aspp2	I-GENE	_	_
,	13062	13063	,	,	O	_	_
ASPP2	13064	13069	NN	aspp2	B-GENE	_	_
(	13070	13071	CD	(	I-GENE	_	_
S827A	13071	13076	NN	s827a	I-GENE	_	_
)	13076	13077	NN	)	I-GENE	_	_
remains	13078	13085	VBZ	remain	O	_	_
at	13086	13088	IN	at	O	_	_
the	13089	13092	DT	the	O	_	_
plasma	13093	13099	NN	plasma	O	_	_
membrane	13100	13108	NN	membrane	O	_	_
following	13109	13118	VBG	follow	O	_	_
RAS	13119	13122	NN	ra	O	_	_
activation	13123	13133	NN	activation	O	_	_
by	13134	13136	IN	by	O	_	_
4-OHT	13137	13142	NN	4-oht	O	_	_
in	13143	13145	IN	in	O	_	_
the	13146	13149	DT	the	O	_	_
HKe3	13150	13154	NN	hke3	B-GENE	_	_
ER	13155	13157	NN	er	I-GENE	_	_
:	13157	13158	:	:	O	_	_
HRASV12	13158	13165	NN	hrasv12	O	_	_
system	13166	13172	NN	system	O	_	_
.	13184	13185	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	16	ccomp
6	9	prep_to
9	8	amod
15	10	nn
15	12	dep
15	14	nn
16	4	mark
16	6	prep_in
16	20	prep_at
20	18	det
20	19	nn
20	23	prep_following
23	22	nn
23	25	prep_by
25	29	prep_in
25	32	dep
29	27	det
29	28	nn
32	31	nn
EOX
Y	1
ROOT	0	0	34	1	S	3	0	34	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	VP	0	3	33	2	VBD	0	3	4	1	observed	3	3	4	0	SBAR	1	4	33	2	IN	0	4	5	1	that	4	4	5	0	S	2	5	33	3	PP	0	5	10	2	IN	0	5	6	1	in	5	5	6	0	NP	0	6	10	2	NP	0	6	7	1	NN	0	6	7	1	contrast	6	6	7	0	PP	0	7	10	2	TO	0	7	8	1	to	7	7	8	0	NP	1	8	10	2	JJ	0	8	9	1	wild	8	8	9	0	NN	0	9	10	1	type	9	9	10	0	NP	5	10	16	6	NN	0	10	11	1	ASPP2	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	CD	0	13	14	1	-LRB-	13	13	14	0	NN	0	14	15	1	S827A	14	14	15	0	NN	0	15	16	1	-RRB-	15	15	16	0	VP	0	16	33	2	VBZ	0	16	17	1	remains	16	16	17	0	PP	0	17	33	2	IN	0	17	18	1	at	17	17	18	0	NP	0	18	33	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	NN	0	19	20	1	plasma	19	19	20	0	NN	0	20	21	1	membrane	20	20	21	0	PP	0	21	33	2	VBG	0	21	22	1	following	21	21	22	0	NP	0	22	33	2	NP	1	22	24	2	NN	0	22	23	1	RAS	22	22	23	0	NN	0	23	24	1	activation	23	23	24	0	PP	0	24	33	2	IN	0	24	25	1	by	24	24	25	0	NP	0	25	33	3	NP	0	25	30	2	NP	0	25	26	1	NN	0	25	26	1	4-OHT	25	25	26	0	PP	0	26	30	2	IN	0	26	27	1	in	26	26	27	0	NP	2	27	30	3	DT	0	27	28	1	the	27	27	28	0	NN	0	28	29	1	HKe3	28	28	29	0	NN	0	29	30	1	ER	29	29	30	0	:	0	30	31	1	:	30	30	31	0	NP	1	31	33	2	NN	0	31	32	1	HRASV12	31	31	32	0	NN	0	32	33	1	system	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	35
This	13186	13190	DT	this	O	_	_
suggests	13191	13199	VBZ	suggest	O	_	_
that	13200	13204	IN	that	O	_	_
ASPP2	13205	13210	NN	aspp2	B-GENE	_	_
binding	13211	13218	NN	binding	O	_	_
to	13219	13221	TO	to	O	_	_
RAS	13222	13225	NN	ra	B-GENE	_	_
at	13226	13228	IN	at	O	_	_
the	13229	13232	DT	the	O	_	_
plasma	13233	13239	NN	plasma	O	_	_
membrane	13240	13248	NN	membrane	O	_	_
occurs	13249	13255	VBZ	occur	O	_	_
prior	13256	13261	RB	prior	O	_	_
to	13262	13264	TO	to	O	_	_
MAPK	13265	13269	NN	mapk	B-GENE	_	_
phosphorylation	13270	13285	NN	phosphorylation	O	_	_
of	13286	13288	IN	of	O	_	_
ASPP2	13289	13294	NN	aspp2	B-GENE	_	_
and	13295	13298	CC	and	O	_	_
that	13299	13303	IN	that	O	_	_
Ser	13304	13307	NN	ser	O	_	_
827	13308	13311	CD	827	O	_	_
phosphorylation	13312	13327	NN	phosphorylation	O	_	_
is	13328	13330	VBZ	be	O	_	_
required	13331	13339	VBN	require	O	_	_
for	13340	13343	IN	for	O	_	_
RAS	13344	13347	NN	ra	B-GENE	_	_
induced	13348	13355	VBD	induce	O	_	_
translocation	13356	13369	NN	translocation	O	_	_
of	13370	13372	IN	of	O	_	_
ASPP2	13373	13378	NN	aspp2	B-GENE	_	_
to	13379	13381	TO	to	O	_	_
the	13382	13385	DT	the	O	_	_
cytosol	13386	13393	NN	cytosol	O	_	_
.	13393	13394	.	.	O	_	_
D	1
1
1	0	nsubj
1	11	ccomp
1	27	ccomp
4	3	nn
4	6	prep_to
6	10	prep_at
10	8	det
10	9	nn
11	2	mark
11	4	nsubj
11	15	prep_prior_to
11	27	conj_and
15	14	nn
15	17	prep_of
20	24	rcmod
22	21	num
24	22	nsubjpass
24	23	auxpass
24	26	prep_for
27	19	mark
27	20	nsubj
27	28	dobj
27	33	prep_to
28	30	prep_of
33	32	det
EOX
Y	1
ROOT	0	0	35	1	S	1	0	35	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	0	1	34	2	VBZ	0	1	2	1	suggests	1	1	2	0	SBAR	0	2	34	3	SBAR	1	2	18	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	18	2	NP	0	3	11	2	NP	1	3	5	2	NN	0	3	4	1	ASPP2	3	3	4	0	NN	0	4	5	1	binding	4	4	5	0	PP	0	5	11	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	11	2	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	at	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	plasma	9	9	10	0	NN	0	10	11	1	membrane	10	10	11	0	VP	0	11	18	2	VBZ	0	11	12	1	occurs	11	11	12	0	PP	1	12	18	2	RB	0	12	13	1	prior	12	12	13	0	PP	0	13	18	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	18	2	NP	1	14	16	2	NN	0	14	15	1	MAPK	14	14	15	0	NN	0	15	16	1	phosphorylation	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	SBAR	1	19	34	2	IN	0	19	20	1	that	19	19	20	0	S	1	20	34	2	NP	0	20	27	2	NP	0	20	21	1	NN	0	20	21	1	Ser	20	20	21	0	SBAR	0	21	27	1	S	1	21	27	2	NP	1	21	23	2	CD	0	21	22	1	827	21	21	22	0	NN	0	22	23	1	phosphorylation	22	22	23	0	VP	1	23	27	2	VBZ	0	23	24	1	is	23	23	24	0	VP	0	24	27	2	VBN	0	24	25	1	required	24	24	25	0	PP	0	25	27	2	IN	0	25	26	1	for	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	RAS	26	26	27	0	VP	0	27	34	3	VBD	0	27	28	1	induced	27	27	28	0	NP	0	28	31	2	NP	0	28	29	1	NN	0	28	29	1	translocation	28	28	29	0	PP	0	29	31	2	IN	0	29	30	1	of	29	29	30	0	NP	0	30	31	1	NN	0	30	31	1	ASPP2	30	30	31	0	PP	0	31	34	2	TO	0	31	32	1	to	31	31	32	0	NP	1	32	34	2	DT	0	32	33	1	the	32	32	33	0	NN	0	33	34	1	cytosol	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	30
(	13396	13397	NN	(	O	_	_
A	13397	13398	NN	a	O	_	_
)	13398	13399	CD	)	O	_	_
RAS	13400	13403	NN	ra	O	_	_
activation	13404	13414	NN	activation	O	_	_
induces	13415	13422	VBZ	induce	O	_	_
cytoplasmic	13423	13434	JJ	cytoplasmic	O	_	_
and	13435	13438	CC	and	O	_	_
nuclear	13439	13446	JJ	nuclear	O	_	_
translocation	13447	13460	NN	translocation	O	_	_
of	13461	13463	IN	of	O	_	_
wild-type	13464	13473	JJ	wild-type	O	_	_
ASPP2	13474	13479	NN	aspp2	O	_	_
but	13480	13483	CC	but	O	_	_
not	13484	13487	RB	not	O	_	_
ASPP2	13488	13493	NN	aspp2	O	_	_
(	13494	13495	CD	(	O	_	_
S827A	13495	13500	NN	s827a	O	_	_
)	13500	13501	NN	)	O	_	_
in	13502	13504	IN	in	O	_	_
HKe3	13505	13509	NN	hke3	B-GENE	_	_
ER	13510	13512	NN	er	I-GENE	_	_
:	13512	13513	:	:	O	_	_
HRAS12	13513	13519	NN	hras12	O	_	_
cells	13520	13525	NNS	cell	O	_	_
as	13526	13528	IN	as	O	_	_
detected	13529	13537	VBN	detect	O	_	_
by	13538	13540	IN	by	O	_	_
immunofluorescence	13541	13559	NN	immunofluorescence	O	_	_
.	13559	13560	.	.	O	_	_
D	1

1	4	dep
4	3	nn
5	1	nsubj
5	9	dobj
6	8	conj_and
9	6	amod
9	8	amod
9	12	prep_of
9	14	cc
12	11	amod
18	15	nn
18	17	nn
18	21	prep_in
18	24	dep
21	20	nn
24	23	nn
24	26	dep
26	25	mark
26	28	prep_by
EOX
Y	1
ROOT	0	0	30	1	S	1	0	30	3	NP	0	0	5	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	NN	0	4	5	1	activation	4	4	5	0	VP	0	5	29	2	VBZ	0	5	6	1	induces	5	5	6	0	NP	0	6	29	3	NP	0	6	13	2	NP	1	6	10	2	ADJP	0	6	9	3	JJ	0	6	7	1	cytoplasmic	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	JJ	0	8	9	1	nuclear	8	8	9	0	NN	0	9	10	1	translocation	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	of	10	10	11	0	NP	1	11	13	2	JJ	0	11	12	1	wild-type	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	CONJP	1	13	15	2	CC	0	13	14	1	but	13	13	14	0	RB	0	14	15	1	not	14	14	15	0	NP	0	15	29	3	NP	0	15	22	2	NP	3	15	19	4	NN	0	15	16	1	ASPP2	15	15	16	0	CD	0	16	17	1	-LRB-	16	16	17	0	NN	0	17	18	1	S827A	17	17	18	0	NN	0	18	19	1	-RRB-	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	in	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	HKe3	20	20	21	0	NN	0	21	22	1	ER	21	21	22	0	:	0	22	23	1	:	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	NN	0	23	24	1	HRAS12	23	23	24	0	NNS	0	24	25	1	cells	24	24	25	0	SBAR	1	25	29	2	IN	0	25	26	1	as	25	25	26	0	S	0	26	29	1	VP	0	26	29	2	VBN	0	26	27	1	detected	26	26	27	0	PP	0	27	29	2	IN	0	27	28	1	by	27	27	28	0	NP	0	28	29	1	NN	0	28	29	1	immunofluorescence	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	9
Arrows	13561	13567	NNS	arrow	O	_	_
indicate	13568	13576	VBP	indicate	O	_	_
cell	13577	13581	NN	cell	O	_	_
membrane	13582	13590	NN	membrane	O	_	_
and	13591	13594	CC	and	O	_	_
stars	13595	13600	NNS	star	O	_	_
indicate	13601	13609	VBP	indicate	O	_	_
cytosol	13610	13617	NN	cytosol	O	_	_
.	13617	13618	.	.	O	_	_
D	1
1
1	0	nsubj
1	6	ccomp
3	2	nn
3	5	conj_and
6	3	nsubj
6	5	nsubj
6	7	dobj
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Arrows	0	0	1	0	VP	0	1	8	2	VBP	0	1	2	1	indicate	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	6	3	NP	1	2	4	2	NN	0	2	3	1	cell	2	2	3	0	NN	0	3	4	1	membrane	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	0	5	6	1	NNS	0	5	6	1	stars	5	5	6	0	VP	0	6	8	2	VBP	0	6	7	1	indicate	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	cytosol	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	20
(	13619	13620	NN	(	O	_	_
B	13620	13621	NN	b	O	_	_
)	13621	13622	CD	)	O	_	_
RAS	13623	13626	NN	ra	B-GENE	_	_
activation	13627	13637	NN	activation	O	_	_
enhances	13638	13646	VBZ	enhance	O	_	_
the	13647	13650	DT	the	O	_	_
binding	13651	13658	NN	binding	O	_	_
of	13659	13661	IN	of	O	_	_
wild-type	13662	13671	JJ	wild-type	O	_	_
ASPP2	13672	13677	NN	aspp2	O	_	_
but	13678	13681	CC	but	O	_	_
not	13682	13685	RB	not	O	_	_
ASPP2	13686	13691	NN	aspp2	O	_	_
(	13692	13693	CD	(	O	_	_
S827A	13693	13698	NN	s827a	O	_	_
)	13698	13699	NN	)	O	_	_
to	13700	13702	TO	to	O	_	_
p53	13703	13706	NN	p53	B-GENE	_	_
.	13706	13707	.	.	O	_	_
D	1

1	5	rcmod
1	12	cc
4	3	nn
5	4	nsubj
5	7	dobj
7	6	det
7	10	prep_of
10	9	amod
16	13	nn
16	15	nn
16	18	prep_to
EOX
Y	1
ROOT	0	0	20	1	NP	0	0	20	4	NP	0	0	11	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	SBAR	0	2	11	1	S	1	2	11	2	NP	2	2	5	3	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	NN	0	4	5	1	activation	4	4	5	0	VP	0	5	11	2	VBZ	0	5	6	1	enhances	5	5	6	0	NP	0	6	11	2	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	binding	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	of	8	8	9	0	NP	1	9	11	2	JJ	0	9	10	1	wild-type	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	CONJP	1	11	13	2	CC	0	11	12	1	but	11	11	12	0	RB	0	12	13	1	not	12	12	13	0	NP	0	13	19	2	NP	3	13	17	4	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NN	0	15	16	1	S827A	15	15	16	0	NN	0	16	17	1	-RRB-	16	16	17	0	PP	0	17	19	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	p53	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	27
Total	13708	13713	JJ	total	O	_	_
cell	13714	13718	NN	cell	O	_	_
lysates	13719	13726	NNS	lysate	O	_	_
from	13727	13731	IN	from	O	_	_
HKe3	13732	13736	NN	hke3	B-GENE	_	_
ER	13737	13739	NN	er	I-GENE	_	_
:	13739	13740	:	:	O	_	_
HRASV12	13740	13747	NN	hrasv12	O	_	_
cells	13748	13753	NNS	cell	O	_	_
treated	13754	13761	VBN	treat	O	_	_
with	13762	13766	IN	with	O	_	_
or	13767	13769	CC	or	O	_	_
without	13770	13777	IN	without	O	_	_
4-OHT	13778	13783	NN	4-oht	O	_	_
were	13784	13788	VBD	be	O	_	_
immunoprecipitated	13789	13807	VBN	immunoprecipitate	O	_	_
with	13808	13812	IN	with	O	_	_
an	13813	13815	DT	a	O	_	_
anti	13816	13820	JJ	anti	B-GENE	_	_
p53	13821	13824	NN	p53	I-GENE	_	_
antibody	13825	13833	NN	antibody	I-GENE	_	_
or	13834	13836	CC	or	O	_	_
control	13837	13844	NN	control	B-GENE	_	_
IgG	13845	13848	NN	igg	I-GENE	_	_
as	13849	13851	IN	as	O	_	_
indicated	13852	13861	VBN	indicate	O	_	_
.	13861	13862	.	.	O	_	_
D	1
15
2	0	amod
2	1	nn
2	5	prep_from
5	4	nn
5	8	dep
8	7	nn
8	9	vmod
9	9	conj_or
9	13	prep_with
9	13	prep_without
15	2	nsubjpass
15	14	auxpass
15	20	prep_with
15	23	prep_with
20	17	det
20	18	amod
20	19	nn
20	23	conj_or
20	25	prep_as
23	22	nn
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	14	2	NP	2	0	3	3	JJ	0	0	1	1	Total	0	0	1	0	NN	0	1	2	1	cell	1	1	2	0	NNS	0	2	3	1	lysates	2	2	3	0	PP	0	3	14	2	IN	0	3	4	1	from	3	3	4	0	NP	0	4	14	3	NP	1	4	6	2	NN	0	4	5	1	HKe3	4	4	5	0	NN	0	5	6	1	ER	5	5	6	0	:	0	6	7	1	:	6	6	7	0	NP	0	7	14	2	NP	1	7	9	2	NN	0	7	8	1	HRASV12	7	7	8	0	NNS	0	8	9	1	cells	8	8	9	0	VP	0	9	14	2	VBN	0	9	10	1	treated	9	9	10	0	PP	0	10	14	4	IN	0	10	11	1	with	10	10	11	0	CC	0	11	12	1	or	11	11	12	0	IN	0	12	13	1	without	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	4-OHT	13	13	14	0	VP	1	14	26	2	VBD	0	14	15	1	were	14	14	15	0	VP	0	15	26	2	VBN	0	15	16	1	immunoprecipitated	15	15	16	0	PP	0	16	26	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	26	2	NP	0	17	24	3	NP	3	17	21	4	DT	0	17	18	1	an	17	17	18	0	JJ	0	18	19	1	anti	18	18	19	0	NN	0	19	20	1	p53	19	19	20	0	NN	0	20	21	1	antibody	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	NP	1	22	24	2	NN	0	22	23	1	control	22	22	23	0	NN	0	23	24	1	IgG	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	as	24	24	25	0	NP	0	25	26	1	VBN	0	25	26	1	indicated	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	43
As	13863	13865	IN	as	O	_	_
the	13866	13869	DT	the	O	_	_
translocation	13870	13883	NN	translocation	O	_	_
of	13884	13886	IN	of	O	_	_
wild-type	13887	13896	JJ	wild-type	O	_	_
ASPP2	13897	13902	NN	aspp2	O	_	_
from	13903	13907	IN	from	O	_	_
the	13908	13911	DT	the	O	_	_
plasma	13912	13918	NN	plasma	O	_	_
membrane	13919	13927	NN	membrane	O	_	_
to	13928	13930	TO	to	O	_	_
the	13931	13934	DT	the	O	_	_
cytosol	13935	13942	NN	cytosol	O	_	_
and	13943	13946	CC	and	O	_	_
nucleus	13947	13954	NN	nucleus	O	_	_
results	13955	13962	NNS	result	O	_	_
in	13963	13965	IN	in	O	_	_
increased	13966	13975	VBN	increase	O	_	_
binding	13976	13983	NN	binding	O	_	_
to	13984	13986	TO	to	O	_	_
p53	13987	13990	NN	p53	B-GENE	_	_
[	13991	13992	NN	[	I-GENE	_	_
2	13992	13993	CD	2	I-GENE	_	_
]	13993	13994	NN	]	I-GENE	_	_
,	13994	13995	,	,	O	_	_
we	13996	13998	PRP	we	O	_	_
tested	13999	14005	VBD	test	O	_	_
whether	14006	14013	IN	whether	O	_	_
the	14014	14017	DT	the	O	_	_
p53	14018	14021	NN	p53	B-GENE	_	_
binding	14022	14029	NN	binding	O	_	_
ability	14030	14037	NN	ability	O	_	_
of	14038	14040	IN	of	O	_	_
ASPP2	14041	14046	NN	aspp2	B-GENE	_	_
phosphorylation	14047	14062	NN	phosphorylation	O	_	_
mutant	14063	14069	NN	mutant	O	_	_
would	14070	14075	MD	would	O	_	_
be	14076	14078	VB	be	O	_	_
influenced	14079	14089	VBN	influence	O	_	_
by	14090	14092	IN	by	O	_	_
RAS	14093	14096	NN	ra	B-GENE	_	_
activation	14097	14107	NN	activation	O	_	_
.	14107	14108	.	.	O	_	_
D	1
26
2	1	det
2	5	prep_of
2	18	prep_in
5	4	amod
5	9	prep_from
9	7	det
9	8	nn
9	15	prep_to
12	14	conj_and
15	11	det
15	12	nn
15	14	nn
18	17	amod
18	21	prep_to
21	20	nn
21	23	dep
23	22	num
26	2	prep_as
26	25	nsubj
26	38	ccomp
31	28	det
31	29	nn
31	30	nn
31	35	prep_of
35	33	nn
35	34	nn
38	27	mark
38	31	nsubjpass
38	36	aux
38	37	auxpass
38	41	agent
41	40	nn
EOX
Y	1
ROOT	0	0	43	1	S	3	0	43	5	PP	0	0	24	2	IN	0	0	1	1	As	0	0	1	0	NP	0	1	24	3	NP	1	1	3	2	DT	0	1	2	1	the	1	1	2	0	NN	0	2	3	1	translocation	2	2	3	0	PP	0	3	16	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	16	2	NP	1	4	6	2	JJ	0	4	5	1	wild-type	4	4	5	0	NN	0	5	6	1	ASPP2	5	5	6	0	PP	0	6	16	2	IN	0	6	7	1	from	6	6	7	0	NP	0	7	16	2	NP	2	7	10	3	DT	0	7	8	1	the	7	7	8	0	NN	0	8	9	1	plasma	8	8	9	0	NN	0	9	10	1	membrane	9	9	10	0	PP	0	10	16	2	TO	0	10	11	1	to	10	10	11	0	NP	2	11	16	3	DT	0	11	12	1	the	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	cytosol	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	nucleus	14	14	15	0	NNS	0	15	16	1	results	15	15	16	0	PP	0	16	24	2	IN	0	16	17	1	in	16	16	17	0	NP	0	17	24	2	NP	1	17	19	2	VBN	0	17	18	1	increased	17	17	18	0	NN	0	18	19	1	binding	18	18	19	0	PP	0	19	24	2	TO	0	19	20	1	to	19	19	20	0	NP	0	20	24	2	NP	1	20	22	2	NN	0	20	21	1	p53	20	20	21	0	NN	0	21	22	1	[	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	2	22	22	23	0	NN	0	23	24	1	]	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	0	25	26	1	PRP	0	25	26	1	we	25	25	26	0	VP	0	26	42	2	VBD	0	26	27	1	tested	26	26	27	0	SBAR	1	27	42	2	IN	0	27	28	1	whether	27	27	28	0	S	1	28	42	2	NP	0	28	36	2	NP	3	28	32	4	DT	0	28	29	1	the	28	28	29	0	NN	0	29	30	1	p53	29	29	30	0	NN	0	30	31	1	binding	30	30	31	0	NN	0	31	32	1	ability	31	31	32	0	PP	0	32	36	2	IN	0	32	33	1	of	32	32	33	0	NP	2	33	36	3	NN	0	33	34	1	ASPP2	33	33	34	0	NN	0	34	35	1	phosphorylation	34	34	35	0	NN	0	35	36	1	mutant	35	35	36	0	VP	1	36	42	2	MD	0	36	37	1	would	36	36	37	0	VP	1	37	42	2	VB	0	37	38	1	be	37	37	38	0	VP	0	38	42	2	VBN	0	38	39	1	influenced	38	38	39	0	PP	0	39	42	2	IN	0	39	40	1	by	39	39	40	0	NP	1	40	42	2	NN	0	40	41	1	RAS	40	40	41	0	NN	0	41	42	1	activation	41	41	42	0	.	0	42	43	1	.	42	42	43	0
EOS
T	33
Indeed	14109	14115	RB	indeed	O	_	_
,	14115	14116	,	,	O	_	_
upon	14117	14121	IN	upon	O	_	_
activation	14122	14132	NN	activation	O	_	_
of	14133	14135	IN	of	O	_	_
RAS	14136	14139	NN	ra	O	_	_
by	14140	14142	IN	by	O	_	_
4-OHT	14143	14148	NN	4-oht	O	_	_
in	14149	14151	IN	in	O	_	_
HKe3	14152	14156	NN	hke3	B-GENE	_	_
ER	14157	14159	NN	er	I-GENE	_	_
:	14159	14160	:	:	O	_	_
HRASV12	14160	14167	NN	hrasv12	O	_	_
cells	14168	14173	NNS	cell	O	_	_
,	14173	14174	,	,	O	_	_
we	14175	14177	PRP	we	O	_	_
observed	14178	14186	VBD	observe	O	_	_
an	14187	14189	DT	a	O	_	_
increase	14190	14198	NN	increase	O	_	_
in	14199	14201	IN	in	O	_	_
the	14202	14205	DT	the	O	_	_
amount	14206	14212	NN	amount	O	_	_
of	14213	14215	IN	of	O	_	_
p53	14216	14219	NN	p53	B-GENE	_	_
co	14220	14222	NN	co	O	_	_
immunoprecipitated	14223	14241	VBN	immunoprecipitate	O	_	_
with	14242	14246	IN	with	O	_	_
transfected	14247	14258	VBN	transfect	O	_	_
V5	14259	14261	NN	v5	O	_	_
tagged	14262	14268	VBD	tag	O	_	_
wild-type	14269	14278	JJ	wild-type	O	_	_
ASPP2	14279	14284	NN	aspp2	O	_	_
.	14319	14320	.	.	O	_	_
D	1
16
3	5	prep_of
7	10	prep_in
7	13	dep
10	9	nn
13	12	nn
16	0	advmod
16	3	prep_upon
16	7	prep_by
16	15	nsubj
16	29	ccomp
18	17	det
18	21	prep_in
21	20	det
21	24	prep_of
24	23	nn
24	25	vmod
25	27	prepc_with
27	28	dobj
29	18	nsubj
29	31	dobj
31	30	amod
EOX
Y	1
ROOT	0	0	33	1	S	5	0	33	7	ADVP	0	0	1	1	RB	0	0	1	1	Indeed	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	14	2	PP	0	2	6	2	IN	0	2	3	1	upon	2	2	3	0	NP	0	3	6	2	NP	0	3	4	1	NN	0	3	4	1	activation	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	PP	0	6	14	2	IN	0	6	7	1	by	6	6	7	0	NP	0	7	14	3	NP	0	7	11	2	NP	0	7	8	1	NN	0	7	8	1	4-OHT	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	in	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	HKe3	9	9	10	0	NN	0	10	11	1	ER	10	10	11	0	:	0	11	12	1	:	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	HRASV12	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	0	15	16	1	PRP	0	15	16	1	we	15	15	16	0	VP	0	16	32	2	VBD	0	16	17	1	observed	16	16	17	0	SBAR	0	17	32	1	S	1	17	32	2	NP	0	17	29	2	NP	1	17	19	2	DT	0	17	18	1	an	17	17	18	0	NN	0	18	19	1	increase	18	18	19	0	PP	0	19	29	2	IN	0	19	20	1	in	19	19	20	0	NP	0	20	29	2	NP	1	20	22	2	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	amount	21	21	22	0	PP	0	22	29	2	IN	0	22	23	1	of	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	NN	0	23	24	1	p53	23	23	24	0	NN	0	24	25	1	co	24	24	25	0	VP	0	25	29	2	VBN	0	25	26	1	immunoprecipitated	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	with	26	26	27	0	S	0	27	29	1	VP	0	27	29	2	VBN	0	27	28	1	transfected	27	27	28	0	NP	0	28	29	1	NN	0	28	29	1	V5	28	28	29	0	VP	0	29	32	2	VBD	0	29	30	1	tagged	29	29	30	0	NP	1	30	32	2	JJ	0	30	31	1	wild-type	30	30	31	0	NN	0	31	32	1	ASPP2	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	24
Under	14321	14326	IN	under	O	_	_
the	14327	14330	DT	the	O	_	_
same	14331	14335	JJ	same	O	_	_
conditions	14336	14346	NNS	condition	O	_	_
,	14346	14347	,	,	O	_	_
the	14348	14351	DT	the	O	_	_
amount	14352	14358	NN	amount	O	_	_
of	14359	14361	IN	of	O	_	_
p53	14362	14365	NN	p53	B-GENE	_	_
in	14366	14368	IN	in	O	_	_
complex	14369	14376	NN	complex	O	_	_
with	14377	14381	IN	with	O	_	_
transfected	14382	14393	VBN	transfect	O	_	_
V5-ASPP2	14394	14402	NN	v5-aspp2	O	_	_
(	14403	14404	CD	(	O	_	_
S827A	14404	14409	NN	s827a	O	_	_
)	14409	14410	NN	)	O	_	_
is	14411	14413	VBZ	be	O	_	_
not	14414	14417	RB	not	O	_	_
affected	14418	14426	VBN	affect	O	_	_
by	14427	14429	IN	by	O	_	_
RAS	14430	14433	NN	ra	B-GENE	_	_
activation	14434	14444	NN	activation	O	_	_
.	14479	14480	.	.	O	_	_
D	1

3	1	det
3	2	amod
6	5	det
6	8	prep_of
8	10	prep_in
10	11	prep
12	3	prep_under
12	6	nsubj
16	13	nn
16	15	nn
16	19	rcmod
19	17	auxpass
19	18	neg
19	22	agent
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	PP	0	0	4	2	IN	0	0	1	1	Under	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	the	1	1	2	0	JJ	0	2	3	1	same	2	2	3	0	NNS	0	3	4	1	conditions	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	12	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	amount	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	12	2	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	in	9	9	10	0	NP	0	10	12	2	NP	0	10	11	1	NN	0	10	11	1	complex	10	10	11	0	PP	0	11	12	1	IN	0	11	12	1	with	11	11	12	0	VP	0	12	23	2	VBN	0	12	13	1	transfected	12	12	13	0	NP	0	13	23	2	NP	3	13	17	4	NN	0	13	14	1	V5-ASPP2	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NN	0	15	16	1	S827A	15	15	16	0	NN	0	16	17	1	-RRB-	16	16	17	0	SBAR	0	17	23	1	S	0	17	23	1	VP	2	17	23	3	VBZ	0	17	18	1	is	17	17	18	0	RB	0	18	19	1	not	18	18	19	0	VP	0	19	23	2	VBN	0	19	20	1	affected	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	by	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	RAS	21	21	22	0	NN	0	22	23	1	activation	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	25
Together	14481	14489	RB	together	O	_	_
these	14490	14495	DT	these	O	_	_
data	14496	14500	NNS	datum	O	_	_
illustrate	14501	14511	VBP	illustrate	O	_	_
that	14512	14516	IN	that	O	_	_
phosphorylation	14517	14532	NN	phosphorylation	O	_	_
of	14533	14535	IN	of	O	_	_
ASPP2	14536	14541	NN	aspp2	B-GENE	_	_
at	14542	14544	IN	at	O	_	_
Ser827	14545	14551	NN	ser827	O	_	_
by	14552	14554	IN	by	O	_	_
MAPK	14555	14559	NN	mapk	O	_	_
is	14560	14562	VBZ	be	O	_	_
necessary	14563	14572	JJ	necessary	O	_	_
for	14573	14576	IN	for	O	_	_
its	14577	14580	PRP$	its	O	_	_
ASPP2	14581	14586	NN	aspp2	O	_	_
to	14587	14589	TO	to	O	_	_
fully	14590	14595	RB	fully	O	_	_
enhance	14596	14603	VB	enhance	O	_	_
p53	14604	14607	NN	p53	B-GENE	_	_
's	14607	14609	POS	's	I-GENE	_	_
pro-apoptotic	14610	14623	JJ	pro-apoptotic	O	_	_
activity	14624	14632	NN	activity	O	_	_
.	14632	14633	.	.	O	_	_
D	1
3
2	1	det
3	0	advmod
3	2	nsubj
3	13	ccomp
5	7	prep_of
7	9	prep_at
9	11	prep_by
13	4	mark
13	5	nsubj
13	12	cop
13	16	prep_for
16	15	poss
16	19	vmod
19	17	aux
19	18	advmod
19	23	dobj
23	20	poss
23	22	amod
EOX
Y	1
ROOT	0	0	25	1	S	2	0	25	4	ADVP	0	0	1	1	RB	0	0	1	1	Together	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	these	1	1	2	0	NNS	0	2	3	1	data	2	2	3	0	VP	0	3	24	2	VBP	0	3	4	1	illustrate	3	3	4	0	SBAR	1	4	24	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	24	2	NP	0	5	12	2	NP	0	5	6	1	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	12	2	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	at	8	8	9	0	NP	0	9	12	2	NP	0	9	10	1	NN	0	9	10	1	Ser827	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	by	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	MAPK	11	11	12	0	VP	1	12	24	2	VBZ	0	12	13	1	is	12	12	13	0	ADJP	0	13	24	2	JJ	0	13	14	1	necessary	13	13	14	0	PP	0	14	24	2	IN	0	14	15	1	for	14	14	15	0	NP	1	15	24	3	PRP$	0	15	16	1	its	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	S	0	17	24	1	VP	1	17	24	2	TO	0	17	18	1	to	17	17	18	0	VP	1	18	24	3	ADVP	0	18	19	1	RB	0	18	19	1	fully	18	18	19	0	VB	0	19	20	1	enhance	19	19	20	0	NP	2	20	24	3	NP	0	20	22	2	NN	0	20	21	1	p53	20	20	21	0	POS	0	21	22	1	's	21	21	22	0	JJ	0	22	23	1	pro-apoptotic	22	22	23	0	NN	0	23	24	1	activity	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	28
ASPP2	14635	14640	NN	aspp2	B-GENE	_	_
is	14641	14643	VBZ	be	O	_	_
a	14644	14645	DT	a	O	_	_
haploinsufficient	14646	14663	JJ	haploinsufficient	O	_	_
tumor	14664	14669	NN	tumor	O	_	_
suppressor	14670	14680	NN	suppressor	O	_	_
[	14681	14682	CD	[	O	_	_
15	14682	14684	CD	15	O	_	_
]	14684	14685	NN	]	O	_	_
[	14686	14687	CD	[	O	_	_
16	14687	14689	CD	16	O	_	_
]	14689	14690	NN	]	O	_	_
and	14691	14694	CC	and	O	_	_
it	14695	14697	PRP	it	O	_	_
can	14698	14701	MD	can	O	_	_
cooperate	14702	14711	VB	cooperate	O	_	_
with	14712	14716	IN	with	O	_	_
p53	14717	14720	NN	p53	B-GENE	_	_
to	14721	14723	TO	to	O	_	_
suppress	14724	14732	VB	suppress	O	_	_
tumour	14733	14739	NN	tumour	O	_	_
growth	14740	14746	NN	growth	O	_	_
in	14747	14749	FW	in	O	_	_
vivo	14750	14754	FW	vivo	O	_	_
[	14755	14756	FW	[	O	_	_
15	14756	14758	CD	15	O	_	_
]	14758	14759	NN	]	O	_	_
.	14759	14760	.	.	O	_	_
D	1
15
7	6	number
8	0	nsubj
8	1	cop
8	2	det
8	3	amod
8	4	nn
8	5	nn
8	7	num
8	11	dep
8	13	conj_and
10	9	number
11	10	num
15	8	dep
15	13	dep
15	14	aux
15	17	prep_with
15	19	xcomp
15	26	nsubj
19	18	aux
19	21	dobj
21	20	nn
21	22	prep
22	24	pobj
24	23	nn
26	25	num
EOX
Y	1
ROOT	0	0	28	1	SINV	1	0	28	4	S	1	0	14	2	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	1	1	14	2	VBZ	0	1	2	1	is	1	1	2	0	NP	0	2	14	4	NP	5	2	9	6	DT	0	2	3	1	a	2	2	3	0	JJ	0	3	4	1	haploinsufficient	3	3	4	0	NN	0	4	5	1	tumor	4	4	5	0	NN	0	5	6	1	suppressor	5	5	6	0	ADJP	0	6	8	1	QP	1	6	8	2	CD	0	6	7	1	[	6	6	7	0	CD	0	7	8	1	15	7	7	8	0	NN	0	8	9	1	]	8	8	9	0	NP	1	9	12	2	QP	1	9	11	2	CD	0	9	10	1	[	9	9	10	0	CD	0	10	11	1	16	10	10	11	0	NN	0	11	12	1	]	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NP	0	13	14	1	PRP	0	13	14	1	it	13	13	14	0	VP	1	14	25	2	MD	0	14	15	1	can	14	14	15	0	VP	0	15	25	3	VB	0	15	16	1	cooperate	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	p53	17	17	18	0	S	0	18	25	1	VP	1	18	25	2	TO	0	18	19	1	to	18	18	19	0	VP	0	19	25	2	VB	0	19	20	1	suppress	19	19	20	0	NP	0	20	25	2	NP	1	20	22	2	NN	0	20	21	1	tumour	20	20	21	0	NN	0	21	22	1	growth	21	21	22	0	PP	0	22	25	2	FW	0	22	23	1	in	22	22	23	0	NP	1	23	25	2	FW	0	23	24	1	vivo	23	23	24	0	FW	0	24	25	1	[	24	24	25	0	NP	1	25	27	2	CD	0	25	26	1	15	25	25	26	0	NN	0	26	27	1	]	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	16
In	14761	14763	IN	in	O	_	_
human	14764	14769	JJ	human	O	_	_
cancer	14770	14776	NN	cancer	O	_	_
,	14776	14777	,	,	O	_	_
ASPP2	14778	14783	NN	aspp2	B-GENE	_	_
expression	14784	14794	NN	expression	O	_	_
is	14795	14797	VBZ	be	O	_	_
down	14798	14802	RB	down	O	_	_
regulated	14803	14812	VBN	regulate	O	_	_
by	14813	14815	IN	by	O	_	_
DNA	14816	14819	NN	dna	O	_	_
methylation	14820	14831	NN	methylation	O	_	_
[	14832	14833	CD	[	O	_	_
9,17-19	14833	14840	CD	9,17-19	O	_	_
]	14840	14841	NN	]	O	_	_
.	14841	14842	.	.	O	_	_
D	1
8
2	1	amod
5	4	nn
8	2	prep_in
8	5	nsubjpass
8	6	auxpass
8	7	advmod
8	11	agent
11	10	nn
11	14	dep
14	12	num
14	13	num
EOX
Y	1
ROOT	0	0	16	1	S	3	0	16	5	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	JJ	0	1	2	1	human	1	1	2	0	NN	0	2	3	1	cancer	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	1	4	6	2	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	expression	5	5	6	0	VP	2	6	15	3	VBZ	0	6	7	1	is	6	6	7	0	ADVP	0	7	8	1	RB	0	7	8	1	down	7	7	8	0	VP	0	8	15	2	VBN	0	8	9	1	regulated	8	8	9	0	PP	0	9	15	2	IN	0	9	10	1	by	9	9	10	0	NP	0	10	15	2	NP	1	10	12	2	NN	0	10	11	1	DNA	10	10	11	0	NN	0	11	12	1	methylation	11	11	12	0	NP	2	12	15	3	CD	0	12	13	1	[	12	12	13	0	CD	0	13	14	1	9,17-19	13	13	14	0	NN	0	14	15	1	]	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	20
Importantly	14843	14854	RB	importantly	O	_	_
,	14854	14855	,	,	O	_	_
in	14856	14858	IN	in	O	_	_
diffuse	14859	14866	JJ	diffuse	O	_	_
large	14867	14872	JJ	large	O	_	_
B	14873	14874	NN	b	O	_	_
cell	14875	14879	NN	cell	O	_	_
lymphomas	14880	14889	NNS	lymphoma	O	_	_
,	14889	14890	,	,	O	_	_
reduced	14891	14898	VBD	reduce	O	_	_
ASPP2	14899	14904	NN	aspp2	B-GENE	_	_
expression	14905	14915	NN	expression	O	_	_
associates	14916	14926	VBZ	associate	O	_	_
with	14927	14931	IN	with	O	_	_
poor	14932	14936	JJ	poor	O	_	_
prognosis	14937	14946	NN	prognosis	O	_	_
[	14947	14948	CD	[	O	_	_
20	14948	14950	CD	20	O	_	_
]	14950	14951	NN	]	O	_	_
.	14951	14952	.	.	O	_	_
D	1
9
7	3	amod
7	4	amod
7	5	nn
7	6	nn
9	0	advmod
9	7	prep_in
9	12	ccomp
11	10	nn
12	11	nsubj
12	15	prep_with
12	18	dep
15	14	amod
17	16	number
18	17	num
EOX
Y	1
ROOT	0	0	20	1	S	4	0	20	6	ADVP	0	0	1	1	RB	0	0	1	1	Importantly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	8	2	IN	0	2	3	1	in	2	2	3	0	NP	4	3	8	5	JJ	0	3	4	1	diffuse	3	3	4	0	JJ	0	4	5	1	large	4	4	5	0	NN	0	5	6	1	B	5	5	6	0	NN	0	6	7	1	cell	6	6	7	0	NNS	0	7	8	1	lymphomas	7	7	8	0	,	0	8	9	1	,	8	8	9	0	VP	0	9	19	2	VBD	0	9	10	1	reduced	9	9	10	0	SBAR	0	10	19	1	S	1	10	19	2	NP	1	10	12	2	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	expression	11	11	12	0	VP	0	12	19	2	VBZ	0	12	13	1	associates	12	12	13	0	PP	0	13	19	3	IN	0	13	14	1	with	13	13	14	0	NP	1	14	16	2	JJ	0	14	15	1	poor	14	14	15	0	NN	0	15	16	1	prognosis	15	15	16	0	NP	1	16	19	2	QP	1	16	18	2	CD	0	16	17	1	[	16	16	17	0	CD	0	17	18	1	20	17	17	18	0	NN	0	18	19	1	]	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	21
ASPP2	14953	14958	NN	aspp2	B-GENE	_	_
expression	14959	14969	NN	expression	O	_	_
is	14970	14972	VBZ	be	O	_	_
also	14973	14977	RB	also	O	_	_
down	14978	14982	RB	down	O	_	_
regulated	14983	14992	VBN	regulate	O	_	_
in	14993	14995	IN	in	O	_	_
both	14996	15000	CC	both	O	_	_
invasive	15001	15009	JJ	invasive	O	_	_
and	15010	15013	CC	and	O	_	_
metastatic	15014	15024	JJ	metastatic	O	_	_
cells	15025	15030	NNS	cell	O	_	_
compared	15031	15039	VBN	compare	O	_	_
with	15040	15044	IN	with	O	_	_
normal	15045	15051	JJ	normal	O	_	_
breast	15052	15058	NN	breast	O	_	_
epithelium	15059	15069	NN	epithelium	O	_	_
[	15070	15071	CD	[	O	_	_
21	15071	15073	CD	21	O	_	_
]	15073	15074	NN	]	O	_	_
.	15074	15075	.	.	O	_	_
D	1
5
1	0	nn
5	1	nsubjpass
5	2	auxpass
5	3	advmod
5	4	advmod
5	11	prep_in
5	13	prepc_compared_with
5	16	pobj
8	7	preconj
8	10	conj_and
11	8	amod
11	10	amod
16	14	amod
16	15	nn
16	19	dep
18	17	number
19	18	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	expression	1	1	2	0	VP	2	2	20	3	VBZ	0	2	3	1	is	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	also	3	3	4	0	VP	1	4	20	4	ADVP	0	4	5	1	RB	0	4	5	1	down	4	4	5	0	VBN	0	5	6	1	regulated	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	in	6	6	7	0	NP	1	7	12	2	ADJP	1	7	11	4	CC	0	7	8	1	both	7	7	8	0	JJ	0	8	9	1	invasive	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	JJ	0	10	11	1	metastatic	10	10	11	0	NNS	0	11	12	1	cells	11	11	12	0	PP	0	12	20	2	VBN	0	12	13	1	compared	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	with	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	JJ	0	14	15	1	normal	14	14	15	0	NN	0	15	16	1	breast	15	15	16	0	NN	0	16	17	1	epithelium	16	16	17	0	X	0	17	20	1	NP	1	17	20	2	QP	1	17	19	2	CD	0	17	18	1	[	17	17	18	0	CD	0	18	19	1	21	18	18	19	0	NN	0	19	20	1	]	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	15
These	15076	15081	DT	these	O	_	_
findings	15082	15090	NNS	finding	O	_	_
established	15091	15102	VBD	establish	O	_	_
ASPP2	15103	15108	NN	aspp2	O	_	_
as	15109	15111	IN	as	O	_	_
a	15112	15113	DT	a	O	_	_
tumor	15114	15119	NN	tumor	O	_	_
suppressor	15120	15130	NN	suppressor	O	_	_
and	15131	15134	CC	and	O	_	_
an	15135	15137	DT	a	O	_	_
activator	15138	15147	NN	activator	O	_	_
of	15148	15150	IN	of	O	_	_
p53	15151	15154	NN	p53	B-GENE	_	_
family	15155	15161	NN	family	I-GENE	_	_
.	15161	15162	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	3	dobj
2	7	prep_as
2	10	prep_as
7	5	det
7	6	nn
7	10	conj_and
10	9	det
10	13	prep_of
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	findings	1	1	2	0	VP	0	2	14	3	VBD	0	2	3	1	established	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	14	2	IN	0	4	5	1	as	4	4	5	0	NP	0	5	14	3	NP	2	5	8	3	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	tumor	6	6	7	0	NN	0	7	8	1	suppressor	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	NP	0	9	14	2	NP	1	9	11	2	DT	0	9	10	1	an	9	9	10	0	NN	0	10	11	1	activator	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	of	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	p53	12	12	13	0	NN	0	13	14	1	family	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	17
ASPP2	15163	15168	NN	aspp2	B-GENE	_	_
is	15169	15171	VBZ	be	O	_	_
involved	15172	15180	VBN	involve	O	_	_
in	15181	15183	IN	in	O	_	_
both	15184	15188	CC	both	O	_	_
senescence	15189	15199	NN	senescence	O	_	_
in	15200	15202	IN	in	O	_	_
fibroblasts	15203	15214	NNS	fibroblast	O	_	_
and	15215	15218	CC	and	O	_	_
apoptosis	15219	15228	NN	apoptosis	O	_	_
in	15229	15231	IN	in	O	_	_
cancer	15232	15238	NN	cancer	O	_	_
cells	15239	15244	NNS	cell	O	_	_
[	15245	15246	VBP	[	O	_	_
2,10	15246	15250	CD	2,10	O	_	_
]	15250	15251	CD	]	O	_	_
.	15251	15252	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	5	prep_in
2	13	conj_and
5	4	dep
5	7	prep_in
9	12	prep_in
12	11	nn
13	9	nsubj
13	15	dobj
15	14	number
EOX
Y	1
ROOT	0	0	17	1	S	0	0	17	4	S	1	0	8	2	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	1	1	8	2	VBZ	0	1	2	1	is	1	1	2	0	VP	0	2	8	2	VBN	0	2	3	1	involved	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	8	2	NP	1	4	6	2	CC	0	4	5	1	both	4	4	5	0	NN	0	5	6	1	senescence	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	in	6	6	7	0	NP	0	7	8	1	NNS	0	7	8	1	fibroblasts	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	16	2	NP	0	9	13	2	NP	0	9	10	1	NN	0	9	10	1	apoptosis	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	cancer	11	11	12	0	NNS	0	12	13	1	cells	12	12	13	0	VP	0	13	16	2	VBP	0	13	14	1	[	13	13	14	0	NP	0	14	16	1	QP	1	14	16	2	CD	0	14	15	1	2,10	14	14	15	0	CD	0	15	16	1	]	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	11
ASPP2	15253	15258	NN	aspp2	B-GENE	_	_
acts	15259	15263	VBZ	act	O	_	_
at	15264	15266	IN	at	O	_	_
several	15267	15274	JJ	several	O	_	_
steps	15275	15280	NNS	step	O	_	_
in	15281	15283	IN	in	O	_	_
promoting	15284	15293	VBG	promote	O	_	_
senescence	15294	15304	NN	senescence	O	_	_
in	15305	15307	IN	in	O	_	_
fibroblasts	15308	15319	NNS	fibroblast	O	_	_
.	15319	15320	.	.	O	_	_
D	1
1
1	0	nsubj
1	4	prep_at
1	6	prepc_in
4	3	amod
6	7	dobj
6	9	prep_in
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	10	3	VBZ	0	1	2	1	acts	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	at	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	several	3	3	4	0	NNS	0	4	5	1	steps	4	4	5	0	PP	0	5	10	2	IN	0	5	6	1	in	5	5	6	0	S	0	6	10	1	VP	0	6	10	3	VBG	0	6	7	1	promoting	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	senescence	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	in	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	fibroblasts	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	29
It	15321	15323	PRP	it	O	_	_
can	15324	15327	MD	can	O	_	_
do	15328	15330	VB	do	O	_	_
so	15331	15333	RB	so	O	_	_
in	15334	15336	IN	in	O	_	_
a	15337	15338	DT	a	O	_	_
RAS	15339	15342	NN	ra	O	_	_
dependent	15343	15352	JJ	dependent	O	_	_
,	15352	15353	,	,	O	_	_
p53	15354	15357	NN	p53	B-GENE	_	_
independent	15358	15369	JJ	independent	O	_	_
manner	15370	15376	NN	manner	O	_	_
,	15376	15377	,	,	O	_	_
through	15378	15385	IN	through	O	_	_
its	15386	15389	PRP$	its	O	_	_
ability	15390	15397	NN	ability	O	_	_
to	15398	15400	TO	to	O	_	_
bind	15401	15405	VB	bind	O	_	_
ATG5	15406	15410	NN	atg5	O	_	_
and	15411	15414	CC	and	O	_	_
to	15415	15417	TO	to	O	_	_
inhibit	15418	15425	VB	inhibit	O	_	_
RAS	15426	15429	NN	ra	O	_	_
induced	15430	15437	VBN	induce	O	_	_
autophagy	15438	15447	NN	autophagy	O	_	_
[	15448	15449	CD	[	O	_	_
10	15449	15451	CD	10	O	_	_
]	15451	15452	NN	]	O	_	_
.	15452	15453	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	aux
2	3	advmod
2	15	prep_through
3	6	prep_in
6	5	det
6	7	amod
6	11	appos
11	9	nn
11	10	amod
15	14	poss
15	17	dep
15	21	dep
17	16	aux
17	18	dobj
17	21	conj_and
21	20	aux
21	22	dobj
22	23	vmod
23	24	dobj
24	25	num
24	27	dep
27	26	num
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	28	2	MD	0	1	2	1	can	1	1	2	0	VP	0	2	28	3	VB	0	2	3	1	do	2	2	3	0	ADVP	0	3	13	2	RB	0	3	4	1	so	3	3	4	0	PP	0	4	13	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	13	4	NP	0	5	8	2	NP	1	5	7	2	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	RAS	6	6	7	0	ADJP	0	7	8	1	JJ	0	7	8	1	dependent	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	2	9	12	3	NN	0	9	10	1	p53	9	9	10	0	JJ	0	10	11	1	independent	10	10	11	0	NN	0	11	12	1	manner	11	11	12	0	,	0	12	13	1	,	12	12	13	0	PP	0	13	28	2	IN	0	13	14	1	through	13	13	14	0	NP	1	14	28	3	PRP$	0	14	15	1	its	14	14	15	0	NN	0	15	16	1	ability	15	15	16	0	S	0	16	28	1	VP	0	16	28	3	VP	1	16	19	2	TO	0	16	17	1	to	16	16	17	0	VP	0	17	19	2	VB	0	17	18	1	bind	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	ATG5	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	VP	1	20	28	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	28	2	VB	0	21	22	1	inhibit	21	21	22	0	NP	0	22	28	2	NP	0	22	23	1	NN	0	22	23	1	RAS	22	22	23	0	VP	0	23	28	2	VBN	0	23	24	1	induced	23	23	24	0	NP	0	24	28	2	NP	0	24	26	2	NN	0	24	25	1	autophagy	24	24	25	0	CD	0	25	26	1	[	25	25	26	0	NP	1	26	28	2	CD	0	26	27	1	10	26	26	27	0	NN	0	27	28	1	]	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	22
Additionally	15454	15466	RB	additionally	O	_	_
,	15466	15467	,	,	O	_	_
it	15468	15470	PRP	it	O	_	_
can	15471	15474	MD	can	O	_	_
bind	15475	15479	VB	bind	O	_	_
active	15480	15486	JJ	active	O	_	_
RAS	15487	15490	NN	ra	O	_	_
directly	15491	15499	RB	directly	O	_	_
leading	15500	15507	VBG	lead	O	_	_
to	15508	15510	TO	to	O	_	_
enhanced	15511	15519	VBN	enhance	O	_	_
activation	15520	15530	NN	activation	O	_	_
of	15531	15533	IN	of	O	_	_
c-Raf	15534	15539	NN	c-raf	B-GENE	_	_
/	15539	15540	:	/	B-GENE	_	_
MAPK	15540	15544	NN	mapk	I-GENE	_	_
mediated	15545	15553	VBD	mediate	O	_	_
senescence	15554	15564	NN	senescence	O	_	_
[	15565	15566	NN	[	O	_	_
6	15566	15567	CD	6	O	_	_
]	15567	15568	NN	]	O	_	_
.	15568	15569	.	.	O	_	_
D	1
4
4	0	advmod
4	2	nsubj
4	3	aux
4	6	dobj
6	5	amod
6	8	vmod
6	16	dep
6	20	dep
8	7	advmod
8	11	prep_to
11	10	amod
11	13	prep_of
16	14	punct
16	15	nsubj
16	18	dobj
18	17	nn
20	19	num
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	ADVP	0	0	1	1	RB	0	0	1	1	Additionally	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	it	2	2	3	0	VP	1	3	21	2	MD	0	3	4	1	can	3	3	4	0	VP	0	4	21	2	VB	0	4	5	1	bind	4	4	5	0	NP	0	5	21	3	NP	0	5	14	2	NP	1	5	7	2	JJ	0	5	6	1	active	5	5	6	0	NN	0	6	7	1	RAS	6	6	7	0	VP	1	7	14	3	ADVP	0	7	8	1	RB	0	7	8	1	directly	7	7	8	0	VBG	0	8	9	1	leading	8	8	9	0	PP	0	9	14	2	TO	0	9	10	1	to	9	9	10	0	NP	0	10	14	2	NP	1	10	12	2	VBN	0	10	11	1	enhanced	10	10	11	0	NN	0	11	12	1	activation	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	c-Raf	13	13	14	0	PRN	1	14	19	2	:	0	14	15	1	/	14	14	15	0	S	1	15	19	2	NP	0	15	16	1	NN	0	15	16	1	MAPK	15	15	16	0	VP	0	16	19	2	VBD	0	16	17	1	mediated	16	16	17	0	NP	1	17	19	2	NN	0	17	18	1	senescence	17	17	18	0	NN	0	18	19	1	[	18	18	19	0	NP	1	19	21	2	CD	0	19	20	1	6	19	19	20	0	NN	0	20	21	1	]	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	23
We	15570	15572	PRP	we	O	_	_
and	15573	15576	CC	and	O	_	_
others	15577	15583	NNS	other	O	_	_
have	15584	15588	VBP	have	O	_	_
recently	15589	15597	RB	recently	O	_	_
shown	15598	15603	VBN	show	O	_	_
that	15604	15608	IN	that	O	_	_
ASPP2	15609	15614	NN	aspp2	B-GENE	_	_
can	15615	15618	MD	can	O	_	_
potentiate	15619	15629	VB	potentiate	O	_	_
RAS	15630	15633	NN	ra	O	_	_
signaling	15634	15643	NN	signaling	O	_	_
by	15644	15646	IN	by	O	_	_
binding	15647	15654	VBG	bind	O	_	_
directly	15655	15663	RB	directly	O	_	_
via	15664	15667	IN	via	O	_	_
the	15668	15671	DT	the	O	_	_
ASPP2	15672	15677	NN	aspp2	O	_	_
N-terminus	15678	15688	NN	n-terminus	O	_	_
[	15689	15690	CD	[	O	_	_
2,6	15690	15693	CD	2,6	O	_	_
]	15693	15694	NN	]	O	_	_
.	15694	15695	.	.	O	_	_
D	1
5
0	2	conj_and
5	0	nsubj
5	2	nsubj
5	3	aux
5	4	advmod
5	9	ccomp
9	6	mark
9	7	nsubj
9	8	aux
9	11	dobj
9	13	prep_by
11	10	nn
13	14	advmod
13	18	prep_via
18	16	det
18	17	nn
18	21	dep
20	19	number
21	20	num
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	0	0	3	3	PRP	0	0	1	1	We	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NNS	0	2	3	1	others	2	2	3	0	VP	2	3	22	3	VBP	0	3	4	1	have	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	recently	4	4	5	0	VP	0	5	22	2	VBN	0	5	6	1	shown	5	5	6	0	SBAR	1	6	22	2	IN	0	6	7	1	that	6	6	7	0	S	1	7	22	2	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	VP	1	8	22	2	MD	0	8	9	1	can	8	8	9	0	VP	0	9	22	3	VB	0	9	10	1	potentiate	9	9	10	0	NP	1	10	12	2	NN	0	10	11	1	RAS	10	10	11	0	NN	0	11	12	1	signaling	11	11	12	0	PP	0	12	22	2	IN	0	12	13	1	by	12	12	13	0	NP	0	13	22	2	NP	0	13	14	1	VBG	0	13	14	1	binding	13	13	14	0	PP	1	14	22	3	ADVP	0	14	15	1	RB	0	14	15	1	directly	14	14	15	0	IN	0	15	16	1	via	15	15	16	0	NP	0	16	22	2	NP	2	16	19	3	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	ASPP2	17	17	18	0	NN	0	18	19	1	N-terminus	18	18	19	0	NP	1	19	22	2	QP	1	19	21	2	CD	0	19	20	1	[	19	19	20	0	CD	0	20	21	1	2,6	20	20	21	0	NN	0	21	22	1	]	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	18
Moreover	15696	15704	RB	moreover	O	_	_
,	15704	15705	,	,	O	_	_
the	15706	15709	DT	the	O	_	_
RAS-ASPP	15710	15718	NN	ras-aspp	O	_	_
interaction	15719	15730	NN	interaction	O	_	_
enhances	15731	15739	VBZ	enhance	O	_	_
the	15740	15743	DT	the	O	_	_
transcription	15744	15757	NN	transcription	O	_	_
function	15758	15766	NN	function	O	_	_
of	15767	15769	IN	of	O	_	_
p53	15770	15773	NN	p53	B-GENE	_	_
in	15774	15776	IN	in	O	_	_
cancer	15777	15783	NN	cancer	O	_	_
cells	15784	15789	NNS	cell	O	_	_
[	15790	15791	VBP	[	O	_	_
2	15791	15792	CD	2	O	_	_
]	15792	15793	CD	]	O	_	_
.	15793	15794	.	.	O	_	_
D	1
5
4	2	det
4	3	nn
5	0	advmod
5	4	nsubj
5	14	ccomp
8	6	det
8	7	nn
8	10	prep_of
10	13	prep_in
13	12	nn
14	8	nsubj
14	16	dobj
16	15	number
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	ADVP	0	0	1	1	RB	0	0	1	1	Moreover	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	RAS-ASPP	3	3	4	0	NN	0	4	5	1	interaction	4	4	5	0	VP	0	5	17	2	VBZ	0	5	6	1	enhances	5	5	6	0	SBAR	0	6	17	1	S	1	6	17	2	NP	0	6	14	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	transcription	7	7	8	0	NN	0	8	9	1	function	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	14	2	NP	0	10	11	1	NN	0	10	11	1	p53	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	in	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	cancer	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	VP	0	14	17	2	VBP	0	14	15	1	[	14	14	15	0	NP	0	15	17	1	QP	1	15	17	2	CD	0	15	16	1	2	15	15	16	0	CD	0	16	17	1	]	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	17
Until	15795	15800	IN	until	O	_	_
now	15801	15804	RB	now	O	_	_
,	15804	15805	,	,	O	_	_
it	15806	15808	PRP	it	O	_	_
has	15809	15812	VBZ	have	O	_	_
been	15813	15817	VBN	be	O	_	_
unclear	15818	15825	JJ	unclear	O	_	_
how	15826	15829	WRB	how	O	_	_
RAS	15830	15833	NNP	RAS	B-GENE	_	_
could	15834	15839	MD	could	O	_	_
affect	15840	15846	VB	affect	O	_	_
ASPP2	15847	15852	NN	aspp2	B-GENE	_	_
to	15853	15855	TO	to	O	_	_
enhance	15856	15863	VB	enhance	O	_	_
p53	15864	15867	NN	p53	B-GENE	_	_
function	15868	15876	NN	function	O	_	_
.	15876	15877	.	.	O	_	_
D	1
6
0	1	pobj
6	0	prep
6	3	nsubj
6	4	aux
6	5	cop
6	10	ccomp
10	7	advmod
10	8	nsubj
10	9	aux
10	11	dobj
10	13	xcomp
13	12	aux
13	15	dobj
15	14	nn
EOX
Y	1
ROOT	0	0	17	1	S	3	0	17	5	PP	0	0	2	2	IN	0	0	1	1	Until	0	0	1	0	NP	0	1	2	1	RB	0	1	2	1	now	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	4	1	PRP	0	3	4	1	it	3	3	4	0	VP	1	4	16	2	VBZ	0	4	5	1	has	4	4	5	0	VP	1	5	16	3	VBN	0	5	6	1	been	5	5	6	0	ADJP	0	6	7	1	JJ	0	6	7	1	unclear	6	6	7	0	SBAR	1	7	16	2	WHADVP	0	7	8	1	WRB	0	7	8	1	how	7	7	8	0	S	1	8	16	2	NP	0	8	9	1	NNP	0	8	9	1	RAS	8	8	9	0	VP	1	9	16	2	MD	0	9	10	1	could	9	9	10	0	VP	0	10	16	3	VB	0	10	11	1	affect	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	S	0	12	16	1	VP	1	12	16	2	TO	0	12	13	1	to	12	12	13	0	VP	0	13	16	2	VB	0	13	14	1	enhance	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	p53	14	14	15	0	NN	0	15	16	1	function	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	45
We	15878	15880	PRP	we	O	_	_
show	15881	15885	VBP	show	O	_	_
here	15886	15890	RB	here	O	_	_
that	15891	15895	IN	that	O	_	_
ASPP2	15896	15901	NN	aspp2	B-GENE	_	_
is	15902	15904	VBZ	be	O	_	_
phosphorylated	15905	15919	VBN	phosphorylate	O	_	_
by	15920	15922	IN	by	O	_	_
the	15923	15926	DT	the	O	_	_
RAS	15927	15930	NN	ra	B-GENE	_	_
/	15930	15931	:	/	B-GENE	_	_
Raf/MAPK	15931	15939	NN	raf/mapk	B-GENE	_	_
pathway	15940	15947	NN	pathway	O	_	_
and	15948	15951	CC	and	O	_	_
that	15952	15956	IN	that	O	_	_
this	15957	15961	DT	this	O	_	_
phosphorylation	15962	15977	NN	phosphorylation	O	_	_
leads	15978	15983	VBZ	lead	O	_	_
to	15984	15986	TO	to	O	_	_
its	15987	15990	PRP$	its	O	_	_
increased	15991	16000	VBN	increase	O	_	_
translocation	16001	16014	NN	translocation	O	_	_
to	16015	16017	TO	to	O	_	_
the	16018	16021	DT	the	O	_	_
cytosol	16022	16029	NN	cytosol	O	_	_
/	16029	16030	:	/	O	_	_
nucleus	16030	16037	NN	nucleus	O	_	_
and	16038	16041	CC	and	O	_	_
increased	16042	16051	VBD	increase	O	_	_
binding	16052	16059	NN	binding	O	_	_
to	16060	16062	TO	to	O	_	_
p53	16063	16066	NN	p53	B-GENE	_	_
,	16066	16067	,	,	O	_	_
providing	16068	16077	VBG	provide	O	_	_
an	16078	16080	DT	a	O	_	_
explanation	16081	16092	NN	explanation	O	_	_
of	16093	16095	IN	of	O	_	_
how	16096	16099	WRB	how	O	_	_
RAS	16100	16103	NNP	RAS	B-GENE	_	_
can	16104	16107	MD	can	O	_	_
activate	16108	16116	VB	activate	O	_	_
p53	16117	16120	NN	p53	B-GENE	_	_
pro-apoptotic	16121	16134	JJ	pro-apoptotic	O	_	_
functions	16135	16144	NNS	function	O	_	_
.	16155	16156	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	advmod
1	6	ccomp
6	3	mark
6	4	nsubjpass
6	5	auxpass
6	9	agent
6	31	prep_to
6	33	xcomp
9	8	det
9	17	dep
9	26	dep
9	29	dep
12	11	nn
12	14	conj_and
16	15	det
17	10	punct
17	12	dep
17	14	dep
17	16	nsubj
17	21	prep_to
17	25	punct
21	19	poss
21	20	amod
21	24	prep_to
24	23	det
26	29	conj_and
29	28	amod
33	35	dobj
35	34	det
35	40	prepc_of
40	37	advmod
40	38	nsubj
40	39	aux
40	43	dobj
43	41	nn
43	42	amod
EOX
Y	1
ROOT	0	0	45	1	S	1	0	45	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	44	3	VBP	0	1	2	1	show	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	here	2	2	3	0	SBAR	1	3	44	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	44	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	44	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	44	5	VBN	0	6	7	1	phosphorylated	6	6	7	0	PP	0	7	30	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	30	3	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	PRN	1	10	26	3	:	0	10	11	1	/	10	10	11	0	SBAR	1	11	25	2	NP	0	11	15	3	NP	1	11	13	2	NN	0	11	12	1	Raf/MAPK	11	11	12	0	NN	0	12	13	1	pathway	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	ADJP	0	14	15	1	IN	0	14	15	1	that	14	14	15	0	S	1	15	25	2	NP	1	15	17	2	DT	0	15	16	1	this	15	15	16	0	NN	0	16	17	1	phosphorylation	16	16	17	0	VP	0	17	25	2	VBZ	0	17	18	1	leads	17	17	18	0	PP	0	18	25	2	TO	0	18	19	1	to	18	18	19	0	NP	0	19	25	2	NP	2	19	22	3	PRP$	0	19	20	1	its	19	19	20	0	VBN	0	20	21	1	increased	20	20	21	0	NN	0	21	22	1	translocation	21	21	22	0	PP	0	22	25	2	TO	0	22	23	1	to	22	22	23	0	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	cytosol	24	24	25	0	:	0	25	26	1	/	25	25	26	0	NP	0	26	30	3	NP	0	26	27	1	NN	0	26	27	1	nucleus	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	NP	1	28	30	2	VBD	0	28	29	1	increased	28	28	29	0	NN	0	29	30	1	binding	29	29	30	0	PP	0	30	32	2	TO	0	30	31	1	to	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	p53	31	31	32	0	,	0	32	33	1	,	32	32	33	0	S	0	33	44	1	VP	0	33	44	2	VBG	0	33	34	1	providing	33	33	34	0	NP	0	34	44	2	NP	1	34	36	2	DT	0	34	35	1	an	34	34	35	0	NN	0	35	36	1	explanation	35	35	36	0	PP	0	36	44	2	IN	0	36	37	1	of	36	36	37	0	SBAR	1	37	44	2	WHADVP	0	37	38	1	WRB	0	37	38	1	how	37	37	38	0	S	1	38	44	2	NP	0	38	39	1	NNP	0	38	39	1	RAS	38	38	39	0	VP	1	39	44	2	MD	0	39	40	1	can	39	39	40	0	VP	0	40	44	2	VB	0	40	41	1	activate	40	40	41	0	NP	2	41	44	3	NN	0	41	42	1	p53	41	41	42	0	JJ	0	42	43	1	pro-apoptotic	42	42	43	0	NNS	0	43	44	1	functions	43	43	44	0	.	0	44	45	1	.	44	44	45	0
EOS
T	20
Additionally	16157	16169	RB	additionally	O	_	_
,	16169	16170	,	,	O	_	_
RAS	16171	16174	NN	ra	B-GENE	_	_
/	16174	16175	:	/	B-GENE	_	_
Raf/MAPK	16175	16183	NN	raf/mapk	B-GENE	_	_
pathway	16184	16191	NN	pathway	O	_	_
activation	16192	16202	NN	activation	O	_	_
stabilizes	16203	16213	VBZ	stabilize	O	_	_
ASPP2	16214	16219	NN	aspp2	B-GENE	_	_
protein	16220	16227	NN	protein	I-GENE	_	_
,	16227	16228	,	,	O	_	_
although	16229	16237	IN	although	O	_	_
the	16238	16241	DT	the	O	_	_
underlying	16242	16252	VBG	underlie	O	_	_
mechanism	16253	16262	NN	mechanism	O	_	_
remains	16263	16270	VBZ	remain	O	_	_
to	16271	16273	TO	to	O	_	_
be	16274	16276	VB	be	O	_	_
investigated	16277	16289	VBN	investigate	O	_	_
.	16289	16290	.	.	O	_	_
D	1
7
2	4	dep
4	3	punct
4	6	dep
6	5	nn
7	0	advmod
7	2	nsubj
7	9	dobj
7	15	advcl
9	8	nn
14	12	det
14	13	amod
15	11	mark
15	14	nsubj
15	18	xcomp
18	16	aux
18	17	auxpass
EOX
Y	1
ROOT	0	0	20	1	S	3	0	20	5	ADVP	0	0	1	1	RB	0	0	1	1	Additionally	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	7	2	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	PRN	1	3	7	2	:	0	3	4	1	/	3	3	4	0	NP	0	4	7	2	NP	0	4	5	1	NN	0	4	5	1	Raf/MAPK	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	pathway	5	5	6	0	NN	0	6	7	1	activation	6	6	7	0	VP	0	7	19	4	VBZ	0	7	8	1	stabilizes	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	protein	9	9	10	0	,	0	10	11	1	,	10	10	11	0	SBAR	1	11	19	2	IN	0	11	12	1	although	11	11	12	0	S	1	12	19	2	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	VBG	0	13	14	1	underlying	13	13	14	0	NN	0	14	15	1	mechanism	14	14	15	0	VP	0	15	19	2	VBZ	0	15	16	1	remains	15	15	16	0	S	0	16	19	1	VP	1	16	19	2	TO	0	16	17	1	to	16	16	17	0	VP	1	17	19	2	VB	0	17	18	1	be	17	17	18	0	VP	0	18	19	1	VBN	0	18	19	1	investigated	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	22
ASPP2	16292	16297	NN	aspp2	B-GENE	_	_
binds	16298	16303	VBZ	bind	O	_	_
active	16304	16310	JJ	active	O	_	_
RAS	16311	16314	NN	ra	O	_	_
at	16315	16317	IN	at	O	_	_
the	16318	16321	DT	the	O	_	_
plasma	16322	16328	NN	plasma	O	_	_
membrane	16329	16337	NN	membrane	O	_	_
,	16337	16338	,	,	O	_	_
thereby	16339	16346	RB	thereby	O	_	_
increasing	16347	16357	VBG	increase	O	_	_
RAS	16358	16361	NN	ra	O	_	_
signaling	16362	16371	NN	signaling	O	_	_
to	16372	16374	TO	to	O	_	_
its	16375	16378	PRP$	its	O	_	_
downstream	16379	16389	JJ	downstream	O	_	_
pathway	16390	16397	NN	pathway	O	_	_
effectors	16398	16407	NNS	effector	O	_	_
Raf	16408	16411	NN	raf	B-GENE	_	_
/	16411	16412	:	/	B-GENE	_	_
MAPK	16412	16416	NN	mapk	I-GENE	_	_
.	16416	16417	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
1	7	prep_at
1	10	vmod
3	2	amod
7	5	det
7	6	nn
10	9	advmod
10	12	dobj
10	18	prep_to
12	11	nn
18	14	poss
18	15	amod
18	16	nn
18	17	nn
18	20	dep
20	19	punct
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	21	5	VBZ	0	1	2	1	binds	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	active	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	at	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	plasma	6	6	7	0	NN	0	7	8	1	membrane	7	7	8	0	,	0	8	9	1	,	8	8	9	0	S	1	9	21	2	ADVP	0	9	10	1	RB	0	9	10	1	thereby	9	9	10	0	VP	0	10	21	3	VBG	0	10	11	1	increasing	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	RAS	11	11	12	0	NN	0	12	13	1	signaling	12	12	13	0	PP	0	13	21	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	21	2	NP	4	14	19	5	PRP$	0	14	15	1	its	14	14	15	0	JJ	0	15	16	1	downstream	15	15	16	0	NN	0	16	17	1	pathway	16	16	17	0	NNS	0	17	18	1	effectors	17	17	18	0	NN	0	18	19	1	Raf	18	18	19	0	PRN	1	19	21	2	:	0	19	20	1	/	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	MAPK	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	17
Activated	16418	16427	VBN	activate	O	_	_
MAPK	16428	16432	NN	mapk	O	_	_
phosphorylates	16433	16447	VBZ	phosphorylate	O	_	_
ASPP2	16448	16453	NN	aspp2	B-GENE	_	_
which	16454	16459	WDT	which	O	_	_
can	16460	16463	MD	can	O	_	_
then	16464	16468	RB	then	O	_	_
relocate	16469	16477	VB	relocate	O	_	_
to	16478	16480	TO	to	O	_	_
the	16481	16484	DT	the	O	_	_
nucleus	16485	16492	NN	nucleus	O	_	_
and	16493	16496	CC	and	O	_	_
activate	16497	16505	VBP	activate	O	_	_
p53	16506	16509	NN	p53	B-GENE	_	_
pro-apoptotic	16510	16523	JJ	pro-apoptotic	O	_	_
signaling	16524	16533	NN	signaling	O	_	_
.	16533	16534	.	.	O	_	_
D	1
0
0	1	dobj
0	2	dep
0	3	nsubj
3	7	ccomp
3	12	ccomp
7	4	nsubj
7	5	aux
7	6	advmod
7	10	prep_to
7	12	conj_and
10	9	det
12	4	nsubj
12	15	dobj
15	13	nn
15	14	amod
EOX
Y	1
ROOT	0	0	17	1	SINV	0	0	17	4	VP	0	0	2	2	VBN	0	0	1	1	Activated	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	MAPK	1	1	2	0	VP	0	2	3	1	VBZ	0	2	3	1	phosphorylates	2	2	3	0	NP	0	3	16	2	NN	0	3	4	1	ASPP2	3	3	4	0	SBAR	1	4	16	2	WHNP	0	4	5	1	WDT	0	4	5	1	which	4	4	5	0	S	0	5	16	1	VP	0	5	16	3	VP	2	5	11	3	MD	0	5	6	1	can	5	5	6	0	RB	0	6	7	1	then	6	6	7	0	VP	0	7	11	2	VB	0	7	8	1	relocate	7	7	8	0	PP	0	8	11	2	TO	0	8	9	1	to	8	8	9	0	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	nucleus	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VP	0	12	16	2	VBP	0	12	13	1	activate	12	12	13	0	NP	2	13	16	3	NN	0	13	14	1	p53	13	13	14	0	JJ	0	14	15	1	pro-apoptotic	14	14	15	0	NN	0	15	16	1	signaling	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	30
Thus	16535	16539	RB	thus	O	_	_
ASPP2	16540	16545	NN	aspp2	O	_	_
is	16546	16548	VBZ	be	O	_	_
both	16549	16553	DT	both	O	_	_
upstream	16554	16562	JJ	upstream	O	_	_
of	16563	16565	IN	of	O	_	_
RAS	16566	16569	NN	ra	B-GENE	_	_
,	16569	16570	,	,	O	_	_
by	16571	16573	IN	by	O	_	_
binding	16574	16581	VBG	bind	O	_	_
active	16582	16588	JJ	active	O	_	_
RAS	16589	16592	NN	ra	O	_	_
and	16593	16596	CC	and	O	_	_
enhancing	16597	16606	VBG	enhance	O	_	_
its	16607	16610	PRP$	its	O	_	_
downstream	16611	16621	JJ	downstream	O	_	_
pathway	16622	16629	NN	pathway	O	_	_
activity	16630	16638	NN	activity	O	_	_
,	16638	16639	,	,	O	_	_
as	16640	16642	RB	as	O	_	_
well	16643	16647	RB	well	O	_	_
as	16648	16650	IN	as	O	_	_
downstream	16651	16661	JJ	downstream	O	_	_
of	16662	16664	IN	of	O	_	_
the	16665	16668	DT	the	O	_	_
RAS	16669	16672	NN	ra	B-GENE	_	_
/	16672	16673	:	/	B-GENE	_	_
RAF/MAPK	16673	16681	NN	raf/mapk	B-GENE	_	_
pathway	16682	16689	NN	pathway	O	_	_
.	16689	16690	.	.	O	_	_
D	1
4
4	0	advmod
4	1	nsubj
4	2	cop
4	3	det
4	6	prep_of
4	11	prep_by
4	13	conj_and
11	9	amod
11	10	amod
13	1	nsubj
13	17	dobj
13	22	dobj
17	14	poss
17	15	amod
17	16	nn
17	22	conj_and
22	25	prep_of
25	24	det
25	28	dep
28	26	punct
28	27	nn
EOX
Y	1
ROOT	0	0	30	1	S	0	0	30	4	S	2	0	12	3	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	12	4	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	7	2	NP	1	3	5	2	DT	0	3	4	1	both	3	3	4	0	JJ	0	4	5	1	upstream	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	,	0	7	8	1	,	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	by	8	8	9	0	NP	2	9	12	3	VBG	0	9	10	1	binding	9	9	10	0	JJ	0	10	11	1	active	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	S	0	13	29	1	VP	0	13	29	2	VBG	0	13	14	1	enhancing	13	13	14	0	NP	0	14	29	4	NP	3	14	18	4	PRP$	0	14	15	1	its	14	14	15	0	JJ	0	15	16	1	downstream	15	15	16	0	NN	0	16	17	1	pathway	16	16	17	0	NN	0	17	18	1	activity	17	17	18	0	,	0	18	19	1	,	18	18	19	0	CONJP	1	19	22	3	RB	0	19	20	1	as	19	19	20	0	RB	0	20	21	1	well	20	20	21	0	IN	0	21	22	1	as	21	21	22	0	NP	0	22	29	2	NP	0	22	23	1	JJ	0	22	23	1	downstream	22	22	23	0	PP	0	23	29	2	IN	0	23	24	1	of	23	23	24	0	NP	0	24	29	2	NP	1	24	26	2	DT	0	24	25	1	the	24	24	25	0	NN	0	25	26	1	RAS	25	25	26	0	PRN	1	26	29	2	:	0	26	27	1	/	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	RAF/MAPK	27	27	28	0	NN	0	28	29	1	pathway	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	15
It	16691	16693	PRP	it	O	_	_
is	16694	16696	VBZ	be	O	_	_
likely	16697	16703	JJ	likely	O	_	_
that	16704	16708	IN	that	O	_	_
this	16709	16713	DT	this	O	_	_
possible	16714	16722	JJ	possible	O	_	_
feedback	16723	16731	NN	feedback	O	_	_
loop	16732	16736	NN	loop	O	_	_
leads	16737	16742	VBZ	lead	O	_	_
to	16743	16745	TO	to	O	_	_
an	16746	16748	DT	a	O	_	_
amplified	16749	16758	VBN	amplify	O	_	_
pro-apoptotic	16759	16772	JJ	pro-apoptotic	O	_	_
signal	16773	16779	NN	signal	O	_	_
.	16779	16780	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	8	ccomp
7	4	det
7	5	amod
7	6	nn
8	3	mark
8	7	nsubj
8	13	prep_to
13	10	det
13	11	amod
13	12	amod
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	14	3	VBZ	0	1	2	1	is	1	1	2	0	ADJP	0	2	3	1	JJ	0	2	3	1	likely	2	2	3	0	SBAR	1	3	14	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	14	2	NP	3	4	8	4	DT	0	4	5	1	this	4	4	5	0	JJ	0	5	6	1	possible	5	5	6	0	NN	0	6	7	1	feedback	6	6	7	0	NN	0	7	8	1	loop	7	7	8	0	VP	0	8	14	2	VBZ	0	8	9	1	leads	8	8	9	0	PP	0	9	14	2	TO	0	9	10	1	to	9	9	10	0	NP	3	10	14	4	DT	0	10	11	1	an	10	10	11	0	VBN	0	11	12	1	amplified	11	11	12	0	JJ	0	12	13	1	pro-apoptotic	12	12	13	0	NN	0	13	14	1	signal	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	24
In	16781	16783	IN	in	O	_	_
a	16784	16785	DT	a	O	_	_
scenario	16786	16794	NN	scenario	O	_	_
where	16795	16800	WRB	where	O	_	_
RAS	16801	16804	NNP	RAS	O	_	_
is	16805	16807	VBZ	be	O	_	_
mutated	16808	16815	VBN	mutate	O	_	_
and	16816	16819	CC	and	O	_	_
thereby	16820	16827	RB	thereby	O	_	_
constitutively	16828	16842	RB	constitutively	O	_	_
active	16843	16849	JJ	active	O	_	_
,	16849	16850	,	,	O	_	_
it	16851	16853	PRP	it	O	_	_
binds	16854	16859	VBZ	bind	O	_	_
ASPP2	16860	16865	NN	aspp2	B-GENE	_	_
,	16865	16866	,	,	O	_	_
resulting	16867	16876	VBG	result	O	_	_
in	16877	16879	IN	in	O	_	_
increased	16880	16889	VBN	increase	O	_	_
RAS	16890	16893	NN	ra	B-GENE	_	_
/	16893	16894	:	/	B-GENE	_	_
MAPK	16894	16898	NN	mapk	I-GENE	_	_
signaling	16899	16908	NN	signaling	O	_	_
.	16908	16909	.	.	O	_	_
D	1
13
2	1	det
2	5	rcmod
5	3	advmod
5	4	nsubj
5	6	dep
5	8	dep
5	10	dep
6	8	conj_and
6	10	conj_and
10	9	advmod
13	2	prep_in
13	12	nsubj
13	14	dobj
13	16	vmod
16	19	prep_in
19	18	amod
19	22	dep
22	20	punct
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	PP	0	0	11	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	11	2	NP	1	1	3	2	DT	0	1	2	1	a	1	1	2	0	NN	0	2	3	1	scenario	2	2	3	0	SBAR	1	3	11	2	WHADVP	0	3	4	1	WRB	0	3	4	1	where	3	3	4	0	S	1	4	11	2	NP	0	4	5	1	NNP	0	4	5	1	RAS	4	4	5	0	VP	0	5	11	2	VBZ	0	5	6	1	is	5	5	6	0	UCP	0	6	11	4	VP	0	6	7	1	VBN	0	6	7	1	mutated	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	thereby	8	8	9	0	ADJP	1	9	11	2	RB	0	9	10	1	constitutively	9	9	10	0	JJ	0	10	11	1	active	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	PRP	0	12	13	1	it	12	12	13	0	VP	0	13	23	4	VBZ	0	13	14	1	binds	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	,	0	15	16	1	,	15	15	16	0	S	0	16	23	1	VP	0	16	23	2	VBG	0	16	17	1	resulting	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	VBN	0	18	19	1	increased	18	18	19	0	NN	0	19	20	1	RAS	19	19	20	0	PRN	1	20	23	2	:	0	20	21	1	/	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	MAPK	21	21	22	0	NN	0	22	23	1	signaling	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	18
This	16910	16914	DT	this	O	_	_
in	16915	16917	IN	in	O	_	_
turn	16918	16922	NN	turn	O	_	_
activates	16923	16932	VBZ	activate	O	_	_
ASPP2	16933	16938	NN	aspp2	B-GENE	_	_
via	16939	16942	IN	via	O	_	_
MAPK	16943	16947	NN	mapk	B-GENE	_	_
phosphorylation	16948	16963	NN	phosphorylation	O	_	_
which	16964	16969	WDT	which	O	_	_
will	16970	16974	MD	will	O	_	_
translocate	16975	16986	VB	translocate	O	_	_
and	16987	16990	CC	and	O	_	_
activate	16991	16999	VB	activate	O	_	_
p53	17000	17003	NN	p53	B-GENE	_	_
to	17004	17006	TO	to	O	_	_
promote	17007	17014	VB	promote	O	_	_
apoptosis	17015	17024	NN	apoptosis	O	_	_
.	17024	17025	.	.	O	_	_
D	1
3
0	2	prep_in
3	0	nsubj
3	4	dobj
4	7	prep_via
4	10	rcmod
4	12	rcmod
7	6	nn
10	8	nsubj
10	9	aux
10	12	conj_and
10	13	dobj
10	15	xcomp
12	8	nsubj
15	14	aux
15	16	dobj
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	0	0	3	2	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	in	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	turn	2	2	3	0	VP	0	3	17	2	VBZ	0	3	4	1	activates	3	3	4	0	NP	0	4	17	3	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	via	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	MAPK	6	6	7	0	NN	0	7	8	1	phosphorylation	7	7	8	0	SBAR	1	8	17	2	WHNP	0	8	9	1	WDT	0	8	9	1	which	8	8	9	0	S	0	9	17	1	VP	1	9	17	2	MD	0	9	10	1	will	9	9	10	0	VP	0	10	17	5	VB	0	10	11	1	translocate	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VB	0	12	13	1	activate	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	p53	13	13	14	0	S	0	14	17	1	VP	1	14	17	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	17	2	VB	0	15	16	1	promote	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	apoptosis	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	19
ASPP2	17026	17031	NN	aspp2	B-GENE	_	_
will	17032	17036	MD	will	O	_	_
also	17037	17041	RB	also	O	_	_
continue	17042	17050	VB	continue	O	_	_
to	17051	17053	TO	to	O	_	_
bind	17054	17058	VB	bind	O	_	_
active	17059	17065	JJ	active	O	_	_
RAS	17066	17069	NN	ra	O	_	_
,	17069	17070	,	,	O	_	_
thereby	17071	17078	RB	thereby	O	_	_
propagating	17079	17090	VBG	propagate	O	_	_
the	17091	17094	DT	the	O	_	_
pro-apoptotic	17095	17108	JJ	pro-apoptotic	O	_	_
signal	17109	17115	NN	signal	O	_	_
from	17116	17120	IN	from	O	_	_
RAS	17121	17124	NN	ra	O	_	_
to	17125	17127	TO	to	O	_	_
p53	17128	17131	NN	p53	B-GENE	_	_
.	17131	17132	.	.	O	_	_
D	1
3
3	0	nsubj
3	1	aux
3	2	advmod
3	5	xcomp
5	4	aux
5	7	dobj
5	10	vmod
7	6	amod
10	9	advmod
10	13	dobj
10	15	prep_from
10	17	prep_to
13	11	det
13	12	amod
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	2	1	18	3	MD	0	1	2	1	will	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	also	2	2	3	0	VP	0	3	18	2	VB	0	3	4	1	continue	3	3	4	0	S	0	4	18	1	VP	1	4	18	2	TO	0	4	5	1	to	4	4	5	0	VP	0	5	18	4	VB	0	5	6	1	bind	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	active	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	,	0	8	9	1	,	8	8	9	0	S	1	9	18	2	ADVP	0	9	10	1	RB	0	9	10	1	thereby	9	9	10	0	VP	0	10	18	4	VBG	0	10	11	1	propagating	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	JJ	0	12	13	1	pro-apoptotic	12	12	13	0	NN	0	13	14	1	signal	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	from	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	RAS	15	15	16	0	PP	0	16	18	2	TO	0	16	17	1	to	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	p53	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	43
If	17133	17135	IN	if	O	_	_
RAS	17136	17139	NN	ra	O	_	_
is	17140	17142	VBZ	be	O	_	_
only	17143	17147	RB	only	O	_	_
temporarily	17148	17159	RB	temporarily	O	_	_
active	17160	17166	JJ	active	O	_	_
,	17166	17167	,	,	O	_	_
as	17168	17170	IN	as	O	_	_
happens	17171	17178	VBZ	happen	O	_	_
in	17179	17181	IN	in	O	_	_
natural	17182	17189	JJ	natural	O	_	_
growth	17190	17196	NN	growth	O	_	_
conditions	17197	17207	NNS	condition	O	_	_
,	17207	17208	,	,	O	_	_
one	17209	17212	CD	one	O	_	_
could	17213	17218	MD	could	O	_	_
hypothesize	17219	17230	VB	hypothesize	O	_	_
that	17231	17235	IN	that	O	_	_
ASPP2	17236	17241	NN	aspp2	B-GENE	_	_
would	17242	17247	MD	would	O	_	_
bind	17248	17252	VB	bind	O	_	_
active	17253	17259	JJ	active	O	_	_
RAS	17260	17263	NN	ra	O	_	_
,	17263	17264	,	,	O	_	_
potentiate	17265	17275	VB	potentiate	O	_	_
its	17276	17279	PRP$	its	O	_	_
downstream	17280	17290	JJ	downstream	O	_	_
pathways	17291	17299	NNS	pathway	O	_	_
,	17299	17300	,	,	O	_	_
and	17301	17304	CC	and	O	_	_
MAPK	17305	17309	NN	mapk	B-GENE	_	_
mediated	17310	17318	VBD	mediate	O	_	_
phosphorylation	17319	17334	NN	phosphorylation	O	_	_
of	17335	17337	IN	of	O	_	_
ASPP2	17338	17343	NN	aspp2	B-GENE	_	_
would	17344	17349	MD	would	O	_	_
lead	17350	17354	VB	lead	O	_	_
to	17355	17357	TO	to	O	_	_
increased	17358	17367	VBN	increase	O	_	_
binding	17368	17375	NN	binding	O	_	_
to	17376	17378	TO	to	O	_	_
p53	17379	17382	NN	p53	B-GENE	_	_
.	17382	17383	.	.	O	_	_
D	1
16
5	0	mark
5	1	nsubj
5	2	cop
5	3	advmod
5	4	advmod
5	8	advcl
8	7	mark
8	12	prep_in
12	10	amod
12	11	nn
16	5	advcl
16	14	nsubj
16	15	aux
16	20	ccomp
16	31	conj_and
20	17	mark
20	18	nsubj
20	19	aux
20	22	dobj
20	24	dep
22	21	amod
24	27	dobj
27	25	poss
27	26	amod
31	30	nsubj
31	36	ccomp
32	34	prep_of
36	32	nsubj
36	35	aux
36	39	prep_to
39	38	amod
39	41	prep_to
EOX
Y	1
ROOT	0	0	43	1	S	0	0	43	5	S	3	0	28	4	SBAR	1	0	13	2	IN	0	0	1	1	If	0	0	1	0	S	1	1	13	2	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	2	2	13	5	VBZ	0	2	3	1	is	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	only	3	3	4	0	ADJP	1	4	6	2	RB	0	4	5	1	temporarily	4	4	5	0	JJ	0	5	6	1	active	5	5	6	0	,	0	6	7	1	,	6	6	7	0	SBAR	1	7	13	2	IN	0	7	8	1	as	7	7	8	0	S	0	8	13	1	VP	0	8	13	2	VBZ	0	8	9	1	happens	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	in	9	9	10	0	NP	2	10	13	3	JJ	0	10	11	1	natural	10	10	11	0	NN	0	11	12	1	growth	11	11	12	0	NNS	0	12	13	1	conditions	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	15	1	CD	0	14	15	1	one	14	14	15	0	VP	1	15	28	2	MD	0	15	16	1	could	15	15	16	0	VP	0	16	28	2	VB	0	16	17	1	hypothesize	16	16	17	0	SBAR	1	17	28	2	IN	0	17	18	1	that	17	17	18	0	S	1	18	28	2	NP	0	18	19	1	NN	0	18	19	1	ASPP2	18	18	19	0	VP	1	19	28	4	MD	0	19	20	1	would	19	19	20	0	VP	0	20	23	2	VB	0	20	21	1	bind	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	active	21	21	22	0	NN	0	22	23	1	RAS	22	22	23	0	,	0	23	24	1	,	23	23	24	0	VP	0	24	28	2	VB	0	24	25	1	potentiate	24	24	25	0	NP	2	25	28	3	PRP$	0	25	26	1	its	25	25	26	0	JJ	0	26	27	1	downstream	26	26	27	0	NNS	0	27	28	1	pathways	27	27	28	0	,	0	28	29	1	,	28	28	29	0	CC	0	29	30	1	and	29	29	30	0	S	1	30	42	2	NP	0	30	31	1	NN	0	30	31	1	MAPK	30	30	31	0	VP	0	31	42	2	VBD	0	31	32	1	mediated	31	31	32	0	SBAR	0	32	42	1	S	1	32	42	2	NP	0	32	35	2	NP	0	32	33	1	NN	0	32	33	1	phosphorylation	32	32	33	0	PP	0	33	35	2	IN	0	33	34	1	of	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	ASPP2	34	34	35	0	VP	1	35	42	2	MD	0	35	36	1	would	35	35	36	0	VP	0	36	42	2	VB	0	36	37	1	lead	36	36	37	0	PP	0	37	42	2	TO	0	37	38	1	to	37	37	38	0	NP	0	38	42	2	NP	1	38	40	2	VBN	0	38	39	1	increased	38	38	39	0	NN	0	39	40	1	binding	39	39	40	0	PP	0	40	42	2	TO	0	40	41	1	to	40	40	41	0	NP	0	41	42	1	NN	0	41	42	1	p53	41	41	42	0	.	0	42	43	1	.	42	42	43	0
EOS
T	31
However	17384	17391	RB	however	O	_	_
,	17391	17392	,	,	O	_	_
once	17393	17397	RB	once	O	_	_
RAS	17398	17401	NNP	RAS	B-GENE	_	_
reverts	17402	17409	VBZ	revert	O	_	_
to	17410	17412	TO	to	O	_	_
its	17413	17416	PRP$	its	O	_	_
inactive	17417	17425	JJ	inactive	O	_	_
state	17426	17431	NN	state	O	_	_
,	17431	17432	,	,	O	_	_
it	17433	17435	PRP	it	O	_	_
would	17436	17441	MD	would	O	_	_
be	17442	17444	VB	be	O	_	_
unable	17445	17451	JJ	unable	O	_	_
to	17452	17454	TO	to	O	_	_
bind	17455	17459	VB	bind	O	_	_
to	17460	17462	TO	to	O	_	_
ASPP2	17463	17468	NN	aspp2	B-GENE	_	_
and	17469	17472	CC	and	O	_	_
would	17473	17478	MD	would	O	_	_
therefore	17479	17488	RB	therefore	O	_	_
be	17489	17491	VB	be	O	_	_
unable	17492	17498	JJ	unable	O	_	_
to	17499	17501	TO	to	O	_	_
amplify	17502	17509	VB	amplify	O	_	_
the	17510	17513	DT	the	O	_	_
RAS	17514	17517	NN	ra	O	_	_
signal	17518	17524	NN	signal	O	_	_
to	17525	17527	TO	to	O	_	_
p53	17528	17531	NN	p53	B-GENE	_	_
.	17531	17532	.	.	O	_	_
D	1
13
4	2	advmod
4	3	nsubj
4	8	prep_to
8	6	poss
8	7	amod
13	0	advmod
13	4	advcl
13	10	nsubj
13	11	aux
13	12	cop
13	15	xcomp
13	22	conj_and
15	14	aux
15	17	prep_to
22	10	nsubj
22	19	aux
22	20	advmod
22	21	cop
22	24	xcomp
24	23	aux
24	27	dobj
24	29	prep_to
27	25	det
27	26	nn
EOX
Y	1
ROOT	0	0	31	1	S	5	0	31	7	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	SBAR	1	2	9	2	RB	0	2	3	1	once	2	2	3	0	S	1	3	9	2	NP	0	3	4	1	NNP	0	3	4	1	RAS	3	3	4	0	VP	0	4	9	2	VBZ	0	4	5	1	reverts	4	4	5	0	PP	0	5	9	2	TO	0	5	6	1	to	5	5	6	0	NP	2	6	9	3	PRP$	0	6	7	1	its	6	6	7	0	JJ	0	7	8	1	inactive	7	7	8	0	NN	0	8	9	1	state	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	PRP	0	10	11	1	it	10	10	11	0	VP	0	11	30	3	VP	1	11	18	2	MD	0	11	12	1	would	11	11	12	0	VP	1	12	18	2	VB	0	12	13	1	be	12	12	13	0	ADJP	0	13	18	2	JJ	0	13	14	1	unable	13	13	14	0	S	0	14	18	1	VP	1	14	18	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	18	2	VB	0	15	16	1	bind	15	15	16	0	PP	0	16	18	2	TO	0	16	17	1	to	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	VP	2	19	30	3	MD	0	19	20	1	would	19	19	20	0	ADVP	0	20	21	1	RB	0	20	21	1	therefore	20	20	21	0	VP	1	21	30	2	VB	0	21	22	1	be	21	21	22	0	ADJP	0	22	30	2	JJ	0	22	23	1	unable	22	22	23	0	S	0	23	30	1	VP	1	23	30	2	TO	0	23	24	1	to	23	23	24	0	VP	0	24	30	3	VB	0	24	25	1	amplify	24	24	25	0	NP	2	25	28	3	DT	0	25	26	1	the	25	25	26	0	NN	0	26	27	1	RAS	26	26	27	0	NN	0	27	28	1	signal	27	27	28	0	PP	0	28	30	2	TO	0	28	29	1	to	28	28	29	0	NP	0	29	30	1	NN	0	29	30	1	p53	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	27
Only	17533	17537	RB	only	O	_	_
in	17538	17540	IN	in	O	_	_
conditions	17541	17551	NNS	condition	O	_	_
where	17552	17557	WRB	where	O	_	_
RAS	17558	17561	NN	ra	O	_	_
is	17562	17564	VBZ	be	O	_	_
constitutively	17565	17579	RB	constitutively	O	_	_
active	17580	17586	JJ	active	O	_	_
would	17587	17592	MD	would	O	_	_
the	17593	17596	DT	the	O	_	_
ASPP2	17597	17602	NN	aspp2	O	_	_
feedback	17603	17611	NN	feedback	O	_	_
loop	17612	17616	NN	loop	O	_	_
reach	17617	17622	VBP	reach	O	_	_
a	17623	17624	DT	a	O	_	_
threshold	17625	17634	NN	threshold	O	_	_
of	17635	17637	IN	of	O	_	_
signaling	17638	17647	VBG	signal	O	_	_
high	17648	17652	JJ	high	O	_	_
enough	17653	17659	JJ	enough	O	_	_
to	17660	17662	TO	to	O	_	_
result	17663	17669	VB	result	O	_	_
in	17670	17672	IN	in	O	_	_
p53	17673	17676	NN	p53	B-GENE	_	_
dependent	17677	17686	JJ	dependent	O	_	_
apoptosis	17687	17696	NN	apoptosis	O	_	_
.	17696	17697	.	.	O	_	_
D	1
13
0	2	prep_in
2	7	rcmod
7	3	advmod
7	4	nsubj
7	5	cop
7	6	advmod
7	8	ccomp
12	9	det
12	10	nn
12	11	nn
13	0	advmod
13	12	nsubj
13	19	xcomp
15	14	det
15	17	prepc_of
17	18	acomp
19	15	nsubj
19	21	xcomp
21	20	aux
21	25	prep_in
25	23	nn
25	24	amod
EOX
Y	1
ROOT	0	0	27	1	S	2	0	27	4	ADVP	0	0	9	2	RB	0	0	1	1	Only	0	0	1	0	PP	0	1	9	2	IN	0	1	2	1	in	1	1	2	0	NP	0	2	9	2	NP	0	2	3	1	NNS	0	2	3	1	conditions	2	2	3	0	SBAR	1	3	9	2	WHADVP	0	3	4	1	WRB	0	3	4	1	where	3	3	4	0	S	1	4	9	2	NP	0	4	5	1	NN	0	4	5	1	RAS	4	4	5	0	VP	1	5	9	2	VBZ	0	5	6	1	is	5	5	6	0	ADJP	1	6	9	3	RB	0	6	7	1	constitutively	6	6	7	0	JJ	0	7	8	1	active	7	7	8	0	SBAR	0	8	9	1	S	0	8	9	1	VP	0	8	9	1	MD	0	8	9	1	would	8	8	9	0	NP	3	9	13	4	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	feedback	11	11	12	0	NN	0	12	13	1	loop	12	12	13	0	VP	0	13	26	2	VBP	0	13	14	1	reach	13	13	14	0	S	1	14	26	2	NP	0	14	19	2	NP	1	14	16	2	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	threshold	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	of	16	16	17	0	S	0	17	19	1	VP	0	17	19	2	VBG	0	17	18	1	signaling	17	17	18	0	ADJP	0	18	19	1	JJ	0	18	19	1	high	18	18	19	0	ADJP	0	19	26	2	JJ	0	19	20	1	enough	19	19	20	0	S	0	20	26	1	VP	1	20	26	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	26	2	VB	0	21	22	1	result	21	21	22	0	PP	0	22	26	2	IN	0	22	23	1	in	22	22	23	0	NP	2	23	26	3	NN	0	23	24	1	p53	23	23	24	0	JJ	0	24	25	1	dependent	24	24	25	0	NN	0	25	26	1	apoptosis	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	32
The	17698	17701	DT	the	O	_	_
ability	17702	17709	NN	ability	O	_	_
of	17710	17712	IN	of	O	_	_
oncogenic	17713	17722	JJ	oncogenic	O	_	_
RAS	17723	17726	NN	ra	O	_	_
to	17727	17729	TO	to	O	_	_
stimulate	17730	17739	VB	stimulate	O	_	_
apoptosis	17740	17749	NN	apoptosis	O	_	_
allows	17750	17756	VBZ	allow	O	_	_
the	17757	17760	DT	the	O	_	_
cell	17761	17765	NN	cell	O	_	_
to	17766	17768	TO	to	O	_	_
have	17769	17773	VB	have	O	_	_
a	17774	17775	DT	a	O	_	_
fail-proof	17776	17786	JJ	fail-proof	O	_	_
mechanism	17787	17796	NN	mechanism	O	_	_
:	17796	17797	:	:	O	_	_
mutated	17798	17805	VBN	mutate	O	_	_
RAS	17806	17809	NN	ra	O	_	_
signals	17810	17817	NNS	signal	O	_	_
to	17818	17820	TO	to	O	_	_
p53	17821	17824	NN	p53	B-GENE	_	_
via	17825	17828	IN	via	O	_	_
ASPP2	17829	17834	NN	aspp2	B-GENE	_	_
to	17835	17837	TO	to	O	_	_
induce	17838	17844	VB	induce	O	_	_
apoptosis	17845	17854	NN	apoptosis	O	_	_
instead	17855	17862	RB	instead	O	_	_
of	17863	17865	IN	of	O	_	_
uncontrolled	17866	17878	JJ	uncontrolled	O	_	_
proliferation	17879	17892	NN	proliferation	O	_	_
.	17892	17893	.	.	O	_	_
D	1
8
1	0	det
1	4	prep_of
4	3	amod
4	6	vmod
6	5	aux
6	7	dobj
8	1	nsubj
8	10	dobj
10	9	det
10	12	vmod
12	11	aux
12	15	dobj
15	13	det
15	14	amod
15	17	vmod
17	19	dobj
17	21	prep_to
17	25	xcomp
19	18	nn
21	23	prep_via
25	24	aux
25	26	dobj
26	30	prep_instead_of
30	29	amod
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	NP	0	0	8	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ability	1	1	2	0	PP	0	2	8	2	IN	0	2	3	1	of	2	2	3	0	NP	1	3	8	3	JJ	0	3	4	1	oncogenic	3	3	4	0	NN	0	4	5	1	RAS	4	4	5	0	S	0	5	8	1	VP	1	5	8	2	TO	0	5	6	1	to	5	5	6	0	VP	0	6	8	2	VB	0	6	7	1	stimulate	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	apoptosis	7	7	8	0	VP	0	8	31	2	VBZ	0	8	9	1	allows	8	8	9	0	NP	1	9	31	3	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	cell	10	10	11	0	S	0	11	31	1	VP	1	11	31	2	TO	0	11	12	1	to	11	11	12	0	VP	0	12	31	2	VB	0	12	13	1	have	12	12	13	0	NP	0	13	31	3	NP	2	13	16	3	DT	0	13	14	1	a	13	13	14	0	JJ	0	14	15	1	fail-proof	14	14	15	0	NN	0	15	16	1	mechanism	15	15	16	0	:	0	16	17	1	:	16	16	17	0	VP	0	17	31	4	VBN	0	17	18	1	mutated	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	RAS	18	18	19	0	NNS	0	19	20	1	signals	19	19	20	0	PP	0	20	24	2	TO	0	20	21	1	to	20	20	21	0	NP	0	21	24	2	NP	0	21	22	1	NN	0	21	22	1	p53	21	21	22	0	PP	0	22	24	2	IN	0	22	23	1	via	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	S	0	24	31	1	VP	1	24	31	2	TO	0	24	25	1	to	24	24	25	0	VP	0	25	31	2	VB	0	25	26	1	induce	25	25	26	0	NP	0	26	31	2	NP	0	26	27	1	NN	0	26	27	1	apoptosis	26	26	27	0	PP	1	27	31	3	RB	0	27	28	1	instead	27	27	28	0	IN	0	28	29	1	of	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	uncontrolled	29	29	30	0	NN	0	30	31	1	proliferation	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	40
However	17894	17901	RB	however	O	_	_
,	17901	17902	,	,	O	_	_
under	17903	17908	IN	under	O	_	_
normal	17909	17915	JJ	normal	O	_	_
conditions	17916	17926	NNS	condition	O	_	_
,	17926	17927	,	,	O	_	_
growth	17928	17934	NN	growth	O	_	_
factors	17935	17942	NNS	factor	O	_	_
or	17943	17945	CC	or	O	_	_
growth	17946	17952	NN	growth	O	_	_
receptors	17953	17962	NNS	receptor	O	_	_
would	17963	17968	MD	would	O	_	_
only	17969	17973	RB	only	O	_	_
activate	17974	17982	VB	activate	O	_	_
RAS	17983	17986	NN	ra	B-GENE	_	_
for	17987	17990	IN	for	O	_	_
short	17991	17996	JJ	short	O	_	_
periods	17997	18004	NNS	period	O	_	_
of	18005	18007	IN	of	O	_	_
time	18008	18012	NN	time	O	_	_
,	18012	18013	,	,	O	_	_
preventing	18014	18024	VBG	prevent	O	_	_
the	18025	18028	DT	the	O	_	_
amplification	18029	18042	NN	amplification	O	_	_
of	18043	18045	IN	of	O	_	_
ASPP2	18046	18051	NN	aspp2	B-GENE	_	_
signaling	18052	18061	NN	signaling	O	_	_
to	18062	18064	TO	to	O	_	_
p53	18065	18068	NN	p53	B-GENE	_	_
via	18069	18072	IN	via	O	_	_
the	18073	18076	DT	the	O	_	_
feedback	18077	18085	NN	feedback	O	_	_
loop	18086	18090	NN	loop	O	_	_
,	18090	18091	,	,	O	_	_
thereby	18092	18099	RB	thereby	O	_	_
eliminating	18100	18111	VBG	eliminate	O	_	_
the	18112	18115	DT	the	O	_	_
apoptotic	18116	18125	JJ	apoptotic	O	_	_
stimulus	18126	18134	NN	stimulus	O	_	_
.	18134	18135	.	.	O	_	_
D	1
13
4	3	amod
7	6	nn
7	10	conj_or
10	9	nn
13	0	advmod
13	4	prep_under
13	7	nsubj
13	10	nsubj
13	11	aux
13	12	advmod
13	14	dobj
13	17	prep_for
13	21	vmod
13	35	xcomp
17	16	amod
17	19	prep_of
21	23	dobj
21	28	prep_to
23	22	det
23	26	prep_of
26	25	nn
28	32	prep_via
32	30	det
32	31	nn
35	34	advmod
35	38	dobj
38	36	det
38	37	amod
EOX
Y	1
ROOT	0	0	40	1	S	5	0	40	7	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	under	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	normal	3	3	4	0	NNS	0	4	5	1	conditions	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	11	3	NP	1	6	8	2	NN	0	6	7	1	growth	6	6	7	0	NNS	0	7	8	1	factors	7	7	8	0	CC	0	8	9	1	or	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	growth	9	9	10	0	NNS	0	10	11	1	receptors	10	10	11	0	VP	2	11	39	3	MD	0	11	12	1	would	11	11	12	0	ADVP	0	12	13	1	RB	0	12	13	1	only	12	12	13	0	VP	0	13	39	7	VB	0	13	14	1	activate	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	RAS	14	14	15	0	PP	0	15	20	2	IN	0	15	16	1	for	15	15	16	0	NP	0	16	20	2	NP	1	16	18	2	JJ	0	16	17	1	short	16	16	17	0	NNS	0	17	18	1	periods	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	time	19	19	20	0	,	0	20	21	1	,	20	20	21	0	S	0	21	33	1	VP	0	21	33	3	VBG	0	21	22	1	preventing	21	21	22	0	NP	0	22	27	2	NP	1	22	24	2	DT	0	22	23	1	the	22	22	23	0	NN	0	23	24	1	amplification	23	23	24	0	PP	0	24	27	2	IN	0	24	25	1	of	24	24	25	0	NP	1	25	27	2	NN	0	25	26	1	ASPP2	25	25	26	0	NN	0	26	27	1	signaling	26	26	27	0	PP	0	27	33	2	TO	0	27	28	1	to	27	27	28	0	NP	0	28	33	2	NP	0	28	29	1	NN	0	28	29	1	p53	28	28	29	0	PP	0	29	33	2	IN	0	29	30	1	via	29	29	30	0	NP	2	30	33	3	DT	0	30	31	1	the	30	30	31	0	NN	0	31	32	1	feedback	31	31	32	0	NN	0	32	33	1	loop	32	32	33	0	,	0	33	34	1	,	33	33	34	0	S	1	34	39	2	ADVP	0	34	35	1	RB	0	34	35	1	thereby	34	34	35	0	VP	0	35	39	2	VBG	0	35	36	1	eliminating	35	35	36	0	NP	2	36	39	3	DT	0	36	37	1	the	36	36	37	0	JJ	0	37	38	1	apoptotic	37	37	38	0	NN	0	38	39	1	stimulus	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	39
The	18136	18139	DT	the	O	_	_
novel	18140	18145	JJ	novel	O	_	_
RAS	18146	18149	NN	ra	B-GENE	_	_
/	18149	18150	:	/	I-GENE	_	_
Raf/MAPK	18150	18158	NN	raf/mapk	B-GENE	_	_
/	18158	18159	:	/	B-GENE	_	_
ASPP2	18159	18164	NN	aspp2	I-GENE	_	_
pathway	18165	18172	NN	pathway	O	_	_
is	18173	18175	VBZ	be	O	_	_
thus	18176	18180	RB	thus	O	_	_
involved	18181	18189	VBN	involve	O	_	_
in	18190	18192	IN	in	O	_	_
an	18193	18195	DT	a	O	_	_
important	18196	18205	JJ	important	O	_	_
feedback	18206	18214	NN	feedback	O	_	_
loop	18215	18219	NN	loop	O	_	_
between	18220	18227	IN	between	O	_	_
RAS	18228	18231	NN	ra	B-GENE	_	_
and	18232	18235	CC	and	O	_	_
p53	18236	18239	NN	p53	B-GENE	_	_
,	18239	18240	,	,	O	_	_
and	18241	18244	CC	and	O	_	_
is	18245	18247	VBZ	be	O	_	_
an	18248	18250	DT	a	O	_	_
effective	18251	18260	JJ	effective	O	_	_
way	18261	18264	NN	way	O	_	_
for	18265	18268	IN	for	O	_	_
mutant	18269	18275	JJ	mutant	O	_	_
RAS	18276	18279	NN	ra	O	_	_
to	18280	18282	TO	to	O	_	_
induce	18283	18289	VB	induce	O	_	_
apoptosis	18290	18299	NN	apoptosis	O	_	_
in	18300	18302	IN	in	O	_	_
cancer	18303	18309	NN	cancer	O	_	_
cells	18310	18315	NNS	cell	O	_	_
with	18316	18320	IN	with	O	_	_
wild-type	18321	18330	JJ	wild-type	B-GENE	_	_
p53	18331	18334	NN	p53	I-GENE	_	_
.	18334	18335	.	.	O	_	_
D	1
2
2	0	det
2	1	amod
2	3	punct
2	10	dep
2	25	dep
4	7	dep
7	5	punct
7	6	nn
10	4	nsubjpass
10	8	auxpass
10	9	advmod
10	15	prep_in
10	25	conj_and
15	12	det
15	13	amod
15	14	nn
15	17	prep_between
15	19	prep_between
17	19	conj_and
25	22	cop
25	23	det
25	24	amod
25	28	prep_for
25	30	vmod
28	27	amod
30	29	aux
30	31	dobj
30	37	prep_with
31	34	prep_in
34	33	nn
37	36	amod
EOX
Y	1
ROOT	0	0	39	1	FRAG	0	0	39	4	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	novel	1	1	2	0	NN	0	2	3	1	RAS	2	2	3	0	:	0	3	4	1	/	3	3	4	0	S	1	4	38	2	NP	0	4	8	2	NP	0	4	5	1	NN	0	4	5	1	Raf/MAPK	4	4	5	0	PRN	1	5	8	2	:	0	5	6	1	/	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	ASPP2	6	6	7	0	NN	0	7	8	1	pathway	7	7	8	0	VP	0	8	38	4	VP	2	8	20	3	VBZ	0	8	9	1	is	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	thus	9	9	10	0	VP	0	10	20	2	VBN	0	10	11	1	involved	10	10	11	0	PP	0	11	20	2	IN	0	11	12	1	in	11	11	12	0	NP	0	12	20	2	NP	3	12	16	4	DT	0	12	13	1	an	12	12	13	0	JJ	0	13	14	1	important	13	13	14	0	NN	0	14	15	1	feedback	14	14	15	0	NN	0	15	16	1	loop	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	between	16	16	17	0	NP	0	17	20	3	NN	0	17	18	1	RAS	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NN	0	19	20	1	p53	19	19	20	0	,	0	20	21	1	,	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	VP	1	22	38	2	VBZ	0	22	23	1	is	22	22	23	0	NP	0	23	38	3	NP	2	23	26	3	DT	0	23	24	1	an	23	23	24	0	JJ	0	24	25	1	effective	24	24	25	0	NN	0	25	26	1	way	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	for	26	26	27	0	NP	1	27	29	2	JJ	0	27	28	1	mutant	27	27	28	0	NN	0	28	29	1	RAS	28	28	29	0	S	0	29	38	1	VP	1	29	38	2	TO	0	29	30	1	to	29	29	30	0	VP	0	30	38	3	VB	0	30	31	1	induce	30	30	31	0	NP	0	31	35	2	NP	0	31	32	1	NN	0	31	32	1	apoptosis	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	in	32	32	33	0	NP	1	33	35	2	NN	0	33	34	1	cancer	33	33	34	0	NNS	0	34	35	1	cells	34	34	35	0	PP	0	35	38	2	IN	0	35	36	1	with	35	35	36	0	NP	1	36	38	2	JJ	0	36	37	1	wild-type	36	36	37	0	NN	0	37	38	1	p53	37	37	38	0	.	0	38	39	1	.	38	38	39	0
EOS
T	16
Saos2	18338	18343	NN	saos2	O	_	_
cells	18344	18349	NNS	cell	O	_	_
were	18350	18354	VBD	be	O	_	_
obtained	18355	18363	VBN	obtain	O	_	_
from	18364	18368	IN	from	O	_	_
the	18369	18372	DT	the	O	_	_
American	18373	18381	JJ	american	O	_	_
Type	18382	18386	NN	type	O	_	_
Culture	18387	18394	NN	culture	O	_	_
Collection	18395	18405	NN	collection	O	_	_
(	18406	18407	CD	(	O	_	_
Manassas	18407	18415	NNP	Manassas	O	_	_
,	18415	18416	,	,	O	_	_
VA	18417	18419	NNP	VA	O	_	_
)	18419	18420	CD	)	O	_	_
.	18420	18421	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	8	prep_from
3	11	dobj
8	5	det
8	6	amod
8	7	nn
11	9	nn
11	13	appos
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	1	0	2	2	NN	0	0	1	1	Saos2	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	1	2	15	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	15	3	VBN	0	3	4	1	obtained	3	3	4	0	PP	0	4	9	2	IN	0	4	5	1	from	4	4	5	0	NP	3	5	9	4	DT	0	5	6	1	the	5	5	6	0	JJ	0	6	7	1	American	6	6	7	0	NN	0	7	8	1	Type	7	7	8	0	NN	0	8	9	1	Culture	8	8	9	0	NP	0	9	15	3	NP	2	9	12	3	NN	0	9	10	1	Collection	9	9	10	0	CD	0	10	11	1	-LRB-	10	10	11	0	NNP	0	11	12	1	Manassas	11	11	12	0	,	0	12	13	1	,	12	12	13	0	NP	0	13	15	2	NNP	0	13	14	1	VA	13	13	14	0	CD	0	14	15	1	-RRB-	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	16
HKe3	18422	18426	NN	hke3	B-GENE	_	_
ER	18427	18429	NN	er	O	_	_
:	18429	18430	:	:	O	_	_
HRASV12	18430	18437	NN	hrasv12	O	_	_
cells	18438	18443	NNS	cell	O	_	_
were	18444	18448	VBD	be	O	_	_
kindly	18449	18455	RB	kindly	O	_	_
provided	18456	18464	VBN	provide	O	_	_
by	18465	18467	IN	by	O	_	_
Dr	18468	18470	NNP	Dr	O	_	_
Julian	18471	18477	NNP	Julian	O	_	_
Downward	18478	18486	NNP	Downward	O	_	_
[	18487	18488	CD	[	O	_	_
2,10,11	18488	18495	CD	2,10,11	O	_	_
]	18495	18496	NN	]	O	_	_
.	18496	18497	.	.	O	_	_
D	1
1
1	0	nn
1	7	dep
4	3	nn
7	4	nsubjpass
7	5	auxpass
7	6	advmod
7	11	agent
7	14	dep
11	9	nn
11	10	nn
13	12	number
14	13	num
EOX
Y	1
ROOT	0	0	16	1	FRAG	0	0	16	4	NP	1	0	2	2	NN	0	0	1	1	HKe3	0	0	1	0	NN	0	1	2	1	ER	1	1	2	0	:	0	2	3	1	:	2	2	3	0	S	1	3	15	2	NP	1	3	5	2	NN	0	3	4	1	HRASV12	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	2	5	15	3	VBD	0	5	6	1	were	5	5	6	0	ADVP	0	6	7	1	RB	0	6	7	1	kindly	6	6	7	0	VP	0	7	15	2	VBN	0	7	8	1	provided	7	7	8	0	PP	0	8	15	3	IN	0	8	9	1	by	8	8	9	0	NP	2	9	12	3	NNP	0	9	10	1	Dr	9	9	10	0	NNP	0	10	11	1	Julian	10	10	11	0	NNP	0	11	12	1	Downward	11	11	12	0	NP	1	12	15	2	QP	1	12	14	2	CD	0	12	13	1	[	12	12	13	0	CD	0	13	14	1	2,10,11	13	13	14	0	NN	0	14	15	1	]	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	29
Cells	18498	18503	NNS	cell	O	_	_
were	18504	18508	VBD	be	O	_	_
cultured	18509	18517	VBN	culture	O	_	_
in	18518	18520	IN	in	O	_	_
DMEM	18521	18525	NNP	DMEM	O	_	_
supplemented	18526	18538	VBN	supplement	O	_	_
with	18539	18543	IN	with	O	_	_
10	18544	18546	CD	10	O	_	_
%	18546	18547	NN	%	O	_	_
fetal	18548	18553	JJ	fetal	O	_	_
bovine	18554	18560	JJ	bovine	O	_	_
serum	18561	18566	NN	serum	O	_	_
(	18567	18568	CD	(	O	_	_
FBS	18568	18571	NN	fb	O	_	_
)	18571	18572	NN	)	O	_	_
and	18573	18576	CC	and	O	_	_
penicillin	18577	18587	NN	penicillin	O	_	_
streptomycin	18588	18600	NN	streptomycin	O	_	_
(	18601	18602	CD	(	O	_	_
Gibco-BRL	18602	18611	NNP	Gibco-BRL	O	_	_
,	18611	18612	,	,	O	_	_
Invitrogen	18613	18623	NNP	Invitrogen	O	_	_
Ltd	18624	18627	NNP	Ltd	O	_	_
,	18627	18628	,	,	O	_	_
Paisley	18629	18636	NNP	Paisley	O	_	_
,	18636	18637	,	,	O	_	_
UK	18638	18640	NNP	UK	O	_	_
)	18640	18641	CD	)	O	_	_
.	18641	18642	.	.	O	_	_
D	1

2	0	nsubjpass
2	1	auxpass
2	4	prep_in
4	5	vmod
5	11	prep_with
5	16	prep_with
8	7	number
11	8	amod
11	9	amod
11	10	amod
11	16	conj_and
14	13	nn
16	19	dep
19	17	nn
19	26	appos
26	21	nn
26	22	nn
26	24	appos
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	28	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	28	2	VBN	0	2	3	1	cultured	2	2	3	0	PP	0	3	28	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	28	2	NP	0	4	5	1	NNP	0	4	5	1	DMEM	4	4	5	0	VP	0	5	28	2	VBN	0	5	6	1	supplemented	5	5	6	0	PP	0	6	28	2	IN	0	6	7	1	with	6	6	7	0	NP	0	7	28	3	NP	0	7	15	2	NP	3	7	12	4	ADJP	1	7	9	2	CD	0	7	8	1	10	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	JJ	0	9	10	1	fetal	9	9	10	0	JJ	0	10	11	1	bovine	10	10	11	0	NN	0	11	12	1	serum	11	11	12	0	NP	2	12	15	3	CD	0	12	13	1	-LRB-	12	12	13	0	NN	0	13	14	1	FBS	13	13	14	0	NN	0	14	15	1	-RRB-	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NP	0	16	28	2	NP	0	16	17	1	NN	0	16	17	1	penicillin	16	16	17	0	NP	0	17	28	3	NP	2	17	20	3	NN	0	17	18	1	streptomycin	17	17	18	0	CD	0	18	19	1	-LRB-	18	18	19	0	NNP	0	19	20	1	Gibco-BRL	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	5	21	28	7	NNP	0	21	22	1	Invitrogen	21	21	22	0	NNP	0	22	23	1	Ltd	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NNP	0	24	25	1	Paisley	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NNP	0	26	27	1	UK	26	26	27	0	CD	0	27	28	1	-RRB-	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	42
For	18643	18646	IN	for	O	_	_
growth	18647	18653	NN	growth	O	_	_
factor	18654	18660	NN	factor	O	_	_
stimulation	18661	18672	NN	stimulation	O	_	_
,	18672	18673	,	,	O	_	_
cells	18674	18679	NNS	cell	O	_	_
were	18680	18684	VBD	be	O	_	_
serum	18685	18690	NN	serum	O	_	_
starved	18691	18698	VBN	starve	O	_	_
for	18699	18702	IN	for	O	_	_
indicated	18703	18712	JJ	indicated	O	_	_
time	18713	18717	NN	time	O	_	_
,	18717	18718	,	,	O	_	_
followed	18719	18727	VBN	follow	O	_	_
by	18728	18730	IN	by	O	_	_
stimulation	18731	18742	NN	stimulation	O	_	_
with	18743	18747	IN	with	O	_	_
20	18748	18750	CD	20	O	_	_
%	18750	18751	NN	%	O	_	_
serum	18752	18757	NN	serum	O	_	_
plus	18758	18762	CC	plus	O	_	_
epidermal	18763	18772	JJ	epidermal	B-GENE	_	_
growth	18773	18779	NN	growth	I-GENE	_	_
factor	18780	18786	NN	factor	I-GENE	_	_
(	18787	18788	CD	(	B-GENE	_	_
EGF	18788	18791	NN	egf	I-GENE	_	_
)	18791	18792	NN	)	O	_	_
,	18792	18793	,	,	O	_	_
EGF	18794	18797	NN	egf	B-GENE	_	_
alone	18798	18803	RB	alone	O	_	_
or	18804	18806	CC	or	O	_	_
insulin	18807	18814	NN	insulin	B-GENE	_	_
(	18815	18816	CD	(	O	_	_
Sigma	18816	18821	NNP	Sigma	O	_	_
,	18821	18822	,	,	O	_	_
Dorset	18823	18829	NNP	Dorset	O	_	_
,	18829	18830	,	,	O	_	_
UK	18831	18833	NNP	UK	O	_	_
)	18833	18834	CD	)	O	_	_
as	18835	18837	IN	as	O	_	_
indicated	18838	18847	VBN	indicate	O	_	_
.	18847	18848	.	.	O	_	_
D	1
7
3	1	nn
3	2	nn
7	3	prep_for
7	5	nsubj
7	6	cop
7	8	vmod
8	11	prep_for
11	10	amod
11	13	vmod
13	15	agent
13	37	dobj
15	19	prep_with
18	17	number
19	18	amod
19	20	prep
26	21	amod
26	22	nn
26	23	nn
26	25	nn
26	28	conj_or
26	31	conj_or
28	29	advmod
37	33	nn
37	35	appos
37	40	prep_as
EOX
Y	1
ROOT	0	0	42	1	S	3	0	42	5	PP	0	0	4	2	IN	0	0	1	1	For	0	0	1	0	NP	2	1	4	3	NN	0	1	2	1	growth	1	1	2	0	NN	0	2	3	1	factor	2	2	3	0	NN	0	3	4	1	stimulation	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	6	1	NNS	0	5	6	1	cells	5	5	6	0	VP	1	6	41	2	VBD	0	6	7	1	were	6	6	7	0	NP	0	7	41	2	NP	0	7	8	1	NN	0	7	8	1	serum	7	7	8	0	VP	0	8	41	2	VBN	0	8	9	1	starved	8	8	9	0	PP	0	9	41	2	IN	0	9	10	1	for	9	9	10	0	NP	0	10	41	3	NP	1	10	12	2	JJ	0	10	11	1	indicated	10	10	11	0	NN	0	11	12	1	time	11	11	12	0	,	0	12	13	1	,	12	12	13	0	VP	0	13	41	3	VBN	0	13	14	1	followed	13	13	14	0	PP	0	14	33	2	IN	0	14	15	1	by	14	14	15	0	NP	0	15	33	2	NP	0	15	16	1	NN	0	15	16	1	stimulation	15	15	16	0	PP	0	16	33	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	33	2	NP	1	17	20	2	ADJP	1	17	19	2	CD	0	17	18	1	20	17	17	18	0	NN	0	18	19	1	%	18	18	19	0	NN	0	19	20	1	serum	19	19	20	0	PP	0	20	33	2	CC	0	20	21	1	plus	20	20	21	0	NP	0	21	33	5	NP	5	21	27	6	JJ	0	21	22	1	epidermal	21	21	22	0	NN	0	22	23	1	growth	22	22	23	0	NN	0	23	24	1	factor	23	23	24	0	CD	0	24	25	1	-LRB-	24	24	25	0	NN	0	25	26	1	EGF	25	25	26	0	NN	0	26	27	1	-RRB-	26	26	27	0	,	0	27	28	1	,	27	27	28	0	NP	0	28	30	2	NN	0	28	29	1	EGF	28	28	29	0	RB	0	29	30	1	alone	29	29	30	0	CC	0	30	31	1	or	30	30	31	0	NP	0	31	33	2	NN	0	31	32	1	insulin	31	31	32	0	CD	0	32	33	1	-LRB-	32	32	33	0	NP	0	33	41	2	NP	4	33	39	6	NNP	0	33	34	1	Sigma	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NNP	0	35	36	1	Dorset	35	35	36	0	,	0	36	37	1	,	36	36	37	0	NNP	0	37	38	1	UK	37	37	38	0	CD	0	38	39	1	-RRB-	38	38	39	0	PP	0	39	41	2	IN	0	39	40	1	as	39	39	40	0	NP	0	40	41	1	VBN	0	40	41	1	indicated	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	13
Full-length	18849	18860	JJ	full-length	O	_	_
ASPP2	18861	18866	NN	aspp2	O	_	_
and	18867	18870	CC	and	O	_	_
ASPP2	18871	18876	NN	aspp2	O	_	_
(	18877	18878	CD	(	O	_	_
693-1128	18878	18886	CD	693-1128	O	_	_
)	18886	18887	NN	)	O	_	_
was	18888	18891	VBD	be	O	_	_
tagged	18892	18898	VBN	tag	O	_	_
with	18899	18903	IN	with	O	_	_
the	18904	18907	DT	the	O	_	_
V5-epitope	18908	18918	NN	v5-epitope	O	_	_
.	18918	18919	.	.	O	_	_
D	1
8
1	0	amod
1	3	conj_and
6	5	dep
8	1	nsubjpass
8	3	nsubjpass
8	7	auxpass
8	11	prep_with
11	10	det
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	7	2	NP	1	0	4	4	JJ	0	0	1	1	Full-length	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	ASPP2	3	3	4	0	ADJP	1	4	7	2	QP	1	4	6	2	CD	0	4	5	1	-LRB-	4	4	5	0	CD	0	5	6	1	693-1128	5	5	6	0	NN	0	6	7	1	-RRB-	6	6	7	0	VP	1	7	12	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	12	2	VBN	0	8	9	1	tagged	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	with	9	9	10	0	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	V5-epitope	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	13
HRASV12	18920	18927	NN	hrasv12	O	_	_
and	18928	18931	CC	and	O	_	_
KRASV12	18932	18939	NN	krasv12	O	_	_
were	18940	18944	VBD	be	O	_	_
tagged	18945	18951	VBN	tag	O	_	_
with	18952	18956	IN	with	O	_	_
the	18957	18960	DT	the	O	_	_
haemagglutinin	18961	18975	NN	haemagglutinin	B-GENE	_	_
(	18976	18977	CD	(	I-GENE	_	_
HA	18977	18979	NNP	HA	I-GENE	_	_
)	18979	18980	CD	)	I-GENE	_	_
epitope	18981	18988	NN	epitope	I-GENE	_	_
.	18988	18989	.	.	O	_	_
D	1
4
0	2	conj_and
4	0	nsubjpass
4	2	nsubjpass
4	3	auxpass
4	7	prep_with
4	11	xcomp
7	6	det
11	9	nn
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	3	3	NN	0	0	1	1	HRASV12	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NN	0	2	3	1	KRASV12	2	2	3	0	VP	1	3	12	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	12	3	VBN	0	4	5	1	tagged	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	with	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	haemagglutinin	7	7	8	0	S	0	8	12	1	NP	3	8	12	4	CD	0	8	9	1	-LRB-	8	8	9	0	NNP	0	9	10	1	HA	9	9	10	0	CD	0	10	11	1	-RRB-	10	10	11	0	NN	0	11	12	1	epitope	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	33
All	18990	18993	DT	all	O	_	_
expression	18994	19004	NN	expression	O	_	_
plasmids	19005	19013	NNS	plasmid	O	_	_
used	19014	19018	VBN	use	O	_	_
in	19019	19021	IN	in	O	_	_
this	19022	19026	DT	this	O	_	_
study	19027	19032	NN	study	O	_	_
were	19033	19037	VBD	be	O	_	_
driven	19038	19044	VBN	drive	O	_	_
by	19045	19047	IN	by	O	_	_
the	19048	19051	DT	the	O	_	_
cytomegalovirus	19052	19067	NN	cytomegalovirus	B-GENE	_	_
immediate-early	19068	19083	JJ	immediate-early	I-GENE	_	_
promoter	19084	19092	NN	promoter	I-GENE	_	_
,	19092	19093	,	,	O	_	_
with	19094	19098	IN	with	O	_	_
the	19099	19102	DT	the	O	_	_
exception	19103	19112	NN	exception	O	_	_
of	19113	19115	IN	of	O	_	_
the	19116	19119	DT	the	O	_	_
RAS	19120	19123	NN	ra	B-GENE	_	_
and	19124	19127	CC	and	O	_	_
Raf	19128	19131	NN	raf	B-GENE	_	_
CAAX	19132	19136	NN	caax	I-GENE	_	_
plasmids	19137	19145	NNS	plasmid	O	_	_
which	19146	19151	WDT	which	O	_	_
were	19152	19156	VBD	be	O	_	_
driven	19157	19163	VBN	drive	O	_	_
by	19164	19166	IN	by	O	_	_
the	19167	19170	DT	the	O	_	_
EF1a	19171	19175	NN	ef1a	B-GENE	_	_
promoter	19176	19184	NN	promoter	I-GENE	_	_
.	19184	19185	.	.	O	_	_
D	1
8
2	0	det
2	1	nn
2	3	vmod
3	6	prep_in
6	5	det
8	2	nsubjpass
8	7	auxpass
8	13	agent
8	17	prep_with
13	10	det
13	11	nn
13	12	amod
17	16	det
17	20	prep_of
17	24	prep_of
17	27	rcmod
20	19	det
20	24	conj_and
24	22	nn
24	23	nn
27	25	nsubjpass
27	26	auxpass
27	31	agent
31	29	det
31	30	nn
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	7	2	NP	2	0	3	3	DT	0	0	1	1	All	0	0	1	0	NN	0	1	2	1	expression	1	1	2	0	NNS	0	2	3	1	plasmids	2	2	3	0	VP	0	3	7	2	VBN	0	3	4	1	used	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	in	4	4	5	0	NP	1	5	7	2	DT	0	5	6	1	this	5	5	6	0	NN	0	6	7	1	study	6	6	7	0	VP	1	7	32	2	VBD	0	7	8	1	were	7	7	8	0	VP	0	8	32	4	VBN	0	8	9	1	driven	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	by	9	9	10	0	NP	3	10	14	4	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	cytomegalovirus	11	11	12	0	JJ	0	12	13	1	immediate-early	12	12	13	0	NN	0	13	14	1	promoter	13	13	14	0	,	0	14	15	1	,	14	14	15	0	PP	0	15	32	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	32	3	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	exception	17	17	18	0	PP	0	18	25	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	25	3	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	RAS	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	NP	2	22	25	3	NN	0	22	23	1	Raf	22	22	23	0	NN	0	23	24	1	CAAX	23	23	24	0	NNS	0	24	25	1	plasmids	24	24	25	0	SBAR	1	25	32	2	WHNP	0	25	26	1	WDT	0	25	26	1	which	25	25	26	0	S	0	26	32	1	VP	1	26	32	2	VBD	0	26	27	1	were	26	26	27	0	VP	0	27	32	2	VBN	0	27	28	1	driven	27	27	28	0	PP	0	28	32	2	IN	0	28	29	1	by	28	28	29	0	NP	2	29	32	3	DT	0	29	30	1	the	29	29	30	0	NN	0	30	31	1	EF1a	30	30	31	0	NN	0	31	32	1	promoter	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	16
The	19186	19189	DT	the	O	_	_
ASPP2	19190	19195	NN	aspp2	B-GENE	_	_
mutants	19196	19203	NNS	mutant	I-GENE	_	_
were	19204	19208	VBD	be	O	_	_
constructed	19209	19220	VBN	construct	O	_	_
using	19221	19226	VBG	use	O	_	_
the	19227	19230	DT	the	O	_	_
QuickChange	19231	19242	NNP	QuickChange	O	_	_
Site	19243	19247	NN	site	O	_	_
Directed	19248	19256	NNP	Directed	O	_	_
Mutagenesis	19257	19268	NN	mutagenesis	O	_	_
Kit	19269	19272	NN	kit	O	_	_
(	19273	19274	CD	(	O	_	_
Stratagene	19274	19284	JJ	stratagene	O	_	_
)	19284	19285	NN	)	O	_	_
.	19285	19286	.	.	O	_	_
D	1

2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	5	xcomp
5	11	xcomp
8	6	det
8	7	nn
11	8	nsubj
11	9	nn
11	10	nn
14	13	dep
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	NNS	0	2	3	1	mutants	2	2	3	0	VP	1	3	15	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	15	2	VBN	0	4	5	1	constructed	4	4	5	0	S	0	5	15	1	VP	0	5	15	2	VBG	0	5	6	1	using	5	5	6	0	S	1	6	15	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NNP	0	7	8	1	QuickChange	7	7	8	0	NN	0	8	9	1	Site	8	8	9	0	NP	0	9	15	2	NP	2	9	12	3	NNP	0	9	10	1	Directed	9	9	10	0	NN	0	10	11	1	Mutagenesis	10	10	11	0	NN	0	11	12	1	Kit	11	11	12	0	ADJP	2	12	15	3	CD	0	12	13	1	-LRB-	12	12	13	0	JJ	0	13	14	1	Stratagene	13	13	14	0	NN	0	14	15	1	-RRB-	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	9
siRNA	19287	19292	NN	sirna	O	_	_
oligos	19293	19299	NNS	oligo	O	_	_
against	19300	19307	IN	against	O	_	_
ASPP2	19308	19313	NN	aspp2	O	_	_
were	19314	19318	VBD	be	O	_	_
purchased	19319	19328	VBN	purchase	O	_	_
from	19329	19333	IN	from	O	_	_
Dharmacon	19334	19343	NNP	Dharmacon	O	_	_
.	19343	19344	.	.	O	_	_
D	1
5
1	0	nn
1	3	prep_against
5	1	nsubjpass
5	4	auxpass
5	7	prep_from
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	siRNA	0	0	1	0	NNS	0	1	2	1	oligos	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	against	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	VP	1	4	8	2	VBD	0	4	5	1	were	4	4	5	0	VP	0	5	8	2	VBN	0	5	6	1	purchased	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	from	6	6	7	0	NP	0	7	8	1	NNP	0	7	8	1	Dharmacon	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	9
Sequences	19345	19354	NNS	sequence	O	_	_
are	19355	19358	VBP	be	O	_	_
available	19359	19368	JJ	available	O	_	_
from	19369	19373	IN	from	O	_	_
Dharmacon	19374	19383	NNP	Dharmacon	O	_	_
or	19384	19386	CC	or	O	_	_
upon	19387	19391	IN	upon	O	_	_
request	19392	19399	NN	request	O	_	_
.	19399	19400	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	2	conj_or
2	4	prep_from
2	7	prep_upon
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Sequences	0	0	1	0	VP	1	1	8	2	VBP	0	1	2	1	are	1	1	2	0	ADJP	0	2	8	2	JJ	0	2	3	1	available	2	2	3	0	PP	0	3	8	3	PP	0	3	5	2	IN	0	3	4	1	from	3	3	4	0	NP	0	4	5	1	NNP	0	4	5	1	Dharmacon	4	4	5	0	CC	0	5	6	1	or	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	upon	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	request	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	20
We	19401	19403	PRP	we	O	_	_
used	19404	19408	VBD	use	O	_	_
siGENOME	19409	19417	NN	sigenome	B-GENE	_	_
RISC-Free	19418	19427	JJ	risc-free	I-GENE	_	_
siRNA	19428	19433	NN	sirna	I-GENE	_	_
(	19434	19435	CD	(	O	_	_
Dharmacon	19435	19444	NNP	Dharmacon	O	_	_
,	19444	19445	,	,	O	_	_
Lafayette	19446	19455	NNP	Lafayette	O	_	_
,	19455	19456	,	,	O	_	_
CO	19457	19459	NNP	CO	O	_	_
,	19459	19460	,	,	O	_	_
United	19461	19467	NNP	United	O	_	_
States	19468	19474	NNPS	States	O	_	_
)	19474	19475	RB	)	O	_	_
as	19476	19478	IN	as	O	_	_
a	19479	19480	DT	a	O	_	_
negative	19481	19489	JJ	negative	O	_	_
control	19490	19497	NN	control	O	_	_
.	19497	19498	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	dobj
1	6	dep
1	18	prep_as
2	3	amod
6	4	nn
6	8	appos
6	10	appos
6	13	appos
13	12	nn
18	16	det
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	19	4	VBD	0	1	2	1	used	1	1	2	0	NP	0	2	4	2	NN	0	2	3	1	siGENOME	2	2	3	0	JJ	0	3	4	1	RISC-Free	3	3	4	0	FRAG	0	4	14	1	NP	0	4	14	7	NP	2	4	7	3	NN	0	4	5	1	siRNA	4	4	5	0	CD	0	5	6	1	-LRB-	5	5	6	0	NNP	0	6	7	1	Dharmacon	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	NNP	0	8	9	1	Lafayette	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	CO	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	United	12	12	13	0	NNPS	0	13	14	1	States	13	13	14	0	PP	1	14	19	3	ADVP	0	14	15	1	RB	0	14	15	1	-RRB-	14	14	15	0	IN	0	15	16	1	as	15	15	16	0	NP	2	16	19	3	DT	0	16	17	1	a	16	16	17	0	JJ	0	17	18	1	negative	17	17	18	0	NN	0	18	19	1	control	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	36
Cells	19499	19504	NNS	cell	O	_	_
were	19505	19509	VBD	be	O	_	_
transfected	19510	19521	VBN	transfect	O	_	_
with	19522	19526	IN	with	O	_	_
the	19527	19530	DT	the	O	_	_
indicated	19531	19540	VBN	indicate	O	_	_
siRNA	19541	19546	NN	sirna	O	_	_
oligos	19547	19553	NNS	oligo	O	_	_
at	19554	19556	IN	at	O	_	_
a	19557	19558	DT	a	O	_	_
final	19559	19564	JJ	final	O	_	_
concentration	19565	19578	NN	concentration	O	_	_
of	19579	19581	IN	of	O	_	_
35nM	19582	19586	NN	35nm	O	_	_
using	19587	19592	VBG	use	O	_	_
Dharmafect	19593	19603	NN	dharmafect	O	_	_
1	19604	19605	CD	1	O	_	_
reagent	19606	19613	NN	reagent	O	_	_
(	19614	19615	CD	(	O	_	_
Dharmacon	19615	19624	NNP	Dharmacon	O	_	_
,	19624	19625	,	,	O	_	_
Lafayette	19626	19635	NNP	Lafayette	O	_	_
,	19635	19636	,	,	O	_	_
CO	19637	19639	NNP	CO	O	_	_
,	19639	19640	,	,	O	_	_
United	19641	19647	NNP	United	O	_	_
States	19648	19654	NNPS	States	O	_	_
)	19654	19655	NN	)	O	_	_
,	19655	19656	,	,	O	_	_
according	19657	19666	VBG	accord	O	_	_
to	19667	19669	TO	to	O	_	_
the	19670	19673	DT	the	O	_	_
manufacturer	19674	19686	NN	manufacturer	O	_	_
's	19686	19688	POS	's	O	_	_
instructions	19689	19701	NNS	instruction	O	_	_
.	19701	19702	.	.	O	_	_
D	1

2	0	nsubjpass
2	1	auxpass
2	7	prep_with
2	11	prep_at
2	30	prepc_according_to
2	34	pobj
7	4	det
7	5	amod
7	6	nn
11	9	det
11	10	amod
11	13	prep_of
13	14	vmod
14	17	dobj
17	15	nn
17	16	num
27	19	nn
27	21	appos
27	23	appos
27	25	appos
27	26	nn
32	31	det
34	32	poss
EOX
Y	1
ROOT	0	0	36	1	S	1	0	36	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	35	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	35	5	VBN	0	2	3	1	transfected	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	with	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	VBN	0	5	6	1	indicated	5	5	6	0	NN	0	6	7	1	siRNA	6	6	7	0	NNS	0	7	8	1	oligos	7	7	8	0	PP	0	8	28	2	IN	0	8	9	1	at	8	8	9	0	NP	0	9	28	2	NP	2	9	12	3	DT	0	9	10	1	a	9	9	10	0	JJ	0	10	11	1	final	10	10	11	0	NN	0	11	12	1	concentration	11	11	12	0	PP	0	12	28	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	28	2	NP	0	13	14	1	NN	0	13	14	1	35nM	13	13	14	0	VP	0	14	28	3	VBG	0	14	15	1	using	14	14	15	0	NP	2	15	18	3	NN	0	15	16	1	Dharmafect	15	15	16	0	CD	0	16	17	1	1	16	16	17	0	NN	0	17	18	1	reagent	17	17	18	0	S	0	18	28	1	NP	9	18	28	10	CD	0	18	19	1	-LRB-	18	18	19	0	NNP	0	19	20	1	Dharmacon	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NNP	0	21	22	1	Lafayette	21	21	22	0	,	0	22	23	1	,	22	22	23	0	NNP	0	23	24	1	CO	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NNP	0	25	26	1	United	25	25	26	0	NNPS	0	26	27	1	States	26	26	27	0	NN	0	27	28	1	-RRB-	27	27	28	0	,	0	28	29	1	,	28	28	29	0	PP	0	29	35	2	VBG	0	29	30	1	according	29	29	30	0	PP	0	30	35	2	TO	0	30	31	1	to	30	30	31	0	NP	1	31	35	2	NP	1	31	34	3	DT	0	31	32	1	the	31	31	32	0	NN	0	32	33	1	manufacturer	32	32	33	0	POS	0	33	34	1	's	33	33	34	0	NNS	0	34	35	1	instructions	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	34
Using	19704	19709	VBG	use	O	_	_
the	19710	19713	DT	the	O	_	_
peptide	19714	19721	NN	peptide	O	_	_
CPAPSpPGLDY	19722	19733	NN	cpapsppgldy	O	_	_
(	19734	19735	CD	(	O	_	_
representing	19735	19747	VBG	represent	O	_	_
residues	19748	19756	NNS	residue	O	_	_
824-832	19757	19764	CD	824-832	O	_	_
)	19764	19765	CD	)	O	_	_
with	19766	19770	IN	with	O	_	_
the	19771	19774	DT	the	O	_	_
serine	19775	19781	NN	serine	O	_	_
phosphorylated	19782	19796	VBN	phosphorylate	O	_	_
as	19797	19799	IN	as	O	_	_
an	19800	19802	DT	a	O	_	_
immunogen	19803	19812	NN	immunogen	O	_	_
,	19812	19813	,	,	O	_	_
a	19814	19815	DT	a	O	_	_
rabbit	19816	19822	NN	rabbit	B-GENE	_	_
polyclonal	19823	19833	JJ	polyclonal	I-GENE	_	_
antibody	19834	19842	NN	antibody	I-GENE	_	_
NGH.S4	19843	19849	NN	ngh.s4	I-GENE	_	_
which	19850	19855	WDT	which	O	_	_
specifically	19856	19868	RB	specifically	O	_	_
recognizes	19869	19879	VBZ	recognize	O	_	_
phosphorylated	19880	19894	VBN	phosphorylate	O	_	_
ASPP2	19895	19900	NN	aspp2	B-GENE	_	_
at	19901	19903	IN	at	O	_	_
amino	19904	19909	NN	amino	O	_	_
acid	19910	19914	NN	acid	O	_	_
827	19915	19918	CD	827	O	_	_
was	19919	19922	VBD	be	O	_	_
raised	19923	19929	VBN	raise	O	_	_
.	19929	19930	.	.	O	_	_
D	1
32
0	3	dobj
0	5	vmod
3	1	det
3	2	nn
5	6	dobj
5	11	prep_with
8	7	num
11	10	det
11	12	vmod
12	15	prep_as
15	14	det
21	17	det
21	18	nn
21	19	amod
21	20	nn
21	24	rcmod
24	22	nsubj
24	23	advmod
24	25	dep
25	26	dobj
25	29	prep_at
29	28	nn
29	30	num
32	0	vmod
32	21	nsubjpass
32	31	auxpass
EOX
Y	1
ROOT	0	0	34	1	S	3	0	34	5	S	0	0	16	1	VP	0	0	16	3	VBG	0	0	1	1	Using	0	0	1	0	NP	2	1	5	4	DT	0	1	2	1	the	1	1	2	0	NN	0	2	3	1	peptide	2	2	3	0	NN	0	3	4	1	CPAPSpPGLDY	3	3	4	0	CD	0	4	5	1	-LRB-	4	4	5	0	S	0	5	16	1	VP	0	5	16	3	VBG	0	5	6	1	representing	5	5	6	0	NP	0	6	7	1	NNS	0	6	7	1	residues	6	6	7	0	PP	1	7	16	3	NP	1	7	9	2	CD	0	7	8	1	824-832	7	7	8	0	CD	0	8	9	1	-RRB-	8	8	9	0	IN	0	9	10	1	with	9	9	10	0	NP	0	10	16	2	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	serine	11	11	12	0	VP	0	12	16	2	VBN	0	12	13	1	phosphorylated	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	as	13	13	14	0	NP	1	14	16	2	DT	0	14	15	1	an	14	14	15	0	NN	0	15	16	1	immunogen	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	0	17	31	2	NP	4	17	22	5	DT	0	17	18	1	a	17	17	18	0	NN	0	18	19	1	rabbit	18	18	19	0	JJ	0	19	20	1	polyclonal	19	19	20	0	NN	0	20	21	1	antibody	20	20	21	0	NN	0	21	22	1	NGH.S4	21	21	22	0	SBAR	1	22	31	2	WHNP	0	22	23	1	WDT	0	22	23	1	which	22	22	23	0	S	1	23	31	2	ADVP	0	23	24	1	RB	0	23	24	1	specifically	23	23	24	0	VP	0	24	31	2	VBZ	0	24	25	1	recognizes	24	24	25	0	VP	0	25	31	3	VBN	0	25	26	1	phosphorylated	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	ASPP2	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	at	27	27	28	0	NP	1	28	31	3	NN	0	28	29	1	amino	28	28	29	0	NN	0	29	30	1	acid	29	29	30	0	CD	0	30	31	1	827	30	30	31	0	VP	1	31	33	2	VBD	0	31	32	1	was	31	31	32	0	VP	0	32	33	1	VBN	0	32	33	1	raised	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	24
An	19931	19933	DT	a	O	_	_
affinity	19934	19942	NN	affinity	O	_	_
column	19943	19949	NN	column	O	_	_
was	19950	19953	VBD	be	O	_	_
made	19954	19958	VBN	make	O	_	_
by	19959	19961	IN	by	O	_	_
cross	19962	19967	NN	cross	O	_	_
linking	19968	19975	VBG	link	O	_	_
the	19976	19979	DT	the	O	_	_
phospho-peptide	19980	19995	NN	phospho-peptide	O	_	_
to	19996	19998	TO	to	O	_	_
epoxy-sepharose-6B	19999	20017	NN	epoxy-sepharose-6b	O	_	_
(	20018	20019	CD	(	O	_	_
Amersham	20019	20027	NNP	Amersham	O	_	_
Pharmacia	20028	20037	NNP	Pharmacia	O	_	_
Biotech	20038	20045	NNP	Biotech	O	_	_
)	20045	20046	CD	)	O	_	_
according	20047	20056	VBG	accord	O	_	_
to	20057	20059	TO	to	O	_	_
the	20060	20063	DT	the	O	_	_
manufacturer	20064	20076	NN	manufacturer	O	_	_
's	20076	20078	POS	's	O	_	_
instructions	20079	20091	NNS	instruction	O	_	_
.	20091	20092	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	6	agent
4	7	xcomp
4	18	prepc_according_to
4	22	pobj
7	9	dobj
7	11	prep_to
7	15	dobj
9	8	det
15	13	nn
15	14	nn
20	19	det
22	20	poss
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	2	0	3	3	DT	0	0	1	1	An	0	0	1	0	NN	0	1	2	1	affinity	1	1	2	0	NN	0	2	3	1	column	2	2	3	0	VP	1	3	23	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	23	4	VBN	0	4	5	1	made	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	by	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	cross	6	6	7	0	S	0	7	17	1	VP	0	7	17	4	VBG	0	7	8	1	linking	7	7	8	0	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	phospho-peptide	9	9	10	0	PP	0	10	13	2	TO	0	10	11	1	to	10	10	11	0	NP	0	11	13	2	NN	0	11	12	1	epoxy-sepharose-6B	11	11	12	0	CD	0	12	13	1	-LRB-	12	12	13	0	NP	0	13	17	2	NP	2	13	16	3	NNP	0	13	14	1	Amersham	13	13	14	0	NNP	0	14	15	1	Pharmacia	14	14	15	0	NNP	0	15	16	1	Biotech	15	15	16	0	NP	0	16	17	1	CD	0	16	17	1	-RRB-	16	16	17	0	PP	0	17	23	2	VBG	0	17	18	1	according	17	17	18	0	PP	0	18	23	2	TO	0	18	19	1	to	18	18	19	0	NP	1	19	23	2	NP	1	19	22	3	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	manufacturer	20	20	21	0	POS	0	21	22	1	's	21	21	22	0	NNS	0	22	23	1	instructions	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	40
Serum	20093	20098	NN	serum	O	_	_
from	20099	20103	IN	from	O	_	_
the	20104	20107	DT	the	O	_	_
final	20108	20113	JJ	final	O	_	_
bleed	20114	20119	VB	bleed	O	_	_
was	20120	20123	VBD	be	O	_	_
clarified	20124	20133	VBN	clarify	O	_	_
by	20134	20136	IN	by	O	_	_
centrifugation	20137	20151	NN	centrifugation	O	_	_
and	20152	20155	CC	and	O	_	_
filtration	20156	20166	NN	filtration	O	_	_
through	20167	20174	IN	through	O	_	_
a	20175	20176	DT	a	O	_	_
0.45	20177	20181	CD	0.45	O	_	_
mum	20181	20184	NN	mum	O	_	_
filter	20185	20191	NN	filter	O	_	_
and	20192	20195	CC	and	O	_	_
was	20196	20199	VBD	be	O	_	_
supplemented	20200	20212	VBN	supplement	O	_	_
with	20213	20217	IN	with	O	_	_
1X	20218	20220	NN	1x	O	_	_
TTBS	20221	20225	NN	ttb	O	_	_
(	20226	20227	CD	(	O	_	_
0.5	20227	20230	CD	0.5	O	_	_
M	20231	20232	NN	m	O	_	_
NaCl	20233	20237	NN	nacl	O	_	_
,	20237	20238	,	,	O	_	_
20	20239	20241	CD	20	O	_	_
mM	20242	20244	NN	mm	O	_	_
Tris	20245	20249	NNP	Tris	O	_	_
[	20250	20251	CD	[	O	_	_
pH	20251	20253	NN	ph	O	_	_
8.0	20254	20257	CD	8.0	O	_	_
]	20257	20258	NN	]	O	_	_
,	20258	20259	,	,	O	_	_
0.1	20260	20263	CD	0.1	O	_	_
%	20263	20264	NN	%	O	_	_
Tween-20	20265	20273	NN	tween-20	O	_	_
)	20273	20274	NN	)	O	_	_
.	20274	20275	.	.	O	_	_
D	1

0	3	prep_from
3	2	det
4	0	nsubj
4	6	dep
4	18	dep
6	5	auxpass
6	8	agent
6	10	agent
6	15	prep_through
6	18	conj_and
6	25	dobj
6	33	nsubjpass
8	10	conj_and
15	12	det
15	13	num
15	14	nn
18	17	auxpass
18	21	prep_with
18	33	nsubjpass
21	20	nn
25	23	num
25	24	nn
25	29	appos
29	27	num
29	28	nn
33	30	num
33	31	nn
33	32	num
36	35	number
38	36	amod
38	37	nn
EOX
Y	1
ROOT	0	0	40	1	S	1	0	40	3	NP	0	0	4	2	NP	0	0	1	1	NN	0	0	1	1	Serum	0	0	1	0	PP	0	1	4	2	IN	0	1	2	1	from	1	1	2	0	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	final	3	3	4	0	VP	0	4	39	3	VP	0	4	34	2	VB	0	4	5	1	bleed	4	4	5	0	SBAR	0	5	34	1	SINV	0	5	34	2	VP	1	5	30	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	30	4	VP	0	6	16	3	VBN	0	6	7	1	clarified	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	centrifugation	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	filtration	10	10	11	0	PP	0	11	16	2	IN	0	11	12	1	through	11	11	12	0	NP	3	12	16	4	DT	0	12	13	1	a	12	12	13	0	CD	0	13	14	1	0.45	13	13	14	0	NN	0	14	15	1	mum	14	14	15	0	NN	0	15	16	1	filter	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	VP	1	17	22	2	VBD	0	17	18	1	was	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	supplemented	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	with	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	1X	20	20	21	0	NN	0	21	22	1	TTBS	21	21	22	0	NP	0	22	30	3	NP	2	22	26	3	QP	1	22	24	2	CD	0	22	23	1	-LRB-	22	22	23	0	CD	0	23	24	1	0.5	23	23	24	0	NN	0	24	25	1	M	24	24	25	0	NN	0	25	26	1	NaCl	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	2	27	30	3	CD	0	27	28	1	20	27	27	28	0	NN	0	28	29	1	mM	28	28	29	0	NNP	0	29	30	1	Tris	29	29	30	0	NP	3	30	34	4	CD	0	30	31	1	[	30	30	31	0	NN	0	31	32	1	pH	31	31	32	0	CD	0	32	33	1	8.0	32	32	33	0	NN	0	33	34	1	]	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NP	2	35	39	3	ADJP	1	35	37	2	CD	0	35	36	1	0.1	35	35	36	0	NN	0	36	37	1	%	36	36	37	0	NN	0	37	38	1	Tween-20	37	37	38	0	NN	0	38	39	1	-RRB-	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	20
This	20276	20280	DT	this	O	_	_
was	20281	20284	VBD	be	O	_	_
passed	20285	20291	VBN	pass	O	_	_
over	20292	20296	IN	over	O	_	_
the	20297	20300	DT	the	O	_	_
affinity	20301	20309	NN	affinity	O	_	_
column	20310	20316	NN	column	O	_	_
and	20317	20320	CC	and	O	_	_
washed	20321	20327	VBN	wash	O	_	_
with	20328	20332	IN	with	O	_	_
TTBS	20333	20337	NN	ttb	O	_	_
until	20338	20343	IN	until	O	_	_
the	20344	20347	DT	the	O	_	_
flow-through	20348	20360	JJ	flow-through	O	_	_
had	20361	20364	VBD	have	O	_	_
an	20365	20367	DT	a	O	_	_
OD280nm	20368	20375	NN	od280nm	O	_	_
<	20376	20377	JJR	<	O	_	_
0.01	20377	20381	CD	0.01	O	_	_
.	20381	20382	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_over
2	8	conj_and
2	18	dobj
6	4	det
6	5	nn
8	0	nsubjpass
8	10	prep_with
8	14	advcl
13	12	det
14	11	mark
14	13	nsubj
14	17	dobj
17	15	det
17	16	dep
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	1	1	19	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	19	4	VP	0	2	7	2	VBN	0	2	3	1	passed	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	over	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	affinity	5	5	6	0	NN	0	6	7	1	column	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	VP	0	8	18	3	VBN	0	8	9	1	washed	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	TTBS	10	10	11	0	SBAR	1	11	18	2	IN	0	11	12	1	until	11	11	12	0	S	1	12	18	2	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	flow-through	13	13	14	0	VP	0	14	18	2	VBD	0	14	15	1	had	14	14	15	0	NP	2	15	18	3	DT	0	15	16	1	an	15	15	16	0	NN	0	16	17	1	OD280nm	16	16	17	0	JJR	0	17	18	1	<	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	0.01	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	22
The	20383	20386	DT	the	O	_	_
antibody	20387	20395	NN	antibody	O	_	_
was	20396	20399	VBD	be	O	_	_
then	20400	20404	RB	then	O	_	_
eluted	20405	20411	VBN	elute	O	_	_
with	20412	20416	IN	with	O	_	_
0.2	20417	20420	CD	0.2	O	_	_
M	20420	20421	NN	m	O	_	_
glycine	20422	20429	NN	glycine	O	_	_
(	20430	20431	CD	(	O	_	_
pH	20431	20433	NN	ph	O	_	_
2.8	20434	20437	CD	2.8	O	_	_
)	20437	20438	NN	)	O	_	_
and	20439	20442	CC	and	O	_	_
neutralized	20443	20454	VBD	neutralize	O	_	_
with	20455	20459	IN	with	O	_	_
Tris-HCl	20460	20468	NN	tris-hcl	O	_	_
(	20469	20470	CD	(	O	_	_
pH	20470	20472	NN	ph	O	_	_
8.0	20473	20476	CD	8.0	O	_	_
)	20476	20477	NN	)	O	_	_
.	20477	20478	.	.	O	_	_
D	1

1	0	det
4	1	dep
4	2	auxpass
4	3	advmod
4	8	prep_with
4	14	conj_and
8	6	num
8	7	nn
12	10	nn
12	11	num
14	16	prep_with
20	18	nn
20	19	num
EOX
Y	1
ROOT	0	0	22	1	SINV	0	0	22	4	SINV	1	0	13	3	FRAG	0	0	2	1	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	antibody	1	1	2	0	VP	2	2	9	3	VBD	0	2	3	1	was	2	2	3	0	RB	0	3	4	1	then	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	eluted	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	with	5	5	6	0	NP	2	6	9	3	CD	0	6	7	1	0.2	6	6	7	0	NN	0	7	8	1	M	7	7	8	0	NN	0	8	9	1	glycine	8	8	9	0	NP	3	9	13	4	CD	0	9	10	1	-LRB-	9	9	10	0	NN	0	10	11	1	pH	10	10	11	0	CD	0	11	12	1	2.8	11	11	12	0	NN	0	12	13	1	-RRB-	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	SINV	0	14	21	2	VP	0	14	17	2	VBD	0	14	15	1	neutralized	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	Tris-HCl	16	16	17	0	NP	3	17	21	4	CD	0	17	18	1	-LRB-	17	17	18	0	NN	0	18	19	1	pH	18	18	19	0	CD	0	19	20	1	8.0	19	19	20	0	NN	0	20	21	1	-RRB-	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	33
A	20479	20480	DT	a	O	_	_
second	20481	20487	JJ	second	O	_	_
phospho	20488	20495	NN	phospho	O	_	_
specific	20496	20504	JJ	specific	O	_	_
antibody	20505	20513	NN	antibody	O	_	_
ES1	20514	20517	NN	es1	O	_	_
was	20518	20521	VBD	be	O	_	_
raised	20522	20528	VBN	raise	O	_	_
against	20529	20536	IN	against	O	_	_
the	20537	20540	DT	the	O	_	_
peptide	20541	20548	NN	peptide	O	_	_
SDMPAPS	20549	20556	NNP	SDMPAPS	O	_	_
[	20556	20557	CD	[	O	_	_
P	20557	20558	NN	p	O	_	_
]	20558	20559	CD	]	O	_	_
PGLDYE	20559	20565	NN	pgldye	O	_	_
where	20566	20571	WRB	where	O	_	_
S	20572	20573	NN	s	O	_	_
[	20573	20574	CD	[	O	_	_
P	20574	20575	NN	p	O	_	_
]	20575	20576	NN	]	O	_	_
is	20577	20579	VBZ	be	O	_	_
the	20580	20583	DT	the	O	_	_
phosphorylated	20584	20598	VBN	phosphorylate	O	_	_
serine	20599	20605	NN	serine	O	_	_
827	20606	20609	CD	827	O	_	_
,	20609	20610	,	,	O	_	_
and	20611	20614	CC	and	O	_	_
was	20615	20618	VBD	be	O	_	_
conjugated	20619	20629	VBN	conjugate	O	_	_
to	20630	20632	TO	to	O	_	_
KLH	20633	20636	NNP	KLH	O	_	_
.	20636	20637	.	.	O	_	_
D	1
7
2	0	det
2	1	amod
2	5	dep
5	3	amod
5	4	nn
7	2	nsubjpass
7	6	auxpass
7	11	prep_against
7	15	dobj
7	29	conj_and
11	9	det
11	10	nn
11	12	num
15	13	nn
15	14	num
15	22	rcmod
17	16	advmod
20	18	num
20	19	nn
22	17	dobj
22	20	nsubj
22	21	cop
22	23	vmod
23	24	dobj
24	25	num
29	2	nsubjpass
29	28	auxpass
29	31	prep_to
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	6	2	NP	2	0	3	3	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	second	1	1	2	0	NN	0	2	3	1	phospho	2	2	3	0	NP	2	3	6	3	JJ	0	3	4	1	specific	3	3	4	0	NN	0	4	5	1	antibody	4	4	5	0	NN	0	5	6	1	ES1	5	5	6	0	VP	0	6	32	4	VP	1	6	26	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	26	3	VBN	0	7	8	1	raised	7	7	8	0	PP	0	8	13	2	IN	0	8	9	1	against	8	8	9	0	NP	2	9	13	4	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	peptide	10	10	11	0	NNP	0	11	12	1	SDMPAPS	11	11	12	0	CD	0	12	13	1	[	12	12	13	0	NP	0	13	26	2	NP	2	13	16	3	NN	0	13	14	1	P	13	13	14	0	CD	0	14	15	1	]	14	14	15	0	NN	0	15	16	1	PGLDYE	15	15	16	0	SBAR	1	16	26	2	WHNP	1	16	18	2	WHADVP	0	16	17	1	WRB	0	16	17	1	where	16	16	17	0	NN	0	17	18	1	S	17	17	18	0	S	1	18	26	2	NP	2	18	21	3	CD	0	18	19	1	[	18	18	19	0	NN	0	19	20	1	P	19	19	20	0	NN	0	20	21	1	]	20	20	21	0	VP	1	21	26	2	VBZ	0	21	22	1	is	21	21	22	0	NP	0	22	26	2	NP	0	22	23	1	DT	0	22	23	1	the	22	22	23	0	VP	0	23	26	2	VBN	0	23	24	1	phosphorylated	23	23	24	0	NP	0	24	26	2	NN	0	24	25	1	serine	24	24	25	0	CD	0	25	26	1	827	25	25	26	0	,	0	26	27	1	,	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	VP	1	28	32	2	VBD	0	28	29	1	was	28	28	29	0	VP	0	29	32	2	VBN	0	29	30	1	conjugated	29	29	30	0	PP	0	30	32	2	TO	0	30	31	1	to	30	30	31	0	NP	0	31	32	1	NNP	0	31	32	1	KLH	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	13
The	20638	20641	DT	the	O	_	_
serum	20642	20647	NN	serum	O	_	_
was	20648	20651	VBD	be	O	_	_
double	20652	20658	JJ	double	O	_	_
affinity	20659	20667	NN	affinity	O	_	_
purified	20668	20676	VBN	purify	O	_	_
against	20677	20684	IN	against	O	_	_
the	20685	20688	DT	the	O	_	_
non	20689	20692	JJ	non	O	_	_
phosphorylated	20693	20707	JJ	phosphorylated	O	_	_
peptide	20708	20715	NN	peptide	O	_	_
SDMPAPSPGLDYE	20716	20729	NNP	SDMPAPSPGLDYE	O	_	_
.	20729	20730	.	.	O	_	_
D	1
4
1	0	det
4	1	nsubj
4	2	cop
4	3	amod
4	5	vmod
5	10	prep_against
10	7	det
10	8	amod
10	9	amod
10	11	appos
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	serum	1	1	2	0	VP	1	2	12	2	VBD	0	2	3	1	was	2	2	3	0	NP	0	3	12	2	NP	1	3	5	2	JJ	0	3	4	1	double	3	3	4	0	NN	0	4	5	1	affinity	4	4	5	0	VP	0	5	12	2	VBN	0	5	6	1	purified	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	against	6	6	7	0	NP	0	7	12	2	NP	3	7	11	4	DT	0	7	8	1	the	7	7	8	0	JJ	0	8	9	1	non	8	8	9	0	JJ	0	9	10	1	phosphorylated	9	9	10	0	NN	0	10	11	1	peptide	10	10	11	0	NP	0	11	12	1	NNP	0	11	12	1	SDMPAPSPGLDYE	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	18
Saos2	20732	20737	NN	saos2	O	_	_
cells	20738	20743	NNS	cell	O	_	_
(	20744	20745	VBP	(	O	_	_
7	20745	20746	CD	7	O	_	_
x	20747	20748	CC	x	O	_	_
105	20749	20752	CD	105	O	_	_
)	20752	20753	NN	)	O	_	_
were	20754	20758	VBD	be	O	_	_
plated	20759	20765	VBN	plate	O	_	_
24	20766	20768	CD	24	O	_	_
hours	20769	20774	NNS	hour	O	_	_
prior	20775	20780	RB	prior	O	_	_
to	20781	20783	TO	to	O	_	_
transfection	20784	20796	NN	transfection	O	_	_
in	20797	20799	IN	in	O	_	_
6-cm-diameter	20800	20813	JJ	6-cm-diameter	O	_	_
dishes	20814	20820	NNS	dish	O	_	_
.	20820	20821	.	.	O	_	_
D	1

1	0	nn
2	1	nsubj
2	8	ccomp
3	4	cc
6	5	num
8	3	nsubjpass
8	7	auxpass
8	10	npadvmod
8	13	prep_prior_to
10	9	num
13	16	prep_in
16	15	amod
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	1	0	2	2	NN	0	0	1	1	Saos2	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	0	2	17	2	VBP	0	2	3	1	-LRB-	2	2	3	0	SBAR	0	3	17	1	S	1	3	17	2	NP	0	3	7	3	NP	0	3	4	1	CD	0	3	4	1	7	3	3	4	0	CC	0	4	5	1	x	4	4	5	0	NP	1	5	7	2	CD	0	5	6	1	105	5	5	6	0	NN	0	6	7	1	-RRB-	6	6	7	0	VP	1	7	17	2	VBD	0	7	8	1	were	7	7	8	0	VP	0	8	17	2	VBN	0	8	9	1	plated	8	8	9	0	PP	1	9	17	3	ADVP	1	9	12	2	NP	1	9	11	2	CD	0	9	10	1	24	9	9	10	0	NNS	0	10	11	1	hours	10	10	11	0	RB	0	11	12	1	prior	11	11	12	0	TO	0	12	13	1	to	12	12	13	0	NP	0	13	17	2	NP	0	13	14	1	NN	0	13	14	1	transfection	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	in	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	6-cm-diameter	15	15	16	0	NNS	0	16	17	1	dishes	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	10
All	20822	20825	DT	all	O	_	_
transactivation	20826	20841	NN	transactivation	O	_	_
assays	20842	20848	NNS	assay	O	_	_
contained	20849	20858	VBD	contain	O	_	_
1	20859	20860	CD	1	O	_	_
mug	20861	20864	NN	mug	O	_	_
of	20865	20867	IN	of	O	_	_
reporter	20868	20876	NN	reporter	O	_	_
plasmid	20877	20884	NN	plasmid	O	_	_
.	20884	20885	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	5	dobj
5	4	num
5	8	prep_of
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	2	0	3	3	DT	0	0	1	1	All	0	0	1	0	NN	0	1	2	1	transactivation	1	1	2	0	NNS	0	2	3	1	assays	2	2	3	0	VP	0	3	9	2	VBD	0	3	4	1	contained	3	3	4	0	NP	0	4	9	2	NP	1	4	6	2	CD	0	4	5	1	1	4	4	5	0	NN	0	5	6	1	mug	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	reporter	7	7	8	0	NN	0	8	9	1	plasmid	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	27
50	20886	20888	CD	50	O	_	_
ng	20889	20891	NN	ng	O	_	_
of	20892	20894	IN	of	O	_	_
p53	20895	20898	NN	p53	B-GENE	_	_
,	20898	20899	,	,	I-GENE	_	_
4	20900	20901	CD	4	I-GENE	_	_
mug	20902	20905	NN	mug	I-GENE	_	_
of	20906	20908	IN	of	I-GENE	_	_
ASPP2	20909	20914	NN	aspp2	I-GENE	_	_
,	20914	20915	,	,	I-GENE	_	_
and	20916	20919	CC	and	I-GENE	_	_
1.5	20920	20923	CD	1.5	I-GENE	_	_
mug	20924	20927	NN	mug	I-GENE	_	_
of	20928	20930	IN	of	I-GENE	_	_
HRASV12	20931	20938	NN	hrasv12	I-GENE	_	_
or	20939	20941	CC	or	I-GENE	_	_
KRASV12	20942	20949	NN	krasv12	I-GENE	_	_
or	20950	20952	CC	or	O	_	_
Raf	20953	20956	NN	raf	B-GENE	_	_
CAAX	20957	20961	NN	caax	I-GENE	_	_
expression	20962	20972	NN	expression	O	_	_
plasmids	20973	20981	NNS	plasmid	O	_	_
were	20982	20986	VBD	be	O	_	_
used	20987	20991	VBN	use	O	_	_
as	20992	20994	IN	as	O	_	_
indicated	20995	21004	VBN	indicate	O	_	_
.	21004	21005	.	.	O	_	_
D	1
23
1	0	num
1	3	prep_of
1	6	conj_and
1	12	conj_and
6	5	num
6	8	prep_of
12	11	num
12	14	prep_of
12	16	prep_of
12	21	prep_of
14	16	conj_or
14	21	conj_or
21	18	nn
21	19	nn
21	20	nn
23	1	nsubjpass
23	6	nsubjpass
23	12	nsubjpass
23	22	auxpass
23	25	prep_as
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	22	6	NP	0	0	4	2	NP	1	0	2	2	CD	0	0	1	1	50	0	0	1	0	NN	0	1	2	1	ng	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	p53	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	9	2	NP	1	5	7	2	CD	0	5	6	1	4	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	ASPP2	8	8	9	0	,	0	9	10	1	,	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NP	0	11	22	2	NP	1	11	13	2	CD	0	11	12	1	1.5	11	11	12	0	NN	0	12	13	1	mug	12	12	13	0	PP	0	13	22	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	22	3	NP	0	14	17	3	NN	0	14	15	1	HRASV12	14	14	15	0	CC	0	15	16	1	or	15	15	16	0	NN	0	16	17	1	KRASV12	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	NP	3	18	22	4	NN	0	18	19	1	Raf	18	18	19	0	NN	0	19	20	1	CAAX	19	19	20	0	NN	0	20	21	1	expression	20	20	21	0	NNS	0	21	22	1	plasmids	21	21	22	0	VP	1	22	26	2	VBD	0	22	23	1	were	22	22	23	0	VP	0	23	26	2	VBN	0	23	24	1	used	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	as	24	24	25	0	NP	0	25	26	1	VBN	0	25	26	1	indicated	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	24
Cells	21006	21011	NNS	cell	O	_	_
were	21012	21016	VBD	be	O	_	_
lysed	21017	21022	VBN	lyse	O	_	_
in	21023	21025	IN	in	O	_	_
reporter	21026	21034	NN	reporter	O	_	_
lysis	21035	21040	NN	lysis	O	_	_
buffer	21041	21047	NN	buffer	O	_	_
16	21048	21050	CD	16	O	_	_
to	21051	21053	TO	to	O	_	_
24	21054	21056	CD	24	O	_	_
hours	21057	21062	NNS	hour	O	_	_
after	21063	21068	IN	after	O	_	_
transfection	21069	21081	NN	transfection	O	_	_
and	21082	21085	CC	and	O	_	_
assayed	21086	21093	VBN	assay	O	_	_
using	21094	21099	VBG	use	O	_	_
the	21100	21103	DT	the	O	_	_
luciferase	21104	21114	NN	luciferase	B-GENE	_	_
assay	21115	21120	NN	assay	O	_	_
kit	21121	21124	NN	kit	O	_	_
(	21125	21126	CD	(	O	_	_
Promega	21126	21133	NNP	Promega	O	_	_
)	21133	21134	CD	)	O	_	_
.	21134	21135	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_in
2	10	npadvmod
2	12	prep_after
2	14	conj_and
6	4	nn
6	5	nn
9	7	number
9	8	dep
10	9	num
14	0	nsubjpass
14	15	xcomp
15	19	dobj
19	16	det
19	17	nn
19	18	nn
19	21	dep
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	23	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	23	3	VP	0	2	13	3	VBN	0	2	3	1	lysed	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	in	3	3	4	0	NP	2	4	7	3	NN	0	4	5	1	reporter	4	4	5	0	NN	0	5	6	1	lysis	5	5	6	0	NN	0	6	7	1	buffer	6	6	7	0	PP	1	7	13	3	NP	1	7	11	2	QP	2	7	10	3	CD	0	7	8	1	16	7	7	8	0	TO	0	8	9	1	to	8	8	9	0	CD	0	9	10	1	24	9	9	10	0	NNS	0	10	11	1	hours	10	10	11	0	IN	0	11	12	1	after	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	transfection	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	VP	0	14	23	2	VBN	0	14	15	1	assayed	14	14	15	0	S	0	15	23	1	VP	0	15	23	2	VBG	0	15	16	1	using	15	15	16	0	NP	0	16	23	2	NP	3	16	20	4	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	luciferase	17	17	18	0	NN	0	18	19	1	assay	18	18	19	0	NN	0	19	20	1	kit	19	19	20	0	NP	1	20	23	3	CD	0	20	21	1	-LRB-	20	20	21	0	NNP	0	21	22	1	Promega	21	21	22	0	CD	0	22	23	1	-RRB-	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	38
The	21136	21139	DT	the	O	_	_
fold	21140	21144	JJ	fold	O	_	_
increase	21145	21153	NN	increase	O	_	_
of	21154	21156	IN	of	O	_	_
p53	21157	21160	NN	p53	B-GENE	_	_
and	21161	21164	CC	and	O	_	_
ASPP	21165	21169	NN	aspp	B-GENE	_	_
by	21170	21172	IN	by	O	_	_
HRASV12	21173	21180	NN	hrasv12	B-GENE	_	_
/	21180	21181	:	/	B-GENE	_	_
KRASV12/Raf	21181	21192	NN	krasv12/raf	B-GENE	_	_
CAAX	21193	21197	NN	caax	O	_	_
was	21198	21201	VBD	be	O	_	_
determined	21202	21212	VBN	determine	O	_	_
by	21213	21215	IN	by	O	_	_
the	21216	21219	DT	the	O	_	_
activity	21220	21228	NN	activity	O	_	_
of	21229	21231	IN	of	O	_	_
p53	21232	21235	NN	p53	B-GENE	_	_
and	21236	21239	CC	and	O	_	_
ASPP	21240	21244	NN	aspp	B-GENE	_	_
in	21245	21247	IN	in	O	_	_
combination	21248	21259	NN	combination	O	_	_
with	21260	21264	IN	with	O	_	_
RASV12	21265	21271	NN	rasv12	B-GENE	_	_
/	21271	21272	:	/	I-GENE	_	_
Raf	21272	21275	NN	raf	I-GENE	_	_
CAAX	21276	21280	NN	caax	I-GENE	_	_
divided	21281	21288	VBN	divide	O	_	_
by	21289	21291	IN	by	O	_	_
the	21292	21295	DT	the	O	_	_
activity	21296	21304	NN	activity	O	_	_
of	21305	21307	IN	of	O	_	_
p53	21308	21311	NN	p53	B-GENE	_	_
and	21312	21315	CC	and	O	_	_
ASPP	21316	21320	NN	aspp	B-GENE	_	_
alone	21321	21326	RB	alone	O	_	_
.	21326	21327	.	.	O	_	_
D	1
28
2	0	det
2	1	amod
2	4	prep_of
2	6	prep_of
2	8	prep_by
2	13	dep
2	27	dep
4	6	conj_and
11	10	nn
13	9	punct
13	11	nsubjpass
13	12	auxpass
13	16	agent
13	22	prep_in
13	24	prep_with
13	25	punct
16	15	det
16	18	prep_of
16	20	prep_of
18	20	conj_and
27	26	nn
28	2	nsubj
28	31	prep_by
28	36	advmod
31	30	det
31	33	prep_of
31	35	prep_of
33	35	conj_and
EOX
Y	1
ROOT	0	0	38	1	S	1	0	38	3	NP	0	0	28	3	NP	0	0	9	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	fold	1	1	2	0	NN	0	2	3	1	increase	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	7	3	NN	0	4	5	1	p53	4	4	5	0	CC	0	5	6	1	and	5	5	6	0	NN	0	6	7	1	ASPP	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	HRASV12	8	8	9	0	PRN	1	9	26	3	:	0	9	10	1	/	9	9	10	0	S	1	10	25	2	NP	1	10	12	2	NN	0	10	11	1	KRASV12/Raf	10	10	11	0	NN	0	11	12	1	CAAX	11	11	12	0	VP	1	12	25	2	VBD	0	12	13	1	was	12	12	13	0	VP	0	13	25	4	VBN	0	13	14	1	determined	13	13	14	0	PP	0	14	21	2	IN	0	14	15	1	by	14	14	15	0	NP	0	15	21	2	NP	1	15	17	2	DT	0	15	16	1	the	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	21	3	NN	0	18	19	1	p53	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NN	0	20	21	1	ASPP	20	20	21	0	PP	0	21	23	2	IN	0	21	22	1	in	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	combination	22	22	23	0	PP	0	23	25	2	IN	0	23	24	1	with	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	RASV12	24	24	25	0	:	0	25	26	1	/	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	Raf	26	26	27	0	NN	0	27	28	1	CAAX	27	27	28	0	VP	0	28	37	3	VBN	0	28	29	1	divided	28	28	29	0	PP	0	29	36	2	IN	0	29	30	1	by	29	29	30	0	NP	0	30	36	2	NP	1	30	32	2	DT	0	30	31	1	the	30	30	31	0	NN	0	31	32	1	activity	31	31	32	0	PP	0	32	36	2	IN	0	32	33	1	of	32	32	33	0	NP	0	33	36	3	NN	0	33	34	1	p53	33	33	34	0	CC	0	34	35	1	and	34	34	35	0	NN	0	35	36	1	ASPP	35	35	36	0	ADVP	0	36	37	1	RB	0	36	37	1	alone	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	97
For	21329	21332	IN	for	O	_	_
Western	21333	21340	NN	western	O	_	_
blotting	21341	21349	NN	blotting	O	_	_
,	21349	21350	,	,	O	_	_
cells	21351	21356	NNS	cell	O	_	_
were	21357	21361	VBD	be	O	_	_
lysed	21362	21367	VBN	lyse	O	_	_
in	21368	21370	IN	in	O	_	_
either	21371	21377	CC	either	O	_	_
NP40	21378	21382	NN	np40	O	_	_
lysis	21383	21388	NN	lysis	O	_	_
buffer	21389	21395	NN	buffer	O	_	_
(	21396	21397	NN	(	O	_	_
1	21397	21398	CD	1	O	_	_
%	21398	21399	NN	%	O	_	_
Nonidet	21400	21407	NNP	Nonidet	O	_	_
P40	21408	21411	NN	p40	O	_	_
,	21411	21412	,	,	O	_	_
50	21413	21415	CD	50	O	_	_
mM	21416	21418	NN	mm	O	_	_
Tris	21419	21423	NNP	Tris	O	_	_
[	21424	21425	CD	[	O	_	_
pH	21425	21427	NN	ph	O	_	_
8.0	21428	21431	CD	8.0	O	_	_
]	21431	21432	NN	]	O	_	_
,	21432	21433	,	,	O	_	_
150	21434	21437	CD	150	O	_	_
mM	21438	21440	NN	mm	O	_	_
NaCl	21441	21445	NN	nacl	O	_	_
,	21445	21446	,	,	O	_	_
and	21447	21450	CC	and	O	_	_
1	21451	21452	CD	1	O	_	_
mM	21453	21455	NN	mm	O	_	_
EDTA	21456	21460	NN	edta	O	_	_
)	21460	21461	NN	)	O	_	_
,	21461	21462	,	,	O	_	_
RIPA	21463	21467	NN	ripa	O	_	_
buffer	21468	21474	NN	buffer	O	_	_
(	21475	21476	NN	(	O	_	_
150	21476	21479	CD	150	O	_	_
mM	21480	21482	NN	mm	O	_	_
NaCl	21483	21487	NN	nacl	O	_	_
,	21487	21488	,	,	O	_	_
1	21489	21490	CD	1	O	_	_
%	21490	21491	NN	%	O	_	_
Nonidet	21492	21499	NNP	Nonidet	O	_	_
P40	21500	21503	NN	p40	O	_	_
,	21503	21504	,	,	O	_	_
0.5	21505	21508	CD	0.5	O	_	_
%	21508	21509	NN	%	O	_	_
sodium	21510	21516	NN	sodium	O	_	_
deoxycholate	21517	21529	NN	deoxycholate	O	_	_
,	21529	21530	,	,	O	_	_
0.1	21531	21534	CD	0.1	O	_	_
%	21534	21535	NN	%	O	_	_
sodium	21536	21542	NN	sodium	O	_	_
dodecyl	21543	21550	NN	dodecyl	O	_	_
sulfate	21551	21558	NN	sulfate	O	_	_
,	21558	21559	,	,	O	_	_
50	21560	21562	CD	50	O	_	_
mM	21563	21565	NN	mm	O	_	_
Tris-HCl	21566	21574	NN	tris-hcl	O	_	_
[	21575	21576	CD	[	O	_	_
pH	21576	21578	NN	ph	O	_	_
8.0	21579	21582	CD	8.0	O	_	_
]	21582	21583	CD	]	O	_	_
)	21583	21584	NN	)	O	_	_
,	21584	21585	,	,	O	_	_
Urea	21586	21590	NN	urea	O	_	_
solution	21591	21599	NN	solution	O	_	_
(	21600	21601	CD	(	O	_	_
8	21601	21602	CD	8	O	_	_
M	21603	21604	NN	m	O	_	_
Urea	21605	21609	NN	urea	O	_	_
,	21609	21610	,	,	O	_	_
1	21611	21612	CD	1	O	_	_
M	21613	21614	NN	m	O	_	_
Thiourea	21615	21623	NN	thiourea	O	_	_
,	21623	21624	,	,	O	_	_
0.5	21625	21628	CD	0.5	O	_	_
%	21628	21629	NN	%	O	_	_
CHAPS	21630	21635	NNS	chap	O	_	_
,	21635	21636	,	,	O	_	_
50	21637	21639	CD	50	O	_	_
mM	21640	21642	NN	mm	O	_	_
DTT	21643	21646	NN	dtt	O	_	_
,	21646	21647	,	,	O	_	_
and	21648	21651	CC	and	O	_	_
24	21652	21654	CD	24	O	_	_
mM	21655	21657	NN	mm	O	_	_
Spermine	21658	21666	NN	spermine	O	_	_
)	21666	21667	CD	)	O	_	_
or	21668	21670	CC	or	O	_	_
luciferase	21671	21681	NN	luciferase	B-GENE	_	_
lysis	21682	21687	NN	lysis	I-GENE	_	_
buffer	21688	21694	NN	buffer	I-GENE	_	_
.	21694	21695	.	.	O	_	_
D	1
6
2	1	nn
6	2	prep_for
6	4	nsubjpass
6	5	auxpass
6	11	prep_in
6	85	conj_and
11	8	dep
11	9	nn
11	10	nn
11	16	dep
11	20	dep
11	28	dep
14	13	number
16	14	amod
16	15	nn
20	18	num
20	19	nn
20	22	dep
20	24	dep
22	21	num
24	23	num
28	26	num
28	27	nn
34	31	num
34	32	nn
34	33	nn
34	41	appos
34	46	appos
34	54	appos
34	61	appos
34	69	appos
34	77	appos
34	81	appos
41	36	nn
41	37	nn
41	39	num
41	40	nn
44	43	number
46	44	amod
46	45	nn
46	51	appos
49	48	number
51	49	amod
51	50	nn
54	53	num
54	57	dep
57	55	nn
57	56	nn
61	59	num
61	60	nn
61	63	dep
63	62	num
65	64	number
66	65	dep
69	68	nn
69	73	dep
73	71	num
73	72	nn
77	75	num
77	76	nn
80	79	number
81	80	amod
85	83	num
85	84	nn
90	88	num
90	89	nn
91	90	dep
91	95	conj_or
95	93	nn
95	94	nn
EOX
Y	1
ROOT	0	0	97	1	S	0	0	97	8	S	3	0	29	4	PP	0	0	3	2	IN	0	0	1	1	For	0	0	1	0	NP	1	1	3	2	NN	0	1	2	1	Western	1	1	2	0	NN	0	2	3	1	blotting	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	5	1	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	29	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	29	2	VBN	0	6	7	1	lysed	6	6	7	0	PP	0	7	29	2	IN	0	7	8	1	in	7	7	8	0	NP	1	8	29	6	CC	0	8	9	1	either	8	8	9	0	NP	0	9	17	2	NP	2	9	12	3	NN	0	9	10	1	NP40	9	9	10	0	NN	0	10	11	1	lysis	10	10	11	0	NN	0	11	12	1	buffer	11	11	12	0	NP	3	12	17	4	NN	0	12	13	1	-LRB-	12	12	13	0	ADJP	1	13	15	2	CD	0	13	14	1	1	13	13	14	0	NN	0	14	15	1	%	14	14	15	0	NNP	0	15	16	1	Nonidet	15	15	16	0	NN	0	16	17	1	P40	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	0	18	25	3	NP	2	18	21	3	CD	0	18	19	1	50	18	18	19	0	NN	0	19	20	1	mM	19	19	20	0	NNP	0	20	21	1	Tris	20	20	21	0	NP	1	21	23	2	CD	0	21	22	1	[	21	21	22	0	NN	0	22	23	1	pH	22	22	23	0	NP	1	23	25	2	CD	0	23	24	1	8.0	23	23	24	0	NN	0	24	25	1	]	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	2	26	29	3	CD	0	26	27	1	150	26	26	27	0	NN	0	27	28	1	mM	27	27	28	0	NN	0	28	29	1	NaCl	28	28	29	0	,	0	29	30	1	,	29	29	30	0	CC	0	30	31	1	and	30	30	31	0	S	1	31	86	2	NP	0	31	83	16	NP	3	31	35	4	CD	0	31	32	1	1	31	31	32	0	NN	0	32	33	1	mM	32	32	33	0	NN	0	33	34	1	EDTA	33	33	34	0	NN	0	34	35	1	-RRB-	34	34	35	0	,	0	35	36	1	,	35	35	36	0	NP	5	36	42	6	NN	0	36	37	1	RIPA	36	36	37	0	NN	0	37	38	1	buffer	37	37	38	0	NN	0	38	39	1	-LRB-	38	38	39	0	CD	0	39	40	1	150	39	39	40	0	NN	0	40	41	1	mM	40	40	41	0	NN	0	41	42	1	NaCl	41	41	42	0	,	0	42	43	1	,	42	42	43	0	NP	0	43	52	3	NP	2	43	47	3	ADJP	1	43	45	2	CD	0	43	44	1	1	43	43	44	0	NN	0	44	45	1	%	44	44	45	0	NNP	0	45	46	1	Nonidet	45	45	46	0	NN	0	46	47	1	P40	46	46	47	0	,	0	47	48	1	,	47	47	48	0	NP	2	48	52	3	ADJP	1	48	50	2	CD	0	48	49	1	0.5	48	48	49	0	NN	0	49	50	1	%	49	49	50	0	NN	0	50	51	1	sodium	50	50	51	0	NN	0	51	52	1	deoxycholate	51	51	52	0	,	0	52	53	1	,	52	52	53	0	NP	0	53	58	2	NP	1	53	55	2	CD	0	53	54	1	0.1	53	53	54	0	NN	0	54	55	1	%	54	54	55	0	NP	2	55	58	3	NN	0	55	56	1	sodium	55	55	56	0	NN	0	56	57	1	dodecyl	56	56	57	0	NN	0	57	58	1	sulfate	57	57	58	0	,	0	58	59	1	,	58	58	59	0	NP	0	59	67	2	NP	2	59	62	3	CD	0	59	60	1	50	59	59	60	0	NN	0	60	61	1	mM	60	60	61	0	NN	0	61	62	1	Tris-HCl	61	61	62	0	NP	0	62	67	2	NP	1	62	64	2	CD	0	62	63	1	[	62	62	63	0	NN	0	63	64	1	pH	63	63	64	0	ADJP	1	64	67	2	QP	1	64	66	2	CD	0	64	65	1	8.0	64	64	65	0	CD	0	65	66	1	]	65	65	66	0	NN	0	66	67	1	-RRB-	66	66	67	0	,	0	67	68	1	,	67	67	68	0	NP	0	68	74	2	NP	1	68	70	2	NN	0	68	69	1	Urea	68	68	69	0	NN	0	69	70	1	solution	69	69	70	0	NP	2	70	74	3	QP	1	70	72	2	CD	0	70	71	1	-LRB-	70	70	71	0	CD	0	71	72	1	8	71	71	72	0	NN	0	72	73	1	M	72	72	73	0	NN	0	73	74	1	Urea	73	73	74	0	,	0	74	75	1	,	74	74	75	0	NP	2	75	78	3	CD	0	75	76	1	1	75	75	76	0	NN	0	76	77	1	M	76	76	77	0	NN	0	77	78	1	Thiourea	77	77	78	0	,	0	78	79	1	,	78	78	79	0	NP	1	79	82	2	ADJP	1	79	81	2	CD	0	79	80	1	0.5	79	79	80	0	NN	0	80	81	1	%	80	80	81	0	NNS	0	81	82	1	CHAPS	81	81	82	0	,	0	82	83	1	,	82	82	83	0	NP	2	83	86	3	CD	0	83	84	1	50	83	83	84	0	NN	0	84	85	1	mM	84	84	85	0	NN	0	85	86	1	DTT	85	85	86	0	,	0	86	87	1	,	86	86	87	0	CC	0	87	88	1	and	87	87	88	0	S	1	88	96	2	NP	2	88	91	3	CD	0	88	89	1	24	88	88	89	0	NN	0	89	90	1	mM	89	89	90	0	NN	0	90	91	1	Spermine	90	90	91	0	NP	0	91	96	3	NP	0	91	92	1	CD	0	91	92	1	-RRB-	91	91	92	0	CC	0	92	93	1	or	92	92	93	0	NP	2	93	96	3	NN	0	93	94	1	luciferase	93	93	94	0	NN	0	94	95	1	lysis	94	94	95	0	NN	0	95	96	1	buffer	95	95	96	0	.	0	96	97	1	.	96	96	97	0
EOS
T	19
Between	21696	21703	IN	between	O	_	_
35	21704	21706	CD	35	O	_	_
and	21707	21710	CC	and	O	_	_
150	21711	21714	CD	150	O	_	_
mug	21715	21718	NN	mug	O	_	_
of	21719	21721	IN	of	O	_	_
extract	21722	21729	NN	extract	O	_	_
was	21730	21733	VBD	be	O	_	_
mixed	21734	21739	VBN	mix	O	_	_
with	21740	21744	IN	with	O	_	_
6x	21745	21747	JJ	6x	O	_	_
sample	21748	21754	NN	sample	O	_	_
buffer	21755	21761	NN	buffer	O	_	_
and	21762	21765	CC	and	O	_	_
loaded	21766	21772	VBN	load	O	_	_
on	21773	21775	IN	on	O	_	_
SDS-PAGE	21776	21784	NN	sds-page	O	_	_
gels	21785	21789	NNS	gel	O	_	_
.	21789	21790	.	.	O	_	_
D	1
8
1	0	amod
1	3	conj_and
4	1	num
4	3	num
4	6	prep_of
8	4	nsubjpass
8	7	auxpass
8	12	prep_with
8	14	conj_and
12	10	amod
12	11	nn
14	4	nsubjpass
14	17	prep_on
17	16	nn
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	7	2	NP	1	0	5	2	QP	0	0	4	3	NP	1	0	2	2	IN	0	0	1	1	Between	0	0	1	0	CD	0	1	2	1	35	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	150	3	3	4	0	NN	0	4	5	1	mug	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	extract	6	6	7	0	VP	1	7	18	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	18	3	VP	0	8	13	2	VBN	0	8	9	1	mixed	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	with	9	9	10	0	NP	2	10	13	3	JJ	0	10	11	1	6x	10	10	11	0	NN	0	11	12	1	sample	11	11	12	0	NN	0	12	13	1	buffer	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	VP	0	14	18	2	VBN	0	14	15	1	loaded	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	on	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	SDS-PAGE	16	16	17	0	NNS	0	17	18	1	gels	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	35
The	21791	21794	DT	the	O	_	_
gels	21795	21799	NNS	gel	O	_	_
were	21800	21804	VBD	be	O	_	_
wet	21805	21808	JJ	wet	O	_	_
transferred	21809	21820	VBN	transfer	O	_	_
onto	21821	21825	IN	onto	O	_	_
Protran	21826	21833	NNP	Protran	O	_	_
nitrocellulose	21834	21848	NN	nitrocellulose	O	_	_
membrane	21849	21857	NN	membrane	O	_	_
and	21858	21861	CC	and	O	_	_
the	21862	21865	DT	the	O	_	_
resulting	21866	21875	VBG	result	O	_	_
blots	21876	21881	NNS	blot	O	_	_
were	21882	21886	VBD	be	O	_	_
blocked	21887	21894	VBN	block	O	_	_
and	21895	21898	CC	and	O	_	_
incubated	21899	21908	VBN	incubate	O	_	_
first	21909	21914	RB	first	O	_	_
in	21915	21917	IN	in	O	_	_
primary	21918	21925	JJ	primary	O	_	_
antibody	21926	21934	NN	antibody	O	_	_
and	21935	21938	CC	and	O	_	_
then	21939	21943	RB	then	O	_	_
with	21944	21948	IN	with	O	_	_
the	21949	21952	DT	the	O	_	_
appropriate	21953	21964	JJ	appropriate	O	_	_
secondary	21965	21974	JJ	secondary	O	_	_
horseradish	21975	21986	NN	horseradish	B-GENE	_	_
peroxidase	21987	21997	NN	peroxidase	I-GENE	_	_
conjugated	21998	22008	VBN	conjugate	I-GENE	_	_
antibody	22009	22017	NN	antibody	I-GENE	_	_
(	22018	22019	CD	(	O	_	_
Dako	22019	22023	NNP	Dako	O	_	_
)	22023	22024	CD	)	O	_	_
.	22024	22025	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubj
3	2	cop
3	4	ccomp
3	14	conj_and
3	16	conj_and
4	8	prep_onto
8	6	nn
8	7	nn
12	10	det
12	11	amod
14	12	nsubjpass
14	13	auxpass
14	14	conj_and
14	16	conj_and
14	17	advmod
14	20	prep_in
14	22	advmod
14	28	prep_with
16	12	nsubjpass
20	19	amod
28	24	det
28	25	amod
28	26	amod
28	27	nn
28	29	vmod
29	30	dobj
30	32	dep
EOX
Y	1
ROOT	0	0	35	1	S	0	0	35	4	S	1	0	9	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	gels	1	1	2	0	VP	1	2	9	2	VBD	0	2	3	1	were	2	2	3	0	ADJP	0	3	9	2	JJ	0	3	4	1	wet	3	3	4	0	SBAR	0	4	9	1	S	0	4	9	1	VP	0	4	9	2	VBN	0	4	5	1	transferred	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	onto	5	5	6	0	NP	2	6	9	3	NNP	0	6	7	1	Protran	6	6	7	0	NN	0	7	8	1	nitrocellulose	7	7	8	0	NN	0	8	9	1	membrane	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	34	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	VBG	0	11	12	1	resulting	11	11	12	0	NNS	0	12	13	1	blots	12	12	13	0	VP	1	13	34	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	34	4	VBN	0	14	15	1	blocked	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	VBN	0	16	17	1	incubated	16	16	17	0	PP	1	17	34	4	RB	0	17	18	1	first	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	in	18	18	19	0	NP	1	19	21	2	JJ	0	19	20	1	primary	19	19	20	0	NN	0	20	21	1	antibody	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	PP	1	22	34	3	RB	0	22	23	1	then	22	22	23	0	IN	0	23	24	1	with	23	23	24	0	NP	0	24	34	2	NP	4	24	29	5	DT	0	24	25	1	the	24	24	25	0	JJ	0	25	26	1	appropriate	25	25	26	0	JJ	0	26	27	1	secondary	26	26	27	0	NN	0	27	28	1	horseradish	27	27	28	0	NN	0	28	29	1	peroxidase	28	28	29	0	VP	0	29	34	2	VBN	0	29	30	1	conjugated	29	29	30	0	NP	0	30	34	2	NP	0	30	32	2	NN	0	30	31	1	antibody	30	30	31	0	CD	0	31	32	1	-LRB-	31	31	32	0	NP	0	32	34	2	NNP	0	32	33	1	Dako	32	32	33	0	CD	0	33	34	1	-RRB-	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	20
The	22026	22029	DT	the	O	_	_
blot	22030	22034	NN	blot	O	_	_
was	22035	22038	VBD	be	O	_	_
exposed	22039	22046	VBN	expose	O	_	_
to	22047	22049	TO	to	O	_	_
hyperfilm	22050	22059	NN	hyperfilm	O	_	_
following	22060	22069	VBG	follow	O	_	_
the	22070	22073	DT	the	O	_	_
use	22074	22077	NN	use	O	_	_
of	22078	22080	IN	of	O	_	_
enhanced	22081	22089	VBN	enhance	O	_	_
chemiluminescence	22090	22107	NN	chemiluminescence	O	_	_
substrate	22108	22117	NN	substrate	O	_	_
solution	22118	22126	NN	solution	O	_	_
(	22127	22128	CD	(	O	_	_
Amersham	22128	22136	NNP	Amersham	O	_	_
Life	22137	22141	NNP	Life	O	_	_
Science	22142	22149	NNP	Science	O	_	_
)	22149	22150	CD	)	O	_	_
.	22150	22151	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	prep_to
5	6	vmod
6	8	iobj
6	17	dobj
8	7	det
8	12	prep_of
12	10	amod
12	11	nn
17	13	nn
17	15	nn
17	16	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	blot	1	1	2	0	VP	1	2	19	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	19	2	VBN	0	3	4	1	exposed	3	3	4	0	PP	0	4	19	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	19	2	NP	0	5	6	1	NN	0	5	6	1	hyperfilm	5	5	6	0	VP	0	6	19	3	VBG	0	6	7	1	following	6	6	7	0	NP	0	7	13	2	NP	1	7	9	2	DT	0	7	8	1	the	7	7	8	0	NN	0	8	9	1	use	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	of	9	9	10	0	NP	2	10	13	3	VBN	0	10	11	1	enhanced	10	10	11	0	NN	0	11	12	1	chemiluminescence	11	11	12	0	NN	0	12	13	1	substrate	12	12	13	0	NP	0	13	19	2	NP	4	13	18	5	NN	0	13	14	1	solution	13	13	14	0	CD	0	14	15	1	-LRB-	14	14	15	0	NNP	0	15	16	1	Amersham	15	15	16	0	NNP	0	16	17	1	Life	16	16	17	0	NNP	0	17	18	1	Science	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	-RRB-	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	55
Primary	22152	22159	JJ	primary	O	_	_
antibodies	22160	22170	NNS	antibody	O	_	_
were	22171	22175	VBD	be	O	_	_
from	22176	22180	IN	from	O	_	_
:	22180	22181	:	:	O	_	_
Abcam	22182	22187	NNP	Abcam	O	_	_
Inc.	22188	22192	NNP	Inc.	O	_	_
,	22192	22193	,	,	O	_	_
Cambridge	22194	22203	NNP	Cambridge	O	_	_
,	22203	22204	,	,	O	_	_
MA	22205	22207	NNP	MA	O	_	_
,	22207	22208	,	,	O	_	_
USA	22209	22212	NNP	USA	O	_	_
(	22213	22214	CD	(	B-GENE	_	_
beta-actin	22214	22224	NN	beta-actin	I-GENE	_	_
,	22224	22225	,	,	O	_	_
beta-Tubulin	22226	22238	NN	beta-tubulin	B-GENE	_	_
)	22238	22239	NN	)	O	_	_
,	22239	22240	,	,	O	_	_
Upstate	22241	22248	NNP	Upstate	O	_	_
Millipore	22249	22258	NNP	Millipore	O	_	_
Corporate	22259	22268	NNP	Corporate	O	_	_
Headquarters	22269	22281	NN	headquarters	O	_	_
,	22281	22282	,	,	O	_	_
Billerica	22283	22292	NNP	Billerica	O	_	_
,	22292	22293	,	,	O	_	_
MA	22294	22296	NNP	MA	O	_	_
USA	22297	22300	NNP	USA	O	_	_
(	22301	22302	CD	(	O	_	_
RAS	22302	22305	NNP	RAS	O	_	_
Clone	22306	22311	NN	clone	O	_	_
10	22312	22314	CD	10	O	_	_
)	22314	22315	NN	)	O	_	_
,	22315	22316	,	,	O	_	_
Cell	22317	22321	NN	cell	O	_	_
Signaling	22322	22331	NN	signaling	O	_	_
Technology	22332	22342	NN	technology	O	_	_
,	22342	22343	,	,	O	_	_
Inc.	22344	22348	NNP	Inc.	O	_	_
,	22348	22349	,	,	O	_	_
Danvers	22350	22357	NNP	Danvers	O	_	_
,	22357	22358	,	,	O	_	_
MA	22359	22361	NNP	MA	O	_	_
,	22361	22362	,	,	O	_	_
USA	22363	22366	NNP	USA	O	_	_
(	22367	22368	CD	(	O	_	_
Phospho-ERK	22368	22379	NN	phospho-erk	B-GENE	_	_
/	22379	22380	:	/	B-GENE	_	_
MAPK	22380	22384	NN	mapk	I-GENE	_	_
,	22384	22385	,	,	O	_	_
ERK	22386	22389	NN	erk	B-GENE	_	_
/	22389	22390	:	/	B-GENE	_	_
MAPK	22390	22394	NN	mapk	I-GENE	_	_
)	22394	22395	NN	)	O	_	_
.	22395	22396	.	.	O	_	_
D	1

1	0	amod
2	1	nsubj
2	3	prep
6	5	nn
6	8	appos
6	10	appos
6	14	appos
6	22	appos
6	24	appos
6	29	appos
14	12	nn
17	16	nn
22	19	nn
22	20	nn
22	21	nn
29	26	nn
29	27	nn
30	31	num
32	6	dep
32	30	dep
32	36	appos
32	38	appos
32	40	appos
32	42	appos
32	44	appos
32	50	appos
36	34	nn
36	35	nn
44	46	dep
46	48	dep
48	47	punct
53	51	punct
53	52	nn
EOX
Y	1
ROOT	0	0	55	1	S	0	0	55	4	S	1	0	4	2	NP	1	0	2	2	JJ	0	0	1	1	Primary	0	0	1	0	NNS	0	1	2	1	antibodies	1	1	2	0	VP	0	2	4	2	VBD	0	2	3	1	were	2	2	3	0	PP	0	3	4	1	IN	0	3	4	1	from	3	3	4	0	:	0	4	5	1	:	4	4	5	0	FRAG	2	5	54	3	X	2	5	51	3	NP	0	5	30	15	NP	1	5	7	2	NNP	0	5	6	1	Abcam	5	5	6	0	NNP	0	6	7	1	Inc.	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	NNP	0	8	9	1	Cambridge	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	MA	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	2	12	15	3	NNP	0	12	13	1	USA	12	12	13	0	CD	0	13	14	1	-LRB-	13	13	14	0	NN	0	14	15	1	beta-actin	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	beta-Tubulin	16	16	17	0	NN	0	17	18	1	-RRB-	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	3	19	23	4	NNP	0	19	20	1	Upstate	19	19	20	0	NNP	0	20	21	1	Millipore	20	20	21	0	NNP	0	21	22	1	Corporate	21	21	22	0	NN	0	22	23	1	Headquarters	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	0	24	25	1	NNP	0	24	25	1	Billerica	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	3	26	30	4	NNP	0	26	27	1	MA	26	26	27	0	NNP	0	27	28	1	USA	27	27	28	0	CD	0	28	29	1	-LRB-	28	28	29	0	NNP	0	29	30	1	RAS	29	29	30	0	NP	0	30	32	2	NN	0	30	31	1	Clone	30	30	31	0	CD	0	31	32	1	10	31	31	32	0	NP	0	32	51	13	NP	0	32	33	1	NN	0	32	33	1	-RRB-	32	32	33	0	,	0	33	34	1	,	33	33	34	0	NP	2	34	37	3	NN	0	34	35	1	Cell	34	34	35	0	NN	0	35	36	1	Signaling	35	35	36	0	NN	0	36	37	1	Technology	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	39	1	NNP	0	38	39	1	Inc.	38	38	39	0	,	0	39	40	1	,	39	39	40	0	NP	0	40	41	1	NNP	0	40	41	1	Danvers	40	40	41	0	,	0	41	42	1	,	41	41	42	0	NP	0	42	43	1	NNP	0	42	43	1	MA	42	42	43	0	,	0	43	44	1	,	43	43	44	0	NP	0	44	49	2	NP	0	44	45	1	NNP	0	44	45	1	USA	44	44	45	0	NP	1	45	49	3	CD	0	45	46	1	-LRB-	45	45	46	0	NN	0	46	47	1	Phospho-ERK	46	46	47	0	PRN	1	47	49	2	:	0	47	48	1	/	47	47	48	0	NP	0	48	49	1	NN	0	48	49	1	MAPK	48	48	49	0	,	0	49	50	1	,	49	49	50	0	NP	0	50	51	1	NN	0	50	51	1	ERK	50	50	51	0	:	0	51	52	1	/	51	51	52	0	NP	1	52	54	2	NN	0	52	53	1	MAPK	52	52	53	0	NN	0	53	54	1	-RRB-	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	42
The	22397	22400	DT	the	O	_	_
V5	22401	22403	NN	v5	O	_	_
epitope	22404	22411	NN	epitope	O	_	_
is	22412	22414	VBZ	be	O	_	_
recognized	22415	22425	VBN	recognize	O	_	_
by	22426	22428	IN	by	O	_	_
the	22429	22432	DT	the	O	_	_
mouse	22433	22438	NN	mouse	B-GENE	_	_
monoclonal	22439	22449	JJ	monoclonal	I-GENE	_	_
anti	22450	22454	JJ	anti	I-GENE	_	_
V5	22455	22457	NN	v5	I-GENE	_	_
antibody	22458	22466	NN	antibody	I-GENE	_	_
(	22467	22468	CD	(	O	_	_
Invitrogen	22468	22478	NNP	Invitrogen	O	_	_
,	22478	22479	,	,	O	_	_
Paisley	22480	22487	NNP	Paisley	O	_	_
,	22487	22488	,	,	O	_	_
UK	22489	22491	NNP	UK	O	_	_
)	22491	22492	NNP	)	O	_	_
and	22493	22496	CC	and	O	_	_
the	22497	22500	DT	the	O	_	_
haemagglutinin	22501	22515	NN	haemagglutinin	B-GENE	_	_
epitope	22516	22523	NN	epitope	O	_	_
is	22524	22526	VBZ	be	O	_	_
recognized	22527	22537	VBN	recognize	O	_	_
by	22538	22540	IN	by	O	_	_
the	22541	22544	DT	the	O	_	_
anti	22545	22549	JJ	anti	B-GENE	_	_
HA	22550	22552	NN	ha	I-GENE	_	_
antibody	22553	22561	NN	antibody	I-GENE	_	_
(	22562	22563	CD	(	B-GENE	_	_
mAb	22563	22566	NN	mab	I-GENE	_	_
)	22566	22567	CD	)	O	_	_
(	22568	22569	CD	(	O	_	_
Covance	22569	22576	NNP	Covance	O	_	_
,	22576	22577	,	,	O	_	_
Princeton	22578	22587	NNP	Princeton	O	_	_
,	22587	22588	,	,	O	_	_
NJ	22589	22591	NNP	NJ	O	_	_
USA	22592	22595	NNP	USA	O	_	_
)	22595	22596	NN	)	O	_	_
.	22596	22597	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	7	agent
4	10	dobj
7	6	det
10	8	amod
10	9	amod
10	24	rcmod
13	11	nn
13	15	conj_and
13	22	conj_and
18	17	nn
22	20	det
22	21	nn
24	13	nsubjpass
24	15	nsubjpass
24	22	nsubjpass
24	23	auxpass
24	29	agent
29	26	det
29	27	amod
29	28	nn
29	31	dep
33	36	dep
36	34	nn
40	38	nn
40	39	nn
EOX
Y	1
ROOT	0	0	42	1	S	1	0	42	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	V5	1	1	2	0	NN	0	2	3	1	epitope	2	2	3	0	VP	1	3	41	2	VBZ	0	3	4	1	is	3	3	4	0	VP	0	4	41	3	VBN	0	4	5	1	recognized	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	by	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	mouse	7	7	8	0	NP	0	8	41	2	NP	2	8	11	3	JJ	0	8	9	1	monoclonal	8	8	9	0	JJ	0	9	10	1	anti	9	9	10	0	NN	0	10	11	1	V5	10	10	11	0	SBAR	0	11	41	1	S	1	11	41	2	NP	0	11	23	7	NP	2	11	14	3	NN	0	11	12	1	antibody	11	11	12	0	CD	0	12	13	1	-LRB-	12	12	13	0	NNP	0	13	14	1	Invitrogen	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	0	15	16	1	NNP	0	15	16	1	Paisley	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	1	17	19	2	NNP	0	17	18	1	UK	17	17	18	0	NNP	0	18	19	1	-RRB-	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NP	2	20	23	3	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	haemagglutinin	21	21	22	0	NN	0	22	23	1	epitope	22	22	23	0	VP	1	23	41	2	VBZ	0	23	24	1	is	23	23	24	0	VP	0	24	41	2	VBN	0	24	25	1	recognized	24	24	25	0	PP	0	25	41	2	IN	0	25	26	1	by	25	25	26	0	NP	0	26	41	4	NP	0	26	32	2	NP	3	26	30	4	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	anti	27	27	28	0	NN	0	28	29	1	HA	28	28	29	0	NN	0	29	30	1	antibody	29	29	30	0	NP	1	30	32	2	CD	0	30	31	1	-LRB-	30	30	31	0	NN	0	31	32	1	mAb	31	31	32	0	NP	0	32	37	2	NP	0	32	34	1	QP	1	32	34	2	CD	0	32	33	1	-RRB-	32	32	33	0	CD	0	33	34	1	-LRB-	33	33	34	0	NP	2	34	37	3	NNP	0	34	35	1	Covance	34	34	35	0	,	0	35	36	1	,	35	35	36	0	NNP	0	36	37	1	Princeton	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	2	38	41	3	NNP	0	38	39	1	NJ	38	38	39	0	NNP	0	39	40	1	USA	39	39	40	0	NN	0	40	41	1	-RRB-	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	20
To	22598	22600	TO	to	O	_	_
detect	22601	22607	VB	detect	O	_	_
RAS	22608	22611	NN	ra	B-GENE	_	_
by	22612	22614	IN	by	O	_	_
immunoprecipitation	22615	22634	NN	immunoprecipitation	O	_	_
the	22635	22638	DT	the	O	_	_
rat	22639	22642	NN	rat	B-GENE	_	_
monoclonal	22643	22653	JJ	monoclonal	I-GENE	_	_
antibody	22654	22662	NN	antibody	I-GENE	_	_
238	22663	22666	CD	238	I-GENE	_	_
was	22667	22670	VBD	be	O	_	_
used	22671	22675	VBN	use	O	_	_
(	22676	22677	CD	(	O	_	_
Santa	22677	22682	NNP	Santa	O	_	_
Cruz	22683	22687	NNP	Cruz	O	_	_
,	22687	22688	,	,	O	_	_
CA	22689	22691	NNP	CA	B-GENE	_	_
USA	22692	22695	NNP	USA	I-GENE	_	_
)	22695	22696	NN	)	O	_	_
.	22696	22697	.	.	O	_	_
D	1

1	0	aux
1	2	dobj
1	4	prep_by
6	5	det
6	7	amod
7	8	dep
8	9	num
11	1	dep
11	6	nsubjpass
11	10	auxpass
11	14	dobj
14	13	nn
18	16	nn
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	2	0	20	4	S	0	0	5	1	VP	1	0	5	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	5	3	VB	0	1	2	1	detect	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	immunoprecipitation	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	rat	6	6	7	0	ADJP	0	7	10	2	JJ	0	7	8	1	monoclonal	7	7	8	0	NP	0	8	10	2	NN	0	8	9	1	antibody	8	8	9	0	CD	0	9	10	1	238	9	9	10	0	VP	1	10	19	2	VBD	0	10	11	1	was	10	10	11	0	VP	0	11	19	2	VBN	0	11	12	1	used	11	11	12	0	NP	0	12	19	3	NP	2	12	15	3	CD	0	12	13	1	-LRB-	12	12	13	0	NNP	0	13	14	1	Santa	13	13	14	0	NNP	0	14	15	1	Cruz	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	2	16	19	3	NNP	0	16	17	1	CA	16	16	17	0	NNP	0	17	18	1	USA	17	17	18	0	NN	0	18	19	1	-RRB-	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	31
The	22698	22701	DT	the	O	_	_
mouse	22702	22707	NN	mouse	O	_	_
and	22708	22711	CC	and	O	_	_
rabbit	22712	22718	NN	rabbit	O	_	_
antibodies	22719	22729	NNS	antibody	O	_	_
to	22730	22732	TO	to	O	_	_
ASPP2	22733	22738	NN	aspp2	B-GENE	_	_
were	22739	22743	VBD	be	O	_	_
described	22744	22753	VBN	describe	O	_	_
previously	22754	22764	RB	previously	O	_	_
[	22765	22766	CD	[	O	_	_
9	22766	22767	CD	9	O	_	_
]	22767	22768	NN	]	O	_	_
:	22768	22769	:	:	O	_	_
rabbit	22770	22776	NN	rabbit	O	_	_
anti	22777	22781	JJ	anti	O	_	_
ASPP2	22782	22787	NN	aspp2	B-GENE	_	_
polyclonal	22788	22798	JJ	polyclonal	I-GENE	_	_
antibody	22799	22807	NN	antibody	I-GENE	_	_
ASPP2	22808	22813	NN	aspp2	I-GENE	_	_
/	22813	22814	:	/	I-GENE	_	_
77	22814	22816	CD	77	I-GENE	_	_
and	22817	22820	CC	and	O	_	_
mouse	22821	22826	NN	mouse	B-GENE	_	_
monoclonal	22827	22837	JJ	monoclonal	I-GENE	_	_
anti	22838	22842	JJ	anti	I-GENE	_	_
ASPP2	22843	22848	NN	aspp2	I-GENE	_	_
antibody	22849	22857	NN	antibody	I-GENE	_	_
DX54	22858	22862	NN	dx54	O	_	_
.10	22862	22865	CD	.10	O	_	_
.	22865	22866	.	.	O	_	_
D	1
8
1	3	conj_and
4	0	det
4	1	nn
4	3	nn
4	6	prep_to
8	4	nsubjpass
8	7	auxpass
8	9	advmod
8	12	dobj
11	10	number
12	11	num
12	16	dep
12	28	dep
16	14	nn
16	15	amod
16	19	dep
19	17	amod
19	18	nn
21	27	conj_and
27	23	nn
27	24	amod
27	25	amod
27	26	nn
28	20	punct
28	21	dep
28	27	dep
28	29	num
EOX
Y	1
ROOT	0	0	31	1	S	1	0	31	3	NP	0	0	7	2	NP	2	0	5	3	DT	0	0	1	1	The	0	0	1	0	NP	0	1	4	3	NN	0	1	2	1	mouse	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	rabbit	3	3	4	0	NNS	0	4	5	1	antibodies	4	4	5	0	PP	0	5	7	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	ASPP2	6	6	7	0	VP	1	7	30	2	VBD	0	7	8	1	were	7	7	8	0	VP	0	8	30	3	VBN	0	8	9	1	described	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	previously	9	9	10	0	NP	0	10	30	2	NP	1	10	20	2	QP	1	10	12	2	CD	0	10	11	1	[	10	10	11	0	CD	0	11	12	1	9	11	11	12	0	NX	0	12	20	3	NP	0	12	13	1	NN	0	12	13	1	]	12	12	13	0	:	0	13	14	1	:	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	NN	0	14	15	1	rabbit	14	14	15	0	JJ	0	15	16	1	anti	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	NP	2	17	20	3	JJ	0	17	18	1	polyclonal	17	17	18	0	NN	0	18	19	1	antibody	18	18	19	0	NN	0	19	20	1	ASPP2	19	19	20	0	PRN	1	20	30	2	:	0	20	21	1	/	20	20	21	0	S	1	21	30	2	NP	0	21	28	3	NP	0	21	22	1	CD	0	21	22	1	77	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NP	4	23	28	5	NN	0	23	24	1	mouse	23	23	24	0	JJ	0	24	25	1	monoclonal	24	24	25	0	JJ	0	25	26	1	anti	25	25	26	0	NN	0	26	27	1	ASPP2	26	26	27	0	NN	0	27	28	1	antibody	27	27	28	0	NP	0	28	30	2	NN	0	28	29	1	DX54	28	28	29	0	CD	0	29	30	1	.10	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	9
The	22867	22870	DT	the	O	_	_
mouse	22871	22876	NN	mouse	B-GENE	_	_
monoclonal	22877	22887	JJ	monoclonal	I-GENE	_	_
DO-1	22888	22892	NN	do-1	I-GENE	_	_
is	22893	22895	VBZ	be	O	_	_
specific	22896	22904	JJ	specific	O	_	_
to	22905	22907	TO	to	O	_	_
p53	22908	22911	NN	p53	B-GENE	_	_
.	22911	22912	.	.	O	_	_
D	1
5
3	0	det
3	1	nn
3	2	amod
5	3	nsubj
5	4	cop
5	7	prep_to
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	mouse	1	1	2	0	JJ	0	2	3	1	monoclonal	2	2	3	0	NN	0	3	4	1	DO-1	3	3	4	0	VP	1	4	8	2	VBZ	0	4	5	1	is	4	4	5	0	ADJP	0	5	8	2	JJ	0	5	6	1	specific	5	5	6	0	PP	0	6	8	2	TO	0	6	7	1	to	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	p53	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	21
Signals	22913	22920	NNS	signal	O	_	_
were	22921	22925	VBD	be	O	_	_
detected	22926	22934	VBN	detect	O	_	_
using	22935	22940	VBG	use	O	_	_
ECL	22941	22944	NN	ecl	O	_	_
detection	22945	22954	NN	detection	O	_	_
system	22955	22961	NN	system	O	_	_
(	22962	22963	CD	(	O	_	_
GE	22963	22965	NNP	GE	O	_	_
Healthcare	22966	22976	NNP	Healthcare	O	_	_
,	22976	22977	,	,	O	_	_
Pollards	22978	22986	NNP	Pollards	O	_	_
Wood	22987	22991	NNP	Wood	O	_	_
,	22991	22992	,	,	O	_	_
Chalfont	22993	23001	NNP	Chalfont	O	_	_
,	23001	23002	,	,	O	_	_
Buckinghamshire	23003	23018	NNP	Buckinghamshire	O	_	_
,	23018	23019	,	,	O	_	_
UK	23020	23022	NNP	UK	O	_	_
)	23022	23023	CD	)	O	_	_
.	23023	23024	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	3	xcomp
3	6	dobj
6	4	nn
6	5	nn
6	9	dep
9	8	nn
9	18	appos
18	11	nn
18	12	nn
18	14	appos
18	16	appos
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	1	1	NNS	0	0	1	1	Signals	0	0	1	0	VP	1	1	20	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	20	2	VBN	0	2	3	1	detected	2	2	3	0	S	0	3	20	1	VP	0	3	20	2	VBG	0	3	4	1	using	3	3	4	0	NP	0	4	20	2	NP	2	4	7	3	NN	0	4	5	1	ECL	4	4	5	0	NN	0	5	6	1	detection	5	5	6	0	NN	0	6	7	1	system	6	6	7	0	NP	0	7	20	3	NP	2	7	10	3	CD	0	7	8	1	-LRB-	7	7	8	0	NNP	0	8	9	1	GE	8	8	9	0	NNP	0	9	10	1	Healthcare	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	7	11	20	9	NNP	0	11	12	1	Pollards	11	11	12	0	NNP	0	12	13	1	Wood	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NNP	0	14	15	1	Chalfont	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NNP	0	16	17	1	Buckinghamshire	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NNP	0	18	19	1	UK	18	18	19	0	CD	0	19	20	1	-RRB-	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	55
Cells	23026	23031	NNS	cell	O	_	_
were	23032	23036	VBD	be	O	_	_
fixed	23037	23042	VBN	fix	O	_	_
in	23043	23045	IN	in	O	_	_
4	23046	23047	CD	4	O	_	_
%	23047	23048	NN	%	O	_	_
PBS-paraformaldeyde	23049	23068	NN	pbs-paraformaldeyde	O	_	_
for	23069	23072	IN	for	O	_	_
15	23073	23075	CD	15	O	_	_
min	23076	23079	NN	min	O	_	_
,	23079	23080	,	,	O	_	_
incubated	23081	23090	VBN	incubate	O	_	_
in	23091	23093	IN	in	O	_	_
0.2	23094	23097	CD	0.2	O	_	_
%	23097	23098	NN	%	O	_	_
Triton-X-100	23099	23111	NN	triton-x-100	O	_	_
for	23112	23115	IN	for	O	_	_
5	23116	23117	CD	5	O	_	_
min	23118	23121	NN	min	O	_	_
,	23121	23122	,	,	O	_	_
then	23123	23127	RB	then	O	_	_
in	23128	23130	IN	in	O	_	_
0.2	23131	23134	CD	0.2	O	_	_
%	23134	23135	NN	%	O	_	_
Fish	23136	23140	NN	fish	O	_	_
Skin	23141	23145	NN	skin	O	_	_
Gelatine	23146	23154	NN	gelatine	O	_	_
in	23155	23157	IN	in	O	_	_
PBS	23158	23161	NNP	PBS	O	_	_
for	23162	23165	IN	for	O	_	_
10	23166	23168	CD	10	O	_	_
min	23169	23172	NN	min	O	_	_
and	23173	23176	CC	and	O	_	_
stained	23177	23184	VBN	stain	O	_	_
for	23185	23188	IN	for	O	_	_
1	23189	23190	CD	1	O	_	_
hr	23191	23193	NN	hr	O	_	_
with	23194	23198	IN	with	O	_	_
anti	23199	23203	JJ	anti	O	_	_
V5	23204	23206	NN	v5	O	_	_
(	23207	23208	CD	(	O	_	_
Invitrogen	23208	23218	NNP	Invitrogen	O	_	_
,	23218	23219	,	,	O	_	_
Paisley	23220	23227	NNP	Paisley	O	_	_
,	23227	23228	,	,	O	_	_
UK	23229	23231	NNP	UK	O	_	_
)	23231	23232	CD	)	O	_	_
or	23233	23235	CC	or	O	_	_
with	23236	23240	IN	with	O	_	_
anti	23241	23245	JJ	anti	B-GENE	_	_
ASPP2	23246	23251	NN	aspp2	I-GENE	_	_
with	23252	23256	IN	with	O	_	_
DX54	23257	23261	NN	dx54	B-GENE	_	_
.10	23261	23264	CD	.10	I-GENE	_	_
.	23264	23265	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_in
2	11	conj_and
2	33	conj_and
5	4	number
6	5	amod
6	9	prep_for
9	8	num
11	0	nsubjpass
11	15	prep_in
11	31	prep_for
14	13	number
15	14	amod
15	18	prep_for
15	20	advmod
15	26	dep
18	17	num
20	23	prep_in
23	22	num
26	24	nn
26	25	nn
26	28	prep_in
31	30	num
33	0	nsubjpass
33	33	conj_or
33	36	prep_for
33	50	prep_with
33	52	prep_with
36	35	num
36	39	prep_with
39	38	amod
39	45	dep
45	41	nn
45	43	appos
50	49	amod
52	53	num
EOX
Y	1
ROOT	0	0	55	1	S	1	0	55	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	54	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	54	5	VP	0	2	10	2	VBN	0	2	3	1	fixed	2	2	3	0	PP	0	3	10	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	10	2	NP	1	4	7	2	ADJP	1	4	6	2	CD	0	4	5	1	4	4	4	5	0	NN	0	5	6	1	%	5	5	6	0	NN	0	6	7	1	PBS-paraformaldeyde	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	for	7	7	8	0	NP	1	8	10	2	CD	0	8	9	1	15	8	8	9	0	NN	0	9	10	1	min	9	9	10	0	,	0	10	11	1	,	10	10	11	0	VP	0	11	32	3	VBN	0	11	12	1	incubated	11	11	12	0	PP	0	12	29	2	IN	0	12	13	1	in	12	12	13	0	NP	0	13	29	4	NP	0	13	19	2	NP	1	13	16	2	ADJP	1	13	15	2	CD	0	13	14	1	0.2	13	13	14	0	NN	0	14	15	1	%	14	14	15	0	NN	0	15	16	1	Triton-X-100	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	for	16	16	17	0	NP	1	17	19	2	CD	0	17	18	1	5	17	17	18	0	NN	0	18	19	1	min	18	18	19	0	,	0	19	20	1	,	19	19	20	0	ADVP	0	20	24	2	RB	0	20	21	1	then	20	20	21	0	PP	0	21	24	2	IN	0	21	22	1	in	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	0.2	22	22	23	0	NN	0	23	24	1	%	23	23	24	0	NP	0	24	29	2	NP	2	24	27	3	NN	0	24	25	1	Fish	24	24	25	0	NN	0	25	26	1	Skin	25	25	26	0	NN	0	26	27	1	Gelatine	26	26	27	0	PP	0	27	29	2	IN	0	27	28	1	in	27	27	28	0	NP	0	28	29	1	NNP	0	28	29	1	PBS	28	28	29	0	PP	0	29	32	2	IN	0	29	30	1	for	29	29	30	0	NP	1	30	32	2	CD	0	30	31	1	10	30	30	31	0	NN	0	31	32	1	min	31	31	32	0	CC	0	32	33	1	and	32	32	33	0	VP	0	33	54	3	VBN	0	33	34	1	stained	33	33	34	0	PP	0	34	51	3	PP	0	34	47	2	IN	0	34	35	1	for	34	34	35	0	NP	0	35	47	2	NP	1	35	37	2	CD	0	35	36	1	1	35	35	36	0	NN	0	36	37	1	hr	36	36	37	0	PP	0	37	47	2	IN	0	37	38	1	with	37	37	38	0	NP	0	38	47	2	NP	1	38	41	3	JJ	0	38	39	1	anti	38	38	39	0	NN	0	39	40	1	V5	39	39	40	0	CD	0	40	41	1	-LRB-	40	40	41	0	NP	4	41	47	6	NNP	0	41	42	1	Invitrogen	41	41	42	0	,	0	42	43	1	,	42	42	43	0	NNP	0	43	44	1	Paisley	43	43	44	0	,	0	44	45	1	,	44	44	45	0	NNP	0	45	46	1	UK	45	45	46	0	CD	0	46	47	1	-RRB-	46	46	47	0	CC	0	47	48	1	or	47	47	48	0	PP	0	48	51	2	IN	0	48	49	1	with	48	48	49	0	NP	1	49	51	2	JJ	0	49	50	1	anti	49	49	50	0	NN	0	50	51	1	ASPP2	50	50	51	0	PP	0	51	54	2	IN	0	51	52	1	with	51	51	52	0	NP	0	52	54	2	NN	0	52	53	1	DX54	52	52	53	0	CD	0	53	54	1	.10	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	15
Antibodies	23266	23276	NNS	antibody	O	_	_
were	23277	23281	VBD	be	O	_	_
used	23282	23286	VBN	use	O	_	_
at	23287	23289	IN	at	O	_	_
1:100	23290	23295	CD	1:100	O	_	_
dilution	23296	23304	NN	dilution	O	_	_
in	23305	23307	IN	in	O	_	_
0.2	23308	23311	CD	0.2	O	_	_
%	23311	23312	NN	%	O	_	_
Fish	23313	23317	NN	fish	O	_	_
Skin	23318	23322	NN	skin	O	_	_
Gelatine-PBS	23323	23335	NN	gelatine-pb	O	_	_
,	23335	23336	,	,	O	_	_
respectively	23337	23349	RB	respectively	O	_	_
.	23349	23350	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	5	prep_at
2	13	advmod
5	4	num
5	8	prep_in
8	7	num
8	11	dep
11	9	nn
11	10	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	1	1	NNS	0	0	1	1	Antibodies	0	0	1	0	VP	1	1	14	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	14	4	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	12	2	IN	0	3	4	1	at	3	3	4	0	NP	0	4	12	2	NP	1	4	6	2	CD	0	4	5	1	1:100	4	4	5	0	NN	0	5	6	1	dilution	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	in	6	6	7	0	NP	0	7	12	2	NP	1	7	9	2	CD	0	7	8	1	0.2	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	NP	2	9	12	3	NN	0	9	10	1	Fish	9	9	10	0	NN	0	10	11	1	Skin	10	10	11	0	NN	0	11	12	1	Gelatine-PBS	11	11	12	0	,	0	12	13	1	,	12	12	13	0	ADVP	0	13	14	1	RB	0	13	14	1	respectively	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	23
Staining	23351	23359	VBG	stain	O	_	_
with	23360	23364	IN	with	O	_	_
the	23365	23368	DT	the	O	_	_
secondary	23369	23378	JJ	secondary	O	_	_
antibody	23379	23387	NN	antibody	O	_	_
and	23388	23391	CC	and	O	_	_
Hoechst	23392	23399	NNP	Hoechst	O	_	_
was	23400	23403	VBD	be	O	_	_
performed	23404	23413	VBN	perform	O	_	_
as	23414	23416	IN	as	O	_	_
described	23417	23426	VBN	describe	O	_	_
[	23427	23428	NN	[	O	_	_
2	23428	23429	CD	2	O	_	_
]	23429	23430	NN	]	O	_	_
,	23430	23431	,	,	O	_	_
followed	23432	23440	VBN	follow	O	_	_
by	23441	23443	IN	by	O	_	_
visualisation	23444	23457	NN	visualisation	O	_	_
under	23458	23463	IN	under	O	_	_
a	23464	23465	DT	a	O	_	_
fluorescence	23466	23478	NN	fluorescence	O	_	_
microscope	23479	23489	NN	microscope	O	_	_
.	23489	23490	.	.	O	_	_
D	1
0
0	4	prep_with
0	6	prep_with
0	8	aux
0	13	nsubj
4	2	det
4	3	amod
4	6	conj_and
8	7	auxpass
8	11	prep_as
11	10	amod
13	12	num
13	15	vmod
15	17	agent
15	21	prep_under
21	19	det
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	SINV	0	0	23	4	VP	0	0	7	2	VBG	0	0	1	1	Staining	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	with	1	1	2	0	NP	0	2	7	3	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	secondary	3	3	4	0	NN	0	4	5	1	antibody	4	4	5	0	CC	0	5	6	1	and	5	5	6	0	NP	0	6	7	1	NNP	0	6	7	1	Hoechst	6	6	7	0	VP	1	7	12	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	12	2	VBN	0	8	9	1	performed	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	as	9	9	10	0	NP	1	10	12	2	VBN	0	10	11	1	described	10	10	11	0	NN	0	11	12	1	[	11	11	12	0	NP	0	12	22	3	NP	1	12	14	2	CD	0	12	13	1	2	12	12	13	0	NN	0	13	14	1	]	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	0	15	22	3	VBN	0	15	16	1	followed	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	by	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	visualisation	17	17	18	0	PP	0	18	22	2	IN	0	18	19	1	under	18	18	19	0	NP	2	19	22	3	DT	0	19	20	1	a	19	19	20	0	NN	0	20	21	1	fluorescence	20	20	21	0	NN	0	21	22	1	microscope	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	58
For	23492	23495	IN	for	O	_	_
immunoprecipitation	23496	23515	NN	immunoprecipitation	O	_	_
,	23515	23516	,	,	O	_	_
cells	23517	23522	NNS	cell	O	_	_
were	23523	23527	VBD	be	O	_	_
lysed	23528	23533	VBN	lyse	O	_	_
in	23534	23536	IN	in	O	_	_
IP	23537	23539	NNP	IP	O	_	_
buffer	23540	23546	NN	buffer	O	_	_
(	23547	23548	CD	(	O	_	_
20	23548	23550	CD	20	O	_	_
mM	23551	23553	NN	mm	O	_	_
Trish-HCl	23554	23563	NN	trish-hcl	O	_	_
[	23564	23565	CD	[	O	_	_
pH	23565	23567	NN	ph	O	_	_
7.5	23568	23571	CD	7.5	O	_	_
]	23571	23572	NN	]	O	_	_
,	23572	23573	,	,	O	_	_
1	23574	23575	CD	1	O	_	_
mM	23576	23578	NN	mm	O	_	_
EDTA	23579	23583	NN	edta	O	_	_
,	23583	23584	,	,	O	_	_
1	23585	23586	CD	1	O	_	_
M	23587	23588	NN	m	O	_	_
KCl	23589	23592	NN	kcl	O	_	_
,	23592	23593	,	,	O	_	_
5	23594	23595	CD	5	O	_	_
mM	23596	23598	NN	mm	O	_	_
MgCl2	23599	23604	NN	mgcl2	O	_	_
,	23605	23606	,	,	O	_	_
10	23607	23609	CD	10	O	_	_
%	23609	23610	NN	%	O	_	_
v	23611	23612	LS	v	O	_	_
/	23612	23613	:	/	O	_	_
v	23613	23614	LS	v	O	_	_
glycerol	23615	23623	NN	glycerol	O	_	_
,	23623	23624	,	,	O	_	_
1	23625	23626	CD	1	O	_	_
%	23626	23627	NN	%	O	_	_
v	23628	23629	LS	v	O	_	_
/	23629	23630	:	/	O	_	_
v	23630	23631	LS	v	O	_	_
Triton	23632	23638	NNP	Triton	O	_	_
X-100	23639	23644	NN	x-100	O	_	_
,	23644	23645	,	,	O	_	_
0.05	23646	23650	CD	0.05	O	_	_
%	23650	23651	NN	%	O	_	_
v	23652	23653	LS	v	O	_	_
/	23653	23654	:	/	O	_	_
v	23654	23655	LS	v	O	_	_
2-Mercaptoethanol	23656	23673	NN	2-mercaptoethanol	O	_	_
and	23674	23677	CC	and	O	_	_
protease	23678	23686	NN	protease	O	_	_
and	23687	23690	CC	and	O	_	_
phosphatase	23691	23702	NN	phosphatase	O	_	_
inhibitors	23703	23713	NNS	inhibitor	O	_	_
)	23713	23714	NN	)	O	_	_
.	23714	23715	.	.	O	_	_
D	1
5
5	1	prep_for
5	3	nsubjpass
5	4	auxpass
5	8	prep_in
5	14	dep
5	20	dep
8	7	nn
14	10	num
14	11	nn
14	12	nn
14	13	num
14	16	amod
16	15	number
20	18	num
20	19	nn
20	24	appos
20	28	appos
20	31	appos
20	32	dep
20	33	punct
20	35	dep
20	39	dep
20	40	punct
20	43	dep
20	47	dep
20	48	punct
24	22	num
24	23	nn
28	26	num
28	27	nn
31	30	num
35	34	dep
35	38	dep
38	37	num
43	41	dep
43	42	nn
43	46	dep
46	45	num
49	50	dep
49	52	dep
49	55	dep
50	52	conj_and
50	55	conj_and
55	54	nn
56	49	prep
EOX
Y	1
ROOT	0	0	58	1	S	2	0	58	6	PP	0	0	2	2	IN	0	0	1	1	For	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	immunoprecipitation	1	1	2	0	,	0	2	3	1	,	2	2	3	0	S	1	3	17	2	NP	0	3	4	1	NNS	0	3	4	1	cells	3	3	4	0	VP	1	4	17	2	VBD	0	4	5	1	were	4	4	5	0	VP	0	5	17	2	VBN	0	5	6	1	lysed	5	5	6	0	PP	0	6	17	3	IN	0	6	7	1	in	6	6	7	0	NP	1	7	9	2	NNP	0	7	8	1	IP	7	7	8	0	NN	0	8	9	1	buffer	8	8	9	0	NP	0	9	17	2	NP	4	9	15	5	QP	1	9	11	2	CD	0	9	10	1	-LRB-	9	9	10	0	CD	0	10	11	1	20	10	10	11	0	NN	0	11	12	1	mM	11	11	12	0	NN	0	12	13	1	Trish-HCl	12	12	13	0	CD	0	13	14	1	[	13	13	14	0	NN	0	14	15	1	pH	14	14	15	0	ADJP	1	15	17	2	CD	0	15	16	1	7.5	15	15	16	0	NN	0	16	17	1	]	16	16	17	0	,	0	17	18	1	,	17	17	18	0	FRAG	0	18	57	3	FRAG	0	18	48	4	FRAG	0	18	40	4	FRAG	0	18	33	2	NP	0	18	32	7	NP	2	18	21	3	CD	0	18	19	1	1	18	18	19	0	NN	0	19	20	1	mM	19	19	20	0	NN	0	20	21	1	EDTA	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	2	22	25	3	CD	0	22	23	1	1	22	22	23	0	NN	0	23	24	1	M	23	23	24	0	NN	0	24	25	1	KCl	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	2	26	29	3	CD	0	26	27	1	5	26	26	27	0	NN	0	27	28	1	mM	27	27	28	0	NN	0	28	29	1	MgCl2	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	1	30	32	2	CD	0	30	31	1	10	30	30	31	0	NN	0	31	32	1	%	31	31	32	0	LS	0	32	33	1	v	32	32	33	0	:	0	33	34	1	/	33	33	34	0	FRAG	0	34	39	3	NP	1	34	36	2	LS	0	34	35	1	v	34	34	35	0	NN	0	35	36	1	glycerol	35	35	36	0	,	0	36	37	1	,	36	36	37	0	NP	1	37	39	2	CD	0	37	38	1	1	37	37	38	0	NN	0	38	39	1	%	38	38	39	0	LS	0	39	40	1	v	39	39	40	0	:	0	40	41	1	/	40	40	41	0	FRAG	0	41	47	3	NP	2	41	44	3	LS	0	41	42	1	v	41	41	42	0	NNP	0	42	43	1	Triton	42	42	43	0	NN	0	43	44	1	X-100	43	43	44	0	,	0	44	45	1	,	44	44	45	0	NP	1	45	47	2	CD	0	45	46	1	0.05	45	45	46	0	NN	0	46	47	1	%	46	46	47	0	LS	0	47	48	1	v	47	47	48	0	:	0	48	49	1	/	48	48	49	0	FRAG	1	49	57	2	PP	0	49	56	2	LS	0	49	50	1	v	49	49	50	0	NP	0	50	56	3	NP	0	50	53	3	NN	0	50	51	1	2-Mercaptoethanol	50	50	51	0	CC	0	51	52	1	and	51	51	52	0	NN	0	52	53	1	protease	52	52	53	0	CC	0	53	54	1	and	53	53	54	0	NP	1	54	56	2	NN	0	54	55	1	phosphatase	54	54	55	0	NNS	0	55	56	1	inhibitors	55	55	56	0	NP	0	56	57	1	NN	0	56	57	1	-RRB-	56	56	57	0	.	0	57	58	1	.	57	57	58	0
EOS
T	33
1-4	23716	23719	CD	1-4	O	_	_
mg	23720	23722	NN	mg	O	_	_
of	23723	23725	IN	of	O	_	_
lysate	23726	23732	NN	lysate	O	_	_
was	23733	23736	VBD	be	O	_	_
pre	23737	23740	JJ	pre	O	_	_
cleared	23741	23748	VBN	clear	O	_	_
with	23749	23753	IN	with	O	_	_
protein	23754	23761	NN	protein	O	_	_
G	23762	23763	NN	g	O	_	_
beads	23764	23769	NNS	bead	O	_	_
for	23770	23773	IN	for	O	_	_
30	23774	23776	CD	30	O	_	_
min	23777	23780	NN	min	O	_	_
at	23781	23783	IN	at	O	_	_
4degreesC	23784	23793	NN	4degreesc	O	_	_
and	23794	23797	CC	and	O	_	_
subsequently	23798	23810	RB	subsequently	O	_	_
incubated	23811	23820	VBN	incubate	O	_	_
with	23821	23825	IN	with	O	_	_
antibody	23826	23834	NN	antibody	O	_	_
pre	23835	23838	JJ	pre	O	_	_
bound	23839	23844	VBN	bind	O	_	_
to	23845	23847	TO	to	O	_	_
protein	23848	23855	NN	protein	O	_	_
G	23856	23857	NN	g	O	_	_
beads	23858	23863	NNS	bead	O	_	_
for	23864	23867	IN	for	O	_	_
2-16	23868	23872	CD	2-16	O	_	_
hrs	23873	23876	NNS	hr	O	_	_
at	23877	23879	IN	at	O	_	_
4degreesC	23880	23889	NN	4degreesc	O	_	_
.	23889	23890	.	.	O	_	_
D	1
5
1	0	num
1	3	prep_of
5	1	nsubj
5	4	cop
5	6	ccomp
5	18	ccomp
6	10	prep_with
6	13	prep_for
6	15	prep_at
6	18	conj_and
10	8	nn
10	9	nn
13	12	num
18	17	advmod
18	20	prep_with
20	21	amod
20	22	vmod
22	26	prep_to
22	29	prep_for
26	24	nn
26	25	nn
29	28	num
29	31	prep_at
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	4	2	NP	1	0	2	2	CD	0	0	1	1	1-4	0	0	1	0	NN	0	1	2	1	mg	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	lysate	3	3	4	0	VP	1	4	32	2	VBD	0	4	5	1	was	4	4	5	0	ADJP	0	5	32	2	JJ	0	5	6	1	pre	5	5	6	0	SBAR	0	6	32	1	S	0	6	32	3	S	0	6	16	1	VP	0	6	16	4	VBN	0	6	7	1	cleared	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	protein	8	8	9	0	NN	0	9	10	1	G	9	9	10	0	NNS	0	10	11	1	beads	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	for	11	11	12	0	NP	1	12	14	2	CD	0	12	13	1	30	12	12	13	0	NN	0	13	14	1	min	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	at	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	4degreesC	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	S	1	17	32	2	ADVP	0	17	18	1	RB	0	17	18	1	subsequently	17	17	18	0	VP	0	18	32	2	VBN	0	18	19	1	incubated	18	18	19	0	PP	0	19	32	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	32	2	NP	0	20	22	2	NN	0	20	21	1	antibody	20	20	21	0	JJ	0	21	22	1	pre	21	21	22	0	VP	0	22	32	3	VBN	0	22	23	1	bound	22	22	23	0	PP	0	23	27	2	TO	0	23	24	1	to	23	23	24	0	NP	2	24	27	3	NN	0	24	25	1	protein	24	24	25	0	NN	0	25	26	1	G	25	25	26	0	NNS	0	26	27	1	beads	26	26	27	0	PP	0	27	32	2	IN	0	27	28	1	for	27	27	28	0	NP	0	28	32	2	NP	1	28	30	2	CD	0	28	29	1	2-16	28	28	29	0	NNS	0	29	30	1	hrs	29	29	30	0	PP	0	30	32	2	IN	0	30	31	1	at	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	4degreesC	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	10
The	23891	23894	DT	the	O	_	_
beads	23895	23900	NNS	bead	O	_	_
were	23901	23905	VBD	be	O	_	_
washed	23906	23912	VBN	wash	O	_	_
three	23913	23918	CD	three	O	_	_
times	23919	23924	NNS	time	O	_	_
with	23925	23929	IN	with	O	_	_
NP40	23930	23934	NN	np40	O	_	_
buffer	23935	23941	NN	buffer	O	_	_
.	23941	23942	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	dobj
3	8	prep_with
5	4	num
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	beads	1	1	2	0	VP	1	2	9	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	9	3	VBN	0	3	4	1	washed	3	3	4	0	NP	1	4	6	2	CD	0	4	5	1	three	4	4	5	0	NNS	0	5	6	1	times	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	with	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	NP40	7	7	8	0	NN	0	8	9	1	buffer	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	15
The	23943	23946	DT	the	O	_	_
immunoprecipitation	23947	23966	NN	immunoprecipitation	O	_	_
beads	23967	23972	NNS	bead	O	_	_
were	23973	23977	VBD	be	O	_	_
mixed	23978	23983	VBN	mix	O	_	_
with	23984	23988	IN	with	O	_	_
6x	23989	23991	JJ	6x	O	_	_
sample	23992	23998	NN	sample	O	_	_
buffer	23999	24005	NN	buffer	O	_	_
and	24006	24009	CC	and	O	_	_
loaded	24010	24016	VBN	load	O	_	_
on	24017	24019	IN	on	O	_	_
SDS-PAGE	24020	24028	NN	sds-page	O	_	_
gels	24029	24033	NNS	gel	O	_	_
.	24033	24034	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	8	prep_with
4	10	conj_and
8	6	amod
8	7	nn
10	2	nsubjpass
10	13	prep_on
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	immunoprecipitation	1	1	2	0	NNS	0	2	3	1	beads	2	2	3	0	VP	1	3	14	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	14	3	VP	0	4	9	2	VBN	0	4	5	1	mixed	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	with	5	5	6	0	NP	2	6	9	3	JJ	0	6	7	1	6x	6	6	7	0	NN	0	7	8	1	sample	7	7	8	0	NN	0	8	9	1	buffer	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	VP	0	10	14	2	VBN	0	10	11	1	loaded	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	on	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	SDS-PAGE	12	12	13	0	NNS	0	13	14	1	gels	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	69
2	24036	24037	CD	2	O	_	_
mug	24038	24041	NN	mug	O	_	_
of	24042	24044	IN	of	O	_	_
GST-ASPP2	24045	24054	NN	gst-aspp2	O	_	_
(	24055	24056	CD	(	O	_	_
693-1128	24056	24064	CD	693-1128	O	_	_
)	24064	24065	NN	)	O	_	_
expressed	24066	24075	VBN	express	O	_	_
in	24076	24078	IN	in	O	_	_
E.	24079	24081	FW	e.	O	_	_
coli	24082	24086	FW	coli	O	_	_
,	24086	24087	,	,	O	_	_
2	24088	24089	CD	2	O	_	_
mug	24090	24093	NN	mug	O	_	_
of	24094	24096	IN	of	O	_	_
1mg	24097	24100	JJ	1mg	O	_	_
/	24100	24101	:	/	O	_	_
ml	24101	24103	NN	ml	O	_	_
recombinant	24104	24115	JJ	recombinant	O	_	_
Histone	24116	24123	NN	histone	O	_	_
2B	24124	24126	NN	2b	O	_	_
or	24127	24129	CC	or	O	_	_
2	24130	24131	CD	2	O	_	_
mul	24132	24135	NN	mul	O	_	_
of	24136	24138	IN	of	O	_	_
water	24139	24144	NN	water	O	_	_
was	24145	24148	VBD	be	O	_	_
incubated	24149	24158	VBN	incubate	O	_	_
in	24159	24161	IN	in	O	_	_
30	24162	24164	CD	30	O	_	_
mul	24165	24168	NN	mul	O	_	_
of	24169	24171	IN	of	O	_	_
reaction	24172	24180	NN	reaction	O	_	_
mixture	24181	24188	NN	mixture	O	_	_
containing	24189	24199	VBG	contain	O	_	_
50	24200	24202	CD	50	O	_	_
mM	24203	24205	NN	mm	O	_	_
Tris-HCl	24206	24214	NN	tris-hcl	O	_	_
,	24214	24215	,	,	O	_	_
pH	24216	24218	NN	ph	O	_	_
7.5	24219	24222	CD	7.5	O	_	_
,	24222	24223	,	,	O	_	_
0.1	24224	24227	CD	0.1	O	_	_
%	24227	24228	NN	%	O	_	_
2-mercaptoethanol	24229	24246	NN	2-mercaptoethanol	O	_	_
,	24246	24247	,	,	O	_	_
1	24248	24249	CD	1	O	_	_
muM	24250	24253	NN	mum	O	_	_
microcystine	24254	24266	NN	microcystine	O	_	_
and	24267	24270	CC	and	O	_	_
100	24271	24274	CD	100	O	_	_
muM	24275	24278	JJ	mum	O	_	_
[	24279	24280	NN	[	O	_	_
gamma-32P	24280	24289	NN	gamma-32p	O	_	_
]	24289	24290	CD	]	O	_	_
ATP	24290	24293	NN	atp	O	_	_
(	24294	24295	NN	(	O	_	_
10	24295	24297	CD	10	O	_	_
000	24298	24301	CD	000	O	_	_
c.p.m.	24302	24308	NN	c.p.m.	O	_	_
/	24308	24309	:	/	O	_	_
pmol	24309	24313	NN	pmol	O	_	_
)	24313	24314	NN	)	O	_	_
at	24315	24317	IN	at	O	_	_
30degreesC	24318	24328	NNP	30degreesC	O	_	_
for	24329	24332	IN	for	O	_	_
30	24333	24335	CD	30	O	_	_
min	24336	24339	NN	min	O	_	_
.	24339	24340	.	.	O	_	_
D	1

1	0	num
1	3	prep_of
6	5	num
7	1	nsubj
7	10	prep_in
7	13	dobj
10	9	nn
13	12	num
13	15	prep_of
13	17	dep
17	16	punct
17	27	rcmod
17	60	punct
20	18	amod
20	19	nn
20	23	conj_or
23	22	num
23	25	prep_of
27	20	nsubjpass
27	23	nsubjpass
27	26	auxpass
27	30	prep_in
27	34	xcomp
30	29	num
30	33	prep_of
33	32	nn
34	37	dobj
34	39	dobj
34	44	dobj
34	48	dobj
34	53	dobj
37	35	num
37	36	nn
37	39	conj_and
37	44	conj_and
37	48	conj_and
37	53	conj_and
39	40	num
44	42	num
44	43	nn
48	46	num
48	47	nn
53	50	num
53	51	amod
53	52	nn
56	54	num
56	55	nn
56	59	dep
58	57	number
59	58	num
62	61	nn
62	64	prep_at
64	67	prep_for
67	66	num
EOX
Y	1
ROOT	0	0	69	1	S	1	0	69	3	NP	0	0	7	2	NP	1	0	2	2	CD	0	0	1	1	2	0	0	1	0	NN	0	1	2	1	mug	1	1	2	0	PP	0	2	7	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	7	2	NP	0	3	5	2	NN	0	3	4	1	GST-ASPP2	3	3	4	0	CD	0	4	5	1	-LRB-	4	4	5	0	NP	1	5	7	2	CD	0	5	6	1	693-1128	5	5	6	0	NN	0	6	7	1	-RRB-	6	6	7	0	VP	0	7	68	3	VP	0	7	11	2	VBN	0	7	8	1	expressed	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	in	8	8	9	0	NP	1	9	11	2	FW	0	9	10	1	E.	9	9	10	0	FW	0	10	11	1	coli	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	68	4	NP	1	12	14	2	CD	0	12	13	1	2	12	12	13	0	NN	0	13	14	1	mug	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	of	14	14	15	0	NP	0	15	16	1	JJ	0	15	16	1	1mg	15	15	16	0	PRN	1	16	61	3	:	0	16	17	1	/	16	16	17	0	NP	0	17	60	2	NP	0	17	18	1	NN	0	17	18	1	ml	17	17	18	0	SBAR	0	18	60	1	S	1	18	60	2	NP	0	18	26	3	NP	2	18	21	3	JJ	0	18	19	1	recombinant	18	18	19	0	NN	0	19	20	1	Histone	19	19	20	0	NN	0	20	21	1	2B	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	NP	0	22	26	2	NP	1	22	24	2	CD	0	22	23	1	2	22	22	23	0	NN	0	23	24	1	mul	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	water	25	25	26	0	VP	1	26	60	2	VBD	0	26	27	1	was	26	26	27	0	VP	0	27	60	3	VBN	0	27	28	1	incubated	27	27	28	0	PP	0	28	34	2	IN	0	28	29	1	in	28	28	29	0	NP	0	29	34	2	NP	1	29	31	2	CD	0	29	30	1	30	29	29	30	0	NN	0	30	31	1	mul	30	30	31	0	PP	0	31	34	2	IN	0	31	32	1	of	31	31	32	0	NP	1	32	34	2	NN	0	32	33	1	reaction	32	32	33	0	NN	0	33	34	1	mixture	33	33	34	0	S	0	34	60	1	VP	0	34	60	2	VBG	0	34	35	1	containing	34	34	35	0	NP	0	35	60	9	NP	2	35	38	3	CD	0	35	36	1	50	35	35	36	0	NN	0	36	37	1	mM	36	36	37	0	NN	0	37	38	1	Tris-HCl	37	37	38	0	,	0	38	39	1	,	38	38	39	0	NP	0	39	41	2	NN	0	39	40	1	pH	39	39	40	0	CD	0	40	41	1	7.5	40	40	41	0	,	0	41	42	1	,	41	41	42	0	NP	2	42	45	3	CD	0	42	43	1	0.1	42	42	43	0	NN	0	43	44	1	%	43	43	44	0	NN	0	44	45	1	2-mercaptoethanol	44	44	45	0	,	0	45	46	1	,	45	45	46	0	NP	2	46	49	3	CD	0	46	47	1	1	46	46	47	0	NN	0	47	48	1	muM	47	47	48	0	NN	0	48	49	1	microcystine	48	48	49	0	CC	0	49	50	1	and	49	49	50	0	NP	0	50	60	2	NP	3	50	54	4	CD	0	50	51	1	100	50	50	51	0	JJ	0	51	52	1	muM	51	51	52	0	NN	0	52	53	1	[	52	52	53	0	NN	0	53	54	1	gamma-32P	53	53	54	0	NP	0	54	60	2	NP	2	54	57	3	CD	0	54	55	1	]	54	54	55	0	NN	0	55	56	1	ATP	55	55	56	0	NN	0	56	57	1	-LRB-	56	56	57	0	NP	1	57	60	2	QP	1	57	59	2	CD	0	57	58	1	10	57	57	58	0	CD	0	58	59	1	000	58	58	59	0	NN	0	59	60	1	c.p.m.	59	59	60	0	:	0	60	61	1	/	60	60	61	0	NP	0	61	68	2	NP	1	61	63	2	NN	0	61	62	1	pmol	61	61	62	0	NN	0	62	63	1	-RRB-	62	62	63	0	PP	0	63	68	2	IN	0	63	64	1	at	63	63	64	0	NP	0	64	68	2	NP	0	64	65	1	NNP	0	64	65	1	30degreesC	64	64	65	0	PP	0	65	68	2	IN	0	65	66	1	for	65	65	66	0	NP	1	66	68	2	CD	0	66	67	1	30	66	66	67	0	NN	0	67	68	1	min	67	67	68	0	.	0	68	69	1	.	68	68	69	0
EOS
T	11
0.35	24341	24345	CD	0.35	B-GENE	_	_
units	24346	24351	NNS	unit	I-GENE	_	_
MAPK1	24352	24357	NN	mapk1	I-GENE	_	_
or	24358	24360	CC	or	I-GENE	_	_
0.1	24361	24364	CD	0.1	I-GENE	_	_
units	24365	24370	NNS	unit	I-GENE	_	_
p38	24371	24374	NN	p38	I-GENE	_	_
SAPK	24375	24379	NN	sapk	I-GENE	_	_
were	24380	24384	VBD	be	O	_	_
used	24385	24389	VBN	use	O	_	_
.	24389	24390	.	.	O	_	_
D	1
9
1	0	num
1	2	dep
1	5	conj_or
5	4	num
5	7	dep
7	6	nn
9	1	nsubjpass
9	5	nsubjpass
9	8	auxpass
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	8	3	NP	0	0	3	2	NP	1	0	2	2	CD	0	0	1	1	0.35	0	0	1	0	NNS	0	1	2	1	units	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	MAPK1	2	2	3	0	CC	0	3	4	1	or	3	3	4	0	NP	0	4	8	2	NP	1	4	6	2	CD	0	4	5	1	0.1	4	4	5	0	NNS	0	5	6	1	units	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	p38	6	6	7	0	NN	0	7	8	1	SAPK	7	7	8	0	VP	1	8	10	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	10	1	VBN	0	9	10	1	used	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	27
The	24391	24394	DT	the	O	_	_
reactions	24395	24404	NNS	reaction	O	_	_
were	24405	24409	VBD	be	O	_	_
terminated	24410	24420	VBN	terminate	O	_	_
as	24421	24423	IN	as	O	_	_
described	24424	24433	VBN	describe	O	_	_
[	24434	24435	NN	[	O	_	_
12	24435	24437	CD	12	O	_	_
]	24437	24438	NN	]	O	_	_
and	24439	24442	CC	and	O	_	_
analyzed	24443	24451	VBN	analyze	O	_	_
by	24452	24454	IN	by	O	_	_
chromatography	24455	24469	NN	chromatography	O	_	_
on	24470	24472	IN	on	O	_	_
a	24473	24474	DT	a	O	_	_
C18	24475	24478	NN	c18	O	_	_
column	24479	24485	NN	column	O	_	_
or	24486	24488	CC	or	O	_	_
resolved	24489	24497	VBN	resolve	O	_	_
on	24498	24500	IN	on	O	_	_
SDS-PAGE	24501	24509	NN	sds-page	O	_	_
gels	24510	24514	NNS	gel	O	_	_
and	24515	24518	CC	and	O	_	_
visualized	24519	24529	VBN	visualize	O	_	_
by	24530	24532	IN	by	O	_	_
autoradiograph	24533	24547	NN	autoradiograph	O	_	_
.	24547	24548	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	advcl
3	10	advcl
3	18	advcl
3	23	advcl
5	4	mark
5	8	dobj
5	10	conj_and
5	18	conj_or
5	23	conj_and
8	6	nn
8	7	num
10	12	prep_by
12	16	prep_on
16	14	det
16	15	nn
18	21	prep_on
21	20	nn
23	25	prep_by
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	reactions	1	1	2	0	VP	1	2	26	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	26	2	VBN	0	3	4	1	terminated	3	3	4	0	SBAR	1	4	26	2	IN	0	4	5	1	as	4	4	5	0	S	0	5	26	3	S	0	5	22	1	VP	0	5	22	5	VP	0	5	9	2	VBN	0	5	6	1	described	5	5	6	0	NP	2	6	9	3	NN	0	6	7	1	[	6	6	7	0	CD	0	7	8	1	12	7	7	8	0	NN	0	8	9	1	]	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	VP	0	10	17	2	VBN	0	10	11	1	analyzed	10	10	11	0	PP	0	11	17	2	IN	0	11	12	1	by	11	11	12	0	NP	0	12	17	2	NP	0	12	13	1	NN	0	12	13	1	chromatography	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	on	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	C18	15	15	16	0	NN	0	16	17	1	column	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	resolved	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	on	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	SDS-PAGE	20	20	21	0	NNS	0	21	22	1	gels	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	S	0	23	26	1	VP	0	23	26	2	VBN	0	23	24	1	visualized	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	by	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	autoradiograph	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	34
Real-time	24550	24559	JJ	real-time	O	_	_
reverse	24560	24567	JJ	reverse	B-GENE	_	_
transcriptase-PCR	24568	24585	NN	transcriptase-pcr	I-GENE	_	_
was	24586	24589	VBD	be	O	_	_
performed	24590	24599	VBN	perform	O	_	_
using	24600	24605	VBG	use	O	_	_
gene	24606	24610	NN	gene	O	_	_
specific	24611	24619	JJ	specific	O	_	_
primers	24620	24627	NNS	primer	O	_	_
(	24628	24629	VBP	(	O	_	_
QuantiTect	24629	24639	NNP	QuantiTect	O	_	_
Primer	24640	24646	NN	primer	O	_	_
Assays	24647	24653	NNS	assay	O	_	_
)	24653	24654	VBP	)	O	_	_
for	24655	24658	IN	for	O	_	_
human	24659	24664	JJ	human	B-GENE	_	_
ASPP2	24665	24670	NN	aspp2	I-GENE	_	_
or	24671	24673	CC	or	O	_	_
GAPDH	24674	24679	NN	gapdh	B-GENE	_	_
with	24680	24684	IN	with	O	_	_
the	24685	24688	DT	the	O	_	_
QuantiTect	24689	24699	NNP	QuantiTect	O	_	_
SYBR	24700	24704	NNP	SYBR	O	_	_
Green	24705	24710	NNP	Green	O	_	_
RT-PCR	24711	24717	NN	rt-pcr	O	_	_
Kit	24718	24721	NN	kit	O	_	_
(	24722	24723	CD	(	O	_	_
Qiagen	24723	24729	NNP	Qiagen	O	_	_
,	24729	24730	,	,	O	_	_
Hilden	24731	24737	NNP	Hilden	O	_	_
,	24737	24738	,	,	O	_	_
Germany	24739	24746	NNP	Germany	O	_	_
)	24746	24747	CD	)	O	_	_
.	24747	24748	.	.	O	_	_
D	1

2	0	amod
2	1	amod
4	2	nsubjpass
4	3	auxpass
4	5	xcomp
5	8	dobj
8	6	nn
8	7	amod
9	4	dep
9	27	nsubj
12	10	nn
12	11	nn
13	12	nsubj
13	16	prep_for
13	18	prep_for
13	24	prep_with
16	15	amod
16	18	conj_or
24	20	det
24	21	nn
24	22	nn
24	23	nn
27	25	nn
27	29	appos
29	31	appos
EOX
Y	1
ROOT	0	0	34	1	SINV	1	0	34	4	S	1	0	9	2	NP	2	0	3	3	JJ	0	0	1	1	Real-time	0	0	1	0	JJ	0	1	2	1	reverse	1	1	2	0	NN	0	2	3	1	transcriptase-PCR	2	2	3	0	VP	1	3	9	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	performed	4	4	5	0	S	0	5	9	1	VP	0	5	9	2	VBG	0	5	6	1	using	5	5	6	0	NP	2	6	9	3	NN	0	6	7	1	gene	6	6	7	0	JJ	0	7	8	1	specific	7	7	8	0	NNS	0	8	9	1	primers	8	8	9	0	VP	0	9	25	2	VBP	0	9	10	1	-LRB-	9	9	10	0	SBAR	0	10	25	1	S	1	10	25	2	NP	2	10	13	3	NNP	0	10	11	1	QuantiTect	10	10	11	0	NN	0	11	12	1	Primer	11	11	12	0	NNS	0	12	13	1	Assays	12	12	13	0	VP	0	13	25	3	VBP	0	13	14	1	-RRB-	13	13	14	0	PP	0	14	19	2	IN	0	14	15	1	for	14	14	15	0	NP	1	15	19	4	JJ	0	15	16	1	human	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	NN	0	18	19	1	GAPDH	18	18	19	0	PP	0	19	25	2	IN	0	19	20	1	with	19	19	20	0	NP	4	20	25	5	DT	0	20	21	1	the	20	20	21	0	NNP	0	21	22	1	QuantiTect	21	21	22	0	NNP	0	22	23	1	SYBR	22	22	23	0	NNP	0	23	24	1	Green	23	23	24	0	NN	0	24	25	1	RT-PCR	24	24	25	0	NP	0	25	33	3	NP	2	25	28	3	NN	0	25	26	1	Kit	25	25	26	0	CD	0	26	27	1	-LRB-	26	26	27	0	NNP	0	27	28	1	Qiagen	27	27	28	0	,	0	28	29	1	,	28	28	29	0	NP	0	29	33	3	NP	0	29	30	1	NNP	0	29	30	1	Hilden	29	29	30	0	,	0	30	31	1	,	30	30	31	0	NP	0	31	33	2	NNP	0	31	32	1	Germany	31	31	32	0	CD	0	32	33	1	-RRB-	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	12
Relative	24749	24757	JJ	relative	O	_	_
transcript	24758	24768	NN	transcript	O	_	_
levels	24769	24775	NNS	level	O	_	_
of	24776	24778	IN	of	O	_	_
ASPP2	24779	24784	NN	aspp2	B-GENE	_	_
were	24785	24789	VBD	be	O	_	_
normalized	24790	24800	VBN	normalize	O	_	_
to	24801	24803	TO	to	O	_	_
GAPDH	24804	24809	NN	gapdh	B-GENE	_	_
mRNA	24810	24814	NN	mrna	I-GENE	_	_
levels	24815	24821	NNS	level	O	_	_
.	24821	24822	.	.	O	_	_
D	1
6
2	0	amod
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	10	prep_to
10	8	nn
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	5	2	NP	2	0	3	3	JJ	0	0	1	1	Relative	0	0	1	0	NN	0	1	2	1	transcript	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	normalized	6	6	7	0	PP	0	7	11	2	TO	0	7	8	1	to	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	GAPDH	8	8	9	0	NN	0	9	10	1	mRNA	9	9	10	0	NNS	0	10	11	1	levels	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	14
SPSS	24824	24828	NNP	SPSS	O	_	_
for	24829	24832	IN	for	O	_	_
Windows	24833	24840	NNP	Windows	O	_	_
(	24841	24842	CD	(	O	_	_
SPSS	24842	24846	NNP	SPSS	O	_	_
Inc.	24847	24851	NNP	Inc.	O	_	_
)	24851	24852	NN	)	O	_	_
was	24853	24856	VBD	be	O	_	_
used	24857	24861	VBN	use	O	_	_
to	24862	24864	TO	to	O	_	_
analyze	24865	24872	VB	analyze	O	_	_
the	24873	24876	DT	the	O	_	_
data	24877	24881	NNS	datum	O	_	_
.	24881	24882	.	.	O	_	_
D	1
8
0	2	prep_for
6	4	nn
6	5	nn
8	0	nsubjpass
8	7	auxpass
8	10	xcomp
10	9	aux
10	12	dobj
12	11	det
EOX
Y	1
ROOT	0	0	14	1	S	2	0	14	4	NP	0	0	3	2	NP	0	0	1	1	NNP	0	0	1	1	SPSS	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	for	1	1	2	0	NP	0	2	3	1	NNP	0	2	3	1	Windows	2	2	3	0	NP	3	3	7	4	CD	0	3	4	1	-LRB-	3	3	4	0	NNP	0	4	5	1	SPSS	4	4	5	0	NNP	0	5	6	1	Inc.	5	5	6	0	NN	0	6	7	1	-RRB-	6	6	7	0	VP	1	7	13	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	13	2	VBN	0	8	9	1	used	8	8	9	0	S	0	9	13	1	VP	1	9	13	2	TO	0	9	10	1	to	9	9	10	0	VP	0	10	13	2	VB	0	10	11	1	analyze	10	10	11	0	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NNS	0	12	13	1	data	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	22
A	24883	24884	DT	a	O	_	_
two	24885	24888	CD	two	O	_	_
tailed	24889	24895	VBD	tail	O	_	_
unpaired	24896	24904	JJ	unpaired	O	_	_
t-test	24905	24911	NN	t-test	O	_	_
was	24912	24915	VBD	be	O	_	_
used	24916	24920	VBN	use	O	_	_
to	24921	24923	TO	to	O	_	_
compare	24924	24931	VB	compare	O	_	_
the	24932	24935	DT	the	O	_	_
statistical	24936	24947	JJ	statistical	O	_	_
significance	24948	24960	NN	significance	O	_	_
of	24961	24963	IN	of	O	_	_
the	24964	24967	DT	the	O	_	_
differences	24968	24979	NNS	difference	O	_	_
in	24980	24982	IN	in	O	_	_
data	24983	24987	NNS	datum	O	_	_
from	24988	24992	IN	from	O	_	_
the	24993	24996	DT	the	O	_	_
two	24997	25000	CD	two	O	_	_
groups	25001	25007	NNS	group	O	_	_
.	25007	25008	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	6	ccomp
4	3	amod
6	4	nsubjpass
6	5	auxpass
6	8	xcomp
8	7	aux
8	11	dobj
8	20	prep_from
11	9	det
11	10	amod
11	14	prep_of
14	13	det
14	16	prep_in
20	18	det
20	19	num
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	1	0	2	2	DT	0	0	1	1	A	0	0	1	0	CD	0	1	2	1	two	1	1	2	0	VP	0	2	21	2	VBD	0	2	3	1	tailed	2	2	3	0	SBAR	0	3	21	1	S	1	3	21	2	NP	1	3	5	2	JJ	0	3	4	1	unpaired	3	3	4	0	NN	0	4	5	1	t-test	4	4	5	0	VP	1	5	21	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	used	6	6	7	0	S	0	7	21	1	VP	1	7	21	2	TO	0	7	8	1	to	7	7	8	0	VP	0	8	21	3	VB	0	8	9	1	compare	8	8	9	0	NP	0	9	17	2	NP	2	9	12	3	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	statistical	10	10	11	0	NN	0	11	12	1	significance	11	11	12	0	PP	0	12	17	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	17	2	NP	1	13	15	2	DT	0	13	14	1	the	13	13	14	0	NNS	0	14	15	1	differences	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	in	15	15	16	0	NP	0	16	17	1	NNS	0	16	17	1	data	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	from	17	17	18	0	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	CD	0	19	20	1	two	19	19	20	0	NNS	0	20	21	1	groups	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	11
p38	25020	25023	NN	p38	B-GENE	_	_
SAPK	25024	25028	NN	sapk	I-GENE	_	_
is	25029	25031	VBZ	be	O	_	_
not	25032	25035	RB	not	O	_	_
an	25036	25038	DT	a	O	_	_
efficient	25039	25048	JJ	efficient	O	_	_
kinase	25049	25055	NN	kinase	O	_	_
for	25056	25059	IN	for	O	_	_
ASPP2	25060	25065	NN	aspp2	B-GENE	_	_
phosphorylation	25066	25081	NN	phosphorylation	O	_	_
.	25081	25082	.	.	O	_	_
D	1
6
1	0	nn
6	1	nsubj
6	2	cop
6	3	neg
6	4	det
6	5	amod
6	9	prep_for
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	1	0	2	2	NN	0	0	1	1	p38	0	0	1	0	NN	0	1	2	1	SAPK	1	1	2	0	VP	2	2	10	3	VBZ	0	2	3	1	is	2	2	3	0	RB	0	3	4	1	not	3	3	4	0	NP	0	4	10	2	NP	2	4	7	3	DT	0	4	5	1	an	4	4	5	0	JJ	0	5	6	1	efficient	5	5	6	0	NN	0	6	7	1	kinase	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	for	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	phosphorylation	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	22
ASPP2	25083	25088	NN	aspp2	O	_	_
(	25089	25090	CD	(	O	_	_
693-1128	25090	25098	CD	693-1128	O	_	_
)	25098	25099	NN	)	O	_	_
fragment	25100	25108	NN	fragment	O	_	_
was	25109	25112	VBD	be	O	_	_
used	25113	25117	VBN	use	O	_	_
as	25118	25120	IN	as	O	_	_
a	25121	25122	DT	a	O	_	_
substrate	25123	25132	NN	substrate	O	_	_
for	25133	25136	IN	for	O	_	_
an	25137	25139	DT	a	O	_	_
in	25140	25142	FW	in	O	_	_
vitro	25143	25148	FW	vitro	O	_	_
phosphorylation	25149	25164	NN	phosphorylation	O	_	_
assay	25165	25170	NN	assay	O	_	_
by	25171	25173	IN	by	O	_	_
the	25174	25177	DT	the	O	_	_
kinase	25178	25184	NN	kinase	O	_	_
p38	25185	25188	NN	p38	B-GENE	_	_
SAPK	25189	25193	NN	sapk	O	_	_
.	25193	25194	.	.	O	_	_
D	1
6
0	4	dep
4	2	num
6	0	nsubjpass
6	5	auxpass
6	9	prep_as
9	8	det
9	20	prep_for
13	12	nn
13	16	dep
15	14	nn
16	15	dep
16	19	pobj
19	17	det
19	18	nn
20	11	det
20	13	dep
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	5	2	NP	0	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	CD	0	1	2	1	-LRB-	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	693-1128	2	2	3	0	NN	0	3	4	1	-RRB-	3	3	4	0	NN	0	4	5	1	fragment	4	4	5	0	VP	1	5	21	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	used	6	6	7	0	PP	0	7	21	2	IN	0	7	8	1	as	7	7	8	0	NP	0	8	21	2	NP	1	8	10	2	DT	0	8	9	1	a	8	8	9	0	NN	0	9	10	1	substrate	9	9	10	0	PP	0	10	21	2	IN	0	10	11	1	for	10	10	11	0	NP	2	11	21	3	DT	0	11	12	1	an	11	11	12	0	UCP	0	12	20	2	ADVP	1	12	14	2	FW	0	12	13	1	in	12	12	13	0	FW	0	13	14	1	vitro	13	13	14	0	PP	1	14	20	2	NP	1	14	16	2	NN	0	14	15	1	phosphorylation	14	14	15	0	NN	0	15	16	1	assay	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	by	16	16	17	0	NP	2	17	20	3	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	kinase	18	18	19	0	NN	0	19	20	1	p38	19	19	20	0	NN	0	20	21	1	SAPK	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	19
As	25195	25197	IN	as	O	_	_
a	25198	25199	DT	a	O	_	_
negative	25200	25208	JJ	negative	O	_	_
control	25209	25216	NN	control	O	_	_
no	25217	25219	DT	no	O	_	_
substrate	25220	25229	NN	substrate	O	_	_
was	25230	25233	VBD	be	O	_	_
used	25234	25238	VBN	use	O	_	_
and	25239	25242	CC	and	O	_	_
Histone	25243	25250	NN	histone	O	_	_
2B	25251	25253	NN	2b	O	_	_
was	25254	25257	VBD	be	O	_	_
the	25258	25261	DT	the	O	_	_
substrate	25262	25271	NN	substrate	O	_	_
for	25272	25275	IN	for	O	_	_
the	25276	25279	DT	the	O	_	_
positive	25280	25288	JJ	positive	O	_	_
control	25289	25296	NN	control	O	_	_
.	25296	25297	.	.	O	_	_
D	1
7
3	1	det
3	2	amod
5	4	det
7	3	prep_as
7	5	nsubjpass
7	6	auxpass
7	13	conj_and
10	9	nn
13	10	nsubj
13	11	cop
13	12	det
13	17	prep_for
17	15	det
17	16	amod
EOX
Y	1
ROOT	0	0	19	1	S	0	0	19	4	S	2	0	8	3	PP	0	0	4	2	IN	0	0	1	1	As	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	a	1	1	2	0	JJ	0	2	3	1	negative	2	2	3	0	NN	0	3	4	1	control	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	no	4	4	5	0	NN	0	5	6	1	substrate	5	5	6	0	VP	1	6	8	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	8	1	VBN	0	7	8	1	used	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	18	2	NP	1	9	11	2	NN	0	9	10	1	Histone	9	9	10	0	NN	0	10	11	1	2B	10	10	11	0	VP	1	11	18	2	VBD	0	11	12	1	was	11	11	12	0	NP	0	12	18	2	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	substrate	13	13	14	0	PP	0	14	18	2	IN	0	14	15	1	for	14	14	15	0	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	positive	16	16	17	0	NN	0	17	18	1	control	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	23
32P	25298	25301	NN	32p	O	_	_
labelled	25302	25310	VBN	label	O	_	_
ATP	25311	25314	NN	atp	O	_	_
was	25315	25318	VBD	be	O	_	_
added	25319	25324	VBN	add	O	_	_
to	25325	25327	TO	to	O	_	_
the	25328	25331	DT	the	O	_	_
kinase	25332	25338	NN	kinase	O	_	_
assay	25339	25344	NN	assay	O	_	_
and	25345	25348	CC	and	O	_	_
the	25349	25352	DT	the	O	_	_
labelled	25353	25361	JJ	labelled	O	_	_
proteins	25362	25370	NNS	protein	O	_	_
were	25371	25375	VBD	be	O	_	_
resolved	25376	25384	VBN	resolve	O	_	_
on	25385	25387	IN	on	O	_	_
SDS-PAGE	25388	25396	NN	sds-page	O	_	_
gels	25397	25401	NNS	gel	O	_	_
and	25402	25405	CC	and	O	_	_
visualized	25406	25416	VBN	visualize	O	_	_
by	25417	25419	IN	by	O	_	_
autoradiograph	25420	25434	NN	autoradiograph	O	_	_
.	25434	25435	.	.	O	_	_
D	1
4
0	1	vmod
1	2	dobj
4	0	nsubjpass
4	3	auxpass
4	8	prep_to
4	14	conj_and
4	19	conj_and
8	6	det
8	7	nn
12	10	det
12	11	amod
14	12	nsubjpass
14	13	auxpass
14	17	prep_on
14	19	conj_and
17	16	nn
19	12	nsubjpass
19	21	prep_by
EOX
Y	1
ROOT	0	0	23	1	S	0	0	23	4	S	1	0	9	2	NP	0	0	3	2	NP	0	0	1	1	NN	0	0	1	1	32P	0	0	1	0	VP	0	1	3	2	VBN	0	1	2	1	labelled	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ATP	2	2	3	0	VP	1	3	9	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	added	4	4	5	0	PP	0	5	9	2	TO	0	5	6	1	to	5	5	6	0	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	kinase	7	7	8	0	NN	0	8	9	1	assay	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	22	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	labelled	11	11	12	0	NNS	0	12	13	1	proteins	12	12	13	0	VP	1	13	22	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	22	3	VP	0	14	18	2	VBN	0	14	15	1	resolved	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	on	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	SDS-PAGE	16	16	17	0	NNS	0	17	18	1	gels	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	VP	0	19	22	2	VBN	0	19	20	1	visualized	19	19	20	0	PP	0	20	22	2	IN	0	20	21	1	by	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	autoradiograph	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	10
(	25436	25437	NN	(	B-GENE	_	_
TIF	25437	25440	NN	tif	I-GENE	_	_
)	25440	25441	CD	)	O	_	_
Click	25442	25447	VB	click	O	_	_
here	25448	25452	RB	here	O	_	_
for	25453	25456	IN	for	O	_	_
additional	25457	25467	JJ	additional	O	_	_
data	25468	25472	NNS	datum	O	_	_
file	25473	25477	NN	file	O	_	_
.	25477	25478	.	.	O	_	_
D	1
8
1	3	rcmod
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	14
Phosphorylation	25489	25504	NN	phosphorylation	O	_	_
of	25505	25507	IN	of	O	_	_
ASPP2	25508	25513	NN	aspp2	B-GENE	_	_
by	25514	25516	IN	by	O	_	_
the	25517	25520	DT	the	O	_	_
Raf	25521	25524	NN	raf	B-GENE	_	_
/	25524	25525	:	/	B-GENE	_	_
MAPK	25525	25529	NN	mapk	I-GENE	_	_
pathway	25530	25537	NN	pathway	O	_	_
enhances	25538	25546	VBZ	enhance	O	_	_
p53	25547	25550	NN	p53	B-GENE	_	_
mediated	25551	25559	JJ	mediated	O	_	_
transactivation	25560	25575	NN	transactivation	O	_	_
.	25575	25576	.	.	O	_	_
D	1
0
0	2	prep_of
0	5	prep_by
0	6	punct
0	9	dep
5	4	det
8	7	nn
9	8	nsubj
9	12	dobj
12	10	nn
12	11	amod
EOX
Y	1
ROOT	0	0	14	1	FRAG	0	0	14	4	NP	0	0	6	3	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	6	2	IN	0	3	4	1	by	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	Raf	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	13	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	13	2	VBZ	0	9	10	1	enhances	9	9	10	0	NP	2	10	13	3	NN	0	10	11	1	p53	10	10	11	0	JJ	0	11	12	1	mediated	11	11	12	0	NN	0	12	13	1	transactivation	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	25
Saos2	25577	25582	NN	saos2	O	_	_
cells	25583	25588	NNS	cell	O	_	_
were	25589	25593	VBD	be	O	_	_
transfected	25594	25605	VBN	transfect	O	_	_
with	25606	25610	IN	with	O	_	_
a	25611	25612	DT	a	O	_	_
Bax-luciferase	25613	25627	NN	bax-luciferase	B-GENE	_	_
reporter	25628	25636	NN	reporter	I-GENE	_	_
,	25636	25637	,	,	O	_	_
ASPP2	25638	25643	NN	aspp2	B-GENE	_	_
and	25644	25647	CC	and	O	_	_
p53	25648	25651	NN	p53	B-GENE	_	_
and	25652	25655	CC	and	O	_	_
treated	25656	25663	VBN	treat	O	_	_
with	25664	25668	IN	with	O	_	_
100	25669	25672	CD	100	O	_	_
muM	25673	25676	NN	mum	O	_	_
PD	25677	25679	NN	pd	O	_	_
98059	25680	25685	CD	98059	O	_	_
or	25686	25688	CC	or	O	_	_
DMSO	25689	25693	NN	dmso	O	_	_
for	25694	25697	IN	for	O	_	_
20	25698	25700	CD	20	O	_	_
hours	25701	25706	NNS	hour	O	_	_
.	25706	25707	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_with
3	9	prep_with
3	11	prep_with
3	13	conj_and
7	5	det
7	6	nn
7	9	conj_and
7	11	conj_and
13	1	nsubjpass
13	17	prep_with
13	20	prep_with
17	15	num
17	16	nn
17	18	dep
17	20	conj_or
20	23	prep_for
23	22	num
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	1	0	2	2	NN	0	0	1	1	Saos2	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	1	2	24	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	24	3	VP	0	3	12	2	VBN	0	3	4	1	transfected	3	3	4	0	PP	0	4	12	2	IN	0	4	5	1	with	4	4	5	0	NP	2	5	12	7	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	Bax-luciferase	6	6	7	0	NN	0	7	8	1	reporter	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NN	0	9	10	1	ASPP2	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	VP	0	13	24	2	VBN	0	13	14	1	treated	13	13	14	0	PP	0	14	24	2	IN	0	14	15	1	with	14	14	15	0	NP	0	15	24	3	NP	0	15	19	2	NP	2	15	18	3	CD	0	15	16	1	100	15	15	16	0	NN	0	16	17	1	muM	16	16	17	0	NN	0	17	18	1	PD	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	98059	18	18	19	0	CC	0	19	20	1	or	19	19	20	0	NP	0	20	24	2	NP	0	20	21	1	NN	0	20	21	1	DMSO	20	20	21	0	PP	0	21	24	2	IN	0	21	22	1	for	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	20	22	22	23	0	NNS	0	23	24	1	hours	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	9
The	25708	25711	DT	the	O	_	_
cells	25712	25717	NNS	cell	O	_	_
were	25718	25722	VBD	be	O	_	_
harvested	25723	25732	VBN	harvest	O	_	_
,	25732	25733	,	,	O	_	_
luciferase	25734	25744	NN	luciferase	B-GENE	_	_
activity	25745	25753	NN	activity	O	_	_
shown	25754	25759	VBN	show	O	_	_
.	25759	25760	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	6	dobj
6	5	nn
6	7	vmod
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	1	2	8	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	8	3	VBN	0	3	4	1	harvested	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	8	2	NP	1	5	7	2	NN	0	5	6	1	luciferase	5	5	6	0	NN	0	6	7	1	activity	6	6	7	0	VP	0	7	8	1	VBN	0	7	8	1	shown	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	10
(	25761	25762	NN	(	B-GENE	_	_
TIF	25762	25765	NN	tif	I-GENE	_	_
)	25765	25766	CD	)	O	_	_
Click	25767	25772	VB	click	O	_	_
here	25773	25777	RB	here	O	_	_
for	25778	25781	IN	for	O	_	_
additional	25782	25792	JJ	additional	O	_	_
data	25793	25797	NNS	datum	O	_	_
file	25798	25802	NN	file	O	_	_
.	25802	25803	.	.	O	_	_
D	1
8
1	3	rcmod
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	5
Oncogenic	25814	25823	JJ	oncogenic	O	_	_
RAS	25824	25827	NN	ra	O	_	_
stabilizes	25828	25838	VBZ	stabilize	O	_	_
ASPP2	25839	25844	NN	aspp2	B-GENE	_	_
.	25844	25845	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	3	dobj
EOX
Y	1
ROOT	0	0	5	1	S	1	0	5	3	NP	1	0	2	2	JJ	0	0	1	1	Oncogenic	0	0	1	0	NN	0	1	2	1	RAS	1	1	2	0	VP	0	2	4	2	VBZ	0	2	3	1	stabilizes	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	20
(	25846	25847	NN	(	O	_	_
A	25847	25848	NN	a	O	_	_
)	25848	25849	CD	)	O	_	_
Quantitative	25850	25862	JJ	quantitative	O	_	_
RT-PCR	25863	25869	NN	rt-pcr	O	_	_
analysis	25870	25878	NN	analysis	O	_	_
of	25879	25881	IN	of	O	_	_
ASPP2	25882	25887	NN	aspp2	B-GENE	_	_
mRNA	25888	25892	NN	mrna	I-GENE	_	_
levels	25893	25899	NNS	level	O	_	_
in	25900	25902	IN	in	O	_	_
HKe3	25903	25907	NN	hke3	B-GENE	_	_
ER	25908	25910	NN	er	I-GENE	_	_
:	25910	25911	:	:	O	_	_
HRASV12	25911	25918	NN	hrasv12	O	_	_
cells	25919	25924	NNS	cell	O	_	_
with	25925	25929	IN	with	O	_	_
indicated	25930	25939	JJ	indicated	O	_	_
treatment	25940	25949	NN	treatment	O	_	_
.	25949	25950	.	.	O	_	_
D	1
1
1	5	dep
1	15	dep
5	3	amod
5	4	nn
5	9	prep_of
9	7	nn
9	8	nn
9	12	prep_in
12	11	nn
15	14	nn
15	18	prep_with
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	NP	0	0	20	4	NP	0	0	13	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	0	2	13	2	NP	3	2	6	4	CD	0	2	3	1	-RRB-	2	2	3	0	JJ	0	3	4	1	Quantitative	3	3	4	0	NN	0	4	5	1	RT-PCR	4	4	5	0	NN	0	5	6	1	analysis	5	5	6	0	PP	0	6	13	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	13	2	NP	2	7	10	3	NN	0	7	8	1	ASPP2	7	7	8	0	NN	0	8	9	1	mRNA	8	8	9	0	NNS	0	9	10	1	levels	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	HKe3	11	11	12	0	NN	0	12	13	1	ER	12	12	13	0	:	0	13	14	1	:	13	13	14	0	NP	0	14	19	2	NP	1	14	16	2	NN	0	14	15	1	HRASV12	14	14	15	0	NNS	0	15	16	1	cells	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	with	16	16	17	0	NP	1	17	19	2	JJ	0	17	18	1	indicated	17	17	18	0	NN	0	18	19	1	treatment	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	26
(	25951	25952	NN	(	O	_	_
B	25952	25953	NN	b	O	_	_
)	25953	25954	CD	)	O	_	_
HKe3	25955	25959	NN	hke3	B-GENE	_	_
ER	25960	25962	NN	er	O	_	_
:	25962	25963	:	:	O	_	_
HRASV12	25963	25970	NN	hrasv12	O	_	_
cells	25971	25976	NNS	cell	O	_	_
were	25977	25981	VBD	be	O	_	_
transfected	25982	25993	VBN	transfect	O	_	_
with	25994	25998	IN	with	O	_	_
ASPP2	25999	26004	NN	aspp2	B-GENE	_	_
wild-type	26005	26014	JJ	wild-type	I-GENE	_	_
(	26015	26016	NN	(	I-GENE	_	_
wt	26016	26018	JJ	wt	I-GENE	_	_
)	26018	26019	NN	)	I-GENE	_	_
expression	26020	26030	NN	expression	O	_	_
plasmid	26031	26038	NN	plasmid	O	_	_
in	26039	26041	IN	in	O	_	_
the	26042	26045	DT	the	O	_	_
presence	26046	26054	NN	presence	O	_	_
or	26055	26057	CC	or	O	_	_
absence	26058	26065	NN	absence	O	_	_
of	26066	26068	IN	of	O	_	_
4-OHT	26069	26074	NN	4-oht	O	_	_
.	26074	26075	.	.	O	_	_
D	1
1
1	4	dep
1	7	dep
4	3	nn
7	6	nn
7	9	rcmod
9	8	auxpass
9	10	prep
9	20	prep_in
9	22	prep_in
13	11	nn
13	12	amod
13	17	dep
17	14	amod
17	16	nn
20	19	det
20	22	conj_or
20	24	prep_of
EOX
Y	1
ROOT	0	0	26	1	NP	0	0	26	4	NP	0	0	5	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	HKe3	3	3	4	0	NN	0	4	5	1	ER	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	0	6	25	2	NP	1	6	8	2	NN	0	6	7	1	HRASV12	6	6	7	0	NNS	0	7	8	1	cells	7	7	8	0	SBAR	0	8	25	1	S	0	8	25	1	VP	1	8	25	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	25	3	VBN	0	9	10	1	transfected	9	9	10	0	PP	0	10	18	2	IN	0	10	11	1	with	10	10	11	0	NP	0	11	18	2	NP	2	11	14	3	NN	0	11	12	1	ASPP2	11	11	12	0	JJ	0	12	13	1	wild-type	12	12	13	0	NN	0	13	14	1	-LRB-	13	13	14	0	NP	3	14	18	4	JJ	0	14	15	1	wt	14	14	15	0	NN	0	15	16	1	-RRB-	15	15	16	0	NN	0	16	17	1	expression	16	16	17	0	NN	0	17	18	1	plasmid	17	17	18	0	PP	0	18	25	2	IN	0	18	19	1	in	18	18	19	0	NP	0	19	25	2	NP	1	19	23	4	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	presence	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	NN	0	22	23	1	absence	22	22	23	0	PP	0	23	25	2	IN	0	23	24	1	of	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	4-OHT	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	23
16	26076	26078	CD	16	O	_	_
hours	26079	26084	NNS	hour	O	_	_
after	26085	26090	IN	after	O	_	_
transfection	26091	26103	NN	transfection	O	_	_
,	26103	26104	,	,	O	_	_
10	26105	26107	CD	10	O	_	_
mug	26108	26111	NN	mug	O	_	_
/	26111	26112	:	/	O	_	_
ml	26112	26114	NN	ml	O	_	_
cycloheximide	26115	26128	NN	cycloheximide	O	_	_
(	26129	26130	CD	(	O	_	_
CHX	26130	26133	NN	chx	O	_	_
)	26133	26134	NN	)	O	_	_
was	26135	26138	VBD	be	O	_	_
added	26139	26144	VBN	add	O	_	_
to	26145	26147	TO	to	O	_	_
the	26148	26151	DT	the	O	_	_
cells	26152	26157	NNS	cell	O	_	_
for	26158	26161	IN	for	O	_	_
the	26162	26165	DT	the	O	_	_
time	26166	26170	NN	time	O	_	_
indicated	26171	26180	VBD	indicate	O	_	_
.	26180	26181	.	.	O	_	_
D	1
1
1	0	num
1	3	prep_after
1	7	punct
1	21	dep
3	6	appos
6	5	num
9	8	nn
9	14	rcmod
12	11	nn
14	13	auxpass
14	17	prep_to
17	16	det
17	20	prep_for
20	19	det
21	9	nsubj
EOX
Y	1
ROOT	0	0	23	1	FRAG	0	0	23	4	NP	0	0	7	2	NP	1	0	2	2	CD	0	0	1	1	16	0	0	1	0	NNS	0	1	2	1	hours	1	1	2	0	PP	0	2	7	2	IN	0	2	3	1	after	2	2	3	0	NP	0	3	7	3	NP	0	3	4	1	NN	0	3	4	1	transfection	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	1	5	7	2	CD	0	5	6	1	10	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	:	0	7	8	1	/	7	7	8	0	S	1	8	22	2	NP	0	8	21	2	NP	1	8	10	2	NN	0	8	9	1	ml	8	8	9	0	NN	0	9	10	1	cycloheximide	9	9	10	0	SBAR	0	10	21	1	S	1	10	21	2	NP	2	10	13	3	CD	0	10	11	1	-LRB-	10	10	11	0	NN	0	11	12	1	CHX	11	11	12	0	NN	0	12	13	1	-RRB-	12	12	13	0	VP	1	13	21	2	VBD	0	13	14	1	was	13	13	14	0	VP	0	14	21	2	VBN	0	14	15	1	added	14	14	15	0	PP	0	15	21	2	TO	0	15	16	1	to	15	15	16	0	NP	0	16	21	2	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NNS	0	17	18	1	cells	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	for	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	time	20	20	21	0	VP	0	21	22	1	VBD	0	21	22	1	indicated	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	12
The	26182	26185	DT	the	O	_	_
protein	26186	26193	NN	protein	O	_	_
levels	26194	26200	NNS	level	O	_	_
of	26201	26203	IN	of	O	_	_
V5-ASPP2	26204	26212	NN	v5-aspp2	O	_	_
were	26213	26217	VBD	be	O	_	_
determined	26218	26228	VBN	determine	O	_	_
by	26229	26231	IN	by	O	_	_
western	26232	26239	NN	western	O	_	_
blot	26240	26244	NN	blot	O	_	_
analysis	26245	26253	NN	analysis	O	_	_
.	26253	26254	.	.	O	_	_
D	1
6
2	0	det
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	10	agent
10	8	nn
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	protein	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	V5-ASPP2	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	determined	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	by	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	western	8	8	9	0	NN	0	9	10	1	blot	9	9	10	0	NN	0	10	11	1	analysis	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	8
beta-Tubulin	26255	26267	NN	beta-tubulin	B-GENE	_	_
was	26268	26271	VBD	be	O	_	_
used	26272	26276	VBN	use	O	_	_
as	26277	26279	IN	as	O	_	_
a	26280	26281	DT	a	O	_	_
loading	26282	26289	VBG	load	O	_	_
control	26290	26297	NN	control	O	_	_
.	26297	26298	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_as
6	4	det
6	5	amod
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	0	0	1	1	NN	0	0	1	1	beta-Tubulin	0	0	1	0	VP	1	1	7	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	7	2	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	as	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	VBG	0	5	6	1	loading	5	5	6	0	NN	0	6	7	1	control	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	23
(	26299	26300	NN	(	O	_	_
C	26300	26301	NN	c	O	_	_
)	26301	26302	CD	)	O	_	_
Saos2	26303	26308	NN	saos2	O	_	_
cells	26309	26314	NNS	cell	O	_	_
were	26315	26319	VBD	be	O	_	_
transfected	26320	26331	VBN	transfect	O	_	_
with	26332	26336	IN	with	O	_	_
ASPP2	26337	26342	NN	aspp2	B-GENE	_	_
wt	26343	26345	JJ	wt	O	_	_
expression	26346	26356	NN	expression	O	_	_
plasmid	26357	26364	NN	plasmid	O	_	_
in	26365	26367	IN	in	O	_	_
the	26368	26371	DT	the	O	_	_
presence	26372	26380	NN	presence	O	_	_
or	26381	26383	CC	or	O	_	_
absence	26384	26391	NN	absence	O	_	_
of	26392	26394	IN	of	O	_	_
co	26395	26397	NN	co	O	_	_
transfected	26398	26409	VBN	transfect	O	_	_
HRAS	26410	26414	NNP	HRAS	O	_	_
V12	26415	26418	NN	v12	O	_	_
.	26418	26419	.	.	O	_	_
D	1
6
4	1	nn
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	11	prep_with
6	14	prep_in
6	16	prep_in
11	8	nn
11	9	amod
11	10	nn
14	13	det
14	16	conj_or
14	18	prep_of
18	19	vmod
19	21	dobj
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	4	0	5	5	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	C	1	1	2	0	CD	0	2	3	1	-RRB-	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	22	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	22	3	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	with	7	7	8	0	NP	3	8	12	4	NN	0	8	9	1	ASPP2	8	8	9	0	JJ	0	9	10	1	wt	9	9	10	0	NN	0	10	11	1	expression	10	10	11	0	NN	0	11	12	1	plasmid	11	11	12	0	PP	0	12	22	2	IN	0	12	13	1	in	12	12	13	0	NP	0	13	22	2	NP	1	13	17	4	DT	0	13	14	1	the	13	13	14	0	NN	0	14	15	1	presence	14	14	15	0	CC	0	15	16	1	or	15	15	16	0	NN	0	16	17	1	absence	16	16	17	0	PP	0	17	22	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	22	2	NP	0	18	19	1	NN	0	18	19	1	co	18	18	19	0	VP	0	19	22	2	VBN	0	19	20	1	transfected	19	19	20	0	NP	1	20	22	2	NNP	0	20	21	1	HRAS	20	20	21	0	NN	0	21	22	1	V12	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	20
16	26420	26422	CD	16	O	_	_
hours	26423	26428	NNS	hour	O	_	_
after	26429	26434	IN	after	O	_	_
transfection	26435	26447	NN	transfection	O	_	_
,	26447	26448	,	,	O	_	_
50	26449	26451	CD	50	O	_	_
mug	26452	26455	NN	mug	O	_	_
/	26455	26456	:	/	O	_	_
ml	26456	26458	NN	ml	O	_	_
CHX	26459	26462	NN	chx	O	_	_
was	26463	26466	VBD	be	O	_	_
added	26467	26472	VBN	add	O	_	_
to	26473	26475	TO	to	O	_	_
the	26476	26479	DT	the	O	_	_
cells	26480	26485	NNS	cell	O	_	_
for	26486	26489	IN	for	O	_	_
the	26490	26493	DT	the	O	_	_
time	26494	26498	NN	time	O	_	_
indicated	26499	26508	VBD	indicate	O	_	_
.	26508	26509	.	.	O	_	_
D	1
18
1	0	num
6	5	num
6	11	dep
9	8	nn
11	7	punct
11	9	nsubjpass
11	10	auxpass
11	14	prep_to
14	13	det
14	17	prep_for
17	16	det
18	1	npadvmod
18	3	prep_after
18	6	nsubj
EOX
Y	1
ROOT	0	0	20	1	S	3	0	20	5	PP	1	0	4	3	NP	1	0	2	2	CD	0	0	1	1	16	0	0	1	0	NNS	0	1	2	1	hours	1	1	2	0	IN	0	2	3	1	after	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	transfection	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	18	2	NP	1	5	7	2	CD	0	5	6	1	50	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	PRN	1	7	18	2	:	0	7	8	1	/	7	7	8	0	S	1	8	18	2	NP	1	8	10	2	NN	0	8	9	1	ml	8	8	9	0	NN	0	9	10	1	CHX	9	9	10	0	VP	1	10	18	2	VBD	0	10	11	1	was	10	10	11	0	VP	0	11	18	2	VBN	0	11	12	1	added	11	11	12	0	PP	0	12	18	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	18	2	NP	1	13	15	2	DT	0	13	14	1	the	13	13	14	0	NNS	0	14	15	1	cells	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	for	15	15	16	0	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	time	17	17	18	0	VP	0	18	19	1	VBD	0	18	19	1	indicated	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	15
The	26510	26513	DT	the	O	_	_
protein	26514	26521	NN	protein	O	_	_
levels	26522	26528	NNS	level	O	_	_
of	26529	26531	IN	of	O	_	_
V5-ASPP2	26532	26540	NN	v5-aspp2	B-GENE	_	_
or	26541	26543	CC	or	O	_	_
HRAS	26544	26548	NN	hra	B-GENE	_	_
V12	26549	26552	NN	v12	I-GENE	_	_
were	26553	26557	VBD	be	O	_	_
determined	26558	26568	VBN	determine	O	_	_
by	26569	26571	IN	by	O	_	_
western	26572	26579	NN	western	O	_	_
blot	26580	26584	NN	blot	O	_	_
analysis	26585	26593	NN	analysis	O	_	_
.	26593	26594	.	.	O	_	_
D	1
9
2	0	det
2	1	nn
2	7	prep_of
4	6	conj_or
7	4	nn
7	6	nn
9	2	nsubjpass
9	8	auxpass
9	13	agent
13	11	nn
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	8	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	protein	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	of	3	3	4	0	NP	1	4	8	2	NP	0	4	7	3	NN	0	4	5	1	V5-ASPP2	4	4	5	0	CC	0	5	6	1	or	5	5	6	0	NN	0	6	7	1	HRAS	6	6	7	0	NN	0	7	8	1	V12	7	7	8	0	VP	1	8	14	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	14	2	VBN	0	9	10	1	determined	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	by	10	10	11	0	NP	2	11	14	3	NN	0	11	12	1	western	11	11	12	0	NN	0	12	13	1	blot	12	12	13	0	NN	0	13	14	1	analysis	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	8
beta-actin	26595	26605	NN	beta-actin	B-GENE	_	_
was	26606	26609	VBD	be	O	_	_
used	26610	26614	VBN	use	O	_	_
as	26615	26617	IN	as	O	_	_
a	26618	26619	DT	a	O	_	_
loading	26620	26627	VBG	load	O	_	_
control	26628	26635	NN	control	O	_	_
.	26635	26636	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_as
6	4	det
6	5	amod
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	0	0	1	1	NN	0	0	1	1	beta-actin	0	0	1	0	VP	1	1	7	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	7	2	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	as	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	VBG	0	5	6	1	loading	5	5	6	0	NN	0	6	7	1	control	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	10
(	26637	26638	NN	(	B-GENE	_	_
TIF	26638	26641	NN	tif	I-GENE	_	_
)	26641	26642	CD	)	O	_	_
Click	26643	26648	VB	click	O	_	_
here	26649	26653	RB	here	O	_	_
for	26654	26657	IN	for	O	_	_
additional	26658	26668	JJ	additional	O	_	_
data	26669	26673	NNS	datum	O	_	_
file	26674	26678	NN	file	O	_	_
.	26678	26679	.	.	O	_	_
D	1
8
1	3	rcmod
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	-LRB-	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	-RRB-	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
EOD
